COMMISSION IMPLEMENTING REGULATION (EU) 2021/637
of 15 March 2021
laying down implementing technical standards with regard to public disclosures by institutions of the information referred to in Titles II and III of Part Eight of Regulation (EU) No 575/2013 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU) No 1423/2013, Commission Delegated Regulation (EU) 2015/1555, Commission Implementing Regulation (EU) 2016/200 and Commission Delegated Regulation (EU) 2017/2295
(Text with EEA relevance)
Article 1
Disclosure of key metrics and overview of risk-weighted exposure amounts
Article 2
Disclosure of risk management objectives and policies
Article 3
Disclosure of the scope of application
Article 4
Disclosure of own funds
Article 5
Disclosure of countercyclical capital buffers
Article 6
Disclosure of the leverage ratio
Article 7
Disclosure of liquidity requirements
Article 8
Disclosure of exposures to credit risk, dilution risk and credit quality
Article 9
Disclosure of the use of credit risk mitigation techniques
Article 10
Disclosure of the use of the standardised approach
Article 11
Disclosure of the use of the IRB approach to credit risk
Article 12
Disclosure of specialised lending and equity exposure under the simple risk weight approach
Article 13
Disclosure of exposures to counterparty credit risk
Article 14
Disclosure of exposures to securitisation positions
Article 15
Disclosure of the use of the standardised approach and of the internal models for market risk
Article 16
Disclosure of operational risk
Article 17
Disclosure of remuneration policy
Article 18
Disclosure of encumbered and unencumbered assets
Article 19
General provisions
Article 20
Repeal
Article 21
Entry into force
ANNEX I
|
Total risk exposure amounts (TREA) |
Total own funds requirements |
||
a |
b |
c |
||
T |
T-1 |
T |
||
1 |
Credit risk (excluding CCR) |
|
|
|
2 |
Of which the standardised approach |
|
|
|
3 |
Of which the Foundation IRB (F-IRB) approach |
|
|
|
4 |
Of which slotting approach |
|
|
|
EU 4a |
Of which equities under the simple riskweighted approach |
|
|
|
5 |
Of which the Advanced IRB (A-IRB) approach |
|
|
|
6 |
Counterparty credit risk - CCR |
|
|
|
7 |
Of which the standardised approach |
|
|
|
8 |
Of which internal model method (IMM) |
|
|
|
EU 8a |
Of which exposures to a CCP |
|
|
|
EU 8b |
Of which credit valuation adjustment - CVA |
|
|
|
9 |
Of which other CCR |
|
|
|
10 |
Not applicable |
|
|
|
11 |
Not applicable |
|
|
|
12 |
Not applicable |
|
|
|
13 |
Not applicable |
|
|
|
14 |
Not applicable |
|
|
|
15 |
Settlement risk |
|
|
|
16 |
Securitisation exposures in the non-trading book (after the cap) |
|
|
|
17 |
Of which SEC-IRBA approach |
|
|
|
18 |
Of which SEC-ERBA (including IAA) |
|
|
|
19 |
Of which SEC-SA approach |
|
|
|
EU 19a |
Of which 1 250 % / deduction |
|
|
|
20 |
Position, foreign exchange and commodities risks (Market risk) |
|
|
|
21 |
Of which the standardised approach |
|
|
|
22 |
Of which IMA |
|
|
|
EU 22a |
Large exposures |
|
|
|
23 |
Operational risk |
|
|
|
EU 23a |
Of which basic indicator approach |
|
|
|
EU 23b |
Of which standardised approach |
|
|
|
EU 23c |
Of which advanced measurement approach |
|
|
|
24 |
Amounts below the thresholds for deduction (subject to 250 % risk weight) |
|
|
|
25 |
Not applicable |
|
|
|
26 |
Not applicable |
|
|
|
27 |
Not applicable |
|
|
|
28 |
Not applicable |
|
|
|
29 |
Total |
|
|
|
|
a |
b |
c |
d |
e |
|
T |
T-1 |
T-2 |
T-3 |
T-4 |
||
|
Available own funds (amounts) |
|||||
1 |
Common Equity Tier 1 (CET1) capital |
|
|
|
|
|
2 |
Tier 1 capital |
|
|
|
|
|
3 |
Total capital |
|
|
|
|
|
|
Risk-weighted exposure amounts |
|||||
4 |
Total risk exposure amount |
|
|
|
|
|
|
Capital ratios (as a percentage of risk-weighted exposure amount) |
|||||
5 |
Common Equity Tier 1 ratio (%) |
|
|
|
|
|
6 |
Tier 1 ratio (%) |
|
|
|
|
|
7 |
Total capital ratio (%) |
|
|
|
|
|
|
Additional own funds requirements to address risks other than the risk of excessive leverage (as a percentage of risk-weighted exposure amount) |
|||||
EU 7a |
Additional own funds requirements to address risks other than the risk of excessive leverage (%) |
|
|
|
|
|
EU 7b |
of which: to be made up of CET1 capital (percentage points) |
|
|
|
|
|
EU 7c |
of which: to be made up of Tier 1 capital (percentage points) |
|
|
|
|
|
EU 7d |
Total SREP own funds requirements (%) |
|
|
|
|
|
|
Combined buffer and overall capital requirement (as a percentage of risk-weighted exposure amount) |
|||||
8 |
Capital conservation buffer (%) |
|
|
|
|
|
EU 8a |
Conservation buffer due to macro-prudential or systemic risk identified at the level of a Member State (%) |
|
|
|
|
|
9 |
Institution specific countercyclical capital buffer (%) |
|
|
|
|
|
EU 9a |
Systemic risk buffer (%) |
|
|
|
|
|
10 |
Global Systemically Important Institution buffer (%) |
|
|
|
|
|
EU 10a |
Other Systemically Important Institution buffer (%) |
|
|
|
|
|
11 |
Combined buffer requirement (%) |
|
|
|
|
|
EU 11a |
Overall capital requirements (%) |
|
|
|
|
|
12 |
CET1 available after meeting the total SREP own funds requirements (%) |
|
|
|
|
|
|
Leverage ratio |
|||||
13 |
Total exposure measure |
|
|
|
|
|
14 |
Leverage ratio (%) |
|
|
|
|
|
|
Additional own funds requirements to address the risk of excessive leverage (as a percentage of total exposure measure) |
|||||
EU 14a |
Additional own funds requirements to address the risk of excessive leverage (%) |
|
|
|
|
|
EU 14b |
of which: to be made up of CET1 capital (percentage points) |
|
|
|
|
|
EU 14c |
Total SREP leverage ratio requirements (%) |
|
|
|
|
|
|
Leverage ratio buffer and overall leverage ratio requirement (as a percentage of total exposure measure) |
|||||
EU 14d |
Leverage ratio buffer requirement (%) |
|
|
|
|
|
EU 14e |
Overall leverage ratio requirement (%) |
|
|
|
|
|
|
Liquidity Coverage Ratio |
|||||
15 |
Total high-quality liquid assets (HQLA) (Weighted value -average) |
|
|
|
|
|
EU 16a |
Cash outflows - Total weighted value |
|
|
|
|
|
EU 16b |
Cash inflows - Total weighted value |
|
|
|
|
|
16 |
Total net cash outflows (adjusted value) |
|
|
|
|
|
17 |
Liquidity coverage ratio (%) |
|
|
|
|
|
|
Net Stable Funding Ratio |
|||||
18 |
Total available stable funding |
|
|
|
|
|
19 |
Total required stable funding |
|
|
|
|
|
20 |
NSFR ratio (%) |
|
|
|
|
|
|
a |
b |
|
Exposure value |
Risk exposure amount |
||
1 |
Own fund instruments held in insurance or re-insurance undertakings or insurance holding company not deducted from own funds |
|
|
|
a |
|
T |
||
1 |
Supplementary own fund requirements of the financial conglomerate (amount) |
|
2 |
Capital adequacy ratio of the financial conglomerate (%) |
|
Legal basis |
Row number |
Free format |
Article 438(a) CRR |
(a) |
Approach to assessing the adequacy of the internal capital |
Article 438(c) CRR |
(b) |
Upon demand from the relevant competent authority, the result of the institution's internal capital adequacy assessment process |
ANNEX II
Instructions for overview disclosure templates
Legal references and instructions |
|||||
Column number |
Explanation |
||||
a |
Total risk exposure amounts (TREA) Total risk exposure amount calculated in accordance with Articles 92(3) and Articles 95, 96 and 98 CRR |
||||
b |
TREA (T-1) TREA as disclosed in the previous disclosure period |
||||
c |
Total own funds requirements Own fund requirements corresponding to the RWEAs for the different risk categories |
||||
Legal references and instructions |
|||||
Row number |
Explanation |
||||
1 |
Credit risk (excluding CCR) RWEAs and own funds requirements calculated in accordance with Chapters 1 to 4 of Title II of Part Three CRR, and with Article 379 CRR. RWEAs for securitisation exposures in the non-trading book and for CCR are excluded and disclosed in rows 6 and 16 of this template. Institutions shall include, in the amount disclosed in this row, RWEAs and own funds requirements for free deliveries risk calculated in accordance with Article 379 CRR. |
||||
2 |
Credit risk (excluding CCR) - Of which the standardised approach RWEAs and own funds requirements calculated in accordance with the CR standardised approach (Chapter 2 of Title II of Part Three CRR and Article 379 CRR). |
||||
3 |
Credit risk (excluding CCR) - Of which the Foundation IRB (F-IRB) approach RWEAs and own funds requirements calculated in accordance with the CR – Foundation Internal Ratings Based Approach (Chapter 3 of Title II of Part Three CRR), excluding the RWEAs disclosed in row 4 for specialised lending exposures subject to the slotting approach, and in row EU 4a for equities under the simple risk weighted approach, and including the RWEAs and own funds requirements calculated in accordance with Article 379 CRR. |
||||
4 |
Credit risk (excluding CCR) - Of which: slotting approach RWEAs and own funds requirements for specialised lending exposures subject to the slotting approach calculated in accordance with Article 153(5) CRR. |
||||
EU 4a |
Credit risk (excluding CCR) - Of which: equities under the simple risk weighted approach RWEAs and own funds requirements for equities under the simple risk weighted approach calculated in accordance with Article 155(2) CRR. |
||||
5 |
Credit risk (excluding CCR) - Of which the Advanced IRB (A-IRB) approach RWEAs and own funds requirements calculated in accordance with the CR – Advanced Internal Ratings Based Approach (Chapter 3 of Title II of Part Three CRR), excluding the RWEAs disclosed in row 4 for specialised lending exposures subject to the slotting approach and in row EU 4a for equities under the simple risk weighted approach and including the RWEAs and own funds requirements calculated in accordance with Article 379 CRR. |
||||
6 |
Counterparty credit risk – CCR RWEAs and own funds requirements calculated in accordance with Chapter 6 of Title II of Part Three CRR for counterparty credit risk. |
||||
7 |
CCR - Of which the standardised approach RWEAs and own funds requirements calculated in accordance with Section 3 of Chapter 6 of Title II of Part Three CRR. |
||||
8 |
CCR - Of which internal model method (IMM) RWEAs and own funds requirements calculated in accordance with Article 283 CRR. |
||||
EU 8a |
CCR – Of which exposures to a CCP RWEAs and own funds requirements calculated in accordance with Section 9 of Chapter 6 of Title II of Part Three CRR. |
||||
EU 8b |
CCR – Of which credit valuation adjustment – CVA RWEAs and own funds requirements calculated in accordance with Title VI of Part Three CRR. |
||||
9 |
CCR - Of which other CCR CCR RWEAs and own funds requirements that are not disclosed under rows 7, 8, EU 8a and EU 8b. |
||||
10 |
Not applicable |
||||
11 |
Not applicable |
||||
12 |
Not applicable |
||||
13 |
Not applicable |
||||
14 |
Not applicable |
||||
15 |
Settlement risk Risk exposure amount (REA) and own funds requirements calculated for settlement/delivery risk in accordance with Article 378 CRR. |
||||
16 |
Securitisation exposures in the non-trading book (after the cap) RWEAs and own funds requirements calculated in accordance with Chapter 5 of Title II of Part Three CRR. |
||||
17 |
Securitisation - Of which SEC-IRBA approach RWEAs and own funds requirements calculated in accordance with the SEC-IRBA regulatory approach, used in accordance with the hierarchy of approaches set out in Article 254 CRR. |
||||
18 |
Securitisation - Of which SEC-ERBA (including IAA) RWEAs and own funds requirements calculated in accordance with the SEC-ERBA (including IAA) regulatory approach, used in accordance with the hierarchy of approaches set out in Article 254 CRR. |
||||
19 |
Securitisation - Of which SEC-SA approach RWEAs and own funds requirements calculated in accordance with the SEC-SA regulatory approach, used in accordance with the hierarchy of approaches set out in Article 254 CRR. |
||||
EU 19a |
Securitisation - Of which 1 250 % / deduction RWEAs and own funds requirements for securitisation exposures on the non-trading book risk-weigh at 1 250 % or deducted from own funds in accordance with Chapter 5 of Title II of Part Three CRR. |
||||
20 |
Position, foreign exchange and commodities risks (Market risk) RWEAs and own funds requirements calculated in accordance with Title IV of Part Three CRR. |
||||
21 |
Market risk - Of which the standardised approach RWEAs and own funds requirements calculated in accordance with Chapters 2 to 4 of Title IV of Part Three CRR. |
||||
22 |
Market risk - Of which IMA REA and own funds requirements calculated in accordance with Chapter 5 of Title IV of Part Three CRR. |
||||
EU 22a |
Large exposures REA and own funds requirements calculated in accordance with point (b)(ii) of Article 92(3) CRR. |
||||
23 |
Operational risk REA and own funds requirements calculated in accordance with Title III of Part Three CRR. |
||||
EU 23a |
Operational risk - Of which basic indicator approach REA and own funds requirements calculated in accordance with Chapter 2 of Title III of Part Three CRR. |
||||
EU 23b |
Operational risk - Of which standardised approach REA and own funds requirements calculated in accordance with Chapter 3 of Title III of Part Three CRR. |
||||
EU 23c |
Operational risk - Of which advanced measurement approach REA and own funds requirements calculated in accordance with Chapter 4 of Title III of Part Three CRR. |
||||
24 |
Amount below the thresholds for deduction (subject to 250% risk weight) The amount shall correspond to the sum of amounts of the items subject to a 250% risk weight referred to in Article 48(4) CRR after application of the 250% risk weight. Those amounts include:
The information in this row is disclosed for information purposes only as the amount included here is also included in row 1, where institutions are asked to disclose information on credit risk. |
||||
25 |
Not applicable |
||||
26 |
Not applicable |
||||
27 |
Not applicable |
||||
28 |
Not applicable |
||||
29 |
Total Total risk exposure amount calculated in accordance with Article 92(3) and Articles 95, 96 and 98 CRR. |
Legal references and instructions |
|||||
Column number |
Explanation |
||||
a - e |
Disclosure periods T, T-1, T-2, T-3 and T-4 are defined as quarterly periods and shall be populated depending on the frequency set by Articles 433a, 433b and 433c CRR. Institutions disclosing the information contained in this template on a quarterly basis shall provide data for periods T, T-1, T-2, T-3 and T-4; institutions disclosing the information in this template on a semi-annual basis shall provide data for periods T, T-2 and T-4; and institutions disclosing the information in this template on an annual basis shall provide data for periods T and T-4. Institutions shall disclose the dates corresponding to the disclosure periods. The disclosure of data for previous periods is not required when data are disclosed for the first time. |
||||
Legal references and instructions |
|||||
Row number |
Explanation |
||||
1 |
Common Equity Tier 1 (CET1) capital Amount of CET1 capital shall be the amount disclosed by institutions inf Annex VII to this Implementing Regulation (row 29 of template EU CC1 Composition of regulatory own funds) |
||||
2 |
Tier 1 capital Amount of Tier 1 capital shall be the amount disclosed by institutions in Annex VII to this Implementing Regulation (row 45 of template EU CC1 Composition of regulatory own funds) |
||||
3 |
Total capital Amount of total capital shall be the amount disclosed by institutions in Annex VII to this Implementing Regulation (row 59 of template EU CC1 Composition of regulatory own funds) |
||||
4 |
Total risk exposure amount Amount of total risk exposure amount (TREA) shall be the amount disclosed by institutions in Annex VII to this Implementing Regulation (row 60 of template EU CC1 Composition of regulatory own funds) |
||||
5 |
Common Equity Tier 1 ratio (%) CET1 capital ratio shall be the value disclosed by institutions in Annex VII to this Implementing Regulation (row 61 of template EU CC1 Composition of regulatory own funds) |
||||
6 |
Tier 1 ratio (%) Tier 1 capital ratio shall be the value disclosed by institutions in Annex VII to this Implementing Regulation (row 62 of template EU CC1 Composition of regulatory own funds) |
||||
7 |
Total capital ratio (%) Total capital ratio shall be the value disclosed by institutions in Annex VII to this Implementing Regulation (row 63 of template EU CC1 Composition of regulatory own funds) |
||||
EU 7a |
Additional own funds requirements to address risks other than the risk of excessive leverage (%) Additional own funds requirements to address risks other than the risk of excessive leverage imposed by the competent authority under point (a) of Article 104(1) CRD, expressed as a percentage of the total risk exposure amount. |
||||
EU 7b |
of which: to be made up of CET1 capital (percentage points) The part of the additional own funds requirements to address risks other than the risk of excessive leverage imposed by the competent authority under point (a) of Article 104(1) CRD, which has to be met with Common Equity Tier 1 capital in accordance with the first and third subparagraph of Article 104a(4). |
||||
EU 7c |
of which: to be made up of Tier 1 capital (percentage points) The part of the additional own funds requirements to address risks other than the risk of excessive leverage imposed by the competent authority under point (a) of Article 104(1) CRD, which has to be met with Tier 1 capital in accordance with the first and third subparagraph of Article 104a(4). |
||||
EU 7d |
Total SREP own funds requirements (TSCR ratio) (%) The sum of values determined under points (i) and (ii) as follows:
This item shall reflect the total SREP capital requirement (TSCR) ratio as communicated to the institution by the competent authority. The TSCR is defined in Section 1.2 EBA SREP GL. Where no additional own funds requirements imposed to address risks other than the risk of excessive leverage were communicated by the competent authority, only point (i) shall be disclosed. |
||||
8 |
Capital conservation buffer (%) Amount of own funds that institutions are required to maintain in accordance with Article 128(1) and Article 129 CRD, expressed as a percentage of total RWEAs. |
||||
EU 8a |
Conservation buffer due to macro-prudential or systemic risk identified at the level of a Member State (%) Amount of the conservation buffer due to macro-prudential or systemic risk identified at the level of a Member State, which can be requested in accordance with Article 458 CRR in addition to the capital conservation buffer, expressed as a percentage of total RWEAs. |
||||
9 |
Institution specific countercyclical capital buffer (%) Amount of own funds that institutions are required to maintain in accordance with Article 128(2), Article 130, and Articles 135 to 140 CRD, expressed as a percentage of total RWEAs. The percentage shall reflect the amount of own funds needed to fulfil the respective capital buffer requirements at the disclosure date. |
||||
EU 9a |
Systemic risk buffer (%) Amount of own funds that institutions are required to maintain in accordance with Article 128(5), Articles 133 and 134 CRD, expressed as a percentage of total RWEAs. The percentage shall reflect the amount of own funds needed to fulfil the respective capital buffer requirements at the disclosure date. |
||||
10 |
Global Systemically Important Institution buffer (%) Amount of own funds that institutions are required to maintain in accordance with Article 128 (3) and Article 131 CRD, expressed as a percentage of total RWEAs. The percentage shall reflect the amount of own funds needed to fulfil the respective capital buffer requirements at the disclosure date. |
||||
EU 10a |
Other Systemically Important Institution buffer (%) Amount of own funds that institutions are required to maintain in accordance with Article 128(4) and Article 131 CRD, expressed as a percentage of total RWEAs. The percentage shall reflect the amount of own funds needed to fulfil the respective capital buffer requirements at the disclosure date. |
||||
11 |
Combined buffer requirement (%) In accordance with point (6) of Article 128 CRD, expressed as a percentage of total RWEAs. |
||||
EU 11a |
Overall capital requirements (OCR) (%) The sum of (i) and (ii) as follows:
This item shall reflect the Overall Capital Requirement (OCR) ratio as defined in Section 1.2 EBA SREP GL. Where no buffer requirement is applicable, only point (i) shall be disclosed. |
||||
12 |
CET1 available after meeting the total SREP own funds requirements (%) |
||||
13 |
Total exposure measure Total exposure measure in accordance with the amount disclosed by institutions in Annex XI to this Implementing Regulation (row 24 of template EU LR2 - LRCom: Leverage ratio common disclosure) |
||||
14 |
Leverage ratio (%) Leverage ratio in accordance with the value disclosed by institutions in Annex XI to this Implementing Regulation (row 25 of template EU LR2 - LRCom: Leverage ratio common disclosure) |
||||
EU 14a |
Additional own funds requirements to address the risk of excessive leverage (%) The additional own funds requirements to address the risk of excessive leverage imposed by the competent authority under point (a) of Article 104(1) CRD, expressed as a percentage of the total exposure measure. Additional own funds requirements in accordance with the value disclosed by institutions in Annex XI to this Implementing Regulation (row EU-26a of template EU LR2 - LRCom: Leverage ratio common disclosure). |
||||
EU 14b |
of which: to be made up of CET1 capital (percentage points) The part of the additional own funds requirements to address the risk of excessive leverage imposed by the competent authority under point (a) of Article 104(1) CRD, which has to be met with CET1 capital in accordance with the third subparagraph of Article 104a(4). Additional own funds requirements in accordance with the value disclosed by institutions in Annex XI to this Implementing Regulation (row EU-26b of template EU LR2 - LRCom: Leverage ratio common disclosure). |
||||
EU 14c |
Total SREP leverage ratio requirements (%) The sum of (i) and (ii) as follows:
This item shall reflect the total SREP leverage ratio requirement (TSLRR) as communicated to the institution by the competent authority. If no additional own funds requirements to address the risk of excessive leverage were imposed by the competent authority, only point (i) shall be disclosed. |
||||
EU 14d |
Leverage ratio buffer requirement (%) Article 92(1a) CRR Applicable leverage ratio buffer in accordance with the value disclosed by institutions in Annex XI to this Implementing Regulation (row 27 of template EU LR2 - LRCom: Leverage ratio common disclosure) |
||||
EU 14e |
Overall leverage ratio requirement (%) Sum of rows EU 14c and EU 14d |
||||
15 |
Total high-quality liquid assets (HQLA) (Weighted value - average) Institutions shall disclose as the weighted value the value of the liquid assets in accordance with Article 9 of Commission Delegated Regulation (EU) 2015/61(3) before applying the adjustment mechanism set out in Article 17(2) of Delegated Regulation (EU) 2015/61. |
||||
EU 16a |
Cash outflows - Total weighted value Institutions shall disclose the sum of the weighted value of their cash outflows, as disclosed in Annex XIII (row 16 of Template EU LIQ1 - Quantitative information of LCR). |
||||
EU 16b |
Cash inflows - Total weighted value Institutions shall disclose the sum of the weighted value of their cash inflows, as disclosed in Annex XIII (row 20 of Template EU LIQ1 - Quantitative information of LCR. |
||||
16 |
Total net cash outflows (Adjusted value) Institutions shall disclose as the adjusted value the net liquidity outflow which equals total outflows less the reduction for fully exempt inflows less the reduction for inflows subject to the 90% cap less the reduction for inflows subject to the 75% cap. |
||||
17 |
Liquidity coverage ratio (%) Institutions shall disclose as the adjusted value the percentage of the item 'Liquidity coverage ratio (%)' as defined in Article 4(1) of Delegated Regulation (EU) 2015/61. The liquidity coverage ratio shall be equal to the ratio of a credit institution's liquidity buffer to its net liquidity outflows over a 30 calendar days stress period and shall be expressed as a percentage. |
||||
18 |
Total available stable funding Institutions shall disclose the amount of available stable funding calculated in accordance with Chapter 3 of Title IV of Part Six CRR, as disclosed in Annex XIII (row 14 of Template EU LIQ2 – Net Stable Funding Ratio). |
||||
19 |
Total required stable funding Institutions shall disclose the amount of required stable funding calculated in accordance with Chapter 4 of Title IV of Part Six CRR, as disclosed in Annex XIII (row 33 of Template EU LIQ2 – Net Stable Funding Ratio). |
||||
20 |
NSFR ratio (%) NSFR ratio calculated in accordance with Article 428b CRR. |
Legal references and instructions |
|
Column number |
Explanation |
a |
Exposure value Exposure value of own fund instruments held in any insurance undertaking, re-insurance undertaking or insurance holding company that the institutions do not deduct from their own funds in accordance with Article 49 CRR when calculating their capital requirements on an individual, sub-consolidated and consolidated basis. |
b |
Risk exposure amount Risk exposure amount of own fund instruments held in any insurance undertaking, re-insurance undertaking or insurance holding company that the institutions do not deduct from their own funds in accordance with Article 49 CRR when calculating their capital requirements on an individual, sub-consolidated and consolidated basis. |
Legal references and instructions |
|
Row number |
Explanation |
1 |
Supplementary own fund requirements of the financial conglomerate (amount) The amount of supplementary own fund requirements of the financial conglomerate calculated in accordance with Article 6 of Directive (EC) 2002/87 of European Parliament and of the Council(4) and Annex I to that Directive where methods 1 or 2 set out in Annex I are applied. |
2 |
Capital adequacy ratio of the financial conglomerate (%) The capital adequacy ratio of the financial conglomerate calculated in accordance with Article 6 of Directive (EC) 2002/87 and Annex I to that Directive where methods 1 or 2 set out in Annex I are applied. |
Legal references and instructions |
|
Row number |
Explanation |
(a) |
Approach to assessing the adequacy of their internal capital Institutions shall disclose a summary of their approach to assessing the adequacy of their internal capital to support current and future activities. |
(b) |
Upon demand from the relevant competent authority, the result of the institution's internal capital adequacy assessment process This information shall only be disclosed by institutions when required by the relevant competent authority. |
ANNEX III
Legal basis |
Row number |
Qualitative information - Free format |
Point (f) of Article 435(1) CRR |
(a) |
Disclosure of concise risk statement approved by the management body |
Point (b) of Article 435(1) CRR |
(b) |
Information on the risk governance structure for each type of risk |
Point (e) of Article 435(1) CRR |
(c) |
Declaration approved by the management body on the adequacy of the risk management arrangements. |
Point (c) of Article 435(1) CRR |
(d) |
Disclosure on the scope and nature of risk disclosure and/or measurement systems. |
Point (c) of Article 435(1) CRR |
(e) |
Disclose information on the main features of risk disclosure and measurement systems. |
Point (a) of Article 435(1) CRR |
(f) |
Strategies and processes to manage risks for each separate category of risk. |
Points (a) and (d) of Article 435(1) CRR |
(g) |
Information on the strategies and processes to manage, hedge and mitigate risks, as well as on the monitoring of the effectiveness of hedges and mitigants. |
Legal basis |
Row number |
Free format |
Point (a) of Article 435(2) CRR |
(a) |
The number of directorships held by members of the management body. |
Point (b) of Article 435(2) CRR |
(b) |
Information regarding the recruitment policy for the selection of members of the management body and their actual knowledge, skills and expertise. |
Point (c) of Article 435(2) CRR |
(c) |
Information on the diversity policy with regard of the members of the management body. |
Point (d) of Article 435(2) CRR |
(d) |
Information whether or not the institution has set up a separate risk committee and the frequency of the meetings. |
Point (e) Article 435(2) CRR |
(e) |
Description on the information flow on risk to the management body. |
ANNEX IV
Instructions for disclosure of risk management objectives and policies
Legal references and instructions |
|||||||||
Row number |
Explanation |
||||||||
(a) |
The concise risk statement approved by the management body in the application of point (f) of Article 435(1) CRR shall describe how the business model determines and interacts with the overall risk profile: for instance, the key risks related to the business model and how each of these risks is reflected and described in the risk disclosures, or how the risk profile of the institution interacts with the risk tolerance approved by the management body. Within the risk statement in the application of point (f) of Article 435(1) CRR, institutions shall also disclose the nature, extent, purpose and economic substance of material transactions within the group, affiliates and related parties. The disclosure shall be limited to transactions that have a material impact on the risk profile of the institution (including reputational risk) or the distribution of risks within the group. Institutions shall also include key ratios and figures that show how the risk profile of the institution interacts with the risk tolerance set by the management body. |
||||||||
(b) |
Information to be disclosed in the application of point (b) of Article 435(1) CRR includes the risk governance structure for each type of risk: responsibilities attributed throughout the institution (including, where relevant, oversight and delegation of authority and breakdown of responsibilities between the management body, the business lines and the risk management function by type of risk, business unit, and other relevant information); relationships between the bodies and functions involved in risk management processes (including, as appropriate, the management body, risk committee, risk management function, compliance function, internal audit function); and the organisational and internal control procedures. When disclosing the structure and organisation of the relevant risk management function, institutions shall complement the disclosure with the following information:
|
||||||||
(c) |
The declaration that institutions shall disclose in compliance with point (e) of Article 435(1) CRR, on the adequacy of the risk management arrangements, has to be approved by the management body and provide assurance that the risk management systems put in place are adequate taking into account the institution’s risk profile and its strategy. |
||||||||
(d) |
As part of the disclosures required in point (c) of Article 435(1) CRR, institutions shall disclose the scope and nature of risk disclosure and/or measurement systems and the description of the flow on risk to the management body and senior management. |
||||||||
(e) |
When providing information on the main features of risk disclosure and measurement systems in the application of point (c) of Article 435(1) CRR, institutions shall disclose their policies regarding systematic and regular reviews of risk management strategies, and the periodical assessment of their effectiveness. |
||||||||
(f) |
Disclosure on the strategies and processes to manage risk in the application of point (a) of Article 435(1) CRR shall include qualitative information on stress testing, such as the portfolios subject to stress testing, scenarios adopted and methodologies used, and the use of stress testing in risk management. |
||||||||
(g) |
Institutions shall provide information on the strategies and processes to manage, hedge and mitigate risks, as well as on the monitoring of the effectiveness of hedges and mitigants in accordance with points (a) and (d) of Article 435(1) CRR for risks that arise from the institutions’ business model. |
Legal references and instructions |
|||||||
Row number |
Explanation |
||||||
(a) |
Institutions shall disclose the number of directorships held by members of the management body in accordance with point (a) of Article 435(2) CRR. When disclosing this information, the following specifications apply:
|
||||||
(b) |
When disclosing information regarding the recruitment policy for the selection of members of the management body in accordance with point (b) of Article 435(2) CRR, institutions shall include information on the actual knowledge, skills and expertise of the members. Institutions shall include information on the policy possibly resulting from succession planning and on any foreseeable changes within the overall composition of the management body. |
||||||
(c) |
When disclosing their diversity policy in accordance with point (c) of Article 435(2) CRR, institutions shall disclose information on the objectives and any relevant targets set out in that policy, and the extent to which those objectives and targets have been achieved. In particular institutions shall disclose the policy on gender diversity, including:
|
||||||
(d) |
Institution shall disclose if they have set up a separate risk committee, and the number of times the risk committee has met in accordance with point (d) of Article 435(2) CRR. |
||||||
(e) |
As part of data on the information flow on risk to the management body in the application of point (e) of Article 435(2) CRR, institutions shall describe the process of the risk disclosure provided to the management body, particularly the frequency, scope and main content of risk exposure and how the management body was involved in defining the content to be disclosed. |
ANNEX V
|
a |
b |
c |
d |
e |
f |
g |
|
Carrying values as reported in published financial statements |
Carrying values under scope of prudential consolidation |
Carrying values of items |
||||||
Subject to the credit risk framework |
Subject to the CCR framework |
Subject to the securitisation framework |
Subject to the market risk framework |
Not subject to own funds requirements or subject to deduction from own funds |
||||
|
Breakdown by asset clases according to the balance sheet in the published financial statements |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
…. |
|
|
|
|
|
|
|
xxx |
Total assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Breakdown by liability classes according to the balance sheet in the published financial statements |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
…. |
|
|
|
|
|
|
|
xxx |
Total liabilities |
|
|
|
|
|
|
|
|
a |
b |
c |
d |
e |
|
Total |
Items subject to |
|||||
Credit risk framework |
Securitisation framework |
CCR framework |
Market risk framework |
|||
1 |
Assets carrying value amount under the scope of prudential consolidation (as per template LI1) |
|
|
|
|
|
2 |
Liabilities carrying value amount under the scope of prudential consolidation (as per template LI1) |
|
|
|
|
|
3 |
Total net amount under the scope of prudential consolidation |
|
|
|
|
|
4 |
Off-balance-sheet amounts |
|
|
|
|
|
5 |
Differences in valuations |
|
|
|
|
|
6 |
Differences due to different netting rules, other than those already included in row 2 |
|
|
|
|
|
7 |
Differences due to consideration of provisions |
|
|
|
|
|
8 |
Differences due to the use of credit risk mitigation techniques (CRMs) |
|
|
|
|
|
9 |
Differences due to credit conversion factors |
|
|
|
|
|
10 |
Differences due to Securitisation with risk transfer |
|
|
|
|
|
11 |
Other differences |
|
|
|
|
|
12 |
Exposure amounts considered for regulatory purposes |
|
|
|
|
|
a |
b |
c |
d |
e |
f |
g |
h |
Name of the entity |
Method of accounting consolidation |
Method of prudential consolidation |
Description of the entity |
||||
Full consolidation |
Proportional consolidation |
Equity method |
Neither consolidated nor deducted |
Deducted |
|
||
Entity A |
Full consolidation |
X |
|
|
|
|
Credit institution |
Entity N |
Full consolidation |
|
X |
|
|
|
Credit institution |
Entity Z |
Full consolidation |
|
|
|
X |
|
Insurance entity |
Entity AA |
Full consolidation |
|
|
X |
|
|
Immaterial leasing company |
Legal basis |
Row number |
Qualitative information - Free format |
Article 436(b) CRR |
(a) |
Differences between columns (a) and (b) in template EU LI1 |
Article 436(d) CRR |
(b) |
Qualitative information on the main sources of differences between the accounting and regulatoy scope of consolidation shown in template EU LI2 |
Legal basis |
Row number |
Qualitative information - Free format |
Article 436(f) CRR |
(a) |
Impediment to the prompt transfer of own funds or to the repayment of liabilities within the group |
Article 436(g) CRR |
(b) |
Subsidiaries not included in the consolidation with own funds less than required |
Article 436(h) CRR |
(c) |
Use of derogation referred to in Article 7 CRR or individual consolidation method laid down in Article 9 CRR |
Article 436(g) CRR |
(d) |
Aggregate amount by which the actual own funds are less than required in all subsidiaries that are not included in the consolidation |
|
a |
b |
c |
d |
e |
EU e1 |
EU e2 |
f |
g |
h |
|
Risk category |
Category level AVA - Valuation uncertainty |
Total category level post-diversification |
|
||||||||
|
Category level AVA |
Equity |
Interest Rates |
Foreign exchange |
Credit |
Commodities |
Unearned credit spreads AVA |
Investment and funding costs AVA |
Of which: Total core approach in the trading book |
Of which: Total core approach in the banking book |
|
1 |
Market price uncertainty |
|
|
|
|
|
|
|
|
|
|
2 |
Not applicable |
|
|
|
|
|
|
|
|
|
|
3 |
Close-out cost |
|
|
|
|
|
|
|
|
|
|
4 |
Concentrated positions |
|
|
|
|
|
|
|
|
|
|
5 |
Early termination |
|
|
|
|
|
|
|
|
|
|
6 |
Model risk |
|
|
|
|
|
|
|
|
|
|
7 |
Operational risk |
|
|
|
|
|
|
|
|
|
|
8 |
Not applicable |
|
|
|
|
|
|
|
|
|
|
9 |
Not applicable |
|
|
|
|
|
|
|
|
|
|
10 |
Future administrative costs |
|
|
|
|
|
|
|
|
|
|
11 |
Not applicable |
|
|
|
|
|
|
|
|
|
|
12 |
Total Additional Valuation Adjustments (AVAs) |
|
|
|
|
|
|
|
|
|
|
ANNEX VI
Instructions for disclosure of information on the scope of application of the regulatory framework
Template EU LI1 - Differences between the accounting scope and the scope of prudential consolidation and mapping of financial statement categories with regulatory risk categories.
Flexible format.
Legal references and instructions |
|
Row number |
Explanation |
1 to XXX |
Total Assets The row structure shall be the same as the row structure of the balance sheet used in the latest available financial reporting of the institution. ‘Financial reporting’ refers to the annual individual or consolidated financial statements defined in Articles 4 and 24 of Directive (EU) 2013/34(2), as well as (when applicable) to the financial statements in the meaning of the international accounting standards as endorsed in the EU in the application of Regulation (EC) 1606/2002(3). |
1 to XXX |
Total Liabilities The row structure shall be the same as the row structure of the balance sheet used in the latest available financial reporting of the institution. ‘Financial reporting’ refers to the annual individual or consolidated financial statements defined in Articles 4 and 24 of Directive (EU) 2013/34/EU, as well as (when applicable) to the financial statements in the meaning of the international accounting standards as endorsed in the EU in the application of Regulation (EC) 1606/2002. |
Legal references and instructions |
|
Column reference |
Explanation |
a |
Carrying values as reported in published financial statements Amount reported on the assets side and the liabilities side of the balance sheet established following the consolidation requirements in the applicable accounting framework, including frameworks based on Directive (EU) 2013/34/EU and with Directive (EEC) 86/635(4), or the international accounting standards as endorsed in the EU |
b |
Carrying values under the scope of prudential consolidation Amount reported on the assets side and the liabilities side of the balance sheet established following the regulatory consolidation requirements in Sections 2 and 3 of Title II of Part One CRR If the scope of accounting consolidation and the scope of prudential consolidation are exactly the same, columns (a) and (b) of this template shall be merged. |
c |
Carrying values of items subject to credit risk framework Carrying amounts under the scope of prudential consolidation of items (other than off-balance-sheet items) to which Chapters 2 and 3 of Title II of Part Three CRR applies |
d |
Carrying values of items subject to counterparty credit risk framework Carrying amounts under the scope of prudential consolidation of items (other than off-balance-sheet items) to which Chapter 6 of Title II of Part Three CRR applies |
e |
Carrying values of items subject to the securitisation framework Carrying amounts under the scope of prudential consolidation of items (other than off-balance-sheet items) from the non-trading book to which Chapter 5 of Title II of Part Three CRR applies |
f |
Carrying values of items subject to the market risk framework Carrying amounts under the scope of prudential consolidation of items (other than off-balance-sheet items) to which Title IV of Part Three CRR applies. Items corresponding to securitisation positions in the trading book -to which the requirements in Title IV of Part Three CRR shall be included in this column. |
g |
Carrying values of items not subject to own funds requirements or subject to deduction from own funds Carrying amounts under the scope of prudential consolidation of items (other than off-balance-sheet items) not subject to own funds requirements in accordance with CRR; carrying amounts under the scope of prudential consolidation of items (other than off-balance-sheet items) that are subject to deductions from own funds in accordance with Part Two CRR Deducted items may include, for instance, the items listed in Articles 37, 38, 39, and 41 CRR. The amounts for assets shall be the amounts actually deducted from own funds, taking into account any netting with liabilities allowed by (and any threshold for) deduction applicable as per the relevant articles in Part Two CRR. When the items listed in point (k) Article 36(1) and in Article 48 CRR are 1 250 % risk-weighted instead of being deducted, they shall not be disclosed in column (g) of this template but in the other appropriate columns of template EU LI1. This also applies to any other item that is 1 250 % risk-weighted in accordance with the requirements in CRR. The amounts for liabilities shall be the amount of liabilities that must be taken into consideration for the determination of the amount of assets to be deducted from own funds as per the relevant articles in Part Two CRR. In addition, all liabilities other than those that (i) are relevant for the application of requirements in Chapter 4 of Title II of Part Three CRR, or (ii) that are relevant for the application of requirements in Chapter 6 of Title II of Part Three CRR and in Title IV of Part Three CRR shall be disclosed in this column. |
all |
Where a single item attracts capital requirements in accordance with more than one risk framework, values shall be disclosed in all columns corresponding to the capital requirements they relate to. As a consequence, the sum of amounts in columns (c) to (g) of this template may be greater than the amount in column (b) of this template. Institutions shall provide qualitative explanations on assets and liabilities that are subject to capital requirements for more than one risk framework listed in Part Three CRR. |
Template EU LI2 - Main sources of differences between regulatory exposure amounts and carrying values in financial statements.
Fixed format.
Legal references and instructions |
|
Row number |
Explanation |
1 |
Assets carrying value amount under the scope of prudential consolidation Amounts in columns (b) to (e) of this template shall be the same as the amounts in columns (c) to (f) of template EU LI1. |
2 |
Liabilities carrying value amount under the scope of prudential consolidation Amounts in columns (b) to (e) of this template shall be the same as the amounts in columns (c) to (f) of template EU LI1. |
3 |
Total net amount under scope of prudential consolidation Amount after on-balance-sheet netting between assets and liabilities under the scope of prudential consolidation, regardless of the eligibility of those assets and liabilities of the specific netting rules in the application of Chapters 4 and 5 of Title II of Part Three CRR and of Title IV of Part Three CRR The amount in this row shall be equal to the value in row 1 deducted by the value in row 2 of this template. |
4 |
Off-balance-sheet amounts Include off-balance-sheet original exposures, prior to the use of a conversion factor, where relevant, from the established off-balance-sheet statement, following the scope of prudential consolidation in column (a) to (d) of this template. |
5 |
Differences in valuations Impact of the carrying amount of value adjustments in accordance with Article 34 of Chapter 2 of Title I of Part Two CRR and with Article 105 of Chapter 3 of Title I of Part Three CRR on trading book and non-trading book exposures measured at fair value in accordance with the applicable accounting framework This amount shall be consistent with the amount in row 7 of template EU CC1 as well as with the amount in row 12 column (f) of template EU PV1. |
6 |
Differences due to different netting rules, other than those already included in row 2 of this template This item refers to the net on-balance-sheet and off-balance-sheet exposure amounts after the application of the specific netting rules in Chapters 4 and 5 of Title II of Part Three CRR and in Title IV of Part Three CRR. The impact of the application of the netting rules can be negative (in case more exposures have to be netted than the use of on-balance-sheet netting in row 2 of this template) or positive (in the case of the application of netting rules in the CRR leading to a lower amount being netted out than on-balance-sheet netting in row 2 of this template). |
7 |
Differences due to consideration of provisions Re-integration in the exposure value of specific and general credit risk adjustments (as defined in the Commission Delegated Regulation (EU) 183/2014(5)) that have been deducted in accordance with the applicable accounting framework from the carrying amount of exposures under Chapter 3 of Title II of Part Three CRR for risk-weighting purposes. Regarding exposures risk-weighted in accordance with Chapter 2 of Title II of Part Three CRR, when the carrying amount in the financial statements under the scope of prudential consolidation has been reduced by elements qualifying as general credit risk adjustments under the aforementioned delegated regulation, these elements shall be re-integrated in the exposure value. |
8 |
Differences due to the use of credit risk mitigation techniques Impact on the exposure value under the scope of prudential consolidation of the application of credit risk mitigation techniques as defined in the CRR. |
9 |
Differences due to credit conversion factors Impact on the exposure value of off-balance sheet exposures under the scope of prudential consolidation of the application of the relevant conversion factors in accordance with CRR The conversion factor for off-balance-sheet items to be risk-weighted in the application of Title II of Part Three CRR shall be determined in accordance with Articles 111, 166, 167 and 182 (as applicable for credit risk), and in Article 246 CRR (as applicable for securitisation risk). |
10 |
Differences due to Securitisation with risk transfer Impact on the exposure value of securitised exposures of the use of securitised transactions to transfer credit risk to third parties in accordance with the CRR |
11 |
Other differences (if relevant) Other meaningful drivers for differences between financial statements’ carrying values under the regulatory scope of application and the exposure amounts considered for regulatory purposes Institutions shall complement the quantitative disclosures included in this row with qualitative explanations on the main drivers of these differences in table EU LIA. |
12 |
Exposure amounts considered for regulatory purposes Aggregate amount considered as a starting point of the RWEA calculation after the application of CRM methods other than netting in Chapter 4 of Title II of Part Three CRR and after the application of netting requirements in Chapters 4 and 5 of Title II of Part Three CRR and in Title IV of Part Three CRR of the same regulation for each of the risk categories In case the Standardised Approach (SA) is applied, this is the value after specific credit adjustments, additional value adjustments in accordance with Articles 34 and 110 CRR and other own funds reductions related to the asset item. For off-balance sheet items listed in Annex I to this Implementing Regulation, the exposure value shall be the nominal value after reduction of specific credit risk adjustments, multiplied with the applicable percentage mentioned in points (a) and (d) of Article 111(1) CRR. For the IRB approach, the disclosed value shall be the exposure value within the meaning of Articles 166, 167 and 168 CRR. Thus, the carrying values as reported in the financial statements under the scope of prudential consolidation shall be disclosed in the corresponding rows 1 to 3 of this template, while the off-balance-sheet original exposures shall be disclosed in row 4 of this template. Any specific regulatory addition or reduction concerning these amounts is to be included in rows 5 to 11 of this template to explain how to reconcile these amounts with the exposure amount for regulatory purposes as the starting point of the RWEA calculation in accordance with each of the frameworks mentioned in columns (b) to (e) of this template. This means that in particular for credit risk, the exposure amounts considered for regulatory purposes to be disclosed in row 12 of this template will be different from the carrying values as reported in the financial statements under the scope of prudential consolidation, due to the particular regulatory treatment of accounting provisions for the calculation of the RWEAs. |
Legal references and instructions |
|
Column reference |
Explanation |
a |
Total Total in Column (a) of template EU LI2 = Amounts in Column (b) of template EU LI1 – Amounts in Column (g) of template EU LI1. |
|
The breakdown of columns in the regulatory risk categories (b) to (e) corresponds to the breakdown listed in Part Three CRR: |
b |
Credit risk framework Exposures in Title II of Part Three CRR Exposures under the credit risk framework shall correspond either to the exposure amount applied in the credit risk standardised approach (see Article 111 of Chapter 2 of Title II of Part Three CRR) or to the exposures at default (EAD) in the credit risk – IRB approach (see Articles 166, 167 and 168 in Chapter 3 of Title II of Part Three CRR). |
c |
Securitisation framework Exposures from the non-trading book given in Chapter 5 of Title II of Part Three CRR Securitisation exposures shall be determined in accordance with Article 246 of Chapter 5 of Title II of Part Three CRR. |
d |
Counterparty Credit Risk framework (CCR) Exposures considered in Chapter 6 of Title II of Part Three CRR |
e |
Market risk framework Market risk exposures corresponding to positions subject to the market risk framework in Title IV of Part Three CRR Only rows 1 to 3 and 12 of this template shall be disclosed regarding this column. |
all |
Where a single item is subject to capital requirements in accordance with more than one risk framework, it shall be disclosed in all the relevant columns corresponding to the capital requirements. As a consequence, the sum of amounts in columns (b) to (e) of this template may be greater than the amount in column (a) of this template. Institutions shall provide qualitative explanations on assets and liabilities that are subject to capital requirements for more than one risk framework listed in Part Three CRR. |
Template EU LI3 - Outline of the differences in the scopes of consolidation (entity by entity)
Legal references and instructions |
|
Row number |
Explanation |
|
The rows are flexible. Disclosures shall be provided for entities included within the accounting and the regulatory scopes of consolidation as defined in accordance with the applicable accounting framework and Sections 2 and 3 of Title II of Part One CRR, for which the method of the accounting consolidation is different from the method of the regulatory consolidation. One row per entity. |
Legal references and instructions |
|
Column reference |
Explanation |
a |
Name of the entity Commercial name of any entity included or deducted from the regulatory and accounting scope of consolidation of an institution |
b |
Method of accounting consolidation Consolidation method used in accordance with the applicable accounting framework |
c to g |
Method of regulatory consolidation Consolidation method implemented for the purpose of Chapter 2 of Title II of Part One CRR At a minimum, the methods listed in point (b) of Article 436 CRR shall be disclosed. Institutions shall tick the applicable columns to identify the method of consolidation of each entity under the accounting framework and whether, under the scope of prudential consolidation, each entity is (i) fully consolidated; (ii) proportionally consolidated; (iii) recognised under the equity method; (iv) neither consolidated nor deducted or; (v) deducted. |
h |
Description of the entity Brief description of the entity, with (at a minimum) disclosure of its sector of activity |
Table EU LIA - Explanations of differences between accounting and regulatory exposure amounts.
Free format text boxes for disclosure of qualitative information
Legal references and instructions |
|
Row number |
Explanation |
(a) |
Institutions shall explain and quantify the origins of any significant differences between the amounts in columns (a) and (b) in template EU LI1, regardless of whether the differences proceed from different consolidation rules or from the use of different accounting standards between the accounting and the regulatory consolidations. |
(b) |
Institutions shall explain the origins of differences between carrying values under the scope of prudential consolidation and amounts considered for regulatory purposes shown in template EU LI2. |
Table EU LIB – Other qualitative information on the scope of application.
Free format text boxes for disclosure of qualitative information
Legal references and instructions |
|
Row number |
Explanation |
(a) |
Institutions shall disclose any current or expected material practical or legal impediment to the prompt transfer of own funds or to the repayment of liabilities between the parent undertaking and its subsidiaries. |
(b) |
Where applicable, institutions shall disclose the name or names of the subsidiaries that are not included in the consolidation. |
(c) |
Where applicable, institutions shall disclose the circumstances under which use is made of the derogation referred to in Article 7 CRR or the individual consolidation method laid down in Article 9 CRR. |
(d) |
Where applicable, institutions shall disclose aggregate amount by which the actual own funds are less than required in all subsidiaries that are not included in the consolidation, and the name or names of those subsidiaries. |
Template EU PV1 – Prudent valuation adjustments (PVA):
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
Rows 1 to 10 |
Category level AVA The category level AVAs for market price uncertainty, close-out costs, model risk, concentrated positions, future administrative costs, early termination and operational risk shall be determined in accordance with Articles 9 to 11 and 14 to 17 of Commission Delegated Regulation (EU) 2016/101 respectively. For the market price uncertainty, close-out cost and model risk categories, which are subject to diversification benefit as set out under Articles 9(6), 10(7) and 11(7) of Delegated Regulation (EU) 2016/101 respectively, category level AVAs shall be disclosed in columns a to EU-e2 of this template as the straight sum of the individual AVAs before diversification benefit. Diversification benefits in accordance with Articles 9(6), 10(7) and 11(7) of Commission Delegated Regulation (EU) 2016/101 shall be included in column (f) of this template. |
1 |
Market price uncertainty Article 105(10) CRR Market price uncertainty AVAs shall be computed in accordance with Article 9 of Commission Delegated Regulation (EU) 2016/101. |
2 |
Not applicable |
3 |
Close-out costs Article 105(10) CRR Close-out costs AVAs shall be computed in accordance with Article 10 of Commission Delegated Regulation (EU) 2016/101 |
4 |
Concentrated positions Article 105(11) CRR Concentrated positions AVAs shall be computed under Article 14 of Commission Delegated Regulation (EU) 2016/101. |
5 |
Early termination Article 105(10) CRR Early termination AVAs shall be computed in accordance with Article 16 of Commission Delegated Regulation (EU) 2016/101. |
6 |
Model risk Article 105(10) CRR Model risk AVAs shall be computed in accordance with Article 11 of Commission Delegated Regulation (EU) 2016/101. |
7 |
Operational risk Article 105(10) CRR Operational risk AVAs shall be computed in accordance with Article 17 of Commission Delegated Regulation (EU) 2016/101. |
8 |
Not applicable |
9 |
Not applicable |
10 |
Future administrative costs Article 105(10) CRR Future administrative costs AVAs shall be computed in accordance with Article 15 of Commission Delegated Regulation (EU) 2016/101. |
11 |
Not applicable |
12 |
Total additional valuation adjustments Total AVA to be deducted from own funds under Articles 34 and 105 CRR shall be disclosed in row 12, column (f) of this template. This amount shall be consistent with the amount in row 7 of template EU CC1 as well as with the amount in row 5, column (a) of template EU LI2. For portfolios subject to the Core approach as set out in Chapter III of the Delegated Regulation (EU) 2016/101 on prudent valuation, the total AVA shall be the sum of amounts in rows 1 to 10 of this template, and, the amounts computed in accordance with point (b) sub-paragraphs (i) to (iii) of Article 7 (2) of Delegated Regulation (EU) 2016/101, for portfolios subject to the Fall-back approach, if any. For portfolios subject to the simplified approach as set out in Chapter II of the Delegated Regulation (EU) 2016/101 on prudent valuation, the total AVA included in column (f) of this template shall be the amount computed in accordance with Article 5 of this Chapter. |
Column letter |
Explanation |
a-e |
Breakdown by RISK CATEGORY Institutions shall allocate their fair-valued assets and liabilities included in the threshold computation in accordance with Article 4(1) of Commission Delegated Regulation (EU) 2016/101 (trading book and non-trading book) in accordance with the following risk categories: interest rates, foreign exchange, credit, equities, commodities. The breakdown in these columns excludes the AVAs computed in accordance with Articles 12 and 13 of Commission Delegated Regulation (EU) 2016/101 that are disclosed in columns EU-e1 and EU-e2 of this template. |
EU e1 |
Category level AVA - Valuation uncertainty: Unearned credit spreads AVA Article 105(10) CRR, Article 12 of Commission Delegated Regulation (EU) 2016/101 The total AVA for unearned credit spreads (‘AVA on CVA’) and its allocation between market price uncertainty, close-out cost or model risk AVAs shall be determined in accordance with Article 12 of Commission Delegated Regulation (EU) 2016/101. |
EU e2 |
Category level AVA - Investment and funding costs AVA Article 105(10) CRR, Article 13 of Commission Delegated Regulation (EU) 2016/101 The total AVA for investing and funding costs and its allocation between market price uncertainty, close-out cost or model risk AVAs shall be determined in accordance with Article 13 of Commission Delegated Regulation (EU) 2016/101. |
f |
Total category level post-diversification For portfolios subject to the Core approach as set out in Chapter III of Commission Delegated Regulation (EU) 2016/101, the total category level post-diversification shall encompass the total AVAs computed in accordance with the Core approach for fair-valued assets and liabilities included in the threshold computation in accordance with Article 4(1) of Commission Delegated Regulation (EU) 2016/101. This includes the diversification benefits defined in accordance with Articles 9(6), 10(7) and 11(7) of Commission Delegated Regulation (EU) 2016/101. The total AVA in row 12, column (f) of this template, shall include the amounts computed in accordance with point (b) sub-paragraphs (i) to (iii) of Article 7 (2) of Delegated Regulation (EU) 2016/101, for portfolios subject to the Fall-back approach, if any. For portfolios subject to the simplified approach as set out in Chapter II of the Delegated Regulation (EU) 2016/101 on prudent valuation, the total AVA included in row 12 of this template shall be the amount computed in accordance with Article 5 of this Chapter. |
g |
Of which: total core approach in the trading book For each relevant category of AVAs, for portfolios subject to the Core approach as set out in Chapter III of Commission Delegated Regulation (EU) 2016/101, share of AVAs stemming from positions held in the 'trading book': all positions in financial instruments and commodities held by an institution with trading intent or to hedge positions held with trading intent in accordance with Article 104 CRR. The disclosed value shall include the diversification benefits defined in accordance with Articles 9(6), 10(7) and 11(7) of Commission Delegated Regulation (EU) 2016/101. |
h |
Of which: total core approach in the banking book For each relevant category of AVAs, for portfolios subject to the Core approach as set out in Chapter III of Commission Delegated Regulation (EU) 2016/101, share of AVAs stemming from fair-valued positions in financial instruments and commodities not held in the trading book The disclosed value shall include the diversification benefits determined in accordance with Articles 9(6), 10(7) and 11(7) of Commission Delegated Regulation (EU) 2016/101. |
ANNEX VII
Template EU CC1 - Composition of regulatory own funds
|
(a) |
(b) |
|
Amounts |
Source based on reference numbers/letters of the balance sheet under the regulatory scope of consolidation |
||
Common Equity Tier 1 (CET1) capital: instruments and reserves |
|||
1 |
Capital instruments and the related share premium accounts |
|
(h) |
|
of which: Instrument type 1 |
|
|
|
of which: Instrument type 2 |
|
|
|
of which: Instrument type 3 |
|
|
2 |
Retained earnings |
|
|
3 |
Accumulated other comprehensive income (and other reserves) |
|
|
EU-3a |
Funds for general banking risk |
|
|
4 |
Amount of qualifying items referred to in Article 484 (3) CRR and the related share premium accounts subject to phase out from CET1 |
|
|
5 |
Minority interests (amount allowed in consolidated CET1) |
|
|
EU-5a |
Independently reviewed interim profits net of any foreseeable charge or dividend |
|
|
6 |
Common Equity Tier 1 (CET1) capital before regulatory adjustments |
|
|
Common Equity Tier 1 (CET1) capital: regulatory adjustments |
|||
7 |
Additional value adjustments (negative amount) |
|
|
8 |
Intangible assets (net of related tax liability) (negative amount) |
|
(a)minus (d) |
9 |
Not applicable |
|
|
10 |
Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability where the conditions in Article 38 (3) CRR are met) (negative amount) |
|
|
11 |
Fair value reserves related to gains or losses on cash flow hedges of financial instruments that are not valued at fair value |
|
|
12 |
Negative amounts resulting from the calculation of expected loss amounts |
|
|
13 |
Any increase in equity that results from securitised assets (negative amount) |
|
|
14 |
Gains or losses on liabilities valued at fair value resulting from changes in own credit standing |
|
|
15 |
Defined-benefit pension fund assets (negative amount) |
|
|
16 |
Direct, indirect and synthetic holdings by an institution of own CET1 instruments (negative amount) |
|
|
17 |
Direct, indirect and synthetic holdings of the CET 1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) |
|
|
18 |
Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above 10% threshold and net of eligible short positions) (negative amount) |
|
|
19 |
Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount above 10% threshold and net of eligible short positions) (negative amount) |
|
|
20 |
Not applicable |
|
|
EU-20a |
Exposure amount of the following items which qualify for a RW of 1 250 %, where the institution opts for the deduction alternative |
|
|
EU-20b |
of which: qualifying holdings outside the financial sector (negative amount) |
|
|
EU-20c |
of which: securitisation positions (negative amount) |
|
|
EU-20d |
of which: free deliveries (negative amount) |
|
|
21 |
Deferred tax assets arising from temporary differences (amount above 10% threshold, net of related tax liability where the conditions in Article 38 (3) CRR are met) (negative amount) |
|
|
22 |
Amount exceeding the 17,65% threshold (negative amount) |
|
|
23 |
of which: direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities |
|
|
24 |
Not applicable |
|
|
25 |
of which: deferred tax assets arising from temporary differences |
|
|
EU-25a |
Losses for the current financial year (negative amount) |
|
|
EU-25b |
Foreseeable tax charges relating to CET1 items except where the institution suitably adjusts the amount of CET1 items insofar as such tax charges reduce the amount up to which those items may be used to cover risks or losses (negative amount) |
|
|
26 |
Not applicable |
|
|
27 |
Qualifying AT1 deductions that exceed the AT1 items of the institution (negative amount) |
|
|
27a |
Other regulatory adjustments |
|
|
28 |
Total regulatory adjustments to Common Equity Tier 1 (CET1) |
|
|
29 |
Common Equity Tier 1 (CET1) capital |
|
|
Additional Tier 1 (AT1) capital: instruments |
|||
30 |
Capital instruments and the related share premium accounts |
|
(i) |
31 |
of which: classified as equity under applicable accounting standards |
|
|
32 |
of which: classified as liabilities under applicable accounting standards |
|
|
33 |
Amount of qualifying items referred to in Article 484 (4) CRR and the related share premium accounts subject to phase out from AT1 |
|
|
EU-33a |
Amount of qualifying items referred to in Article 494a(1) CRR subject to phase out from AT1 |
|
|
EU-33b |
Amount of qualifying items referred to in Article 494b(1) CRR subject to phase out from AT1 |
|
|
34 |
Qualifying Tier 1 capital included in consolidated AT1 capital (including minority interests not included in row 5) issued by subsidiaries and held by third parties |
|
|
35 |
of which: instruments issued by subsidiaries subject to phase out |
|
|
36 |
Additional Tier 1 (AT1) capital before regulatory adjustments |
|
|
Additional Tier 1 (AT1) capital: regulatory adjustments |
|||
37 |
Direct, indirect and synthetic holdings by an institution of own AT1 instruments (negative amount) |
|
|
38 |
Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) |
|
|
39 |
Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above 10% threshold and net of eligible short positions) (negative amount) |
|
|
40 |
Direct, indirect and synthetic holdings by the institution of the AT1 instruments of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) (negative amount) |
|
|
41 |
Not applicable |
|
|
42 |
Qualifying T2 deductions that exceed the T2 items of the institution (negative amount) |
|
|
42a |
Other regulatory adjustments to AT1 capital |
|
|
43 |
Total regulatory adjustments to Additional Tier 1 (AT1) capital |
|
|
44 |
Additional Tier 1 (AT1) capital |
|
|
45 |
Tier 1 capital (T1 = CET1 + AT1) |
|
|
Tier 2 (T2) capital: instruments |
|||
46 |
Capital instruments and the related share premium accounts |
|
|
47 |
Amount of qualifying items referred to in Article 484(5) CRR and the related share premium accounts subject to phase out from T2 as described in Article 486(4) CRR |
|
|
EU-47a |
Amount of qualifying items referred to in Article 494a(2) CRR subject to phase out from T2 |
|
|
EU-47b |
Amount of qualifying items referred to in Article 494b(2) CRR subject to phase out from T2 |
|
|
48 |
Qualifying own funds instruments included in consolidated T2 capital (including minority interests and AT1 instruments not included in rows 5 or 34) issued by subsidiaries and held by third parties |
|
|
49 |
of which: instruments issued by subsidiaries subject to phase out |
|
|
50 |
Credit risk adjustments |
|
|
51 |
Tier 2 (T2) capital before regulatory adjustments |
|
|
Tier 2 (T2) capital: regulatory adjustments |
|||
52 |
Direct, indirect and synthetic holdings by an institution of own T2 instruments and subordinated loans (negative amount) |
|
|
53 |
Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) |
|
|
54 |
Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where the institution does not have a significant investment in those entities (amount above 10% threshold and net of eligible short positions) (negative amount) |
|
|
54a |
Not applicable |
|
|
55 |
Direct, indirect and synthetic holdings by the institution of the T2 instruments and subordinated loans of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) (negative amount) |
|
|
56 |
Not applicable |
|
|
EU-56a |
Qualifying eligible liabilities deductions that exceed the eligible liabilities items of the institution (negative amount) |
|
|
EU-56b |
Other regulatory adjustments to T2 capital |
|
|
57 |
Total regulatory adjustments to Tier 2 (T2) capital |
|
|
58 |
Tier 2 (T2) capital |
|
|
59 |
Total capital (TC = T1 + T2) |
|
|
60 |
Total Risk exposure amount |
|
|
Capital ratios and requirements including buffers |
|||
61 |
Common Equity Tier 1 capital |
|
|
62 |
Tier 1 capital |
|
|
63 |
Total capital |
|
|
64 |
Institution CET1 overall capital requirements |
|
|
65 |
of which: capital conservation buffer requirement |
|
|
66 |
of which: countercyclical capital buffer requirement |
|
|
67 |
of which: systemic risk buffer requirement |
|
|
EU-67a |
of which: Global Systemically Important Institution (G-SII) or Other Systemically Important Institution (O-SII) buffer requirement |
|
|
EU-67b |
of which: additional own funds requirements to address the risks other than the risk of excessive leverage |
|
|
68 |
Common Equity Tier 1 capital (as a percentage of risk exposure amount) available after meeting the minimum capital requirements |
|
|
National minima (if different from Basel III) |
|||
69 |
Not applicable |
|
|
70 |
Not applicable |
|
|
71 |
Not applicable |
|
|
Amounts below the thresholds for deduction (before risk weighting) |
|||
72 |
Direct and indirect holdings of own funds and eligible liabilities of financial sector entities where the institution does not have a significant investment in those entities (amount below 10% threshold and net of eligible short positions) |
|
|
73 |
Direct and indirect holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount below 17.65% thresholds and net of eligible short positions) |
|
|
74 |
Not applicable |
|
|
75 |
Deferred tax assets arising from temporary differences (amount below 17,65% threshold, net of related tax liability where the conditions in Article 38 (3) CRR are met) |
|
|
Applicable caps on the inclusion of provisions in Tier 2 |
|||
76 |
Credit risk adjustments included in T2 in respect of exposures subject to standardised approach (prior to the application of the cap) |
|
|
77 |
Cap on inclusion of credit risk adjustments in T2 under standardised approach |
|
|
78 |
Credit risk adjustments included in T2 in respect of exposures subject to internal ratings-based approach (prior to the application of the cap) |
|
|
79 |
Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach |
|
|
Capital instruments subject to phase-out arrangements (only applicable between 1 Jan 2014 and 1 Jan 2022) |
|||
80 |
Current cap on CET1 instruments subject to phase out arrangements |
|
|
81 |
Amount excluded from CET1 due to cap (excess over cap after redemptions and maturities) |
|
g |
82 |
Current cap on AT1 instruments subject to phase out arrangements |
|
|
83 |
Amount excluded from AT1 due to cap (excess over cap after redemptions and maturities) |
|
|
84 |
Current cap on T2 instruments subject to phase out arrangements |
|
|
85 |
Amount excluded from T2 due to cap (excess over cap after redemptions and maturities) |
|
|
Template EU CC2 - reconciliation of regulatory own funds to balance sheet in the audited financial statements
|
a |
b |
c |
|
Balance sheet as in published financial statements |
Under regulatory scope of consolidation |
Reference |
||
As at period end |
As at period end |
|
||
Assets – Breakdown by asset clases according to the balance sheet in the published financial statements |
||||
1 |
|
|
|
|
2 |
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
xxx |
Total assets |
|
|
|
Liabilities - Breakdown by liability clases according to the balance sheet in the published financial statements |
||||
1 |
|
|
|
|
2 |
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
xxx |
Total liabilities |
|
|
|
Shareholders' Equity |
|
|
|
|
1 |
|
|
|
|
2 |
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
xxx |
Total shareholders' equity |
|
|
|
Template EU CCA: Main features of regulatory own funds instruments and eligible liabilities instruments
|
a |
|
Qualitative or quantitative information - Free format |
||
1 |
Issuer |
|
2 |
Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement) |
|
2a |
Public or private placement |
|
3 |
Governing law(s) of the instrument |
|
3a |
Contractual recognition of write down and conversion powers of resolution authorities |
|
|
Regulatory treatment |
|
4 |
Current treatment taking into account, where applicable, transitional CRR rules |
|
5 |
Post-transitional CRR rules |
|
6 |
Eligible at solo/(sub-)consolidated/ solo&(sub-)consolidated |
|
7 |
Instrument type (types to be specified by each jurisdiction) |
|
8 |
Amount recognised in regulatory capital or eligible liabilities (Currency in million, as of most recent reporting date) |
|
9 |
Nominal amount of instrument |
|
EU-9a |
Issue price |
|
EU-9b |
Redemption price |
|
10 |
Accounting classification |
|
11 |
Original date of issuance |
|
12 |
Perpetual or dated |
|
13 |
Original maturity date |
|
14 |
Issuer call subject to prior supervisory approval |
|
15 |
Optional call date, contingent call dates and redemption amount |
|
16 |
Subsequent call dates, if applicable |
|
|
Coupons / dividends |
|
17 |
Fixed or floating dividend/coupon |
|
18 |
Coupon rate and any related index |
|
19 |
Existence of a dividend stopper |
|
EU-20a |
Fully discretionary, partially discretionary or mandatory (in terms of timing) |
|
EU-20b |
Fully discretionary, partially discretionary or mandatory (in terms of amount) |
|
21 |
Existence of step up or other incentive to redeem |
|
22 |
Noncumulative or cumulative |
|
23 |
Convertible or non-convertible |
|
24 |
If convertible, conversion trigger(s) |
|
25 |
If convertible, fully or partially |
|
26 |
If convertible, conversion rate |
|
27 |
If convertible, mandatory or optional conversion |
|
28 |
If convertible, specify instrument type convertible into |
|
29 |
If convertible, specify issuer of instrument it converts into |
|
30 |
Write-down features |
|
31 |
If write-down, write-down trigger(s) |
|
32 |
If write-down, full or partial |
|
33 |
If write-down, permanent or temporary |
|
34 |
If temporary write-down, description of write-up mechanism |
|
34a |
Type of subordination (only for eligible liabilities) |
|
EU-34b |
Ranking of the instrument in normal insolvency proceedings |
|
35 |
Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument) |
|
36 |
Non-compliant transitioned features |
|
37 |
If yes, specify non-compliant features |
|
37a |
Link to the full term and conditions of the instrument (signposting) |
|
(1) Insert ‘N/A’ if the question is not applicable |
ANNEX VIII
Instructions for own funds disclosure templates
Template EU CC1 – Composition of regulatory own funds
Legal references and instructions |
|
Row number |
Explanation |
1 |
Capital instruments and the related share premium accounts Capital instruments and the related share premium accounts in accordance with points (a) and (b) of Article 26(1) and with Articles 27, 28, 29 CRR and the EBA list as referred to in Article 26(3) CRR, and their breakdown by the type of the instrument. |
2 |
Retained earnings Retained earnings prior to all regulatory adjustments in accordance with point (c) of Article 26(1) CRR (prior to the inclusion of any interim net profits or losses) |
3 |
Accumulated other comprehensive income (and other reserves) Amount of accumulated other comprehensive income and other reserves in accordance with points (d) and (e) of Article 26(1) CRR |
EU-3a |
Funds for general banking risk Amount of funds for general banking risk in accordance with point (f) of Article 26(1) CRR |
4 |
Amount of qualifying items referred to in Article 484 (3) CRR and the related share premium accounts subject to phase out from CET1 Amount of qualifying items referred to in Article 484(3) CRR and the related share premium accounts subject to phase out from CET1 as described in Article 486(2) CRR |
5 |
Minority interests (amount allowed in consolidated CET1) Minority interests (allowed amount in consolidated CET1) as per Article 84 CRR |
EU-5a |
Independently reviewed interim profits net of any foreseeable charge or dividend Independently reviewed interim profits net of any foreseeable charge or dividend as per Article 26(2) CRR |
6 |
Common Equity Tier 1 (CET1) capital before regulatory adjustments Sum of amounts in rows 1 to EU-5a of this template |
7 |
Additional value adjustments (negative amount) Additional value adjustments in accordance with Article 34 and 105 CRR (negative amount) |
8 |
Intangible assets (net of related tax liability) (negative amount) Intangible assets (net of related tax liability) in accordance with point (b) of Article 36(1) and with Article 37 CRR (negative amount) |
9 |
Not applicable |
10 |
Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability where the conditions in Article 38 (3) CRR are met) (negative amount) Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability where the conditions in Article 38(3) CRR are met) in accordance with point (c) of Article 36(1) and with Article 38 CRR (negative amount) |
11 |
Fair value reserves related to gains or losses on cash flow hedges of financial instruments that are not valued at fair value Fair value reserves related to gains or losses on cash flow hedges of financial instruments that are not valued at fair value in accordance with point (a) of Article 33(1) CRR |
12 |
Negative amounts resulting from the calculation of expected loss amounts Negative amounts resulting from the calculation of expected loss amounts in accordance with point (d) of Article 36(1) and with Article 40 CRR |
13 |
Any increase in equity that results from securitised assets (negative amount) Any increase in equity that results from securitised assets in accordance with Article 32(1) CRR (negative amount) |
14 |
Gains or losses on liabilities valued at fair value resulting from changes in own credit standing Gains or losses on liabilities valued at fair value resulting from changes in own credit standing in accordance with point (b) of Article 33(1) of CRR |
15 |
Defined-benefit pension fund assets (negative amount) Defined-benefit pension fund assets in accordance with point (e) of Article 36(1) and Article 41 CRR (negative amount) |
16 |
Direct, indirect and synthetic holdings by an institution of own CET1 instruments (negative amount) Direct, indirect and synthetic holdings by an institution of own CET1 instruments as described in point (f) of Article 36 (1) and in Article 42 CRR (negative amount) |
17 |
Direct, indirect and synthetic holdings of the CET 1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) Direct, indirect and synthetic holdings of the CET1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution as described in point (g) of Article 36(1) and in Article 44 CRR (negative amount) |
18 |
Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) (negative amount) Direct, indirect and synthetic holdings of the CET1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) as described in point (h) of Article 36(1) and in Articles 43, 45, 46, 49(2) and (3) and 79 CRR (negative amount) |
19 |
Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) (negative amount) Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) as described in point (i) of Article 36(1), in Articles 43, 45, 47, in point (b) of Article 48(1), and in Article 49(1) to (3) CRR (negative amount) |
20 |
Not applicable |
EU-20a |
Exposure amount of the following items which qualify for a RW of 1 250 %, where the institution opts for the deduction alternative Exposure amount which qualifies for a RW of 1 250 %, where the institution opts for the deduction alternative, as described in point (k) of Article 36 (1) CRR |
EU-20b |
of which: qualifying holdings outside the financial sector (negative amount) Of the amount in EU-20a, the amount relating to qualifying holdings outside the financial sector in accordance with point (k)(i) of Article 36(1) and with Articles 89 to 91 CRR (negative amount) |
EU-20c |
of which: securitisation positions (negative amount) Of the amount in EU-20a of this template, the amount relating to securitisation positions, in accordance with point (k)(ii) of Article 36(1), with point (b) of Article 243(1), with point (b) of Article 244(1) and with Article 258 CRR (negative amount) |
EU-20d |
of which: free deliveries (negative amount) Of the amount in EU-20a of this template, the amount relating to free deliveries in accordance with point (k)(iii) of Article 36(1) and with Article 379(3) CRR (negative amount) |
21 |
Deferred tax assets arising from temporary differences (amount above 10 % threshold, net of related tax liability where the conditions in Article 38(3) CRR are met) (negative amount) Deferred tax assets arising from temporary differences (amount above 10 % threshold, net of related tax liability where the conditions in Article 38(3) CRR are met) as described in point (c) of Article 36(1), in Article 38 and in point (a) of Article 48(1) CRR (negative amount) |
22 |
Amount exceeding the 17,65 % threshold (negative amount) Amount exceeding the 17.65 % threshold in accordance with Article 48(1) CRR (negative amount) |
23 |
of which: direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities Of the amount in row 22 of this template, the amount of direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities as described in point (i) of Article 36(1) and in point (b) of Article 48(1) CRR |
24 |
Not applicable |
25 |
of which: deferred tax assets arising from temporary differences Of the amount in row 22 of this template the amount of deferred tax assets arising from temporary differences as described in point (c) of Article 36(1) in Article 38 and in point (a) of Article 48(1) CRR |
EU-25a |
Losses for the current financial year (negative amount) Losses for the financial year in accordance with point (a) of Article 36(1) CRR (negative amount) |
EU-25b |
Foreseeable tax charges relating to CET1 items except where the institution suitably adjusts the amount of CET1 items insofar as such tax charges reduce the amount up to which those items may be used to cover risks or losses (negative amount) Amount of foreseeable tax charges relating to CET1 items foreseeable at the moment of their calculation, except where the institution suitably adjusts the amount of CET1 items insofar as such tax charges reduce the amount up to which those items may be applied to cover risks or losses, in accordance with point (l) of Article 36(1) CRR (negative amount) |
26 |
Not applicable |
27 |
Qualifying AT1 deductions that exceed the AT1 items of the institution (negative amount) Qualifying AT1 deductions that exceed the AT1 items of the institution as described in point (j) of Article 36(1) CRR (negative amount) |
EU-27a |
Other regulatory adjustments Institutions shall disclose in this row any regulatory adjustment applicable, reported as part of supervisory reporting and not included in any other row of this template, including the amount of IFRS 9 transitional arrangements, when relevant and until the end of the transitional period |
28 |
Total regulatory adjustments to Common Equity Tier 1 CET1 To be calculated as the sum of amounts in rows 7 to EU-20a, 21, 22 and EU-25a to EU-27a of this template |
29 |
Common Equity Tier 1 (CET1) capital To be calculated as row 6 minus row 28 of this template |
30 |
Capital instruments and the related share premium accounts Capital instruments and the related share premium accounts as per Articles 51 and 52 CRR |
31 |
of which: classified as equity under applicable accounting standards The amount in row 30 of this template classified as equity under applicable accounting standards |
32 |
of which: classified as liabilities under applicable accounting standards The amount in row 30 of this template classified as liabilities under applicable accounting standards |
33 |
Amount of qualifying items referred to in Article 484 (4) CRR and the related share premium accounts subject to phase out from AT1 Amount of qualifying items referred to in Article 484(4) CRR and the related share premium accounts subject to phase out from AT1 in accordance with Article 486(3) CRR |
EU-33a |
Amount of qualifying items referred to in Article 494a(1) CRR subject to phase out from AT1 |
EU-33b |
Amount of qualifying items referred to in Article 494b(1) CRR subject to phase out from AT1 |
34 |
Qualifying Tier 1 capital included in consolidated AT1 capital (including minority interests not included in row 5) issued by subsidiaries and held by third parties Qualifying T1 capital included in consolidated AT1 capital (including minority interests not included in row 5 of this template) issued by subsidiaries and held by third parties as described in Articles 85 and 86 CRR |
35 |
of which: instruments issued by subsidiaries subject to phase out The amount in row 34 of this template that relates to the instruments issued by subsidiaries subject to phase out as described in Article 486(3) CRR |
36 |
Additional Tier 1 (AT1) capital before regulatory adjustments The sum of amounts in rows 30, 33, EU-33a, EU-33b and 34 of this template |
37 |
Direct, indirect and synthetic holdings by an institution of own AT1 instruments (negative amount) Direct, indirect and synthetic holdings by an institution of own AT1 instruments as described in point (b) of Article 52(1), in point (a) of Article 56 and in Article 57 CRR (negative amount) |
38 |
Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution as described in point (b) of Article 56 and in Article 58 CRR (negative amount) |
39 |
Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) (negative amount) Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) as described in point (c) of Article 56 and in Articles 59, 60 and 79 CRR (negative amount) |
40 |
Direct, indirect and synthetic holdings by the institution of the AT1 instruments of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) (negative amount) Direct, indirect and synthetic holdings by the institution of the AT1 instruments of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) as described in point (d) of Articles 56 and in Articles 59 and 79 CRR (negative amount) |
41 |
Not applicable |
42 |
Qualifying T2 deductions that exceed the T2 items of the institution (negative amount) Qualifying T2 deductions that exceed the T2 items of the institution as described in point (e) of Article 56 CRR (negative amount) |
Eu-42a |
Other regulatory adjustments to AT1 capital Institutions shall disclose in this row any regulatory adjustment applicable, reported as part of supervisory reporting and not included in any other row of this template |
43 |
Total regulatory adjustments to Additional Tier 1 (AT1) capital The sum of amounts in rows 37 to EU-42a of this template |
44 |
Additional Tier 1 (AT1) capital Additional Tier 1 (AT1) capital, to be calculated as row 36 minus row 43 of this template |
45 |
Tier 1 capital (T1 = CET1 + AT1) Tier 1 capital, to be calculated as row 29 plus row 44 of this template |
46 |
Capital instruments and the related share premium accounts Capital instruments and the related share premium accounts as described in Articles 62 and 63 CRR |
47 |
Amount of qualifying items referred to in Article 484(5) CRR and the related share premium accounts subject to phase out from T2 as described in Article 486(4) CRR |
EU-47a |
Amount of qualifying items referred to in Article 494a(2) CRR subject to phase out from T2 |
EU-47b |
Amount of qualifying items referred to in Article 494b(2) CRR subject to phase out from T2 |
48 |
Qualifying own funds instruments included in consolidated T2 capital (including minority interests and AT1 instruments not included in rows 5 or 34) issued by subsidiaries and held by third parties Qualifying own funds instruments included in consolidated T2 capital (including minority interests and AT1 instruments not included in rows 5 or 34 of this template) issued by subsidiaries and held by third parties as described in Articles 87 and 88 CRR |
49 |
of which: instruments issued by subsidiaries subject to phase out Of the amount in row 48, the amount relating to instruments issued by subsidiaries subject to phase out, as described in Article 486(4) CRR |
50 |
Credit risk adjustments Credit risk adjustments in accordance with points (c) and (d) of Article 62 CRR |
51 |
Tier 2 (T2) capital before regulatory adjustments The sum of amounts in rows 46 to 48 and row 50 of this template |
52 |
Direct, indirect and synthetic holdings by an institution of own T2 instruments and subordinated loans (negative amount) Direct, indirect and synthetic holdings by an institution of own T2 instruments and subordinated loans as described in sub-point (i) of point (b) of Article 63 in point (a) of Article 66 and in Article 67 CRR (negative amount) |
53 |
Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution as described in point (b) of Article 66 and in Article 68 CRR (negative amount) |
54 |
Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where the institution does not have a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) (negative amount) Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where the institution does not have a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) as described in point (c) of Articles 66 and in Articles 69, 70 and 79 CRR (negative amount) |
54a |
Not applicable |
55 |
Direct, indirect and synthetic holdings by the institution of the T2 instruments and subordinated loans of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) (negative amount) Direct, indirect and synthetic holdings by the institution of the T2 instruments and subordinated loans of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) in accordance with point (d) of Article 66 and Articles 69 and 79 CRR (negative amount) |
56 |
Not applicable |
EU-56a |
Qualifying eligible liabilities deductions that exceed the eligible liabilities items of the institution (negative amount) Qualifying eligible liabilities deductions that exceed the eligible liabilities items of the institution in accordance with in point (e) of Article 66 CRR (negative amount) |
Eu-56b |
Other regulatory adjustments to T2 capital Institutions shall disclose in this row any regulatory adjustment applicable, reported as part of supervisory reporting and not included in any other row of this template. |
57 |
Total regulatory adjustments to Tier 2 (T2) capital The sum of amounts in rows 52 to EU-56b of this template |
58 |
Tier 2 (T2) capital Tier 2 (T2) capital to be calculated as row 51 minus row 57 of this template |
59 |
Total capital (TC = T1 + T2) Total capital to be calculated as row 45 plus row 58 of this template |
60 |
Total Risk exposure amount Total Risk exposure amount of the group |
61 |
Common Equity Tier 1 capital Common Equity Tier 1 (as a percentage of total risk exposure amount) to be calculated as row 29 divided by row 60 (expressed as a percentage) of this template in accordance with point (a) of Article 92(2) CRR |
62 |
Tier 1 capital Tier 1 (as a percentage of total risk exposure amount) to be calculated as row 45 divided by row 60 (expressed as a percentage) of this template in accordance with point (b) of Article 92(2) CRR |
63 |
Total capital Total capital (as a percentage of total risk exposure amount) to be calculated as row 59 divided by row 60 (expressed as a percentage) of this template in accordance with point (c) of Article 92(2) CRR |
64 |
Institution CET1 overall capital requirements Institution CET1 overall capital requirements shall be calculated as CET1 requirement in accordance with point (a) of Article 92(1) CRR, plus additional CET1 requirement which the institutions are required to hold in accordance with point (a) of Article 104(1) of Directive (EU) 2013/36 (‘CRD’), plus combined buffer requirement in accordance with Article 128(6) CRD) expressed as a percentage of risk exposure amount. To be calculated as 4.5 % plus the additional Pillar 2 requirements which the institutions are required to hold in accordance with point (a) of Article 104(1) CRD plus the combined buffer requirement calculated in accordance with Articles 128, 129, 130, 131 and 133 CRD. This row will show the CET1 ratio relevant for the assessment of constraints on distributions. |
65 |
of which: capital conservation buffer requirement The amount in row 64 (expressed as a percentage of total risk exposure amount) of this template that relates to the capital conservation buffer requirement in accordance with Article 129 CRD |
66 |
of which: countercyclical capital buffer requirement The amount in row 64 (expressed as a percentage of total risk exposure amount) of this template that relates to the countercyclical buffer requirement in accordance with Article 130 CRD |
67 |
of which: systemic risk buffer requirement The amount in row 64 (expressed as a percentage of total risk exposure amount) of this template that relates to the systemic risk buffer requirement in accordance with Article 133 CRD |
EU-67a |
of which: Global Systemically Important Institution (G-SII) or Other Systemically Important Institution (O-SII) buffer requirement The amount in row 64 (expressed as a percentage of total risk exposure amount) of this template that relates to the G-SII or O-SII buffer requirement in accordance with Article 131 CRD |
EU-67b |
of which: additional own funds requirements to address the risks other than the risk of excessive leverage The amount in row 64 (expressed as a percentage of total risk exposure amount) of this template that relates to additional own funds requirements resulting from the supervisory review process, which have to be met by CET1 capital, as referred to in point (a) of Article 104(1) of Directive 2013/36/EU |
68 |
Common Equity Tier 1 (as a percentage of risk exposure amount) available after meeting the minimum capital requirements To be calculated as row 61 minus 4.5 (percentage points), minus EU-67b, minus Common Equity Tier 1 capital used by the institution to meet its Additional Tier 1 and Tier 2 capital requirements. |
69 |
Not applicable |
70 |
Not applicable |
71 |
Not applicable |
72 |
Direct and indirect holdings of own funds and eligible liabilities of financial sector entities where the institution does not have a significant investment in those entities (amount below 10 % threshold and net of eligible short positions) Direct and indirect holdings of the own funds and eligible liabilities of financial sector entities where the institution does not have a significant investment in those entities (amount below 10 % threshold and net of eligible short positions) in accordance with point (h) of Article 36(1) and with Articles, 45, 46, point (c) of Article 56, 59, 60, point (c) of Article 66, 69, 70 and 72i CRR |
73 |
Direct and indirect holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount below 17.65 % thresholds and net of eligible short positions) Direct and indirect holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount below 17.65 % threshold and net of eligible short positions) in accordance with point (i) of Article 36(1), with Articles 43, 45, 47, with point (b) of Article 48(1) and with Article 49(1) to (3) CRR (the total amount of such investments that are not disclosed in row 19 and row 23 of this template) |
74 |
Not applicable |
75 |
Deferred tax assets arising from temporary differences (amount below 17,65 % threshold, net of related tax liability where the conditions in Article 38 (3) CRR are met) Deferred tax assets arising from temporary differences (amount below 17.65 % threshold in accordance with point (b) of Article 48(2) CRR, net of related tax liability where the conditions in Article 38(3) CRR are met) in accordance with point (c) of Article 36(1), and with Articles 38 and 48 CRR (the total amount of such deferred tax assets that are not disclosed in row 21 and row 25 of this template) |
76 |
Credit risk adjustments included in T2 in respect of exposures subject to standardised approach (prior to the application of the cap) Credit Risk Adjustments included in T2 in respect of exposures subject to standardised approach in accordance with point (c) of Article 62 CRR |
77 |
Cap on inclusion of credit risk adjustments in T2 under standardised approach Cap on inclusion of credit risk adjustments in T2 under standardised approach in accordance with point (c) of Article 62 CRR |
78 |
Credit risk adjustments included in T2 in respect of exposures subject to internal ratings-based approach (prior to the application of the cap) Credit risk adjustments included in T2 in respect of exposures subject to internal ratings-based approach in accordance with point (d) of Article 62 CRR |
79 |
Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach in accordance with point (d) of Article 62 CRR |
80 |
Current cap on CET1 instruments subject to phase out arrangements Current cap on CET1 instruments subject to phase out arrangements in accordance with Article 484(3) and with Article 486(2) and (5) CRR |
81 |
Amount excluded from CET1 due to cap (excess over cap after redemptions and maturities) Amount excluded from CET1 due to cap (excess over cap after redemptions and maturities) in accordance with Article 484(3) and Article 486(2) and (5) CRR |
82 |
Current cap on AT1 instruments subject to phase out arrangements Current cap on AT1 instruments subject to phase out arrangements in accordance with Articles 484(4), 486(3) and (5) CRR |
83 |
Amount excluded from AT1 due to cap (excess over cap after redemptions and maturities) Amount excluded from AT1 due to cap (excess over cap after redemptions and maturities) in accordance with Articles 484(4), 486(3) and (5) CRR |
84 |
Current cap on T2 instruments subject to phase out arrangements Current cap on T2 instruments subject to phase out arrangements in accordance with Articles 484(5), 486(4) and (5) CRR |
85 |
Amount excluded from T2 due to cap (excess over cap after redemptions and maturities) Amount excluded from T2 due to cap (excess over cap after redemptions and maturities) in accordance with Articles 484(5), 486(4) and (5) CRR |
Template EU CC2 – Reconciliation of regulatory own funds to balance sheet in the audited financial statements
Table EU CCA – Main features of regulatory own funds instruments and eligible liabilities instruments.
Instructions for completing the regulatory own funds and eligible liabilities instruments main features table |
|||||||||
Row number |
Explanation |
||||||||
1 |
Issuer Institutions shall identify the legal name of the issuer. Free text |
||||||||
2 |
Unique identifier (e.g. CUSIP, ISIN or Bloomberg identifier for private placement) Free text |
||||||||
EU-2a |
Public or private placement Institutions shall specify if the instrument has been publicly or privately placed. Select from menu: [Public] [Private] |
||||||||
3 |
Governing law(s) of the instrument Institutions shall specify the governing law(s) of the instrument. Free text |
||||||||
3a |
Contractual recognition of write down and conversion powers of resolution authorities Institutions shall specify whether the instrument contains a clause whereby, upon decision by a resolution authority or a relevant third country authority, the principal amount of the instrument is to be written down on a permanent basis or the instrument is to be converted into Common Equity Tier 1 instrument, in the meaning, where applicable, of the following provisions:
A write down and conversion may be both compliant with Article 55 BRRD and any of the first three indents. Select from menu: [YES] [NO] |
||||||||
4 |
Current treatment taking into account, where applicable, transitional CRR rules Institutions shall specify transitional regulatory own funds treatment contained in CRR. The original classification of the instrument is the point of reference independently of possible reclassification in lower tiers of own funds. Select from menu: [Common Equity Tier 1] [Additional Tier 1] [Tier 2] [Ineligible] [N/A] Free text – specify if a fraction of the issuance has been reclassified in lower tiers of capital. |
||||||||
5 |
Post-transitional CRR rules Institutions shall specify regulatory own funds treatment under CRR without taking into account the transitional treatment. Select from menu: [Common Equity Tier 1] [Additional Tier 1] [Tier 2] ] [eligible liabilities] [Ineligible] |
||||||||
6 |
Eligible at solo/(sub-)consolidated/ solo&(sub-)consolidated Institutions shall specify the level(s) within the group at which the instrument is included in the own funds/eligible liabilities. Select from menu: [Solo] [(Sub-)Consolidated] [Solo and (Sub-)Consolidated] |
||||||||
7 |
Instrument type (types to be specified by each jurisdiction) Institutions shall specify instrument type, varying by jurisdiction. For CET1 instruments, select name of the instrument in the CET1 list published by the EBA pursuant to Article 26(3) CRR. For other instruments, select from: menu options to be provided to institutions by each jurisdiction – legal references of CRR articles for each type of instrument to be inserted |
||||||||
8 |
Amount recognised in regulatory capital or eligible liabilities (Currency in million, as of most recent reporting date) Institutions shall specify the amount recognised in regulatory own funds or eligible liabilities. Free text – specify in particular if some parts of the instruments are in different tiers of the regulatory own funds and if the recognised amount in regulatory own funds is different from the amount issued. |
||||||||
9 |
Nominal amount of instrument Nominal amount of instrument in currency of issuance and currency used for the reporting obligations Free text |
||||||||
EU-9a |
Issue price Issue price of instrument Free text |
||||||||
EU-9b |
Redemption price Redemption price of instrument Free text |
||||||||
10 |
Accounting classification Institutions shall specify accounting classification. Select from menu: [Shareholders’ equity] [Liability – amortised cost] [Liability – fair value option] [Non-controlling interest in consolidated subsidiary] |
||||||||
11 |
Original date of issuance Institutions shall specify the date of issuance. Free text |
||||||||
12 |
Perpetual or dated Institutions shall specify whether an instrument is dated or perpetual. Select from menu: [Perpetual] [Dated] |
||||||||
13 |
Original maturity date For dated instrument, institutions shall specify original maturity date (day, month and year). For perpetual instrument ‘no maturity’ shall be put. Free text |
||||||||
14 |
Issuer call subject to prior supervisory approval Institutions shall specify whether there is an issuer call option (all types of call options). Select from menu: [Yes] [No] |
||||||||
15 |
Optional call date, contingent call dates and redemption amount For instrument with issuer call option, institutions shall specify the first date of call if the instrument has a call option on a specific date (day, month and year) and, in addition, shall specify whether the instrument has a tax and/or regulatory event call. Institutions shall also specify the redemption price, which helps to assess permanence. Free text |
||||||||
16 |
Subsequent call dates, if applicable Institutions shall specify the existence and frequency of subsequent call dates, if applicable, which helps to assess permanence. Free text |
||||||||
17 |
Fixed or floating dividend/coupon Institutions shall specify whether the coupon/dividend is either fixed over the life of the instrument or floating over the life of the instrument or currently fixed but will move to a floating rate in the future, or currently floating but will move to a fixed rate in the future. Select from menu: [Fixed], [Floating] [Fixed to floating], [Floating to fixed] |
||||||||
18 |
Coupon rate and any related index Institutions shall specify the coupon rate of the instrument and any related index that the coupon/dividend rate references. Free text |
||||||||
19 |
Existence of a dividend stopper Institutions shall specify whether the non-payment of a coupon or dividend on the instrument prohibits the payment of dividends on common shares (i.e. whether there is a dividend stopper). Select from menu: [yes], [no] |
||||||||
EU-20a |
Fully discretionary, partially discretionary or mandatory (in terms of timing) Institutions shall specify whether the issuer has full discretion, partial discretion or no discretion over whether a coupon/dividend is paid. If the institution has full discretion to cancel coupon/dividend payments under all circumstances it must select ‘fully discretionary’ (including when there is a dividend stopper that does not have the effect of preventing the institution from cancelling payments on the instrument). If there are conditions that must be met before payment can be cancelled (e.g. own funds below a certain threshold), the institution must select ‘partially discretionary’. If the institution is unable to cancel the payment outside of insolvency the institution must select ‘mandatory’. Select from menu: [Fully discretionary] [Partially discretionary] [Mandatory] Free text (specify the reasons for discretion, existence of dividend pushers, dividend stoppers, ACSM) |
||||||||
EU-20b |
Fully discretionary, partially discretionary or mandatory (in terms of amount) Institutions shall specify whether the issuer has full discretion, partial discretion or no discretion over the amount of the coupon/dividend. Select from menu: [Fully discretionary] [Partially discretionary] [Mandatory] |
||||||||
21 |
Existence of step up or other incentive to redeem Institutions shall specify whether there is a step-up or other incentive to redeem. Select from menu: [Yes] [No] |
||||||||
22 |
Noncumulative or cumulative Institutions shall specify whether dividends / coupons are cumulative or noncumulative. Select from menu: [Noncumulative] [Cumulative] [ACSM] |
||||||||
23 |
Convertible or non-convertible Institutions shall specify whether instrument is convertible or not. Select from menu: [Convertible] [Nonconvertible] |
||||||||
24 |
If convertible, conversion trigger(s) Institutions shall specify the conditions under which the instrument will convert, including point of non-viability. Where one or more authorities have the ability to trigger conversion, the authorities shall be listed. For each of the authorities it shall be stated whether it is the terms of the contract of the instrument that provide the legal basis for the authority to trigger conversion (a contractual approach) or whether the legal basis is provided by statutory means (a statutory approach). Free text |
||||||||
25 |
If convertible, fully or partially Institutions shall specify whether the instrument will always convert fully, may convert fully or partially, or will always convert partially. Select from menu: [Always Fully] [Fully or Partially] [Always partially] |
||||||||
26 |
If convertible, conversion rate Institutions shall specify the rate of conversion into the more loss absorbent instrument. Free text |
||||||||
27 |
If convertible, mandatory or optional conversion For convertible instruments, institutions shall specify whether conversion is mandatory or optional. Select from menu: [Mandatory] [Optional] [NA] and [at the option of the holders] [at the option of the issuer] [at the option of both the holders and the issuer] |
||||||||
28 |
If convertible, specify instrument type convertible into For convertible instruments, institutions shall specify instrument type convertible into. Helps to assess loss absorbency. Select from menu: [Common Equity Tier 1] [Additional Tier 1] [Tier 2] [Other] |
||||||||
29 |
If convertible, specify issuer of instrument it converts into Free text |
||||||||
30 |
Write-down features Institutions shall specify whether there is a write down feature. Select from menu: [Yes] [No] |
||||||||
31 |
If write-down, write-down trigger(s) Institutions shall specify the triggers at which write-down occurs, including point of non-viability. Where one or more authorities have the ability to trigger write-down, the authorities shall be listed. For each of the authorities it shall be stated whether it is the terms of the contract of the instrument that provide the legal basis for the authority to trigger write-down (a contractual approach) or whether the legal basis is provided by statutory means (a statutory approach Free text |
||||||||
32 |
If write-down, full or partial Institutions shall specify whether the instrument will always be written down fully, may be written down partially, or will always be written down partially. Helps assess the level of loss absorbency at write-down. Select from menu: [Always Fully] [Fully or Partially] [Always partially] ] |
||||||||
33 |
If write-down, permanent or temporary For write down instrument, institutions shall specify whether write down is permanent or temporary. Select from menu: [Permanent] [Temporary] [NA] |
||||||||
34 |
If temporary write-down, description of write-up mechanism Institutions shall describe the write-up mechanism. Free text |
||||||||
34a |
Type of subordination (only for eligible liabilities) Institutions shall specify whether the instrument meets any of the types of subordination described in point (d)(i), (ii) and (iii) of Article 72b(2) CRR. Select from menu: [Contractual] if the instrument meets the requirements set out in point (d)(i) of Article 72b(2) CRR; [Statutory] if the instrument meets the requirements set out in point (d)(ii) of Article 72b(2) CRR; [Structural] if the instrument meets the requirements set out in in point (d)(iii) of Article 72b(2) CRR; [Exemption from subordination] where the instrument does not meet any of the abovementioned forms of subordination and provided the institution has been permitted, pursuant to Article 72b(4) CRR, to include unsubordinated liabilities as eligible liabilities items. |
||||||||
EU-34b |
Ranking of the instrument in normal insolvency proceedings Institutions shall specify the ranking of the instrument in normal insolvency proceedings. As defined in [ITS on MREL reporting]. |
||||||||
35 |
Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument) Institutions shall specify the instrument to which it is most immediately subordinate. Where applicable, banks shall specify the column numbers of the instruments in the completed main features table to which the instrument is most immediately subordinate. Free text |
||||||||
36 |
Non-compliant transitioned features Institutions shall specify whether there are non-compliant features. Select from menu: [Yes] [No] |
||||||||
37 |
If yes, specify non-compliant features If there are non-compliant features, institution shall specify which ones. Free text |
||||||||
EU-37a |
Link to the full term and conditions of the instrument (signposting) Institutions shall include the hyperlink that gives access to the prospectus of the issuance, including all the terms and conditions of the instrument. |
ANNEX IX
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
|
General credit exposures |
Relevant credit exposures – Market risk |
Securitisation exposures Exposure value for non-trading book |
Total exposure value |
Own fund requirements |
Risk-weighted exposure amounts |
Own fund requirements weights (%) |
Countercyclical buffer rate (%) |
|||||||
Exposure value under the standardised approach |
Exposure value under the IRB approach |
Sum of long and short positions of trading book exposures for SA |
Value of trading book exposures for internal models |
Relevant credit risk exposures - Credit risk |
Relevant credit exposures – Market risk |
Relevant credit exposures – Securitisation positions in the non-trading book |
Total |
|||||||
010 |
Breakdown by country: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Country: 001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Country: 002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
… |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Country: NNN |
|
|
|
|
|
|
|
|
|
|
|
|
|
020 |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a |
|
1 |
Total risk exposure amount |
|
2 |
Institution specific countercyclical capital buffer rate |
|
3 |
Institution specific countercyclical capital buffer requirement |
|
ANNEX X
Instructions for the disclosure of information on countercyclical capital buffers
Template EU CCyB1 - Geographical distribution of credit exposures relevant for the calculation of the countercyclical capital buffer.
Fixed format for columns, flexible format for rows.
Legal references and instructions |
|
Row number |
Explanation |
010-01X |
Breakdown by country List of countries in which the institution has credit exposures relevant for the calculation of the institution specific countercyclical buffer in accordance with Commission delegated regulation (EU) 1152/2014(3) The number of rows may vary depending on the number of countries where the institution has its credit exposures relevant for the calculation of the countercyclical buffer. Institutions shall number the rows for each country consecutively, starting with 010. In accordance with Commission delegated regulation (EU) 1152/2014, if trading book exposures or foreign credit exposures of an institution represent less than 2% of its aggregate risk weighted exposures, the institution may choose to allocate these exposures to the place of institution (i.e. the home Member State of the institution). If the exposures for the place of institution include exposures from other countries, these shall be clearly identified in a footnote to the disclosure template. |
020 |
Total The value as described in accordance with the explanation for columns a to m of the current template. |
Legal references and instructions |
|||||
Column number |
Explanation |
||||
a |
Exposure value of general credit exposures under the standardised approach Exposure value of relevant credit exposures determined in accordance with point (a) of Article 140(4) CRD, and Article 111 CRR Exposure value of relevant credit exposures determined in accordance with point (c) of Article 140(4) CRD, with points (a) and (c) of Article 248 CRR shall not be included here but in e of this template. Geographical breakdown shall be made in accordance with Commission delegated regulation (EU) 1152/2014. Row 020 (Total): The sum of all relevant credit exposures shall be determined in accordance with point (a) of Article 140(4) CRD, and Article 111 CRR. |
||||
b |
Exposure value of general credit exposures under the IRB approach Exposure value of relevant credit exposures determined in accordance with point (a) of Article 140(4) CRD, Article 166, Article 167 and Article 168 CRR Exposure value of relevant credit exposures determined in accordance with point (c) of Article 140(4) CRD, points (a) and (c) of Article 248 CRR shall not be included here but in column e of this template. Geographical breakdown shall be made in accordance with Commission delegated regulation (EU) 1152/2014. Row 020 (Total): The sum of all relevant credit exposures shall be determined in accordance with point (a) of Article 140(4) CRD, Articles 166, 167 and 168 CRR. |
||||
c |
Sum of long and short positions of trading book exposures for standardised approach Sum of long and short positions of relevant credit exposures determined in accordance with point (b) of Article 140(4) CRD, calculated as the sum of long and short positions determined in accordance with Article 327 CRR Geographical breakdown shall be made in accordance with Commission delegated regulation (EU) 1152/2014. Row 020 (Total): The sum of all long and short positions of relevant credit exposures shall be determined in accordance with point (b) of Article 140(4) CRD, calculated as the sum of long and short positions determined in accordance with Article 327 CRR. |
||||
d |
Value of trading book exposures for internal models Sum of the following:
Geographical breakdown shall be made in accordance with Commission delegated regulation (EU) 1152/2014. Row 020 (Total): The sum of fair value of all cash positions that represent relevant credit exposures shall be determined in accordance with point (b) of Article 140(4) CRD, and Article 104 CRR, and the sum of notional value of all derivatives that represent relevant credit exposures shall be determined in accordance with point (b) of Article 140(4) CRD. |
||||
e |
Securitisation exposures Exposure value for non-trading book Exposure value of relevant credit exposures determined in accordance with point (c) of Article 140(4) CRD, points (a) and (c) of Article 248 CRR Geographical breakdown shall be made in accordance with Commission delegated regulation (EU) 1152/2014. Row 020 (Total): The sum of all relevant credit exposures shall be determined in accordance with point (c) of Article 140(4) CRD, and points (a) and (c) of Article 248 CRR. |
||||
f |
Total exposure value The sum of amounts in columns a, b, c, d and e of this template Row 020 (Total): The sum of all relevant credit exposures shall be determined in accordance to Article 140(4) CRD. |
||||
g |
Own funds requirements - Relevant credit risk exposures – Credit Risk Own funds requirements for relevant credit exposures in the country in question, determined in accordance to point (a) of Article 140(4) CRD, and Title II of Part Three CRR, and taking into account the own funds requirements linked to any country-specific adjustments to risk weights set in accordance with Article 458 CRR Row 020 (Total): The sum of all own funds requirements for relevant credit exposures shall be determined in accordance with point (a) of Article 140(4) CRD, and Title II of Part Three CRR. |
||||
h |
Own funds requirements - Relevant credit exposures – Market risk Own funds requirements for relevant credit exposures in the country in question, determined in accordance with point (b) of Article 140(4) CRD, and Chapter 2 of Title IV of Part Three CRR for specific risk, or in accordance with Chapter 5 of Title IV of Part Three CRR for incremental default and migration risk Row 020 (Total): The sum of all own funds requirements for relevant credit exposures shall be determined in accordance with point (b) of Article 140(4) CRD, and Chapter 2 of Title IV of Part Three CRR for specific risk or Chapter 5 of Title IV of Part Three CRR for incremental default and migration risk. |
||||
i |
Own funds requirements - Relevant credit exposures – Securitisation positions in the non-trading book Own funds requirements for relevant credit exposures in the country in question, determined in accordance to point (c) of Article 140(4) CRD, and Chapter 5 of Title II of Part Three CRR Row 020 (Total): The sum of all own funds requirements for relevant credit exposures shall be determined in accordance with point (c) of Article 140(4) CRD, and Chapter 5 of Title II of Part Three CRR. |
||||
j |
Own funds requirements - Total The sum of amounts in columns g, h and i of this template Row 020 (Total): The sum of all own funds requirements for relevant credit exposures shall be determined in accordance with Article 140(4) CRD. |
||||
k |
Risk-weighted exposure amounts Risk-weighted exposure amounts for relevant credit exposures, determined in accordance with Article 140(4) CRD, broken-down by country and taking into account any country-specific adjustments to risk weights set in accordance with Article 458 CRR Row 020 (Total): The sum of all risk-weighted exposure amounts for relevant credit exposures shall be determined in accordance with Article 140(4) CRD. |
||||
l |
Own funds requirements weights (%) The weight applied to the countercyclical buffer rate in each country, calculated as the total own funds requirements that relates to the relevant credit exposures in the country in question (row 01X, column j of this template), divided by the total own funds requirements that relates to all credit exposures relevant for the calculation of the countercyclical buffer in accordance with Article 140(4) CRD (row 020, column j of this template) This value shall be disclosed as percentage with 2 decimal points. |
||||
m |
Countercyclical capital buffer rate (%) Countercyclical capital buffer rate applicable in the country in question, and set in accordance with Articles 136, 137, 138 and 139 CRD This column shall not include countercyclical capital buffer rates that were set, but are not yet applicable at the time of computation of the institution specific countercyclical capital buffer to which the disclosure relates. This value is disclosed as percentage with the same number of decimal points as set in accordance with Articles 136, 137, 138 and 139 CRD. |
Template EU CCyB2 - Amount of institution specific countercyclical capital buffer
Legal references and instructions |
|
Row number |
Explanation |
1 |
Total risk exposure amount Total risk exposure amount calculated in accordance with Article 92(3) CRR |
2 |
Institution specific countercyclical capital buffer rate Institution specific countercyclical capital buffer rate, determined in accordance with in accordance with Article 140(1) CRD The institution specific countercyclical capital buffer rate is calculated as the weighted average of the countercyclical buffer rates that apply in the countries where the relevant credit exposures of the institution are located in rows 010.1 to 010.X of column m of the template EU CCyB1. The weight applied to the countercyclical buffer rate in each country is the share of funds requirements in total own funds requirements, and is in template EU CCyB1 column l. This value is disclosed as percentage with 2 decimal points. |
3 |
Institution specific countercyclical capital buffer requirement Institution specific countercyclical capital buffer requirement, calculated as the institution specific countercyclical buffer rate, as disclosed in row 2 of this template, applied to the total risk exposure amount as disclosed in row 1 of this template. |
Legal references and instructions |
|
Column number |
Explanation |
a |
The value as described in accordance with the explanation for rows 1 to 3 of the current template. |
ANNEX XI
Template EU LR1 - LRSum: Summary reconciliation of accounting assets and leverage ratio exposures
|
|
a |
|
|
Applicable amount |
1 |
Total assets as per published financial statements |
|
2 |
Adjustment for entities which are consolidated for accounting purposes but are outside the scope of prudential consolidation |
|
3 |
(Adjustment for securitised exposures that meet the operational requirements for the recognition of risk transference) |
|
4 |
(Adjustment for temporary exemption of exposures to central banks (if applicable)) |
|
5 |
(Adjustment for fiduciary assets recognised on the balance sheet pursuant to the applicable accounting framework but excluded from the total exposure measure in accordance with point (i) of Article 429a(1) CRR) |
|
6 |
Adjustment for regular-way purchases and sales of financial assets subject to trade date accounting |
|
7 |
Adjustment for eligible cash pooling transactions |
|
8 |
Adjustment for derivative financial instruments |
|
9 |
Adjustment for securities financing transactions (SFTs) |
|
10 |
Adjustment for off-balance sheet items (ie conversion to credit equivalent amounts of off-balance sheet exposures) |
|
11 |
(Adjustment for prudent valuation adjustments and specific and general provisions which have reduced Tier 1 capital) |
|
EU-11a |
(Adjustment for exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) CRR) |
|
EU-11b |
(Adjustment for exposures excluded from the total exposure measure in accordance with point (j) of Article 429a(1) CRR) |
|
12 |
Other adjustments |
|
13 |
Total exposure measure |
|
Template EU LR2 - LRCom: Leverage ratio common disclosure
|
CRR leverage ratio exposures |
||
|
a |
b |
|
T |
T-1 |
||
On-balance sheet exposures (excluding derivatives and SFTs) |
|||
1 |
On-balance sheet items (excluding derivatives, SFTs, but including collateral) |
|
|
2 |
Gross-up for derivatives collateral provided, where deducted from the balance sheet assets pursuant to the applicable accounting framework |
|
|
3 |
(Deductions of receivables assets for cash variation margin provided in derivatives transactions) |
|
|
4 |
(Adjustment for securities received under securities financing transactions that are recognised as an asset) |
|
|
5 |
(General credit risk adjustments to on-balance sheet items) |
|
|
6 |
(Asset amounts deducted in determining Tier 1 capital) |
|
|
7 |
Total on-balance sheet exposures (excluding derivatives and SFTs) |
|
|
Derivative exposures |
|||
8 |
Replacement cost associated with SA-CCR derivatives transactions (ie net of eligible cash variation margin) |
|
|
EU-8a |
Derogation for derivatives: replacement costs contribution under the simplified standardised approach |
|
|
9 |
Add-on amounts for potential future exposure associated with SA-CCR derivatives transactions |
|
|
EU-9a |
Derogation for derivatives: Potential future exposure contribution under the simplified standardised approach |
|
|
EU-9b |
Exposure determined under Original Exposure Method |
|
|
10 |
(Exempted CCP leg of client-cleared trade exposures) (SA-CCR) |
|
|
EU-10a |
(Exempted CCP leg of client-cleared trade exposures) (simplified standardised approach) |
|
|
EU-10b |
(Exempted CCP leg of client-cleared trade exposures) (Original Exposure Method) |
|
|
11 |
Adjusted effective notional amount of written credit derivatives |
|
|
12 |
(Adjusted effective notional offsets and add-on deductions for written credit derivatives) |
|
|
13 |
Total derivatives exposures |
|
|
Securities financing transaction (SFT) exposures |
|||
14 |
Gross SFT assets (with no recognition of netting), after adjustment for sales accounting transactions |
|
|
15 |
(Netted amounts of cash payables and cash receivables of gross SFT assets) |
|
|
16 |
Counterparty credit risk exposure for SFT assets |
|
|
EU-16a |
Derogation for SFTs: Counterparty credit risk exposure in accordance with Articles 429e(5) and 222 CRR |
|
|
17 |
Agent transaction exposures |
|
|
EU-17a |
(Exempted CCP leg of client-cleared SFT exposure) |
|
|
18 |
Total securities financing transaction exposures |
|
|
Other off-balance sheet exposures |
|||
19 |
Off-balance sheet exposures at gross notional amount |
|
|
20 |
(Adjustments for conversion to credit equivalent amounts) |
|
|
21 |
(General provisions deducted in determining Tier 1 capital and specific provisions associated associated with off-balance sheet exposures) |
|
|
22 |
Off-balance sheet exposures |
|
|
Excluded exposures |
|||
EU-22a |
(Exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) CRR) |
|
|
EU-22b |
(Exposures exempted in accordance with point (j) of Article 429a(1) CRR (on and off balance sheet)) |
|
|
EU-22c |
(Excluded exposures of public development banks (or units) - Public sector investments) |
|
|
EU-22d |
(Excluded exposures of public development banks (or units) - Promotional loans) |
|
|
EU-22e |
(Excluded passing-through promotional loan exposures by non-public development banks (or units)) |
|
|
EU-22f |
(Excluded guaranteed parts of exposures arising from export credits) |
|
|
EU-22g |
(Excluded excess collateral deposited at triparty agents) |
|
|
EU-22h |
(Excluded CSD related services of CSD/institutions in accordance with point (o) of Article 429a(1) CRR) |
|
|
EU-22i |
(Excluded CSD related services of designated institutions in accordance with point (p) of Article 429a(1) CRR) |
|
|
EU-22j |
(Reduction of the exposure value of pre-financing or intermediate loans) |
|
|
EU-22k |
(Total exempted exposures) |
|
|
Capital and total exposure measure |
|||
23 |
Tier 1 capital |
|
|
24 |
Total exposure measure |
|
|
Leverage ratio |
|||
25 |
Leverage ratio (%) |
|
|
EU-25 |
Leverage ratio (excluding the impact of the exemption of public sector investments and promotional loans) (%) |
|
|
25a |
Leverage ratio (excluding the impact of any applicable temporary exemption of central bank reserves) (%) |
|
|
26 |
Regulatory minimum leverage ratio requirement (%) |
|
|
EU-26a |
Additional own funds requirements to address the risk of excessive leverage (%) |
|
|
EU-26b |
of which: to be made up of CET1 capital |
|
|
27 |
Leverage ratio buffer requirement (%) |
|
|
EU-27a |
Overall leverage ratio requirement (%) |
|
|
Choice on transitional arrangements and relevant exposures |
|||
EU-27b |
Choice on transitional arrangements for the definition of the capital measure |
|
|
Disclosure of mean values |
|||
28 |
Mean of daily values of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivable |
|
|
29 |
Quarter-end value of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables |
|
|
30 |
Total exposure measure (including the impact of any applicable temporary exemption of central bank reserves) incorporating mean values from row 28 of gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables) |
|
|
30a |
Total exposure measure (excluding the impact of any applicable temporary exemption of central bank reserves) incorporating mean values from row 28 of gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables) |
|
|
31 |
Leverage ratio (including the impact of any applicable temporary exemption of central bank reserves) incorporating mean values from row 28 of gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables) |
|
|
31a |
Leverage ratio (excluding the impact of any applicable temporary exemption of central bank reserves) incorporating mean values from row 28 of gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables) |
|
|
Template EU LR3 - LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures)
|
a |
|
|
|
CRR leverage ratio exposures |
EU-1 |
Total on-balance sheet exposures (excluding derivatives, SFTs, and exempted exposures), of which: |
|
EU-2 |
Trading book exposures |
|
EU-3 |
Banking book exposures, of which: |
|
EU-4 |
Covered bonds |
|
EU-5 |
Exposures treated as sovereigns |
|
EU-6 |
Exposures to regional governments, MDB, international organisations and PSE, not treated as sovereigns |
|
EU-7 |
Institutions |
|
EU-8 |
Secured by mortgages of immovable properties |
|
EU-9 |
Retail exposures |
|
EU-10 |
Corporates |
|
EU-11 |
Exposures in default |
|
EU-12 |
Other exposures (eg equity, securitisations, and other non-credit obligation assets) |
|
Table EU LRA: Disclosure of LR qualitative information
|
|
a |
Row |
Free format |
|
(a) |
Description of the processes used to manage the risk of excessive leverage |
|
(b) |
Description of the factors that had an impact on the leverage ratio during the period to which the disclosed leverage ratio refers |
|
ANNEX XII
Instructions for leverage ratio disclosures
Template EU LR1 - LRSum: Summary reconciliation of accounting assets and leverage ratio exposures.
Fixed format template.
Legal references and instructions |
|||||
Row number |
Explanation |
||||
1 |
Total assets as per published financial statements Institutions shall disclose the total assets as published in their financial statements under the applicable accounting framework as defined in point (77) of Article 4(1) CRR. |
||||
2 |
Adjustment for entities which are consolidated for accounting purposes but are outside the scope of prudential consolidation Institutions shall disclose the difference in value between the total exposure measure as disclosed in row 13 of template EU LR1 - LRSum and total accounting assets as disclosed in row 1 of template EU LR1 - LRSum, which results from differences between the accounting scope of consolidation and the scope of prudential consolidation. If this adjustment leads to an increase in exposure, institutions shall disclose this as a positive amount. If this adjustment leads to a decrease in exposure, institutions shall place the value in this row between brackets (negative amount). |
||||
3 |
(Adjustment for securitised exposures that meet the operational requirements for the recognition of risk transference) Point (m) of Article 429a(1) CRR Institutions shall disclose the amount of the securitised exposures from traditional securitisations that meet the conditions for significant risk transfer set out in Article 244(2) CRR. As this adjustment reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||
4 |
(Adjustment for temporary exemption of exposures to central banks (if applicable)) Point (n) of Article 429a(1) CRR If applicable, institutions shall disclose the amount of coins and banknotes constituting legal currency in the jurisdiction of the central bank and assets representing claims on the central bank, including reserves held at the central bank. These exposures may be temporarily exempted subject to the conditions mentioned in Article 429a(5) and (6) CRR. As this adjustment reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||
5 |
(Adjustment for fiduciary assets recognised on the balance sheet pursuant to the applicable accounting framework but excluded from the total exposure measure in accordance with point (i) of Article 429a(1) CRR) Institutions shall disclose the amount of derecognised fiduciary items in accordance with point (i) of Article 429a(1) CRR. As this adjustment reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||
6 |
Adjustment for regular-way purchases and sales of financial assets subject to trade date accounting Article 429g(1) and (2) CRR Institutions shall disclose the adjustment of the accounting value related to regular-way purchases or sales awaiting settlement subject to trade date accounting in accordance with Article 429g(1) and (2) CRR. The adjustment is the sum of:
Regular-way purchases or sales awaiting settlement subject to settlement date accounting in accordance with Article 429g(3) CRR shall be included in row 10 of template EU LR1 - LRSum. If this adjustment leads to an increase in exposure, institutions shall disclose this as a positive amount. If this adjustment leads to a decrease in exposure, institutions shall place the value in this row between brackets (negative amount). |
||||
7 |
Adjustment for eligible cash pooling transactions Article 429b(2) and (3) CRR Institutions shall disclose the difference between the accounting value and the leverage ratio exposure value of cash pooling arrangements in accordance with the conditions mentioned in Article 429b(2) and (3) CRR. If this adjustment leads to an increase in exposure, due to transactions that are represented net under the applicable accounting framework but do not meet the conditions for net presentation under Article 429b(2) and (3) CRR, institutions shall disclose this as a positive amount. If this adjustment leads to a decrease in exposure, due to transactions that are not represented net under the applicable accounting framework but do meet the conditions for net presentation under Article 429b(2) and (3) CRR, institutions shall place the value in this row between brackets (negative amount). |
||||
8 |
Adjustment for derivative financial instruments For credit derivatives and contracts listed in Annex II of CRR, institutions shall disclose the difference in value between the accounting value of the derivatives recognised as assets and the leverage ratio exposure value as determined by application of point (b) of Article 429(4), Article 429c, 429d, points (g) and (h) of Article 429a(1), and of Article 429(5) CRR. If this adjustment leads to an increase in exposure, institutions shall disclose this as a positive amount. If this adjustment leads to a decrease in exposure, institutions shall place the value in this row between brackets (negative amount). |
||||
9 |
Adjustment for securities financing transactions (SFTs) For SFTs institutions shall disclose the difference in value between the accounting value of the SFTs recognised as assets and the leverage ratio exposure value as determined by application of points (a) and (c) of Article 429(4) in conjunction with Article 429e, point (b) of Article 429(7) and with point (b) of Article 429b(1), with Article 429b(4), and with points (g) and (h) of 429a(1) CRR. If this adjustment leads to an increase in the exposure, institutions shall disclose this as a positive amount. If this adjustment leads to a decrease in exposure, institutions shall place the value in this row between brackets (negative amount). |
||||
10 |
Adjustment for off-balance sheet items (i.e. conversion to credit equivalent amounts of off- balance sheet exposures) Institutions shall disclose the difference in value between the leverage ratio exposure as disclosed in row 13 of template EU LR1 - LRSum and total accounting assets as disclosed in row 1 of template EU LR1 - LRSum that results from the inclusion of off-balance sheet items in the leverage ratio total exposure measure. This includes the commitments to pay related to regular-way purchases under settlement date accounting as calculated in accordance with Article 429g(3) CRR. As this adjustment increases the total exposure measure, it shall be disclosed as a positive amount. |
||||
11 |
(Adjustment for prudent valuation adjustments and specific and general provisions which have reduced Tier 1 capital) Institutions shall disclose the amount of prudent valuation adjustments in accordance with points (a) and (b) of Article 429a(1) CRR and the amount of specific (if relevant) and general credit risk adjustments to on- and off-balance-sheet items as per the last sentence of Article 429(4) and Article 429f(2) CRR that have reduced Tier 1 capital. Specific provisions shall only be included if, in accordance with the applicable accounting framework, they are not already deducted from the gross carrying amount values. As this adjustment reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||
EU-11a |
(Adjustment for exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) CRR) Point (c) of Article 429a(1) and Article 113(6) and (7) CRR Institutions shall disclose the on-balance sheet portion of exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) CRR. As this adjustment reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||
EU-11b |
(Adjustment for exposures excluded from the total exposure measure in accordance with point (j) of Article 429a(1) CRR Point (j) of Article 429a(1), Article 116(4) CRR Institutions shall disclose the on-balance sheet portion of exposures excluded from the total exposure measure in accordance with point (j) of Article 429a(1) CRR. As this adjustment reduces the total exposure measure, institutions shall place the values in this row between brackets (negative amount). |
||||
12 |
Other adjustments Institutions shall include any remaining difference in value between the total exposure measure and total accounting assets. Institutions shall consider the exposure adjustments in accordance with Article 429(8) CRR and other exposure adjustments mentioned in points (d), (e), (f), (h), (k), (l), (o), (p) of Article 429a(1) CRR that are not disclosed anywhere in the template. If these adjustments lead to an increase in the exposure, institutions shall disclose this as a positive amount. If these adjustments lead to a decrease in exposure, the institutions shall place the value in this row between brackets (negative amount). |
||||
13 |
Total exposure measure Total exposure measure (also disclosed in row 24 of template EU LR2 - LRCom), which is the sum of the previous items. |
Template EULR2 - LRCom: Leverage ratio common disclosure.
Fixed format template
Legal references and instructions |
|||||||
Row number |
Explanation |
||||||
1 |
On-balance sheet items (excluding derivatives, SFTs, but including collateral) Article 429 and 429b CRR Institutions shall disclose all assets, other than contracts listed in Annex II CRR, credit derivatives, and SFTs. Institutions shall base the valuation of these assets on the principles set out in Article 429(7) and 429b(1) CRR. Institutions shall take into account in this calculation, if applicable, points (i), (m) and (n) of Article 429a(1) CRR, Article 429g and the last paragraph of Article 429(4) CRR. Institutions shall include in this cell cash received or any security that is provided to a counterparty via SFTs and that is retained on the balance sheet (i.e. the accounting criteria for derecognition under the applicable accounting framework are not met). Institutions shall not take into account in this calculation Article 429(8) and points (a)-(h), (j) and (k) of Article 429a(1) CRR, i.e. they shall not reduce the amount to be disclosed in this row by those exemptions. |
||||||
2 |
Gross-up for derivatives collateral provided, where deducted from the balance sheet assets pursuant to the applicable accounting framework Article 429c(2) CRR Institutions shall disclose the amount of any derivatives collateral provided where the provision of that collateral reduces the amount of assets under the applicable accounting framework, as set out in Article 429c(2) CRR. Institutions shall not include in this cell initial margin for client-cleared derivative transactions with a qualifying CCP (QCCP) or eligible cash variation margin, as defined in Article 429c(3) CRR. |
||||||
3 |
(Deductions of receivables assets for cash variation margin provided in derivatives transactions) Article 429c(3) CRR Institutions shall disclose the receivables for variation margin paid in cash to the counterparty in derivatives transactions if the institution is required, under the applicable accounting framework, to recognise these receivables as an asset, provided that the conditions in points (a) to (e) of Article 429c(3) CRR are met. As this adjustment reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
4 |
(Adjustment for securities received under securities financing transactions that are recognised as an asset) Adjustment for securities received under a securities financing transaction where the bank has recognised the securities as an asset on its balance sheet. These amounts are to be excluded from the total exposure measure in accordance with Article 429e(6) CRR. As the adjustments in this row reduce the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
5 |
(General credit risk adjustments to on-balance sheet items) The amount of general credit risk adjustments corresponding to on-balance sheet items referred to in point (a) of Article 429(4) CRR, which institutions deduct in accordance with the last paragraph of Article 429(4) CRR. As the adjustments in this row reduce the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
6 |
(Asset amounts deducted in determining Tier 1 capital) Points (a) and (b) of Article 429a(1) and Article 499(2) CRR Institutions shall disclose the amount of regulatory value adjustments made to Tier 1 amounts in accordance with the choice made pursuant to Article 499(2) CRR. More specifically, institutions shall disclose the value of the sum of all the adjustments that target the value of an asset and which are required by:
Institutions shall include in this cell the amount referred to in point (a) of Article 429a(1) CRR. Where the choice to disclose Tier 1 capital is made in accordance with point (a) of Article 499(1) CRR, institutions shall take into account the exemptions, alternatives and waivers to such deductions laid down in Articles 48, 49 and 79 CRR, without taking into account the derogation laid down in Chapters 1 and 2 of Title I of Part Ten CRR. In contrast, where the choice to disclose Tier 1 capital is made in accordance with point (b) of Article 499(1) CRR, institutions shall take into account exemptions, alternatives and waivers to such deductions laid down in Articles 48, 49 and 79 CRR, in addition to taking into account the derogations laid down in Chapter 1 and 2 of Title I of Part Ten CRR. To avoid double counting, institutions shall not disclose adjustments already applied pursuant to Article 111 CRR when calculating the exposure value, nor shall they disclose any adjustment that does not deduct the value of a specific asset. As the amount in this row reduces the total exposure measure, institutions shall place the value in this cell between brackets (negative amount). |
||||||
7 |
Total on-balance sheet exposures (excluding derivatives and SFTs) Sum of rows 1 to 6 |
||||||
8 |
Replacement cost associated with SA-CCR transactions (i.e. net of eligible cash variation margin) Articles 274, 275, 295, 296, 297, 298, 429c and 429c(3) CRR Institutions shall disclose the current replacement cost as specified in Article 275(1) of contracts listed in Annex II CRR and credit derivatives including those that are off-balance sheet. These replacement costs shall be net of eligible cash variation margin in accordance with Article 429c(3) CRR whereas any cash variation margin received on an exempted CCP leg in accordance with points (g) or (h) of Article 429a(1) CRR shall not be included. As determined by Article 429c(1) CRR, institutions may take into account the effects of contracts for novation and other netting agreements in accordance with Article 295 CRR. Cross-product netting shall not apply. However, institutions may net within the product category referred to in point (c) of Article 272(25) CRR and credit derivatives when they are subject to a contractual cross-product netting agreement referred to in point (c) of Article 295 CRR. Institutions shall not include in this cell contracts measured by application of the approaches in accordance with Articles 429c(6), i.e. the approaches in Section 4 or 5 of Chapter 6 of Title II of Part Three CRR (the simplified SA-CCR or Original Exposure Method). When calculating the replacement costs institutions shall include, in accordance with Article 429c(4) CRR, the effect of the recognition of collateral on NICA on derivative contracts with clients where those contracts are cleared by a QCCP. The amount shall be disclosed with the 1,4 alpha factor as specified in Article 274(2) CRR. |
||||||
EU-8a |
Derogation for derivatives: replacement costs contribution under the simplified standardised approach Articles 429c(6) and 281 CRR This cell provides the exposure measure of contracts listed in points 1 and 2 of Annex II CRR, calculated in accordance with the simplified standardised approach set out in Article 281 CRR, without the effect of collateral on NICA. The amount shall be disclosed with the 1,4 alpha factor applied as specified in Article 274(2) CRR. Institutions that apply the simplified standardised approach shall not reduce the total exposure measure by the amount of margin received in accordance with Article 429c(6) CRR. Hence the exception for derivative contracts with clients where those contracts are cleared by a QCCP in Article 429c(4) CRR shall not apply. Institutions shall not consider in this cell contracts measured by application of the SA-CCR or the original exposure method. |
||||||
9 |
Add-on amounts for potential future exposure associated with SA-CCR derivatives transactions Articles 274, 275, 295, 296, 297, 298, 299 (2) and 429c CRR Institutions shall disclose the add-on for the potential future exposure of contracts listed in Annex II of CRR and of credit derivatives including those that are off-balance sheet calculated in accordance with Article 278 CRR for contracts listed in Annex II CRR and Article 299(2) CRR for credit derivatives and applying netting rules in accordance with Article 429c(1) CRR. In determining the exposure value of those contracts, institutions may take into account the effects of contracts for novation and other netting agreements in accordance with Article 295 CRR. Cross-product netting shall not apply. However, institutions may net within the product category referred to in point (c) of Article 272(25) CRR and credit derivatives when they are subject to a contractual cross-product netting agreement referred to in point (c) of Article 295 CRR. In accordance with Article 429c(5) CRR, institutions shall set the value of the multiplier used in the calculation of the potential future exposure in accordance with Article 278(1) CRR to one, except in the case of derivative contracts with clients where those contracts are cleared by a QCCP. Institutions shall not include in this cell contracts measured by application of the approaches in accordance with Articles 429c(6), i.e. the approaches in Section 4 or 5 of Chapter 6 of Title II of Part Three CRR (the simplified SA-CCR or Original Exposure Method). |
||||||
EU-9a |
Derogation for derivatives: Potential future exposure contribution under the simplified standardised approach Article 429c(5) CRR The potential future exposure in accordance with the simplified standardised approach set out in Article 281 CRR, assuming a multiplier of 1. The amount shall be disclosed with the 1,4 alpha factor applied as specified in Article 274(2) CRR. Institutions that apply the simplified standardised approach shall not reduce the total exposure measure by the amount of margin received in accordance with Article 429c(6) CRR. Hence, the exception for derivative contracts with clients where those contracts are cleared by a QCCP in Article 429c(5) CRR shall not apply. Institutions shall not consider in this cell contracts measured by application of the SA-CCR or the original exposure method. |
||||||
EU-9b |
Exposure determined under Original Exposure Method Article 429c(6) and Section 4 or 5 of Chapter 6 of Title II of Part Three CRR Institutions shall disclose the exposure measure of contracts listed in points 1 and 2 of Annex II CRR calculated in accordance with the Original Exposure Method set out in Section 4 or 5 of Chapter 6 of Title II of Part Three CRR. Institutions that apply the Original Exposure Method shall not reduce the exposure measure by the amount of margin they have received in accordance with Article 429c(6) CRR. Institutions that do not use the Original Exposure Method shall not disclose this cell. |
||||||
10 |
(Exempted CCP leg of client-cleared trade exposures) (SA-CCR) Points (g) and (h) of Article 429a(1) CRR Institutions shall disclose the exempted trade exposures to a QCCP from client-cleared derivatives transactions (SA-CCR), provided that those items meet the conditions laid down in point (c) Article 306(1) CRR. Since it reduces the total exposure measure, institutions shall place the value in this cell between brackets (negative amount). The amount disclosed must also be included in the applicable cells above as if no exemption applied. |
||||||
EU-10a |
(Exempted CCP leg of client-cleared trade exposures) (simplified standardised approach) Points (g) and (h) of Article 429a(1) CRR Institutions shall disclose the exempted trade exposures to a QCCP from client-cleared derivatives transactions (simplified standardised approach), provided that those items meet the conditions laid down in point (c) of Article 306(1) CRR. The amount shall be disclosed with the 1,4 alpha factor applied as specified in Article 274(2) CRR (negative amount). The disclosed amount must also be included in the applicable cells above as if no exemption applied. |
||||||
EU-10b |
(Exempted CCP leg of client-cleared trade exposures) (Original Exposure Method) Points (g) and (h) of Article 429a(1) CRR Institutions shall disclose the exempted trade exposures to a QCCP from client-cleared derivatives transactions (original exposure method), provided that those items meet the conditions laid down in point (c) of Article 306(1) CRR. Since it reduces the total exposure measure institutions shall place the value in this cell between brackets (negative amount). The disclosed amount must also be included in the applicable cells above as if no exemption applied. |
||||||
11 |
Adjusted effective notional amount of written credit derivatives Article 429d CRR Institutions shall disclose the capped notional value of written credit derivatives (i.e. where the institution is providing credit protection to a counterparty) as set out in Article 429d CRR. |
||||||
12 |
(Adjusted effective notional offsets and add-on deductions for written credit derivatives) Article 429d CRR Institutions shall disclose the capped notional value of purchased credit derivatives (i.e. where the institution is buying credit protection from a counterparty) on the same reference names as those credit derivatives written by the institution, where the remaining maturity of the purchased protection is equal to or greater than the remaining maturity of the sold protection. Hence, the value shall not be greater than the value entered in row 11 of template EU LR2 - LRCom for each reference name. Since the disclosed amount reduces the total exposure measure, institutions shall place the value in this cell between brackets (negative amount). The disclosed amount must also be included in the previous cell as if no adjustment applied. |
||||||
13 |
Total derivatives exposures Sum of rows 8 to 12 |
||||||
14 |
Gross SFT assets (with no recognition of netting), after adjustment for sales accounting transactions Point (77) of Article 4(1), Articles 206 and 429e(6) CRR Institutions shall disclose the accounting balance sheet value, under the applicable accounting framework, of SFTs both covered and not covered by a master netting agreement eligible under Article 206 CRR, where the contracts are recognised as assets on the balance sheet assuming no prudential or accounting netting or risk mitigation effects (i.e. the accounting balance sheet value adjusted for the effects of accounting netting or risk mitigation). Furthermore, where sale accounting is achieved for a SFT under the applicable accounting framework, institutions shall reverse all sales related accounting entries in accordance with Article 429e(6) CRR. Institutions shall not include in this cell cash received or any security that is provided to a counterparty via the aforementioned transactions and is retained on the balance sheet (i.e. the accounting criteria for derecognition are not met). |
||||||
15 |
(Netted amounts of cash payables and cash receivables of gross SFT assets) Point (77) of Article 4(1), Article 206, point (b) of Article 429b(1), Articles 429b(4) and 429e(6) CRR. Institutions shall disclose the cash payables amount of gross SFT assets that have been netted in accordance with Article 429b(4) CRR. As this adjustment reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
16 |
Counterparty credit risk exposure for SFT assets Article 429e(1) CRR Institutions shall disclose the add-on for SFTs counterparty credit risk, including those that are off-balance sheet, determined in accordance with Article 429e(2) or (3) CRR, as applicable. Institutions shall include in this cell transactions in accordance with point (c) of Article 429e(7) CRR. Institutions shall not include in this cell agent SFTs where the institution provides an indemnity or guarantee to a customer or counterparty limited to any difference between the value of the security or cash the customer has lent and the value of collateral the borrower has provided in accordance with point (a) of Article 429e(7) CRR. |
||||||
EU-16a |
Derogation for SFTs: Counterparty credit risk exposure in accordance with Articles 429e(5) and 222 CRR Articles 429e(5) and 222 CRR Institutions shall disclose the add-on for SFTs including those that are off-balance sheet calculated in accordance with Article 222 CRR, subject to a 20 % floor for the applicable risk weight. Institutions shall include in this cell transactions in accordance with point (c) of Article 429e(7) CRR. Institutions shall not include in this cell transactions for which the add-on part of the leverage ratio exposure value is determined in accordance with the method defined in Article 429e(1) CRR. |
||||||
17 |
Agent transaction exposures Article 429e(2)(3) and point (a) of Article 429e(7) CRR Institutions shall disclose the exposure value for agent SFTs where the institution provides an indemnity or guarantee to a customer or counterparty limited to any difference between the value of the security or cash the customer has lent and the value of collateral the borrower has provided in accordance with point (a) of Article 429e(7) CRR. The exposure value shall consist only of the add-on determined in accordance with Article 429e(2) or (3) CRR, as applicable. Institutions shall not include in this cell transactions in accordance with point (c) of Article 429e(7) CRR. |
||||||
EU-17a |
(Exempted CCP leg of client-cleared SFT exposure) Points (g) and (h) of Article 429a(1) and point (c) of Article 306(1) CRR. Institutions shall disclose the exempted CCP leg of client-cleared trade exposures of SFTs, provided that those items meet the conditions laid down in point (c) of Article 306(1) CRR. Where the exempted leg to the CCP is a security, it shall not be included in this cell, unless it is a repledged security that under the applicable accounting framework (i.e. in accordance with the first sentence of Article 111(1) CRR) is included at full value. As this adjustment reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). The disclosed amount must also be included in the applicable cells above as if no exemption applied. |
||||||
18 |
Total securities financing transaction exposures Sum of rows 14 to EU-17a |
||||||
19 |
Off-balance sheet exposures at gross notional amount Article 429f CRR Institutions shall disclose the nominal value of all off-balance sheet items as defined in Article 429f CRR, before any adjustment for conversion factors and specific credit risk adjustments. |
||||||
20 |
(Adjustments for conversion to credit equivalent amounts) Article 429f CRR Reduction in gross amount of off-balance sheet exposures due to the application of CCFs. Since it reduces the total exposure measure, the value disclosed in this row shall contribute negatively in the calculation of the sum to be disclosed in row 22 of template EU LR2 - LRCom. |
||||||
21 |
(General provisions deducted in determining Tier 1 capital and specific provisions associated with off-balance sheet exposures) Articles 429(4) and 429f(1) and (2) CRR Institutions may reduce the credit exposure equivalent amount of an off-balance-sheet item by the corresponding amount of general credit risk adjustments that are deducted from Tier 1 capital. The calculation shall be subject to a floor of zero. Institutions may reduce the credit exposure equivalent amount of an off-balance-sheet item by the corresponding amount of specific credit risk adjustments. The calculation shall be subject to a floor of zero. The absolute value of these credit risk adjustments shall not exceed the sum of rows 19 and 20. As these adjustments reduce the total exposure measure, institutions shall place the value in this row between brackets (negative amount). The disclosed amount shall also be included in the applicable cells above as if this reduction did not apply. |
||||||
22 |
Off-balance sheet exposures Articles 429f, 111(1) and 166(9) CRR; sum of rows 19 to 21 Institutions shall disclose the leverage ratio exposure values for off-balance sheet items determined in accordance with Article 429f CRR taking into account the relevant conversion factors. Institutions shall take into account that rows 20-21 of template EU LR2 - LRCom contribute negatively in the calculation of this sum. |
||||||
EU-22a |
(Exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) CRR)) Point (c) of Article 429a(1) and Article 113(6) and (7) CRR Institutions shall disclose the exposures exempted in accordance with point (c) of Article 429a(1). The disclosed amount shall also be included in the applicable cells above as if no exemption applied. Since this amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22b |
(Exposures exempted in accordance with point (j) of Article 429a(1) CRR (on and off balance sheet)) Point (j) of Article 429a(1) CRR Institutions shall disclose the exposures exempted in accordance with point (j) of Article 429a(1) CRR subject to the therein stated conditions being met. The disclosed amount shall also be included in the applicable cells above as if no exemption applied. Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22c |
(Excluded exposures of public development banks (or units) – Public sector investments) Point (d) of Article 429a(1) and Article 429a(2) CRR The exposures arising from assets that constitute claims on central governments, regional governments, local authorities or public sector entities in relation to public sector investments, which can be excluded in accordance with point (d) of Article 429a(1) CRR. This shall only include cases where the institution is a public development credit institution, or the exposures are held within a unit treated as a public development unit in accordance with the last subparagraph of Article 429a(2) CRR. Since the amount reduces the total exposure measure, institutions shall place the value in this cell between brackets (negative amount). |
||||||
EU-22d |
(Excluded exposures of public development banks (or units) – Promotional loans) Point (d) of Article 429a(1) and Article 429a(2) CRR Institutions shall disclose the excluded promotional loans in accordance with point (d) of Article 429a(1) CRR. This shall only include cases where the institution is a public development credit institution or promotional loans are held within a unit treated as a public development unit in accordance with the last subparagraph of Article 429a(2) CRR. Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22e |
(Excluded passing-through promotional loan exposures by non-public development banks (or units)) Point (e) of Article 429a(1) CRR Institutions shall disclose the excluded exposures in accordance with point (e) of Article 429a(1) CRR relating to the parts of exposures arising from passing-through promotional loans to other credit institutions. This shall only include cases where the institution is not a public development credit institution and the activity is not with any unit treated as a public development unit in accordance with the last subparagraph of Article 429a(2) CRR. Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22f |
(Excluded guaranteed parts of exposures arising from export credits) Point (f) of Article 429a(1) CRR The guaranteed parts of exposures arising from export credits that can be excluded when the conditions of point (f) of Article 429a(1) CRR are met. Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22g |
(Excluded excess collateral deposited at triparty agents) Point (k) of Article 429a(1) CRR The excess collateral deposited at triparty agents that has not been lent out, which can be excluded in accordance with point (k) of Article 429a(1) CRR. Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22h |
(Excluded CSD related services of CSD/institutions in accordance with point (o) of Article 429a(1) CRR) Point (o) of Article 429a(1) CRR The Central Securities Depositories (CSD) related services of CSD/ institutions that can be excluded in accordance with point (o) of Article 429a(1) CRR. Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22i |
(Excluded CSD related services of designated institutions in accordance with point (p) of Article 429a(1) CRR) Point (p) of Article 429a(1) CRR The CSD related services of designated institutions that can be excluded in accordance with point (p) of Article 429a(1) CRR. Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22j |
(Reduction of the exposure value of pre-financing or intermediate loans) Article 429(8) CRR The amount reduced from the exposure value of a pre-financing loan or an intermediate loan, in accordance with Article 429(8) CRR. Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
EU-22k |
(Total excluded exposures) Sum of rows EU-22a to EU-22j Since the amount reduces the total exposure measure, institutions shall place the value in this row between brackets (negative amount). |
||||||
23 |
Tier 1 capital Articles 429(3) and 499(1) and (2) CRR Institutions shall disclose the amount of Tier 1 capital calculated in accordance with the choice that the institution has made pursuant to Article 499(2) CRR, as disclosed in row EU-27 of template EU LR2 - LRCom. More specifically, where the institution has chosen to disclose Tier 1 capital in accordance with point (a) of Article 499(1) CRR, it shall disclose the amount of Tier 1 capital as calculated in accordance with Article 25 CRR, without taking into account the derogations laid down in Chapters 1 and 2 of Title I of Part Ten of CRR. In contrast, where the institution has chosen to disclose Tier 1 capital in accordance with point (b) of Article 499(1) CRR, it shall disclose the amount of Tier 1 capital as calculated in accordance with Article 25 CRR, after taking into account the derogations laid down in Chapters 1 and 2 of Title I of Part Ten CRR. |
||||||
24 |
Total exposure measure Sum of amounts in rows 7, 13, 18, 22, and EU-22k of EU LR2 - LRCom |
||||||
25 |
Leverage ratio (%) Institutions shall disclose the amount in row 23 of template EU LR2 - LRCom expressed as a percentage of the amount in row 24 of template EU LR2 - LRCom. |
||||||
EU-25 |
Leverage ratio (excluding the impact of the exemption of public sector investments and promotional loans) (%) In accordance with Article 451(2) CRR, public development credit institutions as defined in Article 429a(2) CRR shall disclose the leverage ratio without the adjustment to the total exposure measure determined in accordance with point (d) of Article 429a(1) CRR, i.e. the adjustment that is disclosed in rows EU-22c and EU-22d of this template. |
||||||
25a |
Leverage ratio (excluding the impact of any applicable temporary exemption of central bank reserves) (%) If an institution’s total exposure measure is subject to the temporary exemption of central bank reserves set out in point (n) of Article 429a(1) CRR, this ratio is defined as the Tier 1 capital measure divided by the sum of the total exposure measure and the amount of the central bank reserves exemption, with this ratio expressed as a percentage. If the institution’s total exposure measure is not subject to a temporary exemption of central bank reserves, this ratio will be identical to the ratio disclosed in row 25. |
||||||
26 |
Regulatory minimum leverage ratio requirement (%) Point (d) of Article 92(1), point (n) of Article 429a(1) and Article 429a(7) CRR Institutions shall disclose the leverage ratio requirement as set out in point (d) of Article 92(1) CRR. Where an institution excludes the exposures referred to in point (n) of Article 429a(1) CRR, it shall disclose the adjusted leverage ratio requirement calculated in accordance with Article 429a(7) CRR. |
||||||
EU-26a |
Additional own funds requirements to address the risk of excessive leverage (%) The additional own funds requirements to address the risk of excessive leverage imposed by the competent authority under point (a) of Article 104(1) of Directive 2013/36/EU (‘CRD’), expressed as a percentage of the total exposure measure |
||||||
EU-26b |
of which: to be made up of CET1 capital (percentage points) The part of the additional own funds requirements to address the risk of excessive leverage imposed by the competent authority under point (a) of Article 104(1) CRD, which has to be met with CET 1 capital in accordance with the third subparagraph of Article 104a(4) |
||||||
27 |
Leverage ratio buffer requirement (%) Article 92(1a) CRR Institutions that are subject to Article 92(1a) CRR shall disclose their applicable leverage ratio buffer requirement. |
||||||
EU-27a |
Overall leverage ratio requirement (%) Sum of rows 26, EU-26a, and 27 of this template |
||||||
EU-27b |
Choice on transitional arrangements for the definition of the capital measure Article 499(2) CRR Institutions shall specify their choice of transitional arrangements for capital for the purpose of disclosure requirements by disclosing one of the following two labels:
|
||||||
28 |
Mean of daily values of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables Article 451(3) CRR; mean of the sums of rows 14 and 15, based on the sums calculated as of each day of the disclosure quarter |
||||||
29 |
Quarter-end value of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables If rows 14 and 15 are based on quarter-end values, this amount is the sum of rows 14 and 15. If rows 14 and 15 are based on averaged values, this amount is the sum of quarter-end values corresponding to the content of rows 14 and 15. |
||||||
30 |
Total exposure measure (including the impact of any applicable temporary exemption of central bank reserves) incorporating mean values from row 28 of gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables) Article 451(3) CRR Total exposure measure (including the impact of any applicable temporary exemption of central bank reserves), using mean values calculated as of each day of the disclosure quarter for the amounts of the exposure measure associated with gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables). |
||||||
30a |
Total exposure measure (excluding the impact of any applicable temporary exemption of central bank reserves) incorporating mean values from row 28 of gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables) Article 451(3) CRR Total exposure measure (excluding the impact of any applicable temporary exemption of central bank reserves), using mean values calculated as of each day of the disclosure quarter for the amounts of the exposure measure associated with gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables). If an institutions total exposure measure is not subject to a temporary exemption of central bank reserves, this value will be identical to the value disclosed in row 30 of this template. |
||||||
31 |
Leverage ratio (including the impact of any applicable temporary exemption of central bank reserves) incorporating mean values from row 28 of gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables) Article 451(3) CRR |
||||||
31a |
Leverage ratio (excluding the impact of any applicable temporary exemption of central bank reserves) incorporating mean values from row 28 of gross SFT assets (after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables) Article 451(3) CRR |
Template EU LR3 - LRSpl: Split-up of on-balance sheet exposures (excluding derivatives, SFTs and exempted exposures).
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
EU-1 |
Total on-balance sheet exposures (excluding derivatives and SFTs, and exempted exposures), of which: Institutions shall disclose the sum of the amounts in row EU-2 and EU-3 of template EU LR3 - LRSpl. |
EU-2 |
Trading book exposures Institutions shall disclose the exposures which are part of the total exposure value of assets belonging to the trading book excluding derivatives, SFTs and exempted exposures. |
EU-3 |
Banking book exposures, of which: Institutions shall disclose the sum of values in rows EU-4 to EU-12 of template EU LR3-LRSpl. |
EU-4 |
Covered Bonds Institutions shall disclose the sum of exposures, which is the total exposure value of assets that are in the form of covered bonds as defined in Article 129 and in point (d) of Article 161(1) CRR. Institutions shall disclose the covered bonds total exposure net of defaulted exposures. |
EU-5 |
Exposures treated as sovereigns Institutions shall disclose the sum of exposures, which is the total exposure value towards entities that are treated as sovereigns under CRR. (Central governments and central banks (Article 114, and point (a) of Article 147(2) CRR); regional governments and local authorities treated as sovereigns (Article 115(2) and (4), and point (a) of Article 147(3) CRR), multilateral development banks and international organisations treated as sovereigns (Articles 117(2) and 118, and points (b) and (c) of Article 147(3) CRR), public sector entities (Article 116(4) and point (a) of Article 147(3) CRR) Institutions shall disclose the sovereign total exposure net of defaulted exposures. |
EU-6 |
Exposures to regional governments, MDB, International organisations and PSE, not treated as sovereigns Institutions shall disclose the sum of exposures, which is the total exposure value towards regional governments and local authorities as defined in Article 115(1), (3) and (5) CRR for SA exposures and in point (a) of Article 147(4) CRR for IRB exposures; multilateral development banks as defined in Article 117(1) and (3) CRR for SA exposures and in point (c) of Article 147(4) CRR for IRB exposures; international organisations and public sector entities as defined in Article 116(1), (2), (3) and (5) CRR for SA exposures and in point (b) of Article 147(4) CRR for IRB exposures that are not treated as sovereigns under CRR. Institutions shall disclose the abovementioned total exposure net of defaulted exposures. |
EU-7 |
Institutions Institutions shall disclose the sum of exposures, which is the exposure value of exposures towards institutions that fall under Articles 119 to 121 CRR for SA exposures and for IRB exposures - that fall under point (b) of Article 147(2) CRR and are not exposures in the form of covered bonds under point (d) of Article 161 (1) CRR and do not fall under points (a) to (c) of Article 147(4) CRR. Institutions shall disclose the total exposure net of defaulted exposures. |
EU-8 |
Secured by mortgages of immovable properties Institutions shall disclose the sum of exposures, which is the exposure value of assets that are exposures secured by mortgages on immovable properties that fall under Article 124 CRR in case of SA exposures and that are exposures to corporate under point (c) of Article 147(2) CRR or retail exposures under point (d) of Article 147(2) CRR if these exposures are secured by mortgages on immovable property in accordance with point (a) of Article 199(1) CRR for IRB exposures. Institutions shall disclose the total exposure net of defaulted exposures. |
EU-9 |
Retail exposures Institutions shall disclose the sum of exposures, which is the total exposure value of assets that are retail exposures under Article 123 CRR in case of SA exposures and that are exposures under point (d) of Article 147(2) CRR, if these exposures are not secured by mortgages on immovable property in accordance with point (a) of Article 199(1) CRR – for IRB exposures. Institutions shall disclose the total exposure net of defaulted exposures. |
EU-10 |
Corporates Institutions shall disclose the sum of exposures, which is the total exposure value of assets that are corporate exposure (i.e. financial and non-financial). For SA exposures, these are exposures to corporates that fall under Article 122 CRR and for IRB exposures - that are exposures to corporates under point (c) of Article 147(2) CRR if these exposures are not secured by mortgages on immovable property in accordance with point (a) of Article 199(1) CRR. Financial corporates shall mean regulated and unregulated undertakings other than institutions referred to in EU-7 of this template, whose principal activity is to acquire holdings or to pursue one or more of the activities listed in Annex I CRD, as well as undertakings as defined in point (27) of Article 4(1) CRR, other than institutions referred to in EU-7 of this template. For the purpose of this cell, the term 'small and medium enterprise' is defined in accordance with point (b) of Article 501(2) CRR. Institutions shall disclose the total exposure net of defaulted exposures. |
EU-11 |
Exposures in default Institutions shall disclose the sum of exposures, which is the total exposure value of assets that are in default and – for SA exposures - fall under Article 127 CRR or, in case of IRB exposures, are categorised in the exposures classes listed in Article 147(2) CRR if a default in accordance with Article 178 CRR has occurred. |
EU-12 |
Other exposures (eg equity, securitisations, and other non-credit obligation assets) Institutions shall disclose the sum of exposures, which is the total exposure value of other non-trading book exposures under CRR (e.g. equity, securitisations and non-credit obligation assets; in case of SA exposures these are assets categorised in the exposures classes listed in points (k), (m), (n), (o), (p) and (q) of Article 112 CRR, and in case of IRB exposures – in points (e), (f) and (g) of Article 147(2) CRR). Institutions shall include assets that are deducted in determining Tier 1 capital and therefore are disclosed in row 2 of template EU LR2-LRCom, unless these assets are included in row EU-2, EU-4 to EU-11 of template EU LR3- LRSpl. |
Table EU LRA - Disclosure of LR qualitative information.
Free format text boxes for disclosure of qualitative information
Legal references and instructions |
|||||||||||
Row number |
Explanation |
||||||||||
(a) |
Description of the processes used to manage the risk of excessive leverage Point (d) of Article 451(1) CRR ‘Description of the processes used to manage the risk of excessive leverage’ shall include any relevant information on:
|
||||||||||
(b) |
Description of the factors that had an impact on the leverage ratio during the period to which the disclosed leverage ratio refers Point (e) of Article 451(1) CRR ‘Description of the factors that had an impact on the leverage ratio during the period to which the disclosed leverage ratio refers’ shall include any material information on:
|
ANNEX XIII
Table EU LIQA - Liquidity risk management
Row number |
Qualitative information - Free format |
|
(a) |
Strategies and processes in the management of the liquidity risk, including policies on diversification in the sources and tenor of planned funding, |
|
(b) |
Structure and organisation of the liquidity risk management function (authority, statute, other arrangements). |
|
(c) |
A description of the degree of centralisation of liquidity management and interaction between the group’s units |
|
(d) |
Scope and nature of liquidity risk reporting and measurement systems. |
|
(e) |
Policies for hedging and mitigating the liquidity risk and strategies and processes for monitoring the continuing effectiveness of hedges and mitigants. |
|
(f) |
An outline of the bank's contingency funding plans. |
|
(g) |
An explanation of how stress testing is used. |
|
(h) |
A declaration approved by the management body on the adequacy of liquidity risk management arrangements of the institution providing assurance that the liquidity risk management systems put in place are adequate with regard to the institution’s profile and strategy. |
|
(i) |
A concise liquidity risk statement approved by the management body succinctly describing the institution’s overall liquidity risk profile associated with the business strategy. This statement shall include key ratios and figures (other than those already covered in the EU LIQ1 template under this ITS ) providing external stakeholders with a comprehensive view of the institution’s management of liquidity risk, including how the liquidity risk profile of the institution interacts with the risk tolerance set by the management body. These ratios may include: |
|
|
||
|
||
|
||
|
Template EU LIQ1 - Quantitative information of LCR
Scope of consolidation: (solo/consolidated)
|
a |
b |
c |
d |
e |
f |
g |
h |
|
Total unweighted value (average) |
Total weighted value (average) |
||||||||
EU 1a |
Quarter ending on (DD Month YYY) |
T |
T-1 |
T-2 |
T-3 |
T |
T-1 |
T-2 |
T-3 |
EU 1b |
Number of data points used in the calculation of averages |
|
|
|
|
|
|
|
|
HIGH-QUALITY LIQUID ASSETS |
|||||||||
1 |
Total high-quality liquid assets (HQLA) |
[Bild bitte in Originalquelle ansehen] |
|
|
|
|
|||
CASH - OUTFLOWS |
|||||||||
2 |
Retail deposits and deposits from small business customers, of which: |
|
|
|
|
|
|
|
|
3 |
Stable deposits |
|
|
|
|
|
|
|
|
4 |
Less stable deposits |
|
|
|
|
|
|
|
|
5 |
Unsecured wholesale funding |
|
|
|
|
|
|
|
|
6 |
Operational deposits (all counterparties) and deposits in networks of cooperative banks |
|
|
|
|
|
|
|
|
7 |
Non-operational deposits (all counterparties) |
|
|
|
|
|
|
|
|
8 |
Unsecured debt |
|
|
|
|
|
|
|
|
9 |
Secured wholesale funding |
[Bild bitte in Originalquelle ansehen] |
|
|
|
|
|||
10 |
Additional requirements |
|
|
|
|
|
|
|
|
11 |
Outflows related to derivative exposures and other collateral requirements |
|
|
|
|
|
|
|
|
12 |
Outflows related to loss of funding on debt products |
|
|
|
|
|
|
|
|
13 |
Credit and liquidity facilities |
|
|
|
|
|
|
|
|
14 |
Other contractual funding obligations |
|
|
|
|
|
|
|
|
15 |
Other contingent funding obligations |
|
|
|
|
|
|
|
|
16 |
TOTAL CASH OUTFLOWS |
[Bild bitte in Originalquelle ansehen] |
|
|
|
|
|||
CASH - INFLOWS |
|||||||||
17 |
Secured lending (e.g. reverse repos) |
|
|
|
|
|
|
|
|
18 |
Inflows from fully performing exposures |
|
|
|
|
|
|
|
|
19 |
Other cash inflows |
|
|
|
|
|
|
|
|
EU-19a |
(Difference between total weighted inflows and total weighted outflows arising from transactions in third countries where there are transfer restrictions or which are denominated in non-convertible currencies) |
[Bild bitte in Originalquelle ansehen] |
|
|
|
|
|||
EU-19b |
(Excess inflows from a related specialised credit institution) |
[Bild bitte in Originalquelle ansehen] |
|
|
|
|
|||
20 |
TOTAL CASH INFLOWS |
|
|
|
|
|
|
|
|
EU-20a |
Fully exempt inflows |
|
|
|
|
|
|
|
|
EU-20b |
Inflows subject to 90% cap |
|
|
|
|
|
|
|
|
EU-20c |
Inflows subject to 75% cap |
|
|
|
|
|
|
|
|
TOTAL ADJUSTED VALUE |
|||||||||
EU-21 |
LIQUIDITY BUFFER |
[Bild bitte in Originalquelle ansehen] |
|
|
|
|
|||
22 |
TOTAL NET CASH OUTFLOWS |
[Bild bitte in Originalquelle ansehen] |
|
|
|
|
|||
23 |
LIQUIDITY COVERAGE RATIO |
[Bild bitte in Originalquelle ansehen] |
|
|
|
|
Table EU LIQB on qualitative information on LCR, which complements template EU LIQ1.
in accordance with Article 451a(2) CRR
Row number |
Qualitative information - Free format |
|
(a) |
Explanations on the main drivers of LCR results and the evolution of the contribution of inputs to the LCR’s calculation over time |
|
(b) |
Explanations on the changes in the LCR over time |
|
(c) |
Explanations on the actual concentration of funding sources |
|
(d) |
High-level description of the composition of the institution's liquidity buffer. |
|
(e) |
Derivative exposures and potential collateral calls |
|
(f) |
Currency mismatch in the LCR |
|
(g) |
Other items in the LCR calculation that are not captured in the LCR disclosure template but that the institution considers relevant for its liquidity profile |
|
Template EU LIQ2: Net Stable Funding Ratio
In accordance with Article 451a(3) CRR
|
a |
b |
c |
d |
e |
|
(in currency amount) |
Unweighted value by residual maturity |
Weighted value |
||||
No maturity |
< 6 months |
6 months to < 1yr |
≥ 1yr |
|||
Available stable funding (ASF) Items |
||||||
1 |
Capital items and instruments |
|
|
|
|
|
2 |
Own funds |
|
|
|
|
|
3 |
Other capital instruments |
|
|
|
|
|
4 |
Retail deposits |
|
|
|
|
|
5 |
Stable deposits |
|
|
|
|
|
6 |
Less stable deposits |
|
|
|
|
|
7 |
Wholesale funding: |
|
|
|
|
|
8 |
Operational deposits |
|
|
|
|
|
9 |
Other wholesale funding |
|
|
|
|
|
10 |
Interdependent liabilities |
|
|
|
|
|
11 |
Other liabilities: |
|
|
|
|
|
12 |
NSFR derivative liabilities |
|
|
|
|
|
13 |
All other liabilities and capital instruments not included in the above categories |
|
|
|
|
|
14 |
Total available stable funding (ASF) |
|
|
|
|
|
Required stable funding (RSF) Items |
||||||
15 |
Total high-quality liquid assets (HQLA) |
|
|
|
|
|
EU-15a |
Assets encumbered for a residual maturity of one year or more in a cover pool |
|
|
|
|
|
16 |
Deposits held at other financial institutions for operational purposes |
|
|
|
|
|
17 |
Performing loans and securities: |
|
|
|
|
|
18 |
Performing securities financing transactions with financial customers collateralised by Level 1 HQLA subject to 0% haircut |
|
|
|
|
|
19 |
Performing securities financing transactions with financial customer collateralised by other assets and loans and advances to financial institutions |
|
|
|
|
|
20 |
Performing loans to non- financial corporate clients, loans to retail and small business customers, and loans to sovereigns, and PSEs, of which: |
|
|
|
|
|
21 |
With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
|
|
|
|
|
22 |
Performing residential mortgages, of which: |
|
|
|
|
|
23 |
With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
|
|
|
|
|
24 |
Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products |
|
|
|
|
|
25 |
Interdependent assets |
|
|
|
|
|
26 |
Other assets: |
|
|
|
|
|
27 |
Physical traded commodities |
|
|
|
|
|
28 |
Assets posted as initial margin for derivative contracts and contributions to default funds of CCPs |
|
|
|
||
29 |
NSFR derivative assets |
|
|
|
||
30 |
NSFR derivative liabilities before deduction of variation margin posted |
|
|
|
||
31 |
All other assets not included in the above categories |
|
|
|
|
|
32 |
Off-balance sheet items |
|
|
|
|
|
33 |
Total RSF |
|
|
|
|
|
34 |
Net Stable Funding Ratio (%) |
|
|
|
|
|
ANNEX XIV
Instructions for the liquidity requirements templates
Instructions on Table EU LIQA on liquidity risk management and on template EU LIQ1 regarding LCR
Table EU LIQA - Liquidity risk management
Template EU LIQ1 - Quantitative information of LCR
Legal references and instructions |
|||||||||||||||||
Row number |
Explanation |
||||||||||||||||
1 |
Total high quality liquid assets (HQLA) Institutions shall disclose as the weighted value the amount in accordance with Article 9 of Commission Delegated Regulation (EU) 2015/61 of the liquid assets before applying the adjustment mechanism as referred to in Article 17(2) of Commission Delegated Regulation (EU) 2015/61. |
||||||||||||||||
2 |
Retail deposits and deposits from small business customers, of which: Institutions shall disclose as the unweighted value the amount of the retail deposits in accordance with Articles 24 and 25 of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose as the weighted value the outflow of the retail deposits in accordance with Articles 24 and 25 of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose here on retail deposits in accordance with Article 411(2) CRR. In accordance with Article 28(6) of Commission Delegated Regulation (EU) 2015/61 institutions shall also disclose within the appropriate retail deposit category the amount of the notes, bonds and other securities issued which are sold exclusively in the retail market and held in a retail account. Institutions will consider for this category of liability the applicable outflow rates provided for by the Commission Delegated Regulation (EU) 2015/61 for the different categories of retail deposits. |
||||||||||||||||
3 |
Stable deposits Institutions shall disclose as the unweighted value the sum of the amount of the stable deposits in accordance with Article 24 of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose as the weighted value the sum of the outflow of the stable deposits in accordance with Article 24 of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose here the part of the amounts of retail deposits covered by a Deposit Guarantee Scheme in accordance with Directive 94/19/EC(3) or Directive 2014/49/EU(4) or an equivalent deposit guarantee scheme in a third country and either is part of an established relationship making withdrawal highly unlikely or is held in a transactional account in accordance with Article 24 (2) and (3) of the Commission Delegated Regulation (EU) 2015/61 respectively and where:
|
||||||||||||||||
4 |
Less stable deposits Institutions shall disclose as the unweighted value the sum of the amount of the retail deposits in accordance with Article 25 (1), (2) and (3) of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose as the weighted value the sum of the outflow of the retail deposits in accordance with Article 25(1), (2) and (3) of Commission Delegated Regulation (EU) 2015/61. |
||||||||||||||||
5 |
Unsecured wholesale funding Institutions shall disclose the sums of the unweighted and weighted amounts that are necessary to be disclosed in row 6 'Operational deposits (all counterparties) and deposits in networks of cooperative banks', row 7 'Non-operational deposits (all counterparties)' and row 8 'Unsecured debt' of this template. |
||||||||||||||||
6 |
Operational deposits (all counterparties) and deposits in networks of cooperative banks Institutions shall disclose as the unweighted value the amount of the operational deposits in accordance with Article 27 of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose as the weighted value the outflows of the operational deposits in accordance with Article 27 of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose here the part of the operational deposits, in accordance with Article 27 of the Commission Delegated Regulation (EU) 2015/61, which is necessary for the provision of operational services. Deposits arising out of a correspondent banking relationship or from the provision of prime brokerage services shall be considered non-operational deposits in accordance with Article 27(5) of Commission Delegated Regulation (EU) 2015/61. The part of the operational deposits in excess of the amount necessary for the provision of operational services shall not be disclosed here. |
||||||||||||||||
7 |
Non-operational deposits (all counterparties) Institutions shall disclose as the unweighted value the amount of the non-operational deposits following Article 27(5), Article 28(1) and Article 31A(1) of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose as the weighted value the outflow of the non- operational deposits following Article 27(5), Article 28(1) and Article 31A(1) of Commission Delegated Regulation (EU) 2015/61. Institutions shall disclose here on deposits arising out of a correspondent banking or from the provision of prime brokerage services in accordance with Article 27(5) of Commission Delegated Regulation (EU) 2015/61. The part of operational deposits in accordance with Article 27(5) of Commission Delegated Regulation (EU) 2015/61, in excess of those required for the provision of operational services, shall be disclosed here. |
||||||||||||||||
8 |
Unsecured debt Institutions shall disclose as the unweighted value the outstanding balance of notes, bonds and other debt securities, issued by the institution other than that disclosed as retail deposits as referred to in Article 28(6) of Commission Delegated Regulation (EU) 2015/61. This amount includes also coupons that come due in the next 30 calendar days referred to all these securities. Institutions shall disclose as the weighted value the outflow of those notes, bonds and other debt securities indicated in the previous paragraph. |
||||||||||||||||
9 |
Secured Wholesale funding Institutions shall disclose as the weighted value the sum of the outflow resulting from secured lending or capital market-driven transactions as referred to in in Article 28(3) of Commission Delegated Regulation (EU) 2015/61 and from collateral swaps and other transactions with a similar form in accordance with Articles 28(4) of Commission Delegated Regulation (EU) 2015/61. |
||||||||||||||||
10 |
Additional requirements Institutions shall disclose the sums of the unweighted and weighted amounts that are necessary to be disclosed in row 11 'Outflows related to derivative exposures and other collateral requirements', row 12 'Outflows related to loss of funding on debt products' and row 13 'Credit and liquidity facilities' of this template. |
||||||||||||||||
11 |
Outflows related to derivative exposures and other collateral requirements Institutions shall disclose as the unweighted value and as the weighted value the sum of the following amounts and outflows respectively:
|
||||||||||||||||
12 |
Outflows related to loss of funding on debt products Institutions shall disclose as the unweighted value and as the weighted value the amount and outflows respectively, of the loss of funding on structured financing activities, as envisaged in Article 30(8) to 30(10) of Commission Delegated Regulation (EU) 2015/61. Institutions shall assume 100 % outflow for loss of funding on asset backed securities, covered bonds and other structured financing instruments maturing within the 30 calendar day period issued by the credit institution or by sponsored conduits or SPVs. Institutions that are providers of liquidity facilities associated with financing programs disclosed here do not need to double count the maturing financing instrument and the liquidity facility for consolidated programs. |
||||||||||||||||
13 |
Credit and liquidity facilities Institutions shall disclose as the unweighted value and as the weighted value the amount and outflow respectively, of the credit and liquidity facilities in accordance with Article 31 of Commission Delegated Regulation (EU) 2015/61. Institutions shall also disclose here on committed facilities in accordance with Article 29 of the Commission Delegated Regulation (EU) 2015/61. |
||||||||||||||||
14 |
Other contractual funding obligations Institutions shall disclose as the unweighted value and as the weighted value the sum of amounts and outflows respectively, of the following items:
|
||||||||||||||||
15 |
Other contingent funding obligations Institutions shall disclose as the unweighted value and as the weighted value the sum of amounts and outflows respectively, of the following items:
|
||||||||||||||||
16 |
TOTAL CASH OUTFLOWS Institutions shall disclose the sum of the weighted value of the following items under these instructions:
|
||||||||||||||||
17 |
Secured lending (e.g. reverse repos) Institutions shall disclose as the unweighted value the sum of:
Institutions shall disclose as the weighted value the sum of:
|
||||||||||||||||
18 |
Inflows from fully performing exposures Institutions shall disclose as the unweighted value and as the weighted value the sum of the total amounts and inflows, respectively, of the items:
|
||||||||||||||||
19 |
Other cash inflows Institutions shall disclose as the unweighted value and as the weighted value the sum of the total amounts and inflows respectively, of the items:
|
||||||||||||||||
EU-19a |
(Difference between total weighted inflows and total weighted outflows arising from transactions in third countries where there are transfer restrictions or which are denominated in non-convertible currencies) As envisaged in Article 32(8) of Commission Delegated Regulation (EU) 2015/61, institutions shall disclose as the weighted value the excess of those weighted inflows with respect to those outflows. |
||||||||||||||||
EU-19b |
(Excess inflows from a related specialised credit institution) As envisaged in point (e) of Article 2(3) and in Article 33(6) of Commission Delegated Regulation (EU) 2015/61, credit institutions, for the purposes of disclosing in a consolidated basis, shall disclose as the weighted value the inflows arising from a related specialised credit institution referred to in Article 33(3) and (4) of Commission Delegated Regulation (EU) 2015/61 that are in excess of the amount of outflows arising from the same undertaking. |
||||||||||||||||
20 |
TOTAL CASH INFLOWS Institutions shall disclose the sum of the unweighted and weighted value of the following items under these instructions:
|
||||||||||||||||
EU-20a |
Fully exempt inflows Institutions shall disclose as the unweighted value and as the weighted value the total amount of assets/monies due/maximum amount that can be drawn and their relevant total inflows, respectively, which are exempted from the cap on inflows in accordance with Article 32, Article 33 and Article 34 of Commission Delegated Regulation (EU) 2015/61. |
||||||||||||||||
EU-20b |
Inflows subject to 90 % cap Institutions shall disclose as the unweighted value and as the weighted value the total amount of assets/monies due/maximum amount that can be drawn and their relevant total inflows, respectively, which are subject to the 90 % inflows cap in accordance with Article 32, Article 33 and Article 34 of Commission Delegated Regulation (EU) 2015/61. |
||||||||||||||||
EU-20c |
Inflows subject to 75 % cap Institutions shall disclose as the unweighted value and as the weighted value the total amount of assets/monies due/maximum amount that can be drawn and their relevant total inflows, respectively, which are subject to the 75 % inflows cap in accordance with Article 32, Article 33 and Article 34 of Commission Delegated Regulation (EU) 2015/61. |
||||||||||||||||
EU-21 |
LIQUIDITY BUFFER Institutions shall disclose as the adjusted value the value of the institution's Liquidity buffer calculated in accordance with Annex I – Formulae for the determination of the liquidity buffer composition of Commission Delegated Regulation (EU) 2015/61. |
||||||||||||||||
22 |
TOTAL NET CASH OUTFLOWS Institutions shall disclose as the adjusted value the net liquidity outflow which equals total outflows less the reduction for fully exempt inflows less the reduction for inflows subject to the 90 % cap less the reduction for inflows subject to the 75 % cap. |
||||||||||||||||
23 |
LIQUIDITY COVERAGE RATIO (%) Institutions shall disclose as the adjusted value the percentage of the item 'Liquidity coverage ratio (%)' as defined in Article 4(1) of Commission Delegated Regulation (EU) 2015/61. The liquidity coverage ratio shall be equal to the ratio of a credit institution's liquidity buffer to its net liquidity outflows over a 30 calendar day stress period and shall be expressed as a percentage. |
Table EU LIQB on qualitative information on LCR, which complements template EU LIQ1.
Instructions on template EU LIQ2 on disclosure of Net Stable Funding Ratio (NSFR)
Available stable funding (ASF) Items
Required stable funding (RSF) Items
Legal references and instructions |
|||||||||
Row |
Explanation |
||||||||
|
Available stable funding (ASF) Items |
||||||||
1 |
Capital items and instruments Institutions shall disclose here the sum of amounts in row 2 and row 3 of this template. |
||||||||
2 |
Own funds Points (a), (b) and (c) of Article 428o CRR Institutions shall include here the sum of the following items:
CET1 and AT1 items are perpetual instruments that shall be disclosed in the “no maturity” bucket. In the case of AT1 items callable by the institution, only if the time period to the date of the call options is below one year, they will not be disclosed in the no maturity bucket but in the applicable time bucket (i.e., residual maturity of less than six months or residual maturity of a minimum of six months but less than one year). This is regardless of whether the option has been exercised or not. Regarding T2 items, the maturity bucket of one year or more shall include those instruments with an equivalent residual maturity and, in the exceptional cases of T2 instruments with no maturity, also these instruments. In case T2 items were callable by the institution, and irrespective of whether the institution has exercised the call option, the residual maturity of the instrument will be determined by the date of the call option. In this case, the institution shall disclose these items in the relevant time bucket and shall not apply a 100 % ASF factor if the option may be exercised within one year. |
||||||||
3 |
Other capital instruments Point (d) of Article 428o and point (d) of Article 428k(3) CRR Other capital instruments with a residual maturity of one year or more at the disclosure reference date. In case other capital instruments were callable by the institution, and irrespective of whether the institution has exercised the call option, the residual maturity of the instrument will be determined by the date of the call option. In this case, the institution shall disclose these items in the relevant time bucket and shall not apply a 100 % ASF factor if the option may be exercised within one year. |
||||||||
4 |
Retail deposits Institutions shall disclose here the sum of amounts in row 5 and row 6 of this template. |
||||||||
5 |
Stable retail deposits Article 428n CRR Institutions shall include the part of the amounts of retail deposits covered by a Deposit Guarantee Scheme in accordance with Directive 94/19/EC or Directive 2014/49/EU or an equivalent deposit guarantee scheme in a third country and either is part of an established relationship making withdrawal highly unlikely or is held in a transactional account in accordance with Articles 24(2) and (3) of Commission Delegated Regulation (EU) 2015/61 respectively and where:
|
||||||||
6 |
Less stable retail deposits Article 428m CRR Institutions shall disclose the amount of other retail deposits than those captured as “stable retail deposits” in row 5 of this template. |
||||||||
7 |
Wholesale funding: Institutions shall disclose here the sum of amounts in row 8 and row 9 of this template. |
||||||||
8 |
Operational deposits Point (a) of Article 428l CRR Institutions shall disclose here the part of deposits received (both from financial customers and from other non-financial customers) that fulfil the criteria for operational deposits set out with Article 27 of Commission Delegated Regulation (EU) 2015/61 which is necessary for the provision of operational services. Operational deposits in excess of the amount necessary for the provision of operational services shall not be included here but within row 9, “Other wholesale funding” of this template. Deposits arising out of a correspondent banking relationship or from the provision of prime brokerage services shall be considered non-operational deposits in accordance with Article 27(5) of Commission Delegated Regulation (EU) 2015/61 and shall be disclosed under row 9 “Other wholesale funding” of this template. |
||||||||
9 |
Other wholesale funding Points (b) to (d) of Article 428l, Article 428g and points (c) and (d) of Article 428k (3) CRR Institutions shall disclose here wholesale funding other than the amount of operational deposits that is necessary for the provision of operational services. This shall include liabilities provided by central governments, regional governments, local authorities, public sector entities, multilateral development banks, international organisations, central banks and by any other non-financial or financial customers as well as liabilities where the counterparty cannot be determined, including securities issued where the holder cannot be identified. |
||||||||
10 |
Interdependent liabilities Point (b) of Article 428k(3) CRR Institutions shall disclose liabilities that, having been approved by the relevant competent authority, are treated as interdependent with assets in accordance with Article 428f CRR. |
||||||||
11 |
Other liabilities Institutions shall disclose here the sum of amounts in rows 12 and 13 of this template. |
||||||||
12 |
NSFR derivative liabilities Article 428k(4) CRR Institutions shall disclose the absolute amount of the negative difference between netting sets calculated in accordance with Article 428k(4) CRR. |
||||||||
13 |
All other liabilities and capital instruments not included in the above categories Articles 428k(1) and 428k(3) CRR Institutions shall disclose here the sum of the following items:
|
||||||||
14 |
Total available stable funding (ASF) Chapter 3 of Title IV of Part Six CRR Institutions shall disclose here the total of the items providing available stable funding in accordance with Chapter 3 of Title IV of Part Six CRR (sum of amounts in rows 1, 4, 7, 10 and 11 of this template). |
||||||||
|
Required stable funding (RSF) Items |
||||||||
15 |
Total high-quality liquid assets (HQLA) Institutions shall also include here encumbered and unencumbered high-quality liquid assets pursuant to Commission Delegated Regulation (EU) 2015/61, regardless if they comply with the operational requirements referred to in Article 8 of that Delegated Regulation, in accordance with Articles 428r to 428ae CRR. |
||||||||
EU-15a |
Assets encumbered for a residual maturity of one year or more in a cover pool Article 428ag(h) CRR Institutions shall disclose here the amount of monies due from loans that are not in default in accordance with Article 178 CRR and liquid assets, that are encumbered for a residual maturity of one year or more in a cover pool funded by covered bonds as referred to in Article 52(4) of Directive (EC) 2009/65(7) or covered bonds which meet the eligibility requirements for the treatment as set out in Article 129(4) or (5) CRR. |
||||||||
16 |
Deposits held at other financial institutions for operational purposes Point (b) of Article 428ad CRR Institutions shall disclose here those amounts of monies due from loans that are not in default in accordance with Article 178 CRR, that are operational deposits pursuant to Commission Delegated regulation (EU) 2015/61 and necessary for the provision of operational services. |
||||||||
17 |
Performing loans and securities: Institutions shall disclose here the sum of amounts in rows 18, 19, 20, 22 and 24 of this template. |
||||||||
18 |
Performing securities financing transactions with financial customers collateralised by Level 1 HQLA subject to 0 % haircut Article 428e, point (g) of Article 428r(1) and point (b) of Article 428s CRR Institutions shall disclose here the amount of monies due from securities financing transactions, that are not in default in accordance with Article 178 CRR, with financial customers and that are collateralized by level 1 assets eligible for 0 % haircut pursuant to Commission Delegated Regulation (EU) 2015/61. |
||||||||
19 |
Performing securities financing transactions with financial customers collateralised by other assets and other loans and advances to financial institutions Point (b) of Article 428s, point (d) of Article 428ad, point (b) of Article 428ah(1) and point (a) of Article 428v CRR Institutions shall disclose here the sum of the following items:
|
||||||||
20 |
Performing loans to non- financial corporate clients, loans to retail and small business customers, and loans to sovereigns, and PSEs, of which: Point (c) of Article 428ad, 428af and point (c) of Article 428ag CRR Institutions shall disclose here those amounts of monies due from loans that are not in default in accordance with Article 178 CRR, which are residential loans fully guaranteed by an eligible protection provider as referred to in point (e) of Article 129(1) CRR or loans, excluding loans to financial customers and loans referred to in Articles 428r to 428ad except point (c) of Article 428ad CRR, regardless the risk weights assigned to these loans. This amount shall not include exposures secured by mortgages on residential property. |
||||||||
21 |
With a risk weight of less than or equal to 35 % under the Basel II Standardised Approach for credit risk Point (c) of Article 428ad and 428af CRR Institutions shall disclose here those amounts of loans from row 21 of this template which are assigned a risk weight of less than or equal to 35 % in accordance with Chapter 2 of Title II of Part Three CRR. |
||||||||
22 |
Performing residential mortgages, of which: Point (c) of Article 428ad, point (a) of 428af and point (c) of 428ag CRR Institutions shall disclose here those amounts of monies due from loans that are not in default in accordance with Article 178 CRR, which are loans secured by mortgages on residential property, excluding loans to financial customers and loans referred to in Articles 428r to 428ad CRR, except paragraph (c) of Article 428ad CRR, regardless the risk weights assigned to these loans. |
||||||||
23 |
With a risk weight of less than or equal to 35 % under the Basel II Standardised Approach for credit risk Point (c) of Article 428ad and point (a) of 428af CRR Institutions shall include here those amounts of loans from row 22 of this template, which are assigned a risk weight of less than or equal to 35 % in accordance with Chapter 2 of Title II of Part Three CRR. |
||||||||
24 |
Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products Institutions shall disclose here the sum of:
|
||||||||
25 |
Interdependent assets Article 428f and point (f) of Article 428r(1) CRR Institutions shall disclose here assets that, having been authorized by competent authorities, are being interdependent with liabilities in accordance with Article 428f CRR. |
||||||||
26 |
Other assets: Institutions shall disclose here the sum of amounts in rows 27, 28, 29, 30, and 31 of this template. |
||||||||
27 |
Physically traded commodities Point (g) of Article 428ag CRR Institutions shall disclose here the amount of physically traded commodities. This amount shall not include commodity derivatives. |
||||||||
28 |
Assets posted as initial margin for derivative contracts and contributions to default funds of CCPs Institutions shall disclose here the sum of the following amounts:
|
||||||||
29 |
NSFR derivative assets Articles 428d and 428ah(2) CRR Institutions shall include here the amount of required stable funding arising from derivatives, in accordance with Articles 428d, 428s(2), point (a) of Article 428ag and 428ah(2) CRR, which is calculated as the absolute amount of the positive difference between netting sets calculated in accordance with Article 428ah(2) CRR. |
||||||||
30 |
NSFR derivative liabilities before deduction of variation margin posted Article 428s(2) CRR Institutions shall disclose here the amount of required stable funding related to derivative liabilities, in accordance with Articles 428d, 428s(2), point (a) of 428ag and 428ah(2) CRR, which is the absolute fair value of netting sets with a negative fair value calculated in accordance with Article 428s(2) CRR. |
||||||||
31 |
All other assets not included in the above categories Institutions shall include here the sum of the following items:
|
||||||||
32 |
Off-balance sheet items Institutions shall disclose here the amount of off-balance sheet items that are subject to the required stable funding requirements. |
||||||||
33 |
Total required stable funding (RSF) Chapter 4 of Title IV of Part Six CRR Institutions shall include here the total items subject to the required stable funding in accordance with Chapter 4 of Title IV of Part Six CRR (sum of amounts in rows 15, EU-15a, 16, 17, 25, 26, and 32 of this template). |
||||||||
34 |
Net Stable Funding Ratio (%) NSFR calculated in accordance with Article 428b(1) CRR |
ANNEX XV
Table EU CRA: General qualitative information about credit risk
Qualitative disclosures |
|
(a) |
In the concise risk statement in accordance with point (f) of Article 435(1) CRR, how the business model translates into the components of the institution’s credit risk profile. |
(b) |
When discussing their strategies and processes to manage credit risk and the policies for hedging and mitigating that risk in accordance with points (a) and (d) of Article 435(1) CRR, the criteria and approach used for defining the credit risk management policy and for setting credit risk limits. |
(c) |
When informing on the structure and organisation of the risk management function in accordance with point (b) of Article 435(1) CRR, the structure and organisation of the credit risk management and control function. |
(d) |
When informing on the authority, status and other arrangements for the risk management function in accordance with point (b) of Article 435(1) CRR, the relationships between credit risk management, risk control, compliance and internal audit functions. |
Table EU CRB: Additional disclosure related to the credit quality of assets
Qualitative disclosures |
|
(a) |
The scope and definitions of ‘past-due’ and ‘impaired’ exposures used for accounting purposes and the differences, if any, between the definitions of past due and default for accounting and regulatory purposes as specified by the EBA Guidelines on the application of the definition of default in accordance with Article 178 CRR. |
(b) |
The extent of past-due exposures (more than 90 days) that are not considered to be impaired and the reasons for this. |
(c) |
Description of methods used for determining general and specific credit risk adjustments. |
(d) |
The institution’s own definition of a restructured exposure used for the implementation of point (d) of Article 178(3) CRR specified by the EBA Guidelines on defaultin accordance with Article 178 CRR when different from the definition of forborne exposure defined in Annex V to Commission Implementing Regulation (EU) 680/2014. |
Template EU CR1: Performing and non-performing exposures and related provisions.
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
n |
o |
|
Gross carrying amount/nominal amount |
Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
Accumulated partial write-off |
Collateral and financial guarantees received |
|||||||||||||
Performing exposures |
Non-performing exposures |
Performing exposures – accumulated impairment and provisions |
Non-performing exposures – accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
On performing exposures |
On non-performing exposures |
|||||||||||
|
Of which stage 1 |
Of which stage 2 |
|
Of which stage 2 |
Of which stage 3 |
|
Of which stage 1 |
Of which stage 2 |
|
Of which stage 2 |
Of which stage 3 |
|||||
005 |
Cash balances at central banks and other demand deposits |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
010 |
Loans and advances |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
020 |
Central banks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
030 |
General governments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
040 |
Credit institutions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
050 |
Other financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
060 |
Non-financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
070 |
Of which SMEs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
080 |
Households |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
090 |
Debt securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100 |
Central banks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110 |
General governments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
120 |
Credit institutions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
130 |
Other financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
140 |
Non-financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150 |
Off-balance-sheet exposures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
160 |
Central banks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
170 |
General governments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
180 |
Credit institutions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
190 |
Other financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200 |
Non-financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
210 |
Households |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
220 |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Template EU CR1-A: Maturity of exposures
|
a |
b |
c |
d |
e |
f |
|
Net exposure value |
|||||||
On demand |
<= 1 year |
> 1 year <= 5 years |
> 5 years |
No stated maturity |
Total |
||
1 |
Loans and advances |
|
|
|
|
|
|
2 |
Debt securities |
|
|
|
|
|
|
3 |
Total |
|
|
|
|
|
|
Template EU CR2: Changes in the stock of non-performing loans and advances
|
a |
|
Gross carrying amount |
||
010 |
Initial stock of non-performing loans and advances |
|
020 |
Inflows to non-performing portfolios |
|
030 |
Outflows from non-performing portfolios |
|
040 |
Outflows due to write-offs |
|
050 |
Outflow due to other situations |
|
060 |
Final stock of non-performing loans and advances |
|
Template EU CR2a: Changes in the stock of non-performing loans and advances and related net accumulated recoveries
|
a |
b |
|
Gross carrying amount |
Related net accumulated recoveries |
||
010 |
Initial stock of non-performing loans and advances |
|
|
020 |
Inflows to non-performing portfolios |
|
|
030 |
Outflows from non-performing portfolios |
|
|
040 |
Outflow to performing portfolio |
|
|
050 |
Outflow due to loan repayment, partial or total |
|
|
060 |
Outflow due to collateral liquidations |
|
|
070 |
Outflow due to taking possession of collateral |
|
|
080 |
Outflow due to sale of instruments |
|
|
090 |
Outflow due to risk transfers |
|
|
100 |
Outflows due to write-offs |
|
|
110 |
Outflow due to other situations |
|
|
120 |
Outflow due to reclassification as held for sale |
|
|
130 |
Final stock of non-performing loans and advances |
|
|
Template EU CQ1: Credit quality of forborne exposures
|
a |
b |
c |
d |
e |
f |
g |
h |
|
Gross carrying amount/nominal amount of exposures with forbearance measures |
Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
Collateral received and financial guarantees received on forborne exposures |
|||||||
Performing forborne |
Non-performing forborne |
On performing forborne exposures |
On non-performing forborne exposures |
|
Of which collateral and financial guarantees received on non-performing exposures with forbearance measures |
||||
|
Of which defaulted |
Of which impaired |
|
||||||
005 |
Cash balances at central banks and other demand deposits |
|
|
|
|
|
|
|
|
010 |
Loans and advances |
|
|
|
|
|
|
|
|
020 |
Central banks |
|
|
|
|
|
|
|
|
030 |
General governments |
|
|
|
|
|
|
|
|
040 |
Credit institutions |
|
|
|
|
|
|
|
|
050 |
Other financial corporations |
|
|
|
|
|
|
|
|
060 |
Non-financial corporations |
|
|
|
|
|
|
|
|
070 |
Households |
|
|
|
|
|
|
|
|
080 |
Debt Securities |
|
|
|
|
|
|
|
|
090 |
Loan commitments given |
|
|
|
|
|
|
|
|
100 |
Total |
|
|
|
|
|
|
|
|
Template EU CQ2: Quality of forbearance
|
a |
|
Gross carrying amount of forborne exposures |
||
010 |
Loans and advances that have been forborne more than twice |
|
020 |
Non-performing forborne loans and advances that failed to meet the non-performing exit criteria |
|
Template EU CQ3: Credit quality of performing and non-performing exposures by past due days
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
|
Gross carrying amount/nominal amount |
|||||||||||||
Performing exposures |
Non-performing exposures |
||||||||||||
|
Not past due or past due ≤ 30 days |
Past due > 30 days ≤ 90 days |
|
Unlikely to pay that are not past due or are past due ≤ 90 days |
Past due > 90 days ≤ 180 days |
Past due > 180 days ≤ 1 year |
Past due > 1 year ≤ 2 years |
Past due > 2 years ≤ 5 years |
Past due > 5 years ≤ 7 years |
Past due > 7 years |
Of which defaulted |
||
005 |
Cash balances at central banks and other demand deposits |
|
|
|
|
|
|
|
|
|
|
|
|
010 |
Loans and advances |
|
|
|
|
|
|
|
|
|
|
|
|
020 |
Central banks |
|
|
|
|
|
|
|
|
|
|
|
|
030 |
General governments |
|
|
|
|
|
|
|
|
|
|
|
|
040 |
Credit institutions |
|
|
|
|
|
|
|
|
|
|
|
|
050 |
Other financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
060 |
Non-financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
070 |
Of which SMEs |
|
|
|
|
|
|
|
|
|
|
|
|
080 |
Households |
|
|
|
|
|
|
|
|
|
|
|
|
090 |
Debt securities |
|
|
|
|
|
|
|
|
|
|
|
|
100 |
Central banks |
|
|
|
|
|
|
|
|
|
|
|
|
110 |
General governments |
|
|
|
|
|
|
|
|
|
|
|
|
120 |
Credit institutions |
|
|
|
|
|
|
|
|
|
|
|
|
130 |
Other financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
140 |
Non-financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
150 |
Off-balance-sheet exposures |
|
|
|
|
|
|
|
|
|
|
|
|
160 |
Central banks |
|
|
|
|
|
|
|
|
|
|
|
|
170 |
General governments |
|
|
|
|
|
|
|
|
|
|
|
|
180 |
Credit institutions |
|
|
|
|
|
|
|
|
|
|
|
|
190 |
Other financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
200 |
Non-financial corporations |
|
|
|
|
|
|
|
|
|
|
|
|
210 |
Households |
|
|
|
|
|
|
|
|
|
|
|
|
220 |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
Template EU CQ4: Quality of non-performing exposures by geography
|
a |
b |
c |
d |
e |
f |
g |
|
Gross carrying/nominal amount |
Accumulated impairment |
Provisions on off-balance-sheet commitments and financial guarantees given |
Accumulated negative changes in fair value due to credit risk on non-performing exposures |
|||||
|
Of which non-performing |
Of which subject to impairment |
||||||
|
Of which defaulted |
|||||||
010 |
On-balance-sheet exposures |
|
|
|
|
|
|
|
020 |
Country 1 |
|
|
|
|
|
|
|
030 |
Country 2 |
|
|
|
|
|
|
|
040 |
Country 3 |
|
|
|
|
|
|
|
050 |
Country 4 |
|
|
|
|
|
|
|
060 |
Country N |
|
|
|
|
|
|
|
070 |
Other countries |
|
|
|
|
|
|
|
080 |
Off-balance-sheet exposures |
|
|
|
|
|
|
|
090 |
Country 1 |
|
|
|
|
|
|
|
100 |
Country 2 |
|
|
|
|
|
|
|
110 |
Country 3 |
|
|
|
|
|
|
|
120 |
Country 4 |
|
|
|
|
|
|
|
130 |
Country N |
|
|
|
|
|
|
|
140 |
Other countries |
|
|
|
|
|
|
|
150 |
Total |
|
|
|
|
|
|
|
Template EU CQ5: Credit quality of loans and advances to non-financial corporations by industry
|
a |
b |
c |
d |
e |
f |
|
Gross carrying amount |
Accumulated impairment |
Accumulated negative changes in fair value due to credit risk on non-performing exposures |
|||||
|
Of which non-performing |
Of which loans and advances subject to impairment |
|||||
|
Of which defaulted |
||||||
010 |
Agriculture, forestry and fishing |
|
|
|
|
|
|
020 |
Mining and quarrying |
|
|
|
|
|
|
030 |
Manufacturing |
|
|
|
|
|
|
040 |
Electricity, gas, steam and air conditioning supply |
|
|
|
|
|
|
050 |
Water supply |
|
|
|
|
|
|
060 |
Construction |
|
|
|
|
|
|
070 |
Wholesale and retail trade |
|
|
|
|
|
|
080 |
Transport and storage |
|
|
|
|
|
|
090 |
Accommodation and food service activities |
|
|
|
|
|
|
100 |
Information and communication |
|
|
|
|
|
|
110 |
Financial and insurance actvities |
|
|
|
|
|
|
120 |
Real estate activities |
|
|
|
|
|
|
130 |
Professional, scientific and technical activities |
|
|
|
|
|
|
140 |
Administrative and support service activities |
|
|
|
|
|
|
150 |
Public administration and defense, compulsory social security |
|
|
|
|
|
|
160 |
Education |
|
|
|
|
|
|
170 |
Human health services and social work activities |
|
|
|
|
|
|
180 |
Arts, entertainment and recreation |
|
|
|
|
|
|
190 |
Other services |
|
|
|
|
|
|
200 |
Total |
|
|
|
|
|
|
Template EU CQ6: Collateral valuation - loans and advances
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
|
Loans and advances |
|||||||||||||
|
Performing |
Non-performing |
|||||||||||
|
|
Unlikely to pay that are not past due or are past due ≤ 90 days |
Past due > 90 days |
||||||||||
|
Of which past due > 30 days ≤ 90 days |
|
Of which past due > 90 days ≤ 180 days |
Of which: past due > 180 days ≤ 1 year |
Of which: past due > 1 years ≤ 2 years |
Of which: past due > 2 years ≤ 5 years |
Of which: past due > 5 years ≤ 7 years |
Of which: past due > 7 years |
|||||
010 |
Gross carrying amount |
|
|
|
|
|
|
|
|
|
|
|
|
020 |
Of which secured |
|
|
|
|
|
|
|
|
|
|
|
|
030 |
Of which secured with immovable property |
|
|
|
|
|
|
|
|
|
|
|
|
040 |
Of which instruments with LTV higher than 60% and lower or equal to 80% |
|
|
|
|
|
|
|
|
|
|
|
|
050 |
Of which instruments with LTV higher than 80% and lower or equal to 100% |
|
|
|
|
|
|
|
|
|
|
|
|
060 |
Of which instruments with LTV higher than 100% |
|
|
|
|
|
|
|
|
|
|
|
|
070 |
Accumulated impairment for secured assets |
|
|
|
|
|
|
|
|
|
|
|
|
080 |
Collateral |
|
|
|
|
|
|
|
|
|
|
|
|
090 |
Of which value capped at the value of exposure |
|
|
|
|
|
|
|
|
|
|
|
|
100 |
Of which immovable property |
|
|
|
|
|
|
|
|
|
|
|
|
110 |
Of which value above the cap |
|
|
|
|
|
|
|
|
|
|
|
|
120 |
Of which immovable property |
|
|
|
|
|
|
|
|
|
|
|
|
130 |
Financial guarantees received |
|
|
|
|
|
|
|
|
|
|
|
|
140 |
Accumulated partial write-off |
|
|
|
|
|
|
|
|
|
|
|
|
Template EU CQ7: Collateral obtained by taking possession and execution processes
|
a |
b |
|
Collateral obtained by taking possession |
|||
Value at initial recognition |
Accumulated negative changes |
||
010 |
Property, plant and equipment (PP&E) |
|
|
020 |
Other than PP&E |
|
|
030 |
Residential immovable property |
|
|
040 |
Commercial Immovable property |
|
|
050 |
Movable property (auto, shipping, etc.) |
|
|
060 |
Equity and debt instruments |
|
|
070 |
Other collateral |
|
|
080 |
Total |
|
|
Template EU CQ8: Collateral obtained by taking possession and execution processes – vintage breakdown
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
|||||
Debt balance reduction |
Total collateral obtained by taking possession |
||||||||||||||||
|
Foreclosed ≤ 2 years |
Foreclosed > 2 years ≤ 5 years |
Foreclosed > 5 years |
Of which non-current assets held-for-sale |
|||||||||||||
Gross carrying amount |
Accumulated negative changes |
Value at initial recognition |
Accumulated negative changes |
Value at initial recognition |
Accumulated negative changes |
Value at initial recognition |
Accumulated negative changes |
Value at initial recognition |
Accumulated negative changes |
Value at initial recognition |
Accumulated negative changes |
||||||
010 |
Collateral obtained by taking possession classified as PP&E |
|
|
|
|
|
|
|
|
|
|
|
|
||||
020 |
Collateral obtained by taking possession other than that classified as PP&E |
|
|
|
|
|
|
|
|
|
|
|
|
||||
030 |
Residential immovable property |
|
|
|
|
|
|
|
|
|
|
|
|
||||
040 |
Commercial immovable property |
|
|
|
|
|
|
|
|
|
|
|
|
||||
050 |
Movable property (auto, shipping, etc.) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
060 |
Equity and debt instruments |
|
|
|
|
|
|
|
|
|
|
|
|
||||
070 |
Other collateral |
|
|
|
|
|
|
|
|
|
|
|
|
||||
080 |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
ANNEX XVI
Instructions for disclosure of risk management objectives and policies, exposures to credit risk, dilution risk and credit quality
Table EU CRA: General qualitative information about credit risk
Legal references and instructions |
|
Row number |
Explanation |
(a) |
In the concise risk statement in accordance with point (f) of Article 435(1) CRR, how the business model translates into the components of the institution’s credit risk profile. |
(b) |
When discussing their strategies and processes to manage credit risk and the policies for hedging and mitigating that risk in accordance with points (a) and (d) of Article 435(1) CRR, the criteria and approach used for defining the credit risk management policy and for setting credit risk limits. |
(c) |
When informing on the structure and organisation of the risk management function in accordance with point (b) of Article 435(1) CRR, the structure and organisation of the credit risk management and control function. |
(d) |
When informing on the authority, status and other arrangements for the risk management function in accordance with point (b) of Article 435(1) CRR, the relationships between credit risk management, risk control, compliance and internal audit functions. |
Table EU CRB: Additional disclosure related to the credit quality of assets
Legal references and instructions |
|
Row number |
Explanation |
(a) |
The scope and definitions of ‘past-due’ and ‘impaired’ exposures used for accounting purposes and the differences, if any, between the definitions of past due and default for accounting and regulatory purposes in accordance with Article 178 CRR. |
(b) |
The extent of past-due exposures (more than 90 days) that are not considered to be impaired and the reasons for this. |
(c) |
Description of methods used for determining general and specific credit risk adjustments. |
(d) |
The institution’s own definition of a restructured exposure used for the implementation of point (d) of Article 178(3) CRR in accordance with Article 178 CRR when different from the definition of exposures with forbearance measures as defined in Article 47b CRR. |
Template EU CR1: Performing and non-performing exposures and related provisions
Legal references and instructions |
|
Row number |
Explanation |
005 |
Cash balances at central banks and other demand deposits Institutions shall disclose this information in line with the information reported in Annexes III and IV to Commission Implementing Regulation (EU) 680/2014(2). |
010 |
Loans and advances Loans and advances are debt instruments held by the institutions that are not securities; this item includes ‘loans’ in accordance with Regulation (EU) 1071/2013 (‘ECB BSI Regulation’)(3) as well as advances that cannot be classified as ‘loans’ in accordance with the ECB BSI Regulation, as defined in paragraph 32 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014, but excluding loans and advances classified as held for sale, cash balances at central banks and other demand deposits. |
020 – 060, 080, 100 – 140, 160 –210 |
Counterparty breakdown Institutions shall apply the breakdown by counterparty as defined in paragraph 42 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014. Counterparty sector allocation shall be based exclusively on the nature of the immediate counterparty. The classification of exposures incurred jointly by more than one obligor shall be done based on the characteristics of the obligor that was the more relevant, or determinant, for the institution’s decision to grant the exposure. Among other classifications, the distribution of jointly incurred exposures by counterparty sector, country of residence and NACE code shall be driven by the characteristics of the more relevant or determinant obligor. |
070 |
SMEs As defined in paragraph 5(i) of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014 |
090 |
Debt securities Debt securities are debt instruments held by the institution issued as securities that are not loans in accordance with the ECB BSI Regulation, as defined in paragraph 31 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
150 |
Off-balance-sheet exposures Off-balance sheet exposures shall include the off-balance sheet items listed in Annex I CRR. |
220 |
Total |
Legal references and instructions |
|
Column number |
Explanation |
a |
Gross carrying amount/nominal amount on performing exposures Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014 |
b, c, e, f, h, i, k and l |
Of which stage 1/stage 2/stage 3 For institutions applying IFRS, categories of impairment, as defined in IFRS 9.5.5. ‘Stage 1’ refers to impairment measured in accordance with IFRS 9.5.5.5. ‘Stage 2’ refers to impairment measured in accordance with IFRS 9.5.5.3. ‘Stage 3’ refers to impairment on credit-impaired assets, as defined in Appendix A to IFRS 9. The columns ‘Of which stage 1’, ‘Of which stage 2’ and ‘Of which stage 3’ shall not be disclosed by institutions that apply national generally accepted accounting principles based on Council Directive (EEC) 86/635(4) on the annual accounts and consolidated accounts of banks and other financial institutions. |
d |
Gross carrying amount/nominal amount on non-performing exposures Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014; non-performing exposures as defined in Article 47a CRR. |
g |
Performing exposures – accumulated impairment and provisions This shall include the amounts determined in accordance with paragraphs 11, 69 to 71, 106 and 110 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
j |
Non-performing – accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions Non-performing exposures as defined in Article 47a CRR This shall include the amounts determined in accordance with paragraphs 11, 69 to 71, 106 and 110 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
m |
Accumulated partial write-off This is to include the accumulated partial amount at the reference date of principal and accrued past-due interest and fees for any debt instrument that has been de-recognised to date using either of the methods described in paragraph 74 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014, to be disclosed because the institution has no reasonable expectation of recovering the contractual cash flows. These amounts are to be disclosed until the total extinguishment of all the institution’s rights by expiry of the statute-of-limitations period, forgiveness or another cause, or until recovery. Therefore, where the written-off amounts are not recovered, they are to be disclosed while they are subject to enforcement activities. Write-offs constitute a de-recognition event and relate to a financial asset in its entirety or (in the case of a partial write-off) to a portion of it, including where the modification of an asset leads the institution to give up its right to collect cash flows either on a portion or on the entirety of that asset. |
n |
Collateral and financial guarantees received on performing exposures Amounts for collateral received and guarantees received shall be calculated in accordance with paragraph 239 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. The sum of amounts for both collateral and guarantees is to be capped at the carrying amount of the related exposure. |
o |
Collateral and financial guarantees received on non-performing exposures Non-performing exposures as defined in Article 47a CRR Amounts for collateral received and guarantees received shall be calculated in accordance with paragraph 239 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. The sum of amounts for both collateral and guarantees is to be capped at the carrying amount of the related exposure. |
Template EU CR1-A: Maturity of exposures
Legal references and instructions |
|
Row number |
Explanation |
010 |
Loans and advances Loans and advances are debt instruments held by the institutions that are not securities; this item includes ‘loans’ in accordance with the ECB BSI Regulation as well as advances that cannot be classified as ‘loans’ in accordance with the ECB BSI Regulation, as defined in paragraph 32 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014, but excluding loans and advances classified as held for sale, cash balances at central banks and other demand deposits. |
020 |
Debt securities Debt securities are debt instruments held by the institution issued as securities that are not loans in accordance with the ECB BSI Regulation, as defined in paragraph 31 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
030 |
Total |
Legal references and instructions |
|||||||
Column number |
Explanation |
||||||
a to e |
Net exposure values The net values shall be disclosed by residual contractual maturities. Net value of the exposure: For on-balance-sheet items, the net value is the gross carrying value of exposure less allowances/impairments. For off-balance-sheet items, the net value is the gross carrying value of exposure less provisions. Exposure: In accordance with Article 5 CRR, exposure refers to an asset or an off-balance-sheet item that gives rise to a credit risk exposure in accordance with the CRR. Gross carrying values: The accounting value before any allowance/impairments but after considering write-offs. Institutions shall not take into account any CRM technique in the application of Chapter 4 of Title II of Part Three CRR. Off-balance-sheet items shall be disclosed for their nominal amount gross of any CCF applicable in accordance with Article 111 and 166 CRR or CRM techniques, and gross of any provision, particularly (a) guarantees given (the maximum amount that the institution would have to pay if the guarantee were called) and (b) loan commitments and other commitments (the total amount that the institution has committed to lend). In this disclosure:
|
||||||
f |
Total |
Template EU CR2: Changes in the stock of non-performing loans and advances
Legal references and instructions |
|
Row number |
Explanation |
010 |
Initial stock of non-performing loans and advances The gross carrying amount of the stock of non-performing loans and advances at the end of the last financial year |
020 |
Inflows to non-performing portfolios The gross carrying amount of loans and advances that entered non-performing status during the period (since the end of last financial year) |
030 |
Outflows from non-performing portfolios The gross carrying amount of loans and advances that exited non-performing status |
040 |
Outflow due to write-offs Full or partial write-offs of total loans and advances recorded during the reference period A write-off (full or partial) constitutes a de-recognition event. Therefore, the gross carrying amount of loans and advances is reduced by the amount of the write-offs. Furthermore, debt forgiveness in the context of forbearance measures, i.e. write-offs for which the amount of debt outstanding from the borrower was cancelled (the institution forfeits the right to legally recover it), is also to be included in this category. |
050 |
Outflow due to other situations Any other decreases to the carrying amount of loans and advances other than write-off shall be included in this row. Those adjustments might include, for instance, the outflow due to: i) loan repayment, partial or total; ii) collateral liquidations; iii) taking possession of collateral, iv) sale of instruments; v) risk transfers; vi) FX changes; vii) other closure actions; viii) reclassifications between asset classes, etc. Moreover, the adjustments shall include the outflow due to reclassification as held for sale. Where the amount for this category is significant, institutions are asked to provide additional information in the narrative accompanying this template. |
060 |
Final stock of non-performing loans and advances The gross carrying amount of the stock of non-performing loans and advances at the disclosure reference date. |
Legal references and instructions |
|
Column number |
Explanation |
a |
Gross carrying amount Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
Template EU CR2a: Changes in the stock of non-performing loans and advances and related net accumulated recoveries
Legal references and instructions |
|
Row number |
Explanation |
010 |
Initial stock of non-performing loans and advances The gross carrying amount of the stock of non-performing loans and advances at the end of the last financial year |
020 |
Inflows to non-performing portfolios The gross carrying amount of loans and advances that entered non-performing status during the period (since the end of last financial year) |
030 |
Outflows from non-performing portfolios The gross carrying amount of loans and advances that exited non-performing status |
040 |
Outflow to performing portfolio The gross carrying amount of loans and advances that exited non-performing status and became performing during the period (since the end of last financial year) |
050 |
Outflow due to loan repayment, partial or total The reduction in the gross carrying amount of non-performing loans and advances due to cash payments, namely regular payments of capital and any ad hoc repayments during the period (since the end of last financial year) |
060 |
Outflow due to collateral liquidations The effect on the gross carrying amount of an instrument from the liquidation of any kind of collateral shall be disclosed in this row. Outflows due to other liquidation or legal procedures and voluntary sale of property are also to be included in this row. For the avoidance of doubt, please note that the gross carrying amount of the instrument shall be disclosed, including any potential accompanying partial write-off. Please also note that outflows might not be equal to the sum of net cumulated recoveries and partial write-offs. |
060 column b |
Related net accumulated recoveries Cash recoveries or cash equivalents collected due to collateral liquidations (net of respective collateral liquidation costs) are to be disclosed in this row. |
070 |
Outflow due to taking possession of collateral The effect on the gross carrying amount of an instrument due to the foreclosure of any kind of collateral shall be disclosed in this row. Taking possession refers to the acquisition of non-cash collateral of which the institution or a group subsidiary has acquired ownership and which it has not yet sold to a third party. Debt asset swaps, voluntary surrenders and debt equity swaps are also to be included in this category. For the avoidance of doubt, please note that the gross carrying amount of the instrument shall be disclosed, including any potential accompanying partial write-offs. Please also note that outflows might not be equal to the sum of net cumulated recoveries and partial write-offs. |
070 column b |
Related net accumulated recoveries The initial recognition in the institution’s balance sheet of the fair value of the collateral at the moment of taking possession is to be disclosed in this row. Cash recoveries or cash equivalents collected in the context of taking possession of collateral net of costs shall not be included in this row but be disclosed under Outflow due to loan repayment, partial or total. |
080 |
Outflow due to sale of instruments Total balance changes stemming from loans and advances sold to other institutions, excluding intragroup transactions For the avoidance of doubt, institutions shall note that the gross carrying amount of the loans and advances sold is to be disclosed (including any potential accompanying partial write-offs) and not its valuation or price during the transaction. Institutions shall also note that outflows might not be equal to the sum of net cumulated recoveries and partial write-offs. |
080 column b |
Related net accumulated recoveries Cash recoveries or cash equivalents collected in the context of the sale of loans and advances, net of selling costs, shall be included in this row. |
090 |
Outflow due to risk transfers The gross reduction in non-performing loans and advances due to securitisation or other risk transfers qualifying for de-recognition from the balance sheet Institutions shall note that outflows might not be equal to the sum of net cumulated recoveries and partial write-offs. |
090 column b |
Related net accumulated recoveries Cash recoveries or cash equivalents collected in the context of the outflows due to significant risk transfers are to be disclosed in this row. |
100 |
Outflow due to write-offs Full or partial write-offs of total loans and advances recorded during the reference period A write-off (full or partial) constitutes a de-recognition event. Therefore, the gross carrying amount of loans and advances is reduced by the amount of the write-offs. For the avoidance of doubt, please note that this row reflects changes in the gross carrying amount of loans and advances, and any potential partial write-offs that have already been disclosed in previous rows (e.g. accompanying sale of loans and advances, collateral liquidation, taking possession of collateral or significant risk transfer) shall not be included in this row. Furthermore, debt forgiveness in the context of forbearance measures, i.e. write-offs for which the amount of debt outstanding from the borrower was cancelled (the institution forfeits the right to legally recover it), is also to be included in this category. |
110 |
Outflow due to other situations Any other decreases to the carrying amount of loans and advances that are not covered by the events mentioned above shall be included in this row. Those adjustments might include, for instance, FX changes, other closure actions, reclassifications between asset classes, etc. Where the amount for this category is significant, institutions are asked to provide additional information in the narrative accompanying this template. |
120 |
Outflow due to reclassification as held for sale Decreases to the carrying amount of non-performing loans and advances due to their reclassification as instruments held for sale |
130 |
Final stock of non-performing loans and advances The gross carrying amount of the stock of non-performing loans and advances at the disclosure reference date |
Legal references and instructions |
|
Column number |
Explanation |
a |
Gross carrying amount Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
b |
Related net accumulated recoveries Please refer to the definitions for the rows in this template. |
Template EU CQ1: Credit quality of forborne exposures
Legal references and instructions |
|
Row number |
Explanation |
005 |
Cash balances at central banks and other demand deposits Institutions shall disclose this information in line with the information reported in Annexes III and IV Commission Implementing Regulation (EU) 680/2014. |
010 |
Loans and advances See the definition in EU-CR1: Performing and non-performing exposures and related provisions. |
020 - 070 |
Counterparty breakdown Institutions shall apply the breakdown by counterparty as defined in paragraph 42 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014. Counterparty sector allocation shall be based exclusively on the nature of the immediate counterparty. The classification of exposures incurred jointly by more than one obligor shall be done based on the characteristics of the obligor that was the more relevant, or determinant, for the institution’s decision to grant the exposure. Among other classifications, the distribution of jointly incurred exposures by counterparty sector, country of residence and NACE code shall be driven by the characteristics of the more relevant or determinant obligor. |
080 |
Debt securities See the definition in EU-CR1: Performing and non-performing exposures and related provisions. |
090 |
Loan commitments given For loan commitments given, the nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014 shall be disclosed. |
100 |
Total |
Legal references and instructions |
|
Column number |
Explanation |
a |
Gross carrying amount/nominal amount of exposures with forbearance measures – of which performing forborne Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014; exposures with forbearance measures as defined in Article 47b CRR The gross carrying amount related to the exposures subject to impairment is the net of accumulated partial and total write-off. Depending on whether forborne exposures satisfy the required conditions set out in Articles 47a CRR, they can be identified as performing or non-performing. |
b |
Gross carrying amount/nominal amount of exposures with forbearance measures – of which non-performing forborne Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014 The gross carrying amount related to the exposures subject to impairment is the net of accumulated partial and total write-off. Non-performing exposures with forbearance measures (non-performing forborne exposures) shall comprise forborne exposures that meet the criteria to be considered non-performing and are included in the non-performing exposures category. Those non-performing forborne exposures are to include the following: (a) exposures that have become non-performing due to the application of forbearance measures; (b) exposures that were non-performing prior to the extension of forbearance measures; (c) forborne exposures that have been reclassified from the performing category, including exposures reclassified pursuant to Article 47a CRR. |
c |
Of which defaulted Forborne exposures that are also classified as defaulted in accordance with Article 178 CRR |
d |
Of which impaired Forborne exposures that are also impaired in accordance with the applicable accounting framework under paragraph 215 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014 |
e |
Accumulated impairments, accumulated negative changes in fair value due to credit risk and provisions on performing forborne exposures Exposures with forbearance measures as defined in Article 47b CRR. Institutions shall include the amounts determined in accordance with paragraphs 11, 69 to 71, 106 and 110 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. Depending on whether forborne exposures satisfy the required conditions set out in Article 47a and 47b CRR, they can be identified as performing or non-performing. |
f |
Accumulated impairments, accumulated negative changes in fair value due to credit risk and provisions on non-performing forborne exposures This shall include the amounts determined in accordance with paragraphs 11, 69 to 71, 106 and 110 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. Non-performing exposures with forbearance measures (non-performing forborne exposures) shall comprise forborne exposures that meet the criteria to be considered non-performing and are included in the non-performing exposures category. Those non-performing forborne exposures are to include the following: (a) exposures that have become non-performing due to the application of forbearance measures; (b) exposures that were non-performing prior to the extension of forbearance measures; (c) forborne exposures that have been reclassified from the performing category, including exposures reclassified pursuant to Article 47a CRR. |
g |
Collateral received and financial guarantees received on forborne exposures These shall be disclosed for all exposures with forbearance measures, regardless of their performing or non-performing status. Amounts for collateral received and guarantees received shall be calculated in accordance with paragraph 239 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. The sum of amounts for both collateral and guarantees is to be capped at the carrying amount of the related exposure. |
h |
Of which collateral and financial guarantees received on non-performing exposures with forbearance measures Amounts for collateral received and guarantees received shall be calculated in accordance with paragraph 239 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. The sum of amounts for both collateral and guarantees is to be capped at the carrying amount of the related exposure. Non-performing exposures with forbearance measures (non-performing forborne exposures) shall comprise forborne exposures that meet the criteria to be considered non-performing and are included in the non-performing exposures category. Those non-performing forborne exposures are to include the following: (a) exposures that have become non-performing due to the application of forbearance measures; (b) exposures that were non-performing prior to the extension of forbearance measures; (c) forborne exposures that have been reclassified from the performing category, including exposures reclassified pursuant to Article 47a CRR. |
Template EU CQ2: Quality of forbearance
Legal references and instructions |
|
Row number |
Explanation |
010 |
Loans and advances that have been forborne more than twice Gross carrying amount of loans and advances that had been granted forbearance measures in the past and more than twice Loans and advances for which forbearance was granted that exited the forborne category (i.e. cured forborne loans and advances) are also included here when a new forborne measure has been granted. |
020 |
Non-performing forborne loans and advances that failed to meet the non-performing exit criteria Gross carrying amount of non-performing forborne loans and advances that are in the category of non-performing forborne loans and advances under the cure period of 1 year and that failed to comply with the forbearance measures after the 12-month cure period and therefore did not succeed in moving towards performing forborne status but retained non-performing forborne within cure period status |
Legal references and instructions |
|
Column number |
Explanation |
a |
Gross carrying amount of forborne exposures Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; exposures with forbearance measures as defined in Article 47b CRR Depending on whether forborne exposures satisfy the required conditions set out in Article 47a or 47b CRR, they can be identified as performing or non-performing. |
Template EU CQ3: Credit quality of performing and non-performing exposures by past due days
Legal references and instructions |
|
Row number |
Explanation |
005 |
Cash balances at central banks and other demand deposits Institutions shall disclose this information in line with the information reported in Annexes III and IV Commission Implementing Regulation (EU) 680/2014. |
010 |
Loans and advances See the definition in EU-CR1: Performing and non-performing exposures and related provisions. |
020 – 060, 080, 100 – 140, 160 –210 |
Counterparty breakdown Institutions shall apply the breakdown by counterparty as defined in paragraph 42 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014. Counterparty sector allocation shall be based exclusively on the nature of the immediate counterparty. The classification of exposures incurred jointly by more than one obligor shall be done based on the characteristics of the obligor that was the more relevant, or determinant, for the institution’s decision to grant the exposure. Among other classifications, the distribution of jointly incurred exposures by counterparty sector, country of residence and NACE code shall be driven by the characteristics of the more relevant or determinant obligor. |
070 |
SMEs As defined in paragraph 5(i) of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014 |
090 |
Debt securities See the definition in EU-CR1: Performing and non-performing exposures and related provisions. |
150 |
Off-balance-sheet exposures See the definition in EU-CR1: Performing and non-performing exposures and related provisions. |
210 |
Total |
Legal references and instructions |
|
Column number |
Explanation |
a |
Gross carrying amount/nominal amount on performing exposures Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
b |
Of which: Not past due or past due ≤ 30 days Subcategory of performing exposures that are not past due or are 1–30 days past due |
c |
Of which: Past due > 30 days ≤ 90 days Subcategory of performing exposures that are 31–90 days past due In addition, exposures that are more than 90 days past due that are not material are included in this subcategory. |
d |
Gross carrying amount/nominal amount on non-performing exposures Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014; non-performing exposures as defined in Article 47a CRR. |
e |
Of which: Unlikely to pay that are not past due or are past due ≤ 90 days Subcategory of exposures that are either not past due or are up to 90 days past due but are nevertheless identified as non-performing, pursuant to Article 47a CRR |
f |
Of which: Past due > 90 days ≤ 180 days Subcategory of non-performing exposures that are past due for more than 90 days, but not more than 180 days |
g |
Of which: Past due > 180 days ≤ 1 year Subcategory of non-performing exposures that are past due for more than 180 days, but not more than 1 year |
h |
Of which: Past due > 1 year ≤ 2 years Subcategory of non-performing exposures that are past due for more than 1 year, but not more than 2 years |
i |
Of which: Past due > 2 years ≤ 5 years Subcategory of non-performing exposures that are past due for more than 2 years, but not more than 5 years |
j |
Of which: Past due > 5 years ≤ 7 years Subcategory of non-performing exposures that are past due for more than 5 years, but not more than 7 years |
k |
Of which: Past due > 7 years Subcategory of non-performing exposures that are past due for more than 7 years |
l |
Of which defaulted Defaulted exposures in accordance with Article 178 CRR |
Template EU CQ4: Quality of non-performing exposures by geography
Legal references and instructions |
|
Row number |
Explanation |
010 |
On-balance-sheet exposures Total on-balance-sheet exposures |
020 – 070 and 090 - 140 |
Country A country in which the institution’s exposures are material in accordance with Article 432 CRR When the materiality of countries is determined using a materiality threshold, that threshold shall be disclosed, as shall the list of immaterial countries included in the ‘Other countries’ rows. Institutions shall allocate exposures to a significant country based on the residence of the immediate counterparty. Exposures to supranational organisations shall be assigned not to the country of residence of the institution but to ‘Other countries’. |
080 |
Off-balance-sheet exposures See the definition in EU-CR1: Performing and non-performing exposures and related provisions. |
150 |
Total |
Legal references and instructions |
|
Column number |
Explanation |
a |
Gross carrying amount/nominal amount Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014 The gross carrying amount related to the exposures subject to impairment is the net of accumulated partial and total write-off. |
b |
Gross carrying amount/nominal amount – of which non-performing Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; nominal amount as defined in paragraph 118 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014; non-performing exposures as defined in Article 47a CRR. |
c |
Of which defaulted Defaulted exposures in accordance with Article 178 CRR |
d |
Gross carrying amount/nominal amount – of which subject to impairment The gross carrying or nominal amount related to exposures that are subject to the impairment requirements of the applicable accounting framework |
e |
Accumulated impairment This shall include the amounts determined in accordance with paragraphs 11, 69 to 71, 106 and 110 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014 |
f |
Provisions on off-balance-sheet commitments and financial guarantees given This row shall include the provisions off-balance-sheet commitments and financial guarantees given. |
g |
Accumulated negative changes in fair value due to credit risk on non-performing exposures This shall include the amounts determined in accordance with paragraphs 11, 69 to 71, 106 and 110 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
Template EU CQ5: Credit quality of loans and advances to non-financial corporations by industry
Legal references and instructions |
|
Row number |
Explanation |
010 - 190 |
Counterparty breakdown by industry Counterparty sector allocation includes only the sectors related to non-financial corporation counterparty. Counterparty sector allocation shall be based exclusively on the nature of the immediate counterparty. The classification of exposures incurred jointly by more than one obligor shall be done based on the characteristics of the obligor that was the more relevant, or determinant, for the institution’s decision to grant the exposure. The rows shall be used to disclose the material industry sectors or counterparty types to which institutions have exposures. Materiality shall be assessed in accordance with Article 432 CRR, and immaterial industry sectors or counterparty types shall be aggregated in the row ‘Other services’. |
200 |
Total |
Legal references and instructions |
|
Column number |
Explanation |
a |
Gross carrying amount Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014 The gross carrying amount related to the exposures subject to impairment is the net of accumulated partial and total write-off. |
b |
Gross carrying amount – of which non-performing Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014; non-performing exposures as defined in Article 47a CRR |
c |
Of which defaulted Defaulted exposures in accordance with Article 178 CRR |
d |
Gross carrying amount – of which loans and advances subject to impairment The gross carrying amount related to loans and advances that are subject to the impairment requirements of the applicable accounting framework |
e |
Accumulated impairment This shall include the amounts determined in accordance with paragraphs 11, 69 to 71, 106 and 110 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
f |
Accumulated negative changes in fair value due to credit risk on non-performing exposures Non-performing exposures as defined in Article 47a CRR Institutions shall include the amounts determined in accordance with paragraphs 11, 69 to 71, 106 and 110 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
Template EU CQ6: Collateral valuation - loans and advances
Legal references and instructions |
|
Row number |
Explanation |
010 |
Gross carrying amount Gross carrying amount as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014 |
020 |
Of which secured Gross carrying amount, as defined in paragraph 34 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014, of secured and partially secured loans shall be disclosed in this row. Unsecured loans and advances shall include exposures for which neither collateral was pledged nor financial guarantees were received; the unsecured part of a partially secured or partially guaranteed exposure shall be included in this row, in accordance with paragraph 323 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. Therefore, secured loans and advances must be calculated as the difference between the gross carrying amount of all loans and advances and the gross carrying amount of unsecured loans and advances, and will include both the secured and the unsecured part of the loan. In case of overcollateralization the gross carrying amount of the loan shall be disclosed. |
030 |
Of which secured with immovable property Loans collateralized by immovable property shall include loans and advances formally secured by residential or commercial immovable property collateral, independently of their loan/collateral ratio (commonly referred as ‘loan-to-value’) and the legal form of the collateral, as defined in paragraph 86(a) of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
040 |
Of which instruments with LTV higher than 60 % and lower or equal to 80 % The loan-to-value (LTV) ratio shall be calculated using the calculation method specified for ‘LTV Current’ in the Recommendation of the European Systemic Risk Board on closing real estate data gaps (ESRB/2016/14)(5). Institutions shall disclose the gross carrying amount of loans and advances having an LTV ratio higher than 60 % and lower or equal to 80 %. |
050 |
Of which instruments with LTV higher than 80% and lower or equal to 100 % Institutions shall disclose the gross carrying amount of loans and advances having an LTV ratio higher than 80 % and lower than or equal to 100 %. |
060 |
Of which instruments with LTV higher than 100 % Gross carrying amount of loans and advances having a LTV ratio higher than 100 % |
070 |
Accumulated impairment for secured assets For secured debt instruments, accumulated impairment shall be calculated as the cumulative amount of impairment losses, net of use and reversals that has been recognised, where appropriate for each of the impairment stages (paragraph 70 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014). The accumulated impairment related to the unsecured part of a partially secured or partially guaranteed exposure shall be included in this row. |
090 |
Collateral – of which value capped at the value of exposure Amounts for collateral received shall be calculated in accordance with paragraph 239 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. The sum of amounts for collateral in this row shall be capped at the carrying amount of the related exposure. |
100 |
Of which immovable property The part of the collateral consisting of residential or commercial immovable property (point (a) of paragraph 173 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014) The sum of amounts for collateral in this row shall be capped at the carrying amount of the related exposure. |
110 |
Collateral – of which value above the cap In this row, the difference between the actual value of the collateral and the capped value of the collateral (carrying amount of the related exposure) shall be disclosed (institutions shall not apply for the calculation of the actual value of the collateral paragraph 239 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014). |
120 |
Of which immovable property The difference between the actual value and the capped value of the part of the collateral consisting of residential or commercial immovable property (point (a) of paragraph 173 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014) |
130 |
Financial guarantees received As defined in paragraph 114 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014 |
140 |
Accumulated partial write-off This is to include the accumulated partial amount at the reference date of principal and accrued past-due interest and fees for any debt instrument that has been de-recognised to date using either of the methods described in paragraph 74 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014, to be disclosed because the institution has no reasonable expectation of recovering the contractual cash flows. These amounts are to be disclosed until the total extinguishment of all the institution’s rights by expiry of the statute-of-limitations period, forgiveness or another cause, or until recovery. Therefore, where the written-off amounts are not recovered, they are to be disclosed while they are subject to enforcement activities. Write-offs constitute a de-recognition event and relate to a financial asset in its entirety or (in the case of a partial write-off) to a portion of it, including where the modification of an asset leads the institution to give up its right to collect cash flows either on a portion or on the entirety of that asset. |
Legal references and instructions |
|
Column number |
Explanation |
a |
Loans and advances See the definition in template EU CR1: Performing and non-performing exposures and related provisions. |
b |
Loans and advances – of which performing See the definition in template EU CR1: Performing and non-performing exposures and related provisions. |
c |
Of which past due > 30 days ≤ 90 days Subcategory of performing loans and advances that are 31–90 days past due |
d |
Loans and advances – of which non-performing exposures Non-performing exposures as defined in Article 47a CRR See the definition in template EU CR1: Performing and non-performing exposures and related provisions. |
e |
Of which unlikely to pay that are not past due or are past due ≤ 90 days Subcategory of loans and advances that are either not past due or are up to 90 days past due but are nevertheless identified as non-performing, because of the likelihood of non-full repayment pursuant to Article 47a CRR |
f |
Past due > 90 days Subcategory of loans and advances that are more than 90 days past due |
g |
Of which past due > 90 days ≤ 180 days Subcategory of loans and advances that are 91–180 days past due |
h |
Of which past due > 180 days ≤ 1 year Subcategory of loans and advances that are 181 days to 1 year past due |
i |
Of which past due > 1 years ≤ 2 years Subcategory of loans and advances that are 1–2 years past due |
j |
Of which past due > 2 years ≤ 5 years Subcategory of loans and advances that are 2–5 years past due |
k |
Of which past due > 5 years ≤ 7 years Subcategory of loans and advances that are 5–7 years past due |
l |
Of which past due > 7 years Subcategory of loans and advances that are more than 7 years past due. |
Template EU CQ7: Collateral obtained by taking possession and execution processes
Legal references and instructions |
|
Row number |
Explanation |
010 |
Property, plant and equipment (PP&E) Institutions shall disclose the stock of collateral obtained by taking possession that remains recognised in the balance sheet at the reporting reference date and that is classified as PP&E. |
020 |
Other than PP&E The stock of collateral obtained by taking possession that remains recognised in the balance sheet at the reporting reference date and is not classified as PP&E will automatically be disclosed in this row. The total stock will be calculated taking into account the initial stock (since the end of the last financial year), and the inflows and the outflows that occurred during the disclosure period (since the end of the last financial year). Collateral obtained by taking possession (other than PP&E) is in rows by type of collateral. |
030 |
Residential immovable property Collateral obtained by taking possession of residential property (e.g. houses, apartments, etc.) or property with potential use in the future as such (e.g. unfinished residential property etc.) |
040 |
Commercial immovable property Collateral obtained by taking possession of commercial or industrial property that can be used for business and/or investment purposes, or of any immovable property that is not residential property, as described above Land (both non-agricultural and agricultural) shall also be included in this category. |
050 |
Movable property (auto, shipping, etc.) Collateral obtained by taking possession of property other than immovable property shall be disclosed in this row. |
060 |
Equity and debt instruments Collateral obtained by taking possession of equity or debt instruments shall be disclosed in this row. |
070 |
Other collateral Collateral obtained by taking possession not falling into the categories of the other rows If the amount in this row is relatively material, institutions shall provide additional information in the narrative accompanying this template. |
080 |
Total |
Legal references and instructions |
|
Column number |
Explanation |
a |
Collateral obtained by taking possession - Value at initial recognition Institutions shall disclose in this column the gross carrying amount of the collateral obtained by taking possession at initial recognition in the institution’s balance sheet. |
b |
Collateral obtained by taking possession - Accumulated negative changes Accumulated impairment or accumulated negative changes to the initial recognition value of the collateral obtained by taking possession, as described above Institutions shall also include accumulated negative changes due to amortisation in the case of PP&E and investment properties, if applicable. |
Template EU CQ8: Collateral obtained by taking possession and execution processes – vintage breakdown
Legal references and instructions |
|
Row number |
Explanation |
010 |
Property, plant and equipment (PP&E) Institutions shall disclose the stock of collateral obtained by taking possession that remains recognised in the balance sheet at the reporting reference date and that is classified as PP&E. |
020 |
Other than PP&E The stock of collateral obtained by taking possession that remains recognised in the balance sheet at the reporting reference date and is not classified as PP&E will automatically be disclosed in this row. The total stock will be calculated taking into account the initial stock (since the end of the last financial year), and the inflows and the outflows that occurred during the disclosure period (since the end of the last financial year). Collateral obtained by taking possession (other than PP&E) is in rows by type of collateral. |
030 |
Residential immovable property Collateral obtained by taking possession of residential property (e.g. houses, apartments, etc.) or property with potential use in the future as such (e.g. unfinished residential property etc.) |
040 |
Commercial immovable property Collateral obtained by taking possession of commercial or industrial property that can be used for business and/or investment purposes, or of any immovable property that is not residential property, as described above Land (both non-agricultural and agricultural) shall also be included in this category. |
050 |
Movable property (auto, shipping, etc.) Collateral obtained by taking possession of property other than immovable property shall be disclosed in this row. |
060 |
Equity and debt instruments Collateral obtained by taking possession of equity or debt instruments shall be disclosed in this row. |
070 |
Other collateral Collateral obtained by taking possession not falling into the categories of the other rows. If the amount in this row is relatively material, institutions shall provide additional information in the narrative accompanying this template. |
080 |
Total |
Legal references and instructions |
|
Column number |
Explanation |
a |
Debt balance reduction - Gross carrying amount The gross amount of the debt that was cancelled in exchange for the collateral obtained by taking possession, at the exact moment of the exchange, through judicial procedures or bilateral agreement The gross amount shall be calculated as the gross reduction of the instrument balance, not taking into account any provisions. For the avoidance of doubt, balance reductions due to other reasons (e.g. cash collections) shall not be in this column. |
b |
Debt balance reduction - Accumulated negative changes Accumulated impairment or accumulated negative changes to the initial recognition value of the collateral obtained by taking possession, as described above See the definition in template CQ7, ‘Collateral obtained by taking possession and execution processes’. Institutions shall include accumulated negative changes due to amortisation in the case of PP&E and investment properties, if applicable. |
c |
Total collateral obtained by taking possession - Value at initial recognition The gross carrying amount of the collateral obtained by taking possession at initial recognition in the institution’s balance sheet shall be disclosed in this column. |
d |
Total collateral obtained by taking possession - Accumulated negative changes Accumulated impairment or accumulated negative changes to the initial recognition value of the collateral obtained by taking possession, as described above Institutions shall include accumulated negative changes due to amortisation in the case of PP&E and investment properties, if applicable. |
e |
Total collateral obtained by taking possession - Foreclosed ≤ 2 years – of which value at initial recognition Value at initial recognition for collateral obtained by taking possession and recognised in the balance sheet for 2 years or less at the reporting reference date |
f |
Total collateral obtained by taking possession - Foreclosed ≤ 2 years – of which accumulated negative changes Accumulated negative changes for collateral obtained by taking possession and recognised in the balance sheet for 2 years or less at the reporting reference date |
g |
Total collateral obtained by taking possession - Foreclosed > 2 years ≤ 5 years – of which value at initial recognition Value at initial recognition for collateral obtained by taking possession and recognised in the balance sheet for more than 2 years and up to 5 years at the reporting reference date |
h |
Total collateral obtained by taking possession - Foreclosed > 2 years ≤ 5 years – of which accumulated negative changes Accumulated negative changes for collateral obtained by taking possession and recognised in the balance sheet for more than 2 years and up to 5 years at the reporting reference date |
i |
Total collateral obtained by taking possession - Foreclosed > 5 years – of which value at initial recognition Value at initial recognition for collateral obtained by taking possession and recognised in the balance sheet for more than 5 years at the reporting reference date |
j |
Total collateral obtained by taking possession - Foreclosed > 5 years – of which accumulated negative changes Accumulated negative changes for collateral obtained by taking possession and recognised in the balance sheet for more than 5 years at the reporting reference date |
k |
Total collateral obtained by taking possession - Of which non-current assets held for sale – of which value at initial recognition Initial value for collateral obtained by taking possession that is classified as non-current assets held for sale shall be disclosed. If this classification is not relevant in accordance with the accounting framework applicable to the institution, this information shall not be provided. |
l |
Total collateral obtained by taking possession - Of which non-current assets held for sale – of which accumulated negative changes Accumulated negative changes for collateral obtained by taking possession that is classified as non-current assets held for sale shall be disclosed. If this classification is not relevant in accordance with the accounting framework applicable to the institution, this information shall not be provided. |
ANNEX XVII
Table EU CRC – Qualitative disclosure requirements related to CRM techniques
Legal basis |
Row number |
Free format |
Article 453 (a) CRR |
(a) |
A description of the core features of the policies and processes for on- and off-balance sheet netting and an indication of the extent to which institutions make use of balance sheet netting; |
Article 453 (b) CRR |
(b) |
The core features of policies and processes for eligible collateral evaluation and management; |
Article 453 (c) CRR |
(c) |
A description of the main types of collateral taken by the institution to mitigate credit risk; |
Article 453 (d) CRR |
(d) |
For guarantees and credit derivatives used as credit protection, the main types of guarantor and credit derivative counterparty and their creditworthiness used for the purposes of reducing capital requirements, excluding those used as part of synthetic securitisation structures; |
Article 453 (e) CRR |
(e) |
Information about market or credit risk concentrations within the credit mitigation taken; |
Template EU CR3 – CRM techniques overview: Disclosure of the use of credit risk mitigation techniques
|
Unsecured carrying amount |
Secured carrying amount |
||||
|
Of which secured by collateral |
Of which secured by financial guarantees |
|
|||
Of which secured by credit derivatives |
||||||
a |
b |
c |
d |
e |
||
1 |
Loans and advances |
|
|
|
|
|
2 |
Debt securities |
|
|
|
|
|
3 |
Total |
|
|
|
|
|
4 |
Of which non-performing exposures |
|
|
|
|
|
EU-5 |
Of which defaulted |
|
|
|
|
|
ANNEX XVIII
Disclosure of the use of credit risk mitigation techniques
Table EU CRC – Qualitative disclosure requirements related to CRM techniques. Flexible table
Row reference |
Legal reference and instructions |
|||||||||
Explanation |
||||||||||
(a) |
Point (a) of Article 453 CRR |
When disclosing information on their netting policies and use of netting in accordance with point (a) of Article 453 CRR, institutions shall provide a clear description of CRM policies and processes concerning on-balance-sheet, off-balance-sheet netting and master netting agreements. They shall also indicate to what extent on-balance-sheet, off-balance-sheet netting and master netting agreements have been used and their importance regarding credit risk management. Institutions could especially mention details about the techniques in use as well as the positions covered by on-balance-sheet netting agreements and the financial instruments included in the master netting agreements. Furthermore, the conditions necessary to assure effectiveness of these techniques and the controls in place for legal risk could also be described. |
||||||||
(b) |
Point (b) of Article 453 CRR |
As part of their disclosures on the core features of their policies and processes for eligible collateral valuation and management in accordance with point (b) of Article 453 CRR, institutions shall disclose:
Additionally, institutions could also disclose if there is a system of credit exposure limits in place and the impact of accepted collateral in the quantification of those limits. |
||||||||
(c) |
Point (c) of Article 453 CRR |
When describing the collateral taken in accordance with point (c) of Article 453 CRR, institutions shall provide a detailed description of the main types of collateral accepted to mitigate credit risk, by type of exposures. |
||||||||
(d) |
Point (d) of Article 453 CRR |
The description of the main types of guarantors and counterparties in credit derivatives and their creditworthiness to be disclosed in accordance with point (d) of Article 453 CRR shall cover credit derivatives used for the purposes of reducing capital requirements, excluding those used as part of synthetic securitisation structures. Institutions could also include description of the methods used to recognise the effects of the guarantees or credit derivatives provided by the main types of guarantors and counterparties. |
||||||||
(e) |
Point (e) of Article 453 CRR |
When disclosing information about market or credit risk concentrations within CRM taken in accordance with point (e) of Article 453 CRR, institutions shall provide an analysis of any concentration that arises due to CRM measures and may prevent CRM instruments from being effective. Concentrations in the scope of those disclosures could include concentrations by type of instrument used as collateral, entity (concentration by guarantor type and credit derivative providers), sector, geographical area, currency, rating or other factors that potentially impact the value of the protection and thereby reduce this protection. |
Template EU CR3 – CRM techniques overview: Disclosure of the use of credit risk mitigation techniques. Fixed template.
Column reference |
Legal references and instructions |
Explanation |
|
a |
Unsecured carrying amount: The carrying amount of exposures (net of allowances/impairments) that do not benefit from any CRM technique, regardless of whether this technique is recognised under CRR In particular, it refers to exposures for which neither collateral was pledged nor financial guarantee were received. The unsecured part of a partially secured or partially guaranteed exposure shall not be included. |
b |
Secured carrying amount: Carrying amount of exposures that have at least one CRM technique (collateral, financial guarantees, credit derivatives) associated with them In case the value of collateral, financial guarantees and credit derivatives securing an exposure exceeds the carrying amount of that exposure, only the values up to the carrying amount of that exposure shall be included. In case the carrying amount of an exposure exceeds the value of collateral, financial guarantees and credit derivatives securing that exposure, the full carrying amount of that exposure shall be included. For the purpose of the following columns c, d and e, the allocation of the carrying amount of multi-secured exposures to their different CRM techniques is made by order of priority, starting with the CRM technique expected to be called first in the event of non-payment, and within the limits of the carrying amount of the secured exposures. Any part of exposure shall be included in only one of the columns c, d or e of this template. |
c |
Of which secured by collateral: This is a subset of column b of this template and represents the carrying amount of exposures (net of allowances/impairments) or parts of exposures secured by collateral. In case an exposure is secured by collateral and other CRM technique(s) expected to be called beforehand in the event of non-payment, the carrying amount of the exposure secured by collateral is the remaining share of the exposure after consideration of the shares of the exposures already secured by other mitigation techniques, up to the carrying amount of that exposure. |
d |
Of which secured by financial guarantees: This is a subset of column b of this template and represents the carrying amount of exposures (net of allowances/impairments) or parts of exposures secured by guarantees. In case an exposure is secured by guarantees and other CRM techniques expected to be called beforehand in the event of non-payment, the carrying amount of the exposure secured by guarantees is the remaining part of the exposure after consideration of the shares of the exposure already secured by other mitigation techniques, up to the carrying amount of that exposure. |
e |
Of which secured by credit derivatives: This is a subset of column d (financial guarantees) of this template and represents the carrying amount of exposures (net of allowances/impairments) or parts of exposures secured by credit derivatives. In case an exposure is secured by credit derivatives and other CRM techniques expected to be called beforehand in the event of non-payment, the carrying amount of the exposure secured by credit derivatives is the remaining share of the exposure after consideration of the shares of the exposure already secured by other mitigation techniques, up to the carrying amount of that exposure. |
Row reference |
Legal references and instructions |
Explanation |
|
1 |
Loans and advances ‘Loans and advances’ are debt instruments held by the institutions that are not securities; this item includes ‘loans’ in accordance with Regulation (EU) 1071/2013 (“ECB BSI Regulation”)(2) as well as advances that cannot be classified as ‘loans’ in accordance with the ECB BSI Regulation, as defined in paragraph 32 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014(3). |
2 |
Debt securities Debt securities are debt instruments held by the institution issued as securities that are not loans in accordance with the ECB BSI Regulation, as defined in paragraph 31 of Part 1 of Annex V to Commission Implementing Regulation (EU) 680/2014. |
3 |
Total Sum of amounts in rows 1 and 2 of this template |
4 |
Of which non-performing exposures Non-performing exposures in accordance with Article 47a CRR |
EU-5 |
Of which defaulted Defaulted exposures in accordance with Article 178 CRR |
ANNEX XIX
Table EU CRD – Qualitative disclosure requirements related to standardised approach
Legal basis |
Row number |
Qualitative information - Free format |
Article 444 (a) CRR |
(a) |
Names of the external credit assessment institutions (ECAIs) and export credit agencies (ECAs) nominated by the institution, and the reasons for any changes over the disclosure period; |
Article 444 (b) CRR |
(b) |
The exposure classes for which each ECAI or ECA is used; |
Article 444 (c) CRR |
(c) |
A description of the process used to transfer the issuer and issue credit ratings onto comparable assets items not included in the trading book; |
Article 444 (d) CRR |
(d) |
The association of the external rating of each nominated ECAI or ECA (as referred to in row (a)) with the risk weights that correspond with the credit quality steps as set out in Chapter 2 of Title II of Part Three CRR (except where the institution complies with the standard association published by the EBA). |
Template EU CR4 – standardised approach – Credit risk exposure and CRM effects
|
Exposure classes |
Exposures before CCF and before CRM |
Exposures post CCF and post CRM |
RWAs and RWAs density |
|||
On-balance-sheet exposures |
Off-balance-sheet exposures |
On-balance-sheet exposures |
Off-balance-sheet exposures |
RWAs |
RWAs density (%) |
||
a |
b |
c |
d |
e |
f |
||
1 |
Central governments or central banks |
|
|
|
|
|
|
2 |
Regional government or local authorities |
|
|
|
|
|
|
3 |
Public sector entities |
|
|
|
|
|
|
4 |
Multilateral development banks |
|
|
|
|
|
|
5 |
International organisations |
|
|
|
|
|
|
6 |
Institutions |
|
|
|
|
|
|
7 |
Corporates |
|
|
|
|
|
|
8 |
Retail |
|
|
|
|
|
|
9 |
Secured by mortgages on immovable property |
|
|
|
|
|
|
10 |
Exposures in default |
|
|
|
|
|
|
11 |
Exposures associated with particularly high risk |
|
|
|
|
|
|
12 |
Covered bonds |
|
|
|
|
|
|
13 |
Institutions and corporates with a short-term credit assessment |
|
|
|
|
|
|
14 |
Collective investment undertakings |
|
|
|
|
|
|
15 |
Equity |
|
|
|
|
|
|
16 |
Other items |
|
|
|
|
|
|
17 |
TOTAL |
|
|
|
|
|
|
Template EU CR5 – standardised approach
|
Exposure classes |
Risk weight |
Total |
Of which unrated |
||||||||||||||
0 % |
2 % |
4 % |
10 % |
20 % |
35 % |
50 % |
70 % |
75 % |
100 % |
150 % |
250 % |
370 % |
1 250 % |
Others |
||||
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
n |
o |
p |
q |
||
1 |
Central governments or central banks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Regional government or local authorities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
Public sector entities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
Multilateral development banks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
International organisations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
Institutions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
Corporates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
Retail exposures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
Exposures secured by mortgages on immovable property |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
Exposures in default |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
Exposures associated with particularly high risk |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 |
Covered bonds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
Exposures to institutions and corporates with a short-term credit assessment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
Units or shares in collective investment undertakings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 |
Equity exposures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
Other items |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17 |
TOTAL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ANNEX XX
Instructions regarding disclosure of the use of the credit risk standardised approach (excluding counterparty credit risk and securitisation positions)
Table EU CRD – Qualitative disclosure requirements related to standardised approach.
Flexible format
Row reference |
Legal reference and instructions |
|
Explanation |
||
(a) |
Point (a) of Article 444 CRR |
Institutions shall disclose the names of the nominated external credit assessment institutions (ECAIs) and export credit agencies (ECAs) used and the reasons for any changes in those nominations over the disclosure period. |
(b) |
Point (b) of Article 444 CRR |
Institutions shall indicate the exposure classes, specified in Article 112 CRR, for which institutions calculate the risk-weighted exposure amounts in accordance with Chapter 2 of Title II of Part Three CRR using the credit assessment of the nominated ECAI or ECA. |
(c) |
Point (c) of Article 444 CRR |
When an issuer or an issue credit assessment is used to determine the risk weight to be assigned to an exposure not included in the trading book in accordance with Article 139 of Chapter 2 of Title II of Part Three CRR, the institutions shall describe the process used. |
(d) |
Point (d) of Article 444 CRR |
Institutions shall indicate, for each of the exposure classes specified in Article 112 CRR, the alphanumerical scale of each nominated ECAI/ECA (as referred to in row (a) of this template) with the risk weights that correspond with the credit quality steps as set out in Chapter 2 of Title II of Part Three CRR, except where the institution complies with the standard association published by the EBA |
Template EU CR4 – Credit risk exposure and CRM effects.
Fixed format
Column reference |
Legal references and instructions |
Explanation |
|
a |
Exposures before CCF and before CRM – On-balance-sheet exposures: Institutions shall disclose the on-balance-sheet exposure value under the scope of prudential consolidation in accordance with Article 111 CRR, after specific credit risk adjustments in accordance with Article 110 CRR, additional value adjustments in accordance with Articles 34 and 105 CRR, deducted amounts in accordance with point (m) of Article 36(1) CRR, other own funds reductions and write-offs (as defined in the applicable accounting framework), but before (i) the application of credit conversion factors as specified in the same Article and (ii) the application of CRM techniques specified in Chapter 4 of Title II of Part Three CRR. Exposure values for leases are subject to Article 134(7) CRR. |
b |
Exposures before CCF and before CRM – Off-balance-sheet exposures: Institutions shall disclose the off-balance-sheet exposure value under the scope of prudential consolidation, after reduction of specific credit risk adjustments and deducted amounts in accordance with point (m) of Article 36 (1) CRR, but before the application of credit conversion factors in accordance with Article 111 CRR and before the effect of CRM techniques (in application of Chapter 4 of Title II of Part Three CRR). |
c |
Exposures post CCF and post CRM – On-balance-sheet exposures: Institutions shall disclose the amount of the on-balance-sheet exposure value under the scope of prudential consolidation (in accordance with Article 111 CRR), after specific credit risk adjustments in accordance with Article 110 CRR, additional value adjustments in accordance with Article 34 and 105 CRR, deducted amounts in accordance with point (m) of Article 36(1) CRR, other own funds reductions and write-offs as defined in the applicable accounting framework, after the application of all credit risk mitigants and credit conversion factors. This is the amount to which the risk weights (in accordance with Article 113 CRR and with Section 1 of Chapter 2 of Title II of Part Three CRR) are applied. It is a net credit equivalent amount, after having applied CRM techniques and CCF. |
d |
Exposures post CCF and post CRM – Off-balance-sheet exposures: Institutions shall disclose the amount of the off-balance-sheet exposure value after taking into account specific credit risk adjustments as defined in the Commission Delegated Regulation (EU) 183/2014(2), additional value adjustments and other own funds reductions, after the application of all credit risk mitigants and credit conversion factors. This is the amount to which the risk weights (in accordance with Article 113 CRR and with Section 1 of Chapter 2 of Title II of Part Three CRR) are applied. It is a net credit equivalent amount, after having applied CRM techniques and CCF. |
e |
RWEAs The risk-weighted exposure amounts (RWEAs) calculated in accordance with Section 1 of Chapter 2 of Title II of Part Three CRR |
f |
RWEA density (Column e/Columns(c+d) of this template) The ratio shall be calculated by dividing the RWEAs of the respective exposure class (column e of this template) by the amount of the respective exposures after taking into account all credit risk mitigants and credit conversion factors (sum of amounts in columns c and d of this template). |
Row number |
Legal references and instructions |
||||
Explanation |
|||||
1 - 16 |
Exposure classes as defined in accordance with Article 112 CRR Exposures assigned to exposure class ‘items representing securitisation positions’ that is referred to in point (m) of Article 112 CRR are not included. |
||||
16 |
‘Other items’ exposure class refers to:
|
Template EU CR5 – Standardised approach
. Fixed format
Column reference |
Legal references and instructions |
||||||
Explanation |
|||||||
a - o |
Risk weight: Institutions shall disclose the information on the allocation of risk weights within the respective exposure class according to Section 2 of Chapter 2 of Title II of Part Three CRR. |
||||||
p |
Total: Total amount of on-balance-sheet and off-balance-sheet exposures under the scope of prudential consolidation:
|
||||||
q |
Of which unrated: Exposures for which a credit assessment by a nominated ECAI is not available and that are applied specific risk weights depending on their exposure class, as specified in Article 113 to Article 134 CRR |
Row number |
Legal references and instructions |
||||
Explanation |
|||||
1 - 16 |
Exposure classes in accordance with Article 112 CRR Exposures assigned to exposure class ‘items representing securitisation positions’ that is referred to in point (m) of Article 112 CRR are not included. |
||||
16 |
‘Other items’ exposure class refers to:
|
ANNEX XXI
Table EU CRE – Qualitative disclosure requirements related to IRB approach
Legal basis |
Row number |
Free format |
||||||||||
Article 452 (a) CRR |
(a) |
The competent authority's permission of the approach or approved transition |
||||||||||
Article 452 (c) CRR |
(b) |
|
||||||||||
Article 452 (d) CRR |
(c) |
The role of the functions involved in the development, approval and subsequent changes of the credit risk models; |
||||||||||
Article 452 (e) CRR |
(d) |
The scope and main content of the reporting related to credit risk models; |
||||||||||
Article 452 (f) CRR |
(e) |
A description of the internal ratings process by exposure class, including the number of key models used with respect to each portfolio and a brief discussion of the main differences between the models within the same portfolio, covering:
|
Template EU CR6 – IRB approach – Credit risk exposures by exposure class and PD range
A-IRB |
PD range |
On-balance sheet exposures |
Off-balance-sheet exposures pre-CCF |
Exposure weighted average CCF |
Exposure post CCF and post CRM |
Exposure weighted average PD (%) |
Number of obligors |
Exposure weighted average LGD (%) |
Exposure weighted average maturity (years) |
Risk weighted exposure amount after supporting factors |
Density of risk weighted exposure amount |
Expected loss amount |
Value adjust-ments and provisions |
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
|
Exposure class X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0,00 to < 0,15 |
|
|
|
|
|
|
|
|
|
|
|
|
0,00 to < 0,10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,10 to < 0,15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,15 to < 0,25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,25 to < 0,50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,50 to < 0,75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,75 to < 2,50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,75 to < 1,75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,75 to < 2,5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,50 to < 10,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,5 to < 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 to < 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
10,00 to < 100,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
10 to < 20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
20 to < 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
30,00 to < 100,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
100,00 (Default) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal (exposure class) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total (all exposures classes) |
|
|
|
|
|
|
|
|
|
|
|
|
F-IRB |
PD range |
On-balance sheet exposures |
Off-balance-sheet exposures pre-CCF |
Exposure weighted average CCF |
Exposure post CCF and post CRM |
Exposure weighted average PD (%) |
Number of obligors |
Exposure weighted average LGD (%) |
Exposure weighted average maturity (years) |
Risk weighted exposure amount after supporting factors |
Density of risk weighted exposure amount |
Expected loss amount |
Value adjust-ments and provisions |
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
|
Exposure class X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0,00 to < 0,15 |
|
|
|
|
|
|
|
|
|
|
|
|
0,00 to < 0,10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,10 to < 0,15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,15 to < 0,25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,25 to < 0,50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,50 to < 0,75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,75 to < 2,50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0,75 to < 1,75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,75 to < 2,5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,50 to < 10,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,5 to < 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 to < 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
10,00 to < 100,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
10 to < 20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
20 to < 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
30,00 to < 100,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
100,00 (Default) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal (exposure class) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total (all exposures classes) |
|
|
|
|
|
|
|
|
|
|
|
|
Template EU CR6-A – Scope of the use of IRB and SA approaches
|
Exposure value as defined in Article 166 CRR for exposrues subject to IRB approach |
Total exposure value for exposures subject to the Standardised approach and to the IRB approach |
Percentage of total exposure value subject to the permanent partial use of the SA (%) |
Percentage of total exposure value subject to IRB Approach (%) |
Percentage of total exposurevalue subject to a roll-out plan (%) |
|
a |
b |
c |
d |
e |
||
1 |
Central governments or central banks |
|
|
|
|
|
1,1 |
Of which Regional governments or local authorities |
|
|
|
|
|
1,2 |
Of which Public sector entities |
|
|
|
|
|
2 |
Institutions |
|
|
|
|
|
3 |
Corporates |
|
|
|
|
|
3,1 |
Of which Corporates - Specialised lending, excluding slotting approach |
|
|
|
|
|
3,2 |
Of which Corporates - Specialised lending under slotting approach |
|
|
|
|
|
4 |
Retail |
|
|
|
|
|
4,1 |
of which Retail – Secured by real estate SMEs |
|
|
|
|
|
4,2 |
of which Retail – Secured by real estate non-SMEs |
|
|
|
|
|
4,3 |
of which Retail – Qualifying revolving |
|
|
|
|
|
4,4 |
of which Retail – Other SMEs |
|
|
|
|
|
4,5 |
of which Retail – Other non-SMEs |
|
|
|
|
|
5 |
Equity |
|
|
|
|
|
6 |
Other non-credit obligation assets |
|
|
|
|
|
7 |
Total |
|
|
|
|
|
Template EU CR7 – IRB approach – Effect on the RWEAs of credit derivatives used as CRM techniques
|
Pre-credit derivatives risk weighted exposure amount |
Actual risk weighted exposure amount |
|
a |
b |
||
1 |
Exposures under F-IRB |
|
|
2 |
Central governments and central banks |
|
|
3 |
Institutions |
|
|
4 |
Corporates |
|
|
4,1 |
of which Corporates - SMEs |
|
|
4,2 |
of which Corporates - Specialised lending |
|
|
5 |
Exposures under A-IRB |
|
|
6 |
Central governments and central banks |
|
|
7 |
Institutions |
|
|
8 |
Corporates |
|
|
8,1 |
of which Corporates - SMEs |
|
|
8,2 |
of which Corporates - Specialised lending |
|
|
9 |
Retail |
|
|
9,1 |
of which Retail – SMEs - Secured by immovable property collateral |
|
|
9,2 |
of which Retail – non-SMEs - Secured by immovable property collateral |
|
|
9,3 |
of which Retail – Qualifying revolving |
|
|
9,4 |
of which Retail – SMEs - Other |
|
|
9,5 |
of which Retail – Non-SMEs- Other |
|
|
10 |
TOTAL (including F-IRB exposures and A-IRB exposures) |
|
|
Template EU CR7-A – IRB approach – Disclosure of the extent of the use of CRM techniques
A-IRB |
Total exposures |
Credit risk Mitigation techniques |
Credit risk Mitigation methods in the calculation of RWEAs |
||||||||||||
Funded credit Protection (FCP) |
Unfunded credit Protection (UFCP) |
RWEA without substitution effects (reduction effects only) |
RWEA with substitution effects (both reduction and sustitution effects) |
||||||||||||
Part of exposures covered by Financial Collaterals (%) |
Part of exposures covered by Other eligible collaterals (%) |
|
Part of exposures covered by Other funded credit protection (%) |
|
Part of exposures covered by Guarantees (%) |
Part of exposures covered by Credit Derivatives (%) |
|||||||||
Part of exposures covered by Immovable property Collaterals (%) |
Part of exposures covered by Receivables (%) |
Part of exposures covered by Other physical collateral (%) |
Part of exposures covered by Cash on deposit (%) |
Part of exposures covered by Life insurance policies (%) |
Part of exposures covered by Instruments held by a third party (%) |
||||||||||
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
n |
||
1 |
Central governments and central banks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Institutions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
Corporates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,1 |
Of which Corporates – SMEs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,2 |
Of which Corporates – Specialised lending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,3 |
Of which Corporates – Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
Retail |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,1 |
Of which Retail – Immovable property SMEs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,2 |
Of which Retail – Immovable property non-SMEs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,3 |
Of which Retail – Qualifying revolving |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,4 |
Of which Retail – Other SMEs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,5 |
Of which Retail – Other non-SMEs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-IRB |
Total exposures |
Credit risk Mitigation techniques |
Credit risk Mitigation methods in the calculation of RWEAs |
||||||||||||
Funded credit Protection (FCP) |
Unfunded credit Protection (UFCP) |
RWEA without substitution effects (reduction effects only) |
RWEA with substitution effects (both reduction and sustitution effects) |
||||||||||||
Part of exposures covered by Financial Collaterals (%) |
Part of exposures covered by Other eligible collaterals (%) |
|
Part of exposures covered by Other funded credit protection (%) |
|
Part of exposures covered by Guarantees (%) |
Part of exposures covered by Credit Derivatives (%) |
|||||||||
Part of exposures covered by Immovable property Collaterals (%) |
Part of exposures covered by Receivables (%) |
Part of exposures covered by Other physical collateral (%) |
Part of exposures covered by Cash on deposit (%) |
Part of exposures covered by Life insurance policies (%) |
Part of exposures covered by Instruments held by a third party (%) |
||||||||||
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
n |
||
1 |
Central governments and central banks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Institutions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
Corporates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,1 |
Of which Corporates – SMEs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,2 |
Of which Corporates – Specialised lending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,3 |
Of which Corporates – Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Template EU CR8 – RWEA flow statements of credit risk exposures under the IRB approach
|
Risk weighted exposure amount |
|
a |
||
1 |
Risk weighted exposure amount as at the end of the previous reporting period |
|
2 |
Asset size (+/–) |
|
3 |
Asset quality (+/–) |
|
4 |
Model updates (+/–) |
|
5 |
Methodology and policy (+/–) |
|
6 |
Acquisitions and disposals (+/–) |
|
7 |
Foreign exchange movements (+/–) |
|
8 |
Other (+/–) |
|
9 |
Risk weighted exposure amount as at the end of the reporting period |
|
Template CR9 –IRB approach – Back-testing of PD per exposure class (fixed PD scale)
Exposure class |
PD range |
Number of obligors at the end of previous year |
Observed average default rate (%) |
Exposures weighted average PD (%) |
Average PD (%) |
Average historical annual default rate (%) |
|
|
Of which number of obligors which defaulted in the year |
||||||
a |
b |
c |
d |
e |
f |
g |
h |
|
0,00 to < 0,15 |
|
|
|
|
|
|
0,00 to < 0,10 |
|
|
|
|
|
|
|
0,10 to < 0,15 |
|
|
|
|
|
|
|
0,15 to < 0,25 |
|
|
|
|
|
|
|
0,25 to < 0,50 |
|
|
|
|
|
|
|
0,50 to < 0,75 |
|
|
|
|
|
|
|
0,75 to < 2,50 |
|
|
|
|
|
|
|
0,75 to < 1,75 |
|
|
|
|
|
|
|
1,75 to < 2,5 |
|
|
|
|
|
|
|
2,50 to < 10,00 |
|
|
|
|
|
|
|
2,5 to < 5 |
|
|
|
|
|
|
|
5 to < 10 |
|
|
|
|
|
|
|
10,00 to < 100,00 |
|
|
|
|
|
|
|
10 to < 20 |
|
|
|
|
|
|
|
20 to < 30 |
|
|
|
|
|
|
|
30,00 to < 100,00 |
|
|
|
|
|
|
|
100,00 (Default) |
|
|
|
|
|
|
Exposure class |
PD range |
Number of obligors in the end of previous year |
Observed average default rate (%) |
Exposure weighted average PD (%) |
Average PD (%) |
Average historical annual default rate (%) |
|
|
Of which number of obligors which defaulted in the year |
||||||
a |
b |
c |
d |
e |
f |
g |
h |
|
0,00 to < 0,15 |
|
|
|
|
|
|
0,00 to < 0,10 |
|
|
|
|
|
|
|
0,10 to < 0,15 |
|
|
|
|
|
|
|
0,15 to < 0,25 |
|
|
|
|
|
|
|
0,25 to < 0,50 |
|
|
|
|
|
|
|
0,50 to < 0,75 |
|
|
|
|
|
|
|
0,75 to < 2,50 |
|
|
|
|
|
|
|
0,75 to < 1,75 |
|
|
|
|
|
|
|
1,75 to < 2,5 |
|
|
|
|
|
|
|
2,50 to < 10,00 |
|
|
|
|
|
|
|
2,5 to < 5 |
|
|
|
|
|
|
|
5 to < 10 |
|
|
|
|
|
|
|
10,00 to < 100,00 |
|
|
|
|
|
|
|
10 to < 20 |
|
|
|
|
|
|
|
20 to < 30 |
|
|
|
|
|
|
|
30,00 to < 100,00 |
|
|
|
|
|
|
|
100,00 (Default) |
|
|
|
|
|
|
Template CR9.1 –IRB approach – Back-testing of PD per exposure class (only for PD estimates according to point (f) of Article 180(1) CRR)
Exposure class |
PD range |
External rating equivalent |
Number of obligors at the end of previous year |
Observed average default rate (%) |
Average PD (%) |
Average historical annual default rate (%) |
|
|
Of which number of obligors which defaulted in the year |
||||||
a |
b |
c |
d |
e |
f |
g |
h |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exposure class |
PD range |
External rating equivalent |
Number of obligors in the end of previous year |
Observed average default rate (%) |
Average PD (%) |
Average historical annual default rate (%) |
|
|
Of which number of obligors which defaulted in the year |
||||||
a |
b |
c |
d |
e |
f |
g |
h |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ANNEX XXII
Disclosure of the use of the IRB Approach to credit risk (excluding counterparty credit risk)
Table EU CRE – Qualitative disclosure requirements related to IRB Approach. Flexible table.
Row reference |
Legal references and instructions |
|||||||||
Explanation |
||||||||||
(a) |
Point (a) of Article 452 CRR |
When disclosing information on the scope of the competent authority’s permission of approach or approved transition in accordance with point (a) of Article 452 CRR, institutions shall describe the main characteristics of the rating systems used under the IRB Approach for which the permission has been granted by a competent authority and the types of exposures covered by these rating systems. Institutions shall also describe the types of exposures for which they have permission to use permanent partial use of the Standardised Approach in accordance with Article 150 CRR and which are under their IRB roll-out plans in accordance with Article 148 CRR. The description shall be provided at the group level. |
||||||||
(b) |
Point (c)(i)-(iv) of Article 452 CRR |
The description of the control mechanisms for rating systems shall cover the estimation of risk parameters, including internal model development and calibration, as well as controls in the application of the models and changes to rating systems. In accordance with point (c)(i)-(iv) of Article 452 CRR the description of the role of the functions referred to above shall also include:
|
||||||||
(c) |
Point (d) of Article 452 CRR |
Institutions shall specify the role of the functions involved in the model development, calibration, approval and subsequent changes of the rating systems. |
||||||||
(d) |
Point (e) of Article 452 CRR |
Institutions shall disclose the scope and main content of management reporting related to IRB models referred to in Article 189 CRR, as well as addressees and frequency of such reporting. |
||||||||
(e) |
Point (f) of Article 452 CRR |
The disclosure of the internal rating systems by exposure class shall include the number of key models used in each exposure class with respect different types of exposures, with a brief description of the main differences among the models within the same exposure class. It shall also include a description of the main characteristics of the key approved models, in particular:
|
Template EU CR6 – IRB approach – Credit risk exposures by exposure class and PD range. Fixed template.
Column reference |
Legal references and instructions |
Explanation |
|
a |
PD range This is a fixed PD range which shall not be altered. In case that the data on defaulted exposures in accordance with Article 178 CRR is further broken down in accordance with possible definitions for categories of defaulted exposures, the definitions and amounts for categories of defaulted exposures shall be explained in an accompanying narrative. Exposures shall be allocated to an appropriate bucket of the fixed PD range based on the PD estimated for each obligor assigned to this exposure class (without considering any substitution effects due to CRM). All defaulted exposures shall be included in the bucket representing PD of 100 %. |
b |
On-balance sheet exposures Exposure value calculated in accordance with Article 166(1) to (7) CRR without taking into account any credit risk adjustments and any conversion factors |
c |
Off-balance sheet exposures pre-conversion factors (CCF) Exposure value in accordance with Article 166(1) to (7) CRR, without taking into account any credit risk adjustments and any conversion factors, neither own estimates nor conversion factors specified in Article 166(8) CRR, or any percentages specified in Article 166(10) CRR Off balance sheet exposures shall comprise all committed but undrawn amounts and all off-balance sheet items, as listed in Annex I to CRR. |
d |
Exposure weighted average CCF For all exposures included in each bucket of the fixed PD scale, the average conversion factor used by institutions in their calculation of risk-weighted exposure amounts, weighted by the off-balance sheet exposure pre-CCF as in column c of this template |
e |
Exposure value post CCF and post CRM Exposure value in accordance with Article 166 CRR This column includes the sum of exposure value of on-balance sheet exposures and off-balance sheet exposures post conversion factors and percentages in accordance with Article 166(8) to (10) CRR. |
f |
Exposure weighted average PD (%) For all exposures included in each bucket of the fixed PD range, the average PD estimate of each obligor, weighted by the exposure value post-CCF and CRM as in column e of this template |
g |
Number of obligors The number of legal entities or obligors allocated to each bucket of the fixed PD range, which were separately rated, regardless of the number of different loans or exposures granted Joint obligors shall be treated the same as for the purpose of PD calibration. Where different exposures to the same obligor are separately rated, they shall be counted separately. Such situation may take place within the retail exposure class if the definition of default is applied at the level of individual credit facility in accordance with the last sentence of Article 178(1) CRR, or if separate exposures to the same obligor are assigned to different obligor grades in accordance with the second sentence of point (e) of Article 172(1) CRR in other exposure classes. |
h |
Exposure weighted average LGD (%) For all exposures included in each bucket of the fixed PD range, the average of the LGD estimates for each exposure, weighted by the exposure value post-CCF and post-CRM as in column e of this template The disclosed LGD shall correspond to the final LGD estimate used in the calculation of risk weighted amounts obtained after considering any CRM effects and downturn conditions where relevant. For retail exposures secured by immovable properties the disclosed LGD shall take into account the floors specified in Article 164(4) CRR. In the case of exposures subject to the double default treatment the LGD to be disclosed shall correspond to the one selected in accordance with Article 161 (4) CRR. For defaulted exposures under A-IRB Approach, provisions laid down in point (h) of Article 181(1) CRR shall be considered. The disclosed LGD shall correspond to the estimate of LGD in-default in accordance with the applicable estimation methodologies. |
i |
Exposure-weighted average maturity (years) For all exposures included in each bucket of the fixed PD range, the average maturity of each exposure, weighted by the exposure value post-CCF as in column e of this template The disclosed value of maturity reflects Article 162 CRR. The average maturity shall be disclosed in years. This data shall not be disclosed for the exposure values for which the maturity is not an element in the calculation of risk weighted exposure amounts in accordance with Chapter 3 of Title II of Part Three CRR. This means that this column shall not be filled in for the exposure class ‘retail’. |
j |
Risk weighted exposure amount after supporting factors For exposures to central governments and central banks, institutions and corporates, the risk weighted exposure amount calculated in accordance with Article 153(1) to (4) CRR; for retail exposures, the risk weighted exposure amount calculated in accordance with Article 154 CRR The SME and infrastructure supporting factors in accordance with Article 501 and Article 501a CRR shall be taken into account. |
k |
Density of risk weighted exposure amounts Ratio between the sum of risk weighted exposure amounts after supporting factors as in column j of this template and the exposure value as in column e of this template |
l |
Expected loss amount The expected loss amount calculated in accordance with Article 158 CRR The expected loss amount to be disclosed shall be based on the actual risk parameters used in the internal rating system approved by the respective competent authority. |
m |
Value adjustments and provisions Specific and general credit risk adjustments in accordance with the Commission Delegated Regulation (EU) 183/2014(2), additional value adjustments in accordance with Articles 34 and 110 CRR, as well as other own funds reductions related to the exposures allocated to each bucket on the fixed PD range These value adjustments and provisions shall be those considered for the implementation of Article 159 CRR. General provisions shall be disclosed by assigning the amount pro rata – in accordance with the expected loss of different obligor grades. |
Row reference |
Legal references and instructions |
||||||||||||||||||||||||||||||||||||||||||||
Explanation |
|||||||||||||||||||||||||||||||||||||||||||||
Exposure class X |
Where institutions have received permission to use own LGDs and convertion factors for the calculation of risk-weighted exposure amounts, they shall disclose the information required in this template separately for the exposure classes subject to that permission (A-IRB). For the exposure classes for which the institution does not have permission to use own estimates of LGD and conversion factors (F-IRB) the institution shall disclose the information on the relevant exposures separately using the F-IRB template. |
||||||||||||||||||||||||||||||||||||||||||||
A-IRB |
Exposure class X For each exposure class listed in Article 147(2) CRR, with the exceptions indicated above, institutions shall disclose a separate template, with a further breakdown for the following exposure classes:
The total exposures row shall be included at the end of each separate template per exposure class. |
||||||||||||||||||||||||||||||||||||||||||||
F-IRB |
Exposure class X For each exposure class listed in Article 147(2) CRR, with the exceptions indicated above, institutions shall disclose a separate template, with a further breakdown for the following exposure classes:
|
Template EU CR6-A – IRB Approach – Scope of the use of IRB and SA approaches. Fixed template
Legal references and instructions |
|||||||||
Column reference |
Explanation |
||||||||
a |
Exposure value as defined in Article 166 CRR for exposures subject to IRB approach Institutions shall disclose in this column the exposure value as defined in Article 166 CRR, only for those exposures under the IRB approach. |
||||||||
b |
Total exposure value for exposures subject to the Standardised approach and to the IRB approach Institutions shall use the e posure value in accordance with Article 429(4) CRR to disclose the total exposure value, including both the exposures under the standardized approach and the exposures under the IRB approach. |
||||||||
c |
Percentage of total exposure value subject to the permanent partial use of the SA (%) Part of exposure for each exposure class subject to the Standardised Approach (exposure subject to the Standardised Approach laid down in Chapter 2 of Title II of Part Three, in accordance with the scope of permission for permanent partial use of the Standardised Approach received from a competent authority in accordance with Article 150 CRR), over the total exposure in that exposure class as in column b of this template. |
||||||||
d |
Percentage of total exposure value subject to IRB Approach (%) Part of exposure for each exposure class subject to the IRB approach (exposure subject to the IRB Approach laid down in Chapter 3 of Title II of Part Three over the total exposure in that exposure class), respecting the scope of permission received from a competent authority to use the IRB Approach in accordance with Article 143 CRR, over the total exposure in that exposure class as in column b of this template. This shall include both exposures where institutions have the permission to use their own estimation of LGD and conversion factors or not (F-IRB and A-IRB), including supervisory slotting approach for specialized lending exposures and equity exposures under the simple risk weight approach. |
||||||||
e |
Percentage of total exposure value subject to a roll-out plan (%) Part of exposure for each asset class subject to the sequential implementation of IRB approach pursuant to Article 148 CRR, over the total exposure in that exposure class as in column b. This shall include:
|
Row number |
Legal references and instructions |
Explanation |
|
Exposure classes |
Institutions shall include the information in template CR 6-A by exposure classes, in accordance with the breakdown of exposure classes included in the rows of the template. |
Template EU CR7 – IRB approach – Effect on the Risk Weighted Exposure amounts of credit derivatives used as CRM techniques. Fixed template.
Column reference |
Legal references and instructions |
Explanation |
|
a |
Pre-credit derivatives risk weighted exposure amount Hypothetical risk weighted exposure amount calculated the actual RWEA assuming only the absence of recognition of the credit derivative as a CRM technique as specified in Article 204 CRR. The amounts shall be presented in the exposure classes relevant for the exposures to the original obligor. |
b |
Actual risk weighted exposure amount Risk weighted exposure amount calculated taking into account the impact of the credit derivatives. Where institutions substitute the risk weight or the risk parameters of the obligor with the risk weight or risk parameters of the protection provider, the risk weighted exposure amounts shall be presented in the exposure class relevant for direct exposures to the protection provider. |
Row reference |
Legal references and instructions |
||||||||||||||||||||||||||||||||||||||||
Explanation |
|||||||||||||||||||||||||||||||||||||||||
1 to 9 |
Institutions shall include the breakdown of pre-credit derivatives risk weighted exposure amount and actual risk weighted exposure by exposure class, in accordance with the exposure classes listed in Article 147 CRR with further breakdown as included in the template, and separately for exposures under F-IRB approach and exposures under A-IRB approach. Institutions shall disclose under rows 1 and 6 of this template the subtotals for F-IRB exposures and for A-IRB exposures. Institutions shall disclose further breakdown for exposure class ‘exposures to corporates’ (point (c) of Article 147(2) CRR) in accordance with the below:
Institutions shall disclose further breakdown for exposure class ‘retail exposures’ (point (d) of Article 147(2) and Article 147(5) CRR) Institutions shall disclose further breakdown for:
|
||||||||||||||||||||||||||||||||||||||||
10 |
TOTAL EXPOSURES (including F-IRB exposures and A-IRB exposures) Total pre-credit derivatives risk weighted exposure amount, and total actual risk weighted exposure amount for all IRB exposures (including F-IRB and A-IRB) |
Template EU CR7-A IRB approach – Disclosure of the extent of the use of CRM techniques
Column reference |
Legal references and instructions |
||||||
Explanation |
|||||||
a |
Total exposures Exposure value (post conversion factors) in accordance with Articles 166 to 167 CRR Exposures shall be disclosed in accordance with the exposure class applicable to the obligor, without taking into account any substitution effects due to the existence of a guarantee. Institutions applying the simple risk weight approach shall also consider the offsetting provisions referred to in Article 155(2) CRR. |
||||||
b |
FCP - Part of exposures covered by financial collateral (%) Percentage of exposures secured by financial collateral over total exposures as in column a of this template. Financial collateral, including cash collateral, debt securities, and gold, as listed in Articles 197 and 198 CRR, shall be included in the numerator where all the requirements laid down in Article 207 (2) to (4) CRR are met. The value of collateral disclosed shall be limited to the value of the exposure at the level of an individual exposure. When own estimates of LGD are used: financial collateral taken into account in the LGD estimates in accordance with points (e) and (f) of Article 181 (1) CRR. The amount to be disclosed shall be the estimated market value of the collateral. |
||||||
c |
FCP - Part of exposures covered by other eligible collaterals (%) Percentage of exposures secured by other eligible collateral over total exposures as in column a of this template The values disclosed in this column shall be the sum of the values in columns d to f of this template. Where own estimates of LGD are not used: Article 199 (1) to (8) CRR and Article 229 CRR. Where own estimates of LGD are used: other collateral taken into account in the LGD estimates in accordance with points (e) and (f) of Article 181 (1) CRR. |
||||||
d |
FCP - Part of exposures covered by immovable property collaterals (%) Percentage of exposures secured by immovable property collateral including leasing in accordance with Article 199(7) CRR over total exposures as in column a of this template Immovable property collateral shall be included in the numerator where they meet all the eligibility requirements laid down in Article 208(2) to (5) CRR. Leasing on immovable property shall be included in the numerator where they meet all the eligibility requirements laid down in Article 211 CRR. The disclosed value of collateral shall be limited to the value of the exposure at the level of an individual exposure. |
||||||
e |
Part of exposures covered by Receivables (%) Percentage of exposures secured by receivables in accordance with Article 199 (5) CRR over total exposures as in column a of this template Receivables shall be included in the numerator where they meet all the eligibility requirements laid down in Article 209 CRR. The disclosed value of collateral shall be limited to the value of the exposure at the level of an individual exposure |
||||||
f |
Part of exposures covered by Other physical collateral (%) Percentage of exposures secured by other physical collateral including leasing of those collaterals in accordance with Article 199 (6) and (8) CRR over total exposures as in column a of this template Other physical collateral shall be included in the numerator where they meet all the eligibility requirements laid down in Article 210 CRR. The disclosed value of collateral shall be limited to the value of the exposure at the level of an individual exposure. |
||||||
g |
FCP - Part of exposures covered by Other funded credit protection (%) Percentage of exposures secured by other FCP over total exposures as in column a The values in this column shall be the sum of the values in columns h, i and j of this template. |
||||||
h |
FCP - Part of exposures covered by cash on deposit (%) Percentage of exposures secured by cash or cash assimilated instruments held by third party institution over total exposures as in column a of this template; in accordance with point (a) of Article 200 CRR, other funded credit protection includes cash on deposit with, or cash assimilated instruments held by third party institution in a non-custodial arrangement and pledged to the lending institution. The disclosed value of collateral shall be limited to the value of the exposure at the level of an individual exposure. |
||||||
i |
FCP - Part of exposures covered by life insurance policies (%) Percentage of exposures secured by life insurance policies over total exposures as in column a of this template In accordance with point (b) of Article 200 CRR, other funded credit protection includes life insurance policies pledged to the lending institution. The disclosed value of collateral shall be limited to the value of the exposure at the level of an individual exposure. |
||||||
j |
FCP - Part of exposures covered by instrument held by a third party (%) Percentage of exposures secured by collateral in the form of instruments held by a third party over total exposures as in column a of this template; part of exposures covered by instruments issued by a third party over total exposures In accordance with point (c) of Article 200 CRR, the disclosed value shall include instruments issued by a third party institution which will be repurchased by that institution on request. The value of collateral shall be limited to the value of the exposure at the level of an individual exposure. The percentage shall exclude those exposures covered by instruments held by a third party where, following Article 232 (4) CRR institutions treat instruments repurchased on request that are eligible under point (c) of Article 200 CRR as a guarantee by the issuing institution. |
||||||
k |
UFCP - Part of exposures covered by guarantees (%) Percentage of exposures secured by guarantees over total exposures as in column a of this template. The guarantees shall meet the requirement laid down in Articles 213, 214, 215 and, when relevant, 217 and 232(4) CRR. The value of guarantees shall be limited to the value of the exposure at the level of an individual exposure. |
||||||
l |
UFCP - Part of exposures covered by credit derivatives (%) Percentage of exposures secured by credit derivatives over total exposures as in column a of this template. Credit derivatives include the following:
These instruments shall meet the requirement laid down in Articles 204(1) and (2), 213, 216, and when relevant, Article 217 CRR. The value of credit derivatives shall be limited to the value of the exposure at the level of an individual exposure. |
||||||
m |
RWEA without substitution effects (reduction effects only) The risk-weighted exposure amounts calculated in accordance with points (a) and (f) of Article 92(3) CRR, including any reduction of RWEA due to the existence of funded or unfunded credit protection, including where the PD and LGD or the risk weight is substituted due to the existence of unfunded credit protection. Nevertheless, in all cases, including where substitution approach is used, exposures are disclosed in the original exposure classes applicable to the obligor. |
||||||
n |
RWEA with substitution effects (both reduction and substitution effects) The risk-weighted exposure amounts calculated in accordance with Article 153 to 157 CRR, including any reduction of RWEA due to the existence of funded or unfunded credit protection. Where the PD and LGD or the risk weight is substituted due to the existence of unfunded credit protection, exposures are disclosed in the exposure class applicable to the protection provider. |
Row reference |
Legal references and instructions |
||||||||||||||||||||||||||||||||||||||||
Explanation |
|||||||||||||||||||||||||||||||||||||||||
|
This disclosure shall be made separately for exposures under A-IRB approach, F-IRB approach as well as specialised lending under the slotting approach and equity exposures. |
||||||||||||||||||||||||||||||||||||||||
A-IRB |
Institutions shall include the information on credit risk mitigation techniques included in this template by exposure class, in accordance with the exposure classes listed in Article 147 CRR with further breakdown for exposure class ‘Corporates’ (point (c) of Article 147(2) CRR) in accordance with the below:
Institutions shall disclose further breakdown for exposure class ‘Retail’ (point (d) of Article 147(2) and Article 147(5) CRR) Institutions shall disclose further breakdown for:
|
||||||||||||||||||||||||||||||||||||||||
F-IRB |
Institutions shall include the information on credit risk mitigation techniques included in this template by exposure class, in accordance with the exposure classes listed in Article 147 CRR with further breakdown for exposure class ‘Corporates’ (point (c) of Article 147(2) CRR) in accordance with the below:
|
Template EU CR8 – RWEA flow statements of credit risk exposures under the IRB approach. Fixed template.
Column reference |
Legal references and instructions |
Explanation |
|
a |
Risk weighted exposure amount Total risk weighted exposure amount for credit risk calculated under the IRB Approach, taking into account supporting factors in accordance with Articles 501 and 501a CRR. |
Row number |
Legal references and instructions |
Explanation |
|
1 |
Risk weighted exposure amount at the end of the previous disclosure period |
2 |
Asset size (+/-) Change in the risk weighted exposure amount between the end of the previous disclosure period and the end of the current disclosure period, due to asset size, i.e. organic changes in book size and composition (including the origination of new businesses and maturing loans) but excluding changes in book size due to acquisitions and disposal of entities Increases in risk weighted exposure amounts shall be disclosed as a positive amount and decreases in risk weighted exposure amounts shall be disclosed as a negative amount. |
3 |
Asset quality (+/-) Change in the risk weighted exposure amount between the end of the previous disclosure period and the end of the current disclosure period, due to asset quality, i.e. changes in the assessed quality of the institution’s assets due to changes in borrower risk, such as rating grade migration or similar effects Increases in risk weighted exposure amounts shall be disclosed as a positive amount and decreases in risk weighted exposure amounts shall be disclosed as a negative amount. |
4 |
Model updates (+/-) Change in the risk weighted exposure amount between the end of the previous disclosure period and the end of the current disclosure period, due to model updates, i.e. changes due to implementation of new models, changes in the models, changes in model scope, or any other changes intended to address model weaknesses Increases in risk weighted exposure amounts shall be disclosed as a positive amount and decreases in risk weighted exposure amounts shall be disclosed as a negative amount. |
5 |
Methodology and policy (+/-) Change in the risk weighted exposure amount between the end of the previous disclosure period and the end of the current disclosure period, due to methodology and policy i.e. changes due to methodological changes in calculations driven by regulatory policy changes, including both revisions to existing regulations and new regulations, excluding changes in models, which are included in row 4 of this template Increases in risk weighted exposure amounts shall be disclosed as a positive amount and decreases in risk weighted exposure amounts shall be disclosed as a negative amount. |
6 |
Acquisitions and disposals (+/-) Change in the risk weighted exposure amount between the end of the previous disclosure period and the end of the current disclosure period, due to acquisitions and disposals, i.e. changes in book sizes due to acquisitions and/or disposals Increases in risk weighted exposure amounts shall be disclosed as a positive amount and decreases in risk weighted exposure amounts shall be disclosed as a negative amount. |
7 |
Foreign exchange movements (+/-) Change in the risk weighted exposure amount between the end of the previous disclosure period and the end of the current disclosure period, due to foreign exchange movements, i.e. changes arising from foreign currency translation movements Increases in risk weighted exposure amounts shall be disclosed as a positive amount and decreases in risk weighted exposure amounts shall be disclosed as a negative amount. |
8 |
Other (+/-) Change in the risk weighted exposure amount between the end of the previous disclosure period and the end of the current disclosure period, due to other drivers This category shall be used to capture changes that cannot be attributed to any other category. Institutions shall further describe any other material drivers of risk weighted amounts movements over the disclosure period included in this row in the accompanying narrative for this template. Increases in risk weighted exposure amounts shall be disclosed as a positive amount and decreases in risk weighted exposure amounts shall be disclosed as a negative amount. |
9 |
Risk weighted exposure amount at the end of the disclosure period |
Template EU CR9 – IRB approach – Back-testing of PD per exposure class. Fixed template.
Column reference |
Legal references and instructions |
||||||||||||||||||||||||||||||||||||||||||||
Explanation |
|||||||||||||||||||||||||||||||||||||||||||||
a (A-IRB) |
Exposure classes For each exposure class listed in Article 147(2) CRR, institutions shall disclose a separate template, with a further breakdown for the following exposure classes:
|
||||||||||||||||||||||||||||||||||||||||||||
a (F-IRB) |
Exposure classes For each exposure class listed in Article 147(2) CRR, institutions shall disclose a separate template, with a further breakdown for the following exposure classes:
|
||||||||||||||||||||||||||||||||||||||||||||
b |
PD range This is a fixed PD range that shall not be altered. Exposures shall be allocated to an appropriate bucket of the fixed PD range based on the PD estimated at the beginning of the disclosure period for each obligor assigned to this exposure class (without considering any substitution effects due to CRM). All defaulted exposures shall be included in the bucket representing PD of 100 %. |
||||||||||||||||||||||||||||||||||||||||||||
c, d |
Number of obligors at the end of the previous year Institutions shall disclose the following two sets of information:
|
||||||||||||||||||||||||||||||||||||||||||||
e |
Observed average default rate Arithmetic average of one-year default rates as defined in point (78) of Article 4(1) CRR, observed within the available dataset. When calculating one-year default rates institutions shall ensure both of the following:
Institutions shall choose an appropriate approach between an approach based on overlapping one-year time windows, and an approach based on non-overlapping one-year time windows, to calculate the observed average default rate. |
||||||||||||||||||||||||||||||||||||||||||||
f |
Exposure weighted average PD (%) Exposure weighted average PD (%) as in column f of template EU CR6; for all exposures included in each bucket of the fixed PD range, the average PD estimate of each obligor, weighted by the exposure value post-CCF and CRM as in column e of template EU CR6 |
||||||||||||||||||||||||||||||||||||||||||||
g |
Average PD at the disclosure date (%) Arithmetic average of PD at the beginning of the disclosure period of the obligors that fall within the bucket of the fixed PD range and counted in d (average weighted by the number of obligors) |
||||||||||||||||||||||||||||||||||||||||||||
h |
Average historical annual default rate (%) The simple average of the annual default rate of at least five most recent years (obligors at the beginning of each year that are defaulted during that year/total number of obligors at the beginning of the year) The institution may use a longer historical period that is consistent with the institution’s actual risk management practices. If the institution uses a longer historical period they shall explain and clarify this in the accompanying narrative to the template. |
Template EU CR9.1 – IRB approach– Back-testing of PD per exposure class (only for PD estimates in accordance with point (f) of Article 180(1) CRR
ANNEX XXIII
Template EU CR10 – Specialised lending and equity exposures under the simple riskweighted approach
Specialised lending: Project finance (Slotting approach) |
|||||||
Regulatory categories |
Remaining maturity |
On-balancesheet exposure |
Off-balancesheet exposure |
Risk weight |
Exposure value |
Risk weighted exposure amount |
Expected loss amount |
a |
b |
c |
d |
e |
f |
||
Category 1 |
Less than 2.5 years |
|
|
50 % |
|
|
|
Equal to or more than 2.5 years |
|
|
70 % |
|
|
|
|
Category 2 |
Less than 2.5 years |
|
|
70 % |
|
|
|
Equal to or more than 2.5 years |
|
|
90 % |
|
|
|
|
Category 3 |
Less than 2.5 years |
|
|
115 % |
|
|
|
Equal to or more than 2.5 years |
|
|
115 % |
|
|
|
|
Category 4 |
Less than 2.5 years |
|
|
250 % |
|
|
|
Equal to or more than 2.5 years |
|
|
250 % |
|
|
|
|
Category 5 |
Less than 2.5 years |
|
|
— |
|
|
|
Equal to or more than 2.5 years |
|
|
— |
|
|
|
|
Total |
Less than 2.5 years |
|
|
|
|
|
|
Equal to or more than 2.5 years |
|
|
|
|
|
|
Specialised lending: Income-producing real estate and high volatility commercial real estate (Slotting approach) |
|||||||
Regulatory categories |
Remaining maturity |
On-balancesheet exposure |
Off-balancesheet exposure |
Risk weight |
Exposure value |
Risk weighted exposure amount |
Expected loss amount |
a |
b |
c |
d |
e |
f |
||
Category 1 |
Less than 2.5 years |
|
|
50 % |
|
|
|
Equal to or more than 2.5 years |
|
|
70 % |
|
|
|
|
Category 2 |
Less than 2.5 years |
|
|
70 % |
|
|
|
Equal to or more than 2.5 years |
|
|
90 % |
|
|
|
|
Category 3 |
Less than 2.5 years |
|
|
115 % |
|
|
|
Equal to or more than 2.5 years |
|
|
115 % |
|
|
|
|
Category 4 |
Less than 2.5 years |
|
|
250 % |
|
|
|
Equal to or more than 2.5 years |
|
|
250 % |
|
|
|
|
Category 5 |
Less than 2.5 years |
|
|
— |
|
|
|
Equal to or more than 2.5 years |
|
|
— |
|
|
|
|
Total |
Less than 2.5 years |
|
|
|
|
|
|
Equal to or more than 2.5 years |
|
|
|
|
|
|
Specialised lending: Object finance (Slotting approach) |
|||||||
Regulatory categories |
Remaining maturity |
On-balancesheet exposure |
Off-balancesheet exposure |
Risk weight |
Exposure value |
Risk weighted exposure amount |
Expected loss amount |
a |
b |
c |
d |
e |
f |
||
Category 1 |
Less than 2.5 years |
|
|
50 % |
|
|
|
Equal to or more than 2.5 years |
|
|
70 % |
|
|
|
|
Category 2 |
Less than 2.5 years |
|
|
70 % |
|
|
|
Equal to or more than 2.5 years |
|
|
90 % |
|
|
|
|
Category 3 |
Less than 2.5 years |
|
|
115 % |
|
|
|
Equal to or more than 2.5 years |
|
|
115 % |
|
|
|
|
Category 4 |
Less than 2.5 years |
|
|
250 % |
|
|
|
Equal to or more than 2.5 years |
|
|
250 % |
|
|
|
|
Category 5 |
Less than 2.5 years |
|
|
— |
|
|
|
Equal to or more than 2.5 years |
|
|
— |
|
|
|
|
Total |
Less than 2.5 years |
|
|
|
|
|
|
Equal to or more than 2.5 years |
|
|
|
|
|
|
Specialised lending: Commodities finance (Slotting approach) |
|||||||
Regulatory categories |
Remaining maturity |
On-balancesheet exposure |
Off-balancesheet exposure |
Risk weight |
Exposure value |
Risk weighted exposure amount |
Expected loss amount |
a |
b |
c |
d |
e |
f |
||
Category 1 |
Less than 2.5 years |
|
|
50 % |
|
|
|
Equal to or more than 2.5 years |
|
|
70 % |
|
|
|
|
Category 2 |
Less than 2.5 years |
|
|
70 % |
|
|
|
Equal to or more than 2.5 years |
|
|
90 % |
|
|
|
|
Category 3 |
Less than 2.5 years |
|
|
115 % |
|
|
|
Equal to or more than 2.5 years |
|
|
115 % |
|
|
|
|
Category 4 |
Less than 2.5 years |
|
|
250 % |
|
|
|
Equal to or more than 2.5 years |
|
|
250 % |
|
|
|
|
Category 5 |
Less than 2.5 years |
|
|
— |
|
|
|
Equal to or more than 2.5 years |
|
|
— |
|
|
|
|
Total |
Less than 2.5 years |
|
|
|
|
|
|
Equal to or more than 2.5 years |
|
|
|
|
|
|
Equity exposures under the simple risk-weighted approach |
||||||
Categories |
On-balancesheet exposure |
Off-balancesheet exposure |
Risk weight |
Exposure value |
Risk weighted exposure amount |
Expected loss amount |
a |
b |
c |
d |
e |
f |
|
Private equity exposures |
|
|
190 % |
|
|
|
Exchange-traded equity exposures |
|
|
290 % |
|
|
|
Other equity exposures |
|
|
370 % |
|
|
|
Total |
|
|
|
|
|
|
ANNEX XXIV
Disclosure of specialised lending and equity exposures under the simple risk weight approach
Template EU CR10 – Specialised lending and equity exposures under the simple risk-weighted approach.
Fixed template.
Column reference |
Legal references and instructions |
Explanation |
|
a |
On-balance-sheet exposures Institutions shall disclose the exposure value of on-balance sheet exposures in accordance with Article 166(1) to (7) and Article 167(1) CRR. |
b |
Off-balance-sheet exposure Institutions shall disclose the exposure value of off-balance sheet exposures in accordance with Articles 166 and 167 (2) CRR without taking into account any conversion factors specified in Article 166(8) or (9) CRR, or any percentages specified in Article 166(10) CRR. Off balance sheet exposures shall comprise all committed but undrawn amounts and all off-balance sheet items, as listed in Annex I CRR. |
c |
Risk weight This is a fixed column. It shall not be altered. This column has been specified in accordance with Article 153(5) CRR for templates EU CR10.1 to EU CR10.4 and in accordance with Article 155(2) CRR for template EU CR10.5. |
d |
Exposure value Exposure value in accordance with Article 166 or Article 167 CRR This column shall include the sum of exposure value of on-balance sheet exposures and exposure value of off-balance sheet exposures post conversion factors and percentages in accordance with Article 166(8) to (10) CRR. |
e (templates EU CR10.1 to EU CR10.4) |
Risk-weighted exposure amount (specialised lending exposures under the slotting approach) The risk-weighted exposure amount calculated in accordance with Article 153 (5) CRR, after supporting factors in accordance with Article 501 and 501a CRR, where relevant |
e (template EU CR10.5) |
Risk-weighted exposure amount (equity exposures under the simple risk weight approach) The risk-weighted exposure amount calculated in accordance with Article 155(2) CRR |
f (templates EU CR10.1 to EU CR10.4) |
Expected loss amount (specialised lending exposures under the slotting approach) Amount of expected loss calculated in accordance with Article 158 (6) CRR |
f (template EU CR10.5) |
Expected loss amount (equity exposures under the simple risk weight approach) Amount of expected loss calculated in accordance with Article 158(7) CRR |
Row number |
Legal references and instructions |
Explanation |
|
Regulatory category |
Templates EU CR10.1 – EU CR10.4 Regulatory categories applicable to specialised lending under the slotting approach for each class of specialised lending exposures; as specified in Article 153(5) CRR and in the final draft RTS on slotting approach |
Categories |
Template EU CR10.5 Regulatory categories applicable to equities under the simple risk-weight approach in accordance with Article 155(2) CRR |
ANNEX XXV
Table EU CCRA – Qualitative disclosure related to CCR
|
Flexible format disclosure |
|
(a) |
Article 439 (a) CRR Description of the methodology used to assign internal capital and credit limits for counterparty credit exposures, including the methods to assign those limits to exposures to central counterparties |
|
(b) |
Article 439 (b) CRR Description of policies related to guarantees and other credit risk mitigants, such as the policies for securing collateral and establishing credit reserves |
|
(c) |
Article 439 (c) CRR Description of policies with respect to Wrong-Way risk as defined in Article 291 of the CRR |
|
(d) |
Article 431 (3) and (4) CRR Any other risk management objectives and relevant policies related to CCR |
|
(e) |
Article 439 (d) CRR The amount of collateral the institution would have to provide if its credit rating was downgraded |
|
Template EU CCR1 – Analysis of CCR exposure by approach
Fixed format
|
|
a |
b |
c |
d |
e |
f |
g |
h |
|
|
Replacement cost (RC) |
Potential future exposure (PFE) |
EEPE |
Alpha used for computing regulatory exposure value |
Exposure value pre-CRM |
Exposure value post-CRM |
Exposure value |
RWEA |
EU-1 |
EU - Original Exposure Method (for derivatives) |
|
|
|
1,4 |
|
|
|
|
EU-2 |
EU - Simplified SA-CCR (for derivatives) |
|
|
|
1,4 |
|
|
|
|
1 |
SA-CCR (for derivatives) |
|
|
|
1,4 |
|
|
|
|
2 |
IMM (for derivatives and SFTs) |
|
|
|
|
|
|
|
|
2a |
Of which securities financing transactions netting sets |
|
|
|
|
|
|
|
|
2b |
Of which derivatives and long settlement transactions netting sets |
|
|
|
|
|
|
|
|
2c |
Of which from contractual cross-product netting sets |
|
|
|
|
|
|
|
|
3 |
Financial collateral simple method (for SFTs) |
|
|
|
|
|
|
|
|
4 |
Financial collateral comprehensive method (for SFTs) |
|
|
|
|
|
|
|
|
5 |
VaR for SFTs |
|
|
|
|
|
|
|
|
6 |
Total |
|
|
|
|
|
|
|
|
Template EU CCR2 – Transactions subject to own funds requirements for CVA risk
Fixed format
|
a |
b |
|||
Exposure value |
RWEA |
||||
1 |
Total transactions subject to the Advanced method |
|
|
||
2 |
|
|
|
||
3 |
|
|
|
||
4 |
Transactions subject to the Standardised method |
|
|
||
EU-4 |
Transactions subject to the Alternative approach (Based on the Original Exposure Method) |
|
|
||
5 |
Total transactions subject to own funds requirements for CVA risk |
|
|
Template EU CCR3 – Standardised approach – CCR exposures by regulatory exposure class and risk weights
Fixed format
|
Exposure classes |
Risk weight |
|
||||||||||
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
||
0 % |
2 % |
4 % |
10 % |
20 % |
50 % |
70 % |
75 % |
100 % |
150 % |
Others |
Total exposure value |
||
1 |
Central governments or central banks |
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Regional government or local authorities |
|
|
|
|
|
|
|
|
|
|
|
|
3 |
Public sector entities |
|
|
|
|
|
|
|
|
|
|
|
|
4 |
Multilateral development banks |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
International organisations |
|
|
|
|
|
|
|
|
|
|
|
|
6 |
Institutions |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
Corporates |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
Retail |
|
|
|
|
|
|
|
|
|
|
|
|
9 |
Institutions and corporates with a short-term credit assessment |
|
|
|
|
|
|
|
|
|
|
|
|
10 |
Other items |
|
|
|
|
|
|
|
|
|
|
|
|
11 |
Total exposure value |
|
|
|
|
|
|
|
|
|
|
|
|
Template EU CCR4 – IRB approach – CCR exposures by exposure class and PD scale
Fixed format
|
|
a |
b |
c |
d |
e |
f |
g |
|
PD scale |
Exposure value |
Exposure weighted average PD (%) |
Number of obligors |
Exposure weighted average LGD (%) |
Exposure weighted average maturity (years) |
RWEA |
Density of risk weighted exposure amounts |
||
1 … x |
Exposure class X |
|
|
|
|
|
|
|
|
1 |
|
0,00 to < 0,15 |
|
|
|
|
|
|
|
2 |
|
0,15 to < 0,25 |
|
|
|
|
|
|
|
3 |
|
0,25 to < 0,50 |
|
|
|
|
|
|
|
4 |
|
0,50 to < 0,75 |
|
|
|
|
|
|
|
5 |
|
0,75 to < 2,50 |
|
|
|
|
|
|
|
6 |
|
2,50 to < 10,00 |
|
|
|
|
|
|
|
7 |
|
10,00 to < 100,00 |
|
|
|
|
|
|
|
8 |
|
100,00 (Default) |
|
|
|
|
|
|
|
x |
|
Sub-total (Exposure class X) |
|
|
|
|
|
|
|
y |
Total (all CCR relevant exposure classes) |
|
|
|
|
|
|
|
Template EU CCR5 – Composition of collateral for CCR exposure
s
Fixed columns
|
a |
b |
c |
d |
e |
f |
g |
h |
|
Collateral used in derivative transactions |
Collateral used in SFTs |
||||||||
|
Collateral type |
Fair value of collateral received |
Fair value of posted collateral |
Fair value of collateral received |
Fair value of posted collateral |
||||
Segregated |
Unsegregated |
Segregated |
Unsegregated |
Segregated |
Unsegregated |
Segregated |
Unsegregated |
||
1 |
Cash – domestic currency |
|
|
|
|
|
|
|
|
2 |
Cash – other currencies |
|
|
|
|
|
|
|
|
3 |
Domestic sovereign debt |
|
|
|
|
|
|
|
|
4 |
Other sovereign debt |
|
|
|
|
|
|
|
|
5 |
Government agency debt |
|
|
|
|
|
|
|
|
6 |
Corporate bonds |
|
|
|
|
|
|
|
|
7 |
Equity securities |
|
|
|
|
|
|
|
|
8 |
Other collateral |
|
|
|
|
|
|
|
|
9 |
Total |
|
|
|
|
|
|
|
|
Template EU CCR6 – Credit derivatives exposures
Fixed
|
a |
b |
|
Protection bought |
Protection sold |
||
Notionals |
|
|
|
1 |
Single-name credit default swaps |
|
|
2 |
Index credit default swaps |
|
|
3 |
Total return swaps |
|
|
4 |
Credit options |
|
|
5 |
Other credit derivatives |
|
|
6 |
Total notionals |
|
|
Fair values |
|
|
|
7 |
Positive fair value (asset) |
|
|
8 |
Negative fair value (liability) |
|
|
Template EU CCR7 – RWEA flow statements of CCR exposures under the IMM
Fixed format
|
a |
|
RWEA |
||
1 |
RWEA as at the end of the previous reporting period |
|
2 |
Asset size |
|
3 |
Credit quality of counterparties |
|
4 |
Model updates (IMM only) |
|
5 |
Methodology and policy (IMM only) |
|
6 |
Acquisitions and disposals |
|
7 |
Foreign exchange movements |
|
8 |
Other |
|
9 |
RWEA as at the end of the current reporting period |
|
Template EU CCR8 – Exposures to CCPs
Fixed format
|
a |
b |
|||
Exposure value |
RWEA |
||||
1 |
Exposures to QCCPs (total) |
|
|
||
2 |
Exposures for trades at QCCPs (excluding initial margin and default fund contributions); of which |
|
|
||
3 |
|
|
|
||
4 |
|
|
|
||
5 |
|
|
|
||
6 |
|
|
|
||
7 |
Segregated initial margin |
|
|
||
8 |
Non-segregated initial margin |
|
|
||
9 |
Prefunded default fund contributions |
|
|
||
10 |
Unfunded default fund contributions |
|
|
||
11 |
Exposures to non-QCCPs (total) |
|
|
||
12 |
Exposures for trades at non-QCCPs (excluding initial margin and default fund contributions); of which |
|
|
||
13 |
|
|
|
||
14 |
|
|
|
||
15 |
|
|
|
||
16 |
|
|
|
||
17 |
Segregated initial margin |
|
|
||
18 |
Non-segregated initial margin |
|
|
||
19 |
Prefunded default fund contributions |
|
|
||
20 |
Unfunded default fund contributions |
|
|
ANNEX XXVI
Counterparty credit risk disclosure tables and templates: Instructions
Legal references and instructions |
|
Row number |
Explanation |
(a) |
When disclosing information required in point (a) of Article 439 CRR, institutions shall provide a description of the methodology used to assign internal capital and credit limits for counterparty credit exposures, including the methods to assign those limits to exposures to central counterparties. |
(b) |
When disclosing information required in point (b) of Article 439 CRR, institutions shall provide a description of policies related to guarantees and other credit risk mitigants, such as the policies for securing collateral and establishing credit reserves. |
(c) |
When disclosing information required in point (c) of Article 439 CRR, institutions shall provide a description of policies with respect to Wrong-Way risk as defined in Article 291 CRR. |
(d) |
In accordance with Article 431 (3) and (4) CRR institutions shall complement the above information by any other risk management objectives and relevant policies related to CCR. |
(e) |
When disclosing information required in point (d) of Article 439 CRR institutions shall provide the amount of collateral the institutions would have to provide if their credit rating was downgraded. Where the central bank of a Member State undertakes liquidity assistance in the form of collateral swap transactions, the competent authority may exempt institutions to provide this information where it deems that the disclosure of the information referred to therein could reveal the provision of emergency liquidity assistance. For these purposes, the competent authority shall set out appropriate thresholds and objective criteria. |
Template EU CCR1 - Analysis of CCR exposure by approach:
Fixed format
Legal references and instructions |
|||||||
Row number |
Explanation |
||||||
EU-1 |
Original Exposure Method (for derivatives) Derivatives and long settlement transactions for which the institutions have chosen to calculate the exposure value as alpha*(RC+PFE) with α = 1,4, RC and PFE computed in accordance with Article 282 of Section 5 of Chapter 6 of Title II of Part Three CRR This simplified method for calculating the exposure value of derivative positions can only be used by institutions meeting the conditions laid down in Article 273a (2) or (4) of Chapter 6 of Title II of Part Three CRR. |
||||||
EU-2 |
Simplified Standardised Approach for CCR (Simplified SA-CCR for derivatives) Derivatives and long settlement transactions for which the institutions have chosen to calculate the exposure value as alpha*(RC+PFE) with α = 1,4, RC and PFE computed in accordance with Article 281 of Section 4 of Chapter 6 of Title II of Part Three CRR This simplified standardised approach for calculating the exposure value of derivative positions can only be used by institutions meeting the conditions laid down in Article 273a (1) or (4) of Chapter 6 of Title II of Part Three CRR. |
||||||
1 |
Standardised Approach for CCR (SA-CCR for derivatives) Derivatives and long settlement transactions for which the institutions have chosen to calculate the exposure value as alpha*(RC+PFE) with α = 1,4, RC and PFE computed in accordance with Section 3 of Chapter 6 of Title II of Part Three CRR |
||||||
2 |
IMM (for derivatives and SFTs) Derivatives and long settlement transactions and SFTs for which institutions have been permitted to calculate the exposure value using the Internal Model Method (IMM) in accordance with Section 6 of Chapter 6 of Title II of Part Three CRR |
||||||
EU-2a |
Of which securities financing transactions netting sets Netting sets containing only SFTs, as defined in point (139) of Article 4(1) CRR, for which institutions have been permitted to determine the exposure value using the IMM |
||||||
EU-2b |
Of which derivatives and long settlement transactions netting sets Netting sets containing only derivative instruments listed in Annex II to CRR and long settlement transactions as defined in point (2) of Article 272 CRR, for which institutions have been permitted to determine the exposure value using the IMM |
||||||
EU-2c |
Of which from contractual cross-product netting sets Netting sets containing transactions of different product categories (point (11) of Article 272 CRR), i.e. derivatives and SFTs, for which a contractual cross product netting agreement as defined in point (25) of Article 272 CRR exists and for which institutions have been permitted to determine the exposure value using the IMM |
||||||
3, 4 |
Financial collateral simple method (for SFTs) and Financial collateral comprehensive method (for SFTs) Repurchase transactions, securities or commodities lending or borrowing transactions and margin lending transactions for which institutions have chosen to determine the exposure value in accordance with Articles 222 and 223 of Chapter 4 of Title II of Part Three CRR, as opposed to Article 271(2) of Chapter 6 of Title II of Part Three CRR |
||||||
5 |
VaR for SFTs Repurchase transactions, securities or commodities lending or borrowing transactions, margin lending transactions, or other capital market-driven transactions other than derivative transactions for which (in accordance with Article 221 CRR) the exposure value is calculated using an internal model approach (IMA) that takes into account correlation effects between security positions subject to the master netting agreement, as well as the liquidity of the instruments concerned |
||||||
6 |
Total |
||||||
Column letter |
Explanation |
||||||
a, b |
Replacement cost (RC) and Potential future exposure (PFE) RC and PFE shall be computed:
Institutions shall disclose the sum of the replacement costs for all netting sets in the corresponding rows. |
||||||
c |
Effective expected positive exposure (EEPE) The EEPE per netting set is defined in point (22) of Article 272 CRR and shall be calculated in accordance with Article 284(6) CRR. The EEPE to be disclosed here shall be the one applied for the determination of own funds requirements in accordance with Article 284 (3) CRR, i.e. either the EEPE calculated using current market data, or the EEPE calculated using a stress calibration, whichever leads to a higher own funds requirement. Institutions shall specify in the narrative accompanying this template which EEPE has been inserted. |
||||||
d |
Alpha used for computing regulatory exposure value The value of α is fixed as 1,4 in rows EU-1, EU-2 and 1 of this template in accordance with Articles 282(2), 281(1) and 274(2) CRR For IMM purposes, the value of α can either be the default of 1,4 or different when competent authorities require a higher α in accordance with Article 284(4) CRR or permit institutions to use their own estimates in accordance with Article 284(9) of Section 6 of Chapter 6 of Title II of Part Three CRR. |
||||||
e |
Exposure value pre-CRM The exposure value pre-CRM for CCR business shall be calculated in accordance with the methods laid down in Chapters 4 and 6 of Title II of Part Three CRR taking into account the effect of netting, but disregarding any other credit risk mitigation techniques (e.g. through margin collateral). In the case of SFTs the security leg shall not be considered in the determination of the exposure value pre-CRM when collateral is received and therefore shall not decrease the exposure value. On the contrary, the SFTs security leg shall be considered in the determination of the exposure value pre-CRM in the regular way when collateral is posted. Furthermore, collateralised business shall be handled as uncollateralised, i.e. no margining effects apply. For transactions where specific wrong way risk has been identified, the exposure value pre-CRM must be determined in accordance with Article 291 CRR. The exposure value pre-CRM shall not consider the deduction of the incurred CVA loss in accordance with Article 273(6) CRR. The institution shall disclose the sum of all exposure values pre-CRM in the respective row. |
||||||
f |
Exposure value (post-CRM) The exposure value post-CRM for CCR business shall be calculated in accordance with the methods laid down in Chapters 4 and 6 of Title II of Part Three CRR, having applied CRM techniques as applicable in accordance with Chapters 4 and 6 of Title II of Part Three CRR For transactions where specific wrong way risk has been identified, the exposure value shall be determined in accordance with Article 291 CRR. In accordance with Article 273(6) CRR, the incurred CVA loss shall not be deducted from the exposure value post-CRM. The institution shall disclose the sum of all exposure values post-CRM in the respective row. |
||||||
g |
Exposure value Exposure value for CCR business calculated in accordance with the methods laid down in Chapters 4 and 6 of Title II of Part Three CRR, which is the relevant amount for the own funds requirement calculation, i.e. having applied CRM techniques as applicable in accordance with Chapters 4 and 6 of Title II of Part Three CRR and considering the deduction of the incurred CVA loss in accordance with Article 273 (6) CRR The exposure value for transactions where specific wrong way risk has been identified shall be determined in accordance with Article 291 CRR. For cases in which more than one CCR approach is used for a single counterparty, the incurred CVA loss, which is deducted at counterparty level, shall be assigned to the exposure value of the different netting sets in each CCR approach reflecting the proportion of the exposure value post-CRM of the respective netting sets to the total exposure value post-CRM of the counterparty. The institution shall disclose the sum of all exposure values post-CRM in the respective row. |
||||||
h |
RWEA Risk weighted exposure amounts as defined in Article 92 (3) and (4) CRR calculated in accordance with Article 107 CRR, for elements whose risk weights are estimated on the basis of the requirements in Chapters 2 and 3 of Title II of Part Three CRR and for which the exposure value for CCR business is calculated in accordance with Chapters 4 and 6 of Title II of Part Three CRR |
Template EU CCR2 – Transactions subject to own funds requirements for CVA risk:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1 |
Total transactions subject to the Advanced method Transactions subject to the advanced method to calculate own funds requirements for CVA risk in accordance with Article 383 CRR |
2 |
VaR component (including the 3 × multiplier) Transactions subject to own funds requirements for CVA risk for which the risk weighed exposure amounts are obtained via the formula in Article 383 CRR, using VaR calculation based on internal models for market risk (with current parameter calibrations for expected exposure as set out in the first subparagraph of Article 292 (2) CRR). The calculation shall includes the use of a multiplier that is at least 3 (set by the supervisor). |
3 |
Stressed VaR component (including the 3 × multiplier) Transactions subject to own funds requirements for CVA risk for which the risk weighted exposure amounts are obtained via the formula in Article 383 CRR using stressed VaR calculation based on internal models for market risk (with stressed parameters for the calibration of the formula as set out in the first subparagraph of Article 292 (2) CRR). The calculation shall include the use of a multiplier that is at least 3 (set by the supervisor). |
4 |
Transactions subject to the Standardised method Transactions subject to the standardised method to calculate own funds requirements for CVA risk in accordance with Article 384 CRR |
EU-4 |
Transactions subject to the Alternative approach (Based on the Original Exposure Method) Transactions subject to the alternative approach to calculate own funds requirements for CVA risk, in accordance with Article 385 CRR |
5 |
Total transactions subject to own funds requirements for CVA risk |
Column letter |
Explanation |
a |
Exposure value Exposure value that is determined in accordance with Chapter 6 of Title II of Part Three CRR (or in the case of transactions in the scope of Article 271(2) CRR, in accordance with Chapter 4 of Title II of Part Three CRR) for transactions that are in the scope of Title VI of Part Three CRR The exposure value shall be the value used in the calculation of own funds requirements for CVA risk considering mitigation effects in accordance with Title VI of Part Three CRR. For transactions treated under the Original Exposure Method (alternative approach), the exposure value shall be the value that has been used for computing risk weighted exposure amounts. |
b |
RWEA Risk weighted exposure amounts in accordance with point (d) of Article 438 and with point (d) of Article 92 (3) CRR, i.e. own funds requirements for CVA risk calculated via the chosen method multiplied by 12.5 in accordance with point (b) of Article 92(4) CRR |
Template EU CCR3 - Standardised approach – CCR exposures by regulatory exposure class and risk weights:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1-9 |
Exposure classes These rows refer to the regulatory exposure classes as defined in Article 112 to Article 134 of Chapter 4 of Title II of Part Three CRR. In each line, the corresponding exposure values (see definition provided in column g of template EU CCR1) shall be disclosed. |
10 |
Other items This refers to assets subject to a specific risk weight set out in Article 134 of Chapter 4 of Title II of Part Three CRR and any other items not covered in rows 1 to 9 of this template. It also refers to assets not deducted in the application of Article 39 CRR (tax overpayments, tax loss carrybacks and deferred tax assets that do not rely on future profitability), Article 41 CRR (defined benefit pension fund assets), Article 46 and Article 469 CRR (non-significant investments in CET1 of financial sector entities), Article 49 and Article 471 CRR (participations in insurance entities whether or not insurance entities are supervised under the conglomerate directive), Article 60 and Article 475 CRR (non-significant and significant indirect and investments in AT1 of financial sector entities), Article 70 and Article 477 CRR (insignificant and significant indirect and synthetic holdings of T2 from a financial sector entity) when not allocated to other exposure classes, and to qualifying holdings outside the financial sector when they are not 1 250 % risk-weighted in the application of point (k) of Article 36 of Chapter 2 of Title I of Part Two CRR. |
11 |
Total exposure value |
Column letter |
Explanation |
a-k |
These columns refer to the credit risk quality steps/risk weights as set out in Chapter 2 of Title II of Part Three CRR for which the corresponding exposure values (see definition provided in column g of template EU CCR1) shall be disclosed. |
l |
Total exposure value |
Template EU CCR4 - IRB approach – CCR exposures by exposure class and PD scale:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1 to 8 |
PD scale CCR exposures shall be allocated to the appropriate bucket of the fixed PD scale based on the PD estimated for each obligor assigned to this exposure class (without considering any substitution due to existence of guarantee or credit derivative). Institutions shall map exposure by exposure to the PD scale provided in the template, also taking into account continuous scales. All defaulted exposures shall be included in the bucket representing PD of 100 %. |
1 to x |
Exposure class X This refers to the different exposure classes listed in Article 147 of Chapter 3 of Title II of Part Three CRR. |
x and y |
Sub-total (Exposure class X) / Total (all CCR relevant exposure classes) The (sub-) total of exposure values, risk weighted exposure amounts and number of obligors shall just be the sum of the respective columns. Concerning the different parameters Average PD, Average LGD, Average Maturity and RWEA density the below definitions apply with respect to the sample of exposure class X or all CCR relevant exposure classes. |
Column letter |
Explanation |
a |
Exposure value Exposure value (see definition provided in column g of template EU CCR1), broken down by exposure classes and the given PD scale as set out in Chapter 3 of Title II of Part Three CRR |
b |
Exposure weighted average PD (%) Average of individual obligor grade PDs weighted by their corresponding exposure value in column a of this template |
c |
Number of obligors The number of legal entities or obligors allocated to each bucket of the fixed PD scale, which were separately rated, regardless of the number of different loans or exposures granted Where different exposures to the same obligor are separately rated, they shall be counted separately. Such situation may take place if separate exposures to the same obligor are assigned to different obligor grades in accordance with the second sentence of point (e) of Article 172(1) CRR. |
d |
Exposure weighted average LGD (%) Average of obligor grade LGDs weighted by their corresponding exposure value The disclosed LGD shall correspond to the final LGD estimate used in the calculation of own funds requirements obtained after considering any CRM effects and downturn conditions where relevant. In the case of exposures subject to the double default treatment the LGD to be disclosed shall correspond to the one selected in accordance with Article 161 (4) CRR. For defaulted exposures under A-IRB Approach, provisions laid down in point (h) of Article 181(1) CRR shall be considered. The disclosed LGD shall correspond to the estimate of LGD in-default. |
e |
Exposure weighted average maturity (years) Average of obligor maturities in years weighted by their corresponding exposure value in column a of this template. The disclosed value of maturity shall be determined in accordance with Article 162 CRR. |
f |
RWEA Risk weighted exposure amounts calculated in accordance with the requirements laid down in Chapter 3 of Title II of Part Three CRR; for exposures to central governments and central banks, institutions and corporates, the risk weighted exposure amount calculated in accordance with Article 153(1) to (4) CRR; the SME and infrastructure supporting factor determined in accordance with Article 501 CRR and Article 501a CRR shall be taken into account; for equity exposures under the PD/LGD approach, the risk weighted exposure amount calculated in accordance with Article 155(3) CRR |
g |
Density of risk weighted exposure amounts Ratio of the total risk weighted exposure amounts (in column f of this template) to the exposure value (in column a of this template) |
Template EU CCR5 - Composition of collateral for CCR exposures:
Fixed columns
Legal references and instructions |
|
Row number |
Explanation |
1-8 |
Collateral type Breakdown by type of collateral |
9 |
Total |
Column letter |
Explanation |
a, c, e and g |
Segregated Collateral that is held in a bankruptcy-remote manner as defined in Article 300(1) CRR |
b, d, f and h |
Unsegregated Collateral that is not held in a bankruptcy-remote manner as defined in Article 300(1) CRR |
a to d |
Collateral used in derivative transactions Collateral (including the initial margin and variation margin collateral) that is used in CCR exposures related to any derivative instrument listed in Annex II CRR or a long settlement transaction as per Article 271(2) CRR not qualifying as an SFTs |
e to h |
Collateral used in SFTs Collateral (including the initial margin and variation margin collateral as well as the collateral appearing in the security leg of the SFT) that is used in CCR exposures related to any SFT or a long settlement transaction not qualifying as a derivative |
Template EU CCR6 - Credit derivatives exposures:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1-6 |
Notionals Sum of absolute notional derivative amounts before any netting broken down by product type |
7-8 |
Fair values Fair values broken down by assets (positive fair values) and liabilities (negative fair values) |
Column letter |
Explanation |
a-b |
Credit derivative protection Credit derivative protection bought or sold in accordance with Chapter 6 of Title II of Part Three CRR |
Template EU CCR7 - RWEA flow statements of CCR exposures under the IMM:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1 |
RWEA as at the end of the previous disclosure period Risk weighted exposure amounts for CCR exposures under the IMM as at the end of the previous disclosure period |
2 |
Asset size RWEA changes (positive or negative) due to organic changes in book size and composition (including the origination of new businesses and maturing exposures) but excluding changes in book size due to acquisitions and disposal of entities |
3 |
Credit quality of counterparties RWEA changes (positive or negative) due to changes in the assessed quality of the institution’s counterparties as measured under the credit risk framework, whatever approach the institution uses This row shall include potential RWEA changes due to IRB models when the institution uses an IRB approach. |
4 |
Model updates (IMM only) RWEA changes (positive or negative) due to model implementation, changes in model scope, or any changes intended to address model weaknesses This row shall reflect only changes in the IMM. |
5 |
Methodology and policy (IMM only) RWEA changes (positive or negative) due to methodological changes in calculations driven by regulatory policy changes, such as new regulations (only in the IMM) |
6 |
Acquisitions and disposals RWEA changes (positive or negative) due to changes in book sizes due to acquisitions and disposal of entities |
7 |
Foreign exchange movements RWEA changes (positive or negative) due to changes arising from foreign currency translation movements |
8 |
Other This category shall be used to capture RWEA changes (positive or negative) that cannot be attributed to the above categories. Institutions shall include the sum of these RWEA changes in this row. Institutions shall further describe any other material drivers of risk weighted amounts movements over the disclosure period in the accompanying narrative for this template. |
9 |
RWEA as at the end of the current disclosure period Risk weighted exposure amounts for CCR exposures under the IMM as at the end of the current disclosure period |
Column letter |
Explanation |
a |
RWEA |
Template EU CCR8 - Exposures to CCPs:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1-10 |
Qualifying CCP (QCCP) A qualifying central counterparty or “QCCP” as defined in point (88) of Article 4(1) CRR |
7 and 8 17 and 18 |
Initial margin Institutions shall disclose the fair values of collateral received or posted as initial margin defined in point (140) of Article 4(1) CRR. For the purposes of this template, initial margin does not include contributions to a CCP for mutualised loss-sharing arrangements (i.e. in cases where a CCP uses initial margin to mutualise losses among the clearing members, it will be treated as a default fund exposure). |
9 and 19 |
Prefunded default fund contributions The contribution to the default fund of a CCP that is paid in by the institutions ‘Default fund’ is defined in point (89) of Article 4(1) CRR. |
20 |
Unfunded default fund contributions Contributions that an institution acting as a clearing member has contractually committed to provide to a CCP after the CCP has depleted its default fund to cover the losses it incurred following the default of one or more of its clearing members. ‘Default fund’ is defined in point (89) of Article 4(1) CRR. |
7 and 17 |
Segregated See definition in included in template EU CCR5. |
8 and 18 |
Unsegregated See definition in included in template EU CCR5. |
Column letter |
Explanation |
a |
Exposure value Exposure value calculated in accordance with the methods laid down in Chapters 4 and 6 of Title II of Part Three CRR for transactions in the scope of Section 9 of Chapter 6 of Title II of Part Three CRR, after the application of the relevant adjustments provided for by Articles 304, 306 and 308 of that section An exposure can be a trade exposure, as defined in point (91) of Article 4(1) CRR. The disclosed exposure value is the amount relevant for the own funds requirements calculation in accordance with Section 9 of Chapter 6 of Title II of Part Three CRR, considering the requirements in Article 497 CRR during the transitional period provided for by that Article. |
b |
RWEA Risk weighted exposure amounts referred to in point (a) of Article 92(3) CRR calculated in accordance with Article 107 of Section 9 of Chapter 6 of Title II of Part Three CRR. |
ANNEX XXVII
Table EU-SECA - Qualitative disclosure requirements related to securitisation exposures
Legal basis |
Row number |
Qualitative information - Free format |
||||||||
Article 449(a) CRR |
(a) |
Description of securitisation and re-securitisation activities; including institutions' risk management and investment objectives in connection with those activities, their role in securitisation and re-securitisation transactions whether they use the Simple Transparent and Standardised (STS) securitisation framework and the extent to which they use securitisation transactions to transfer the credit risk of the securitised exposures to third parties with, where applicable, a separate description of their synthetic securitisation risk transfer policy |
||||||||
Article 449(b) CRR |
(b) |
The type of risk that institutions are exposed to in their securitisation and re-securitisation activities by level of seniority of the relevant securitisation positions, providing a distinction between STS and non-STS positions and:
|
||||||||
Article 449(c ) CRR |
(c) |
Institutions’ approaches to calculating the risk-weighted exposure amounts that they apply to their securitisation activities, including the types of securitisation positions to which each approach applies with a distinction between STS and non-STS positions |
||||||||
Article 449(d) CRR |
(d) |
A list of SSPEs falling into any of the following categories, with a description of types of institution's exposures to those SSPEs, including derivatives contracts:
|
||||||||
Article 449(e ) CRR |
(e) |
A list of any legal entities in relation to which the institutions have disclosed that they have provided support in accordance with Chapter 5 of Title II of Part Three CRR |
||||||||
Article 449(f) CRR |
(f) |
A list of legal entities affiliated with the institutions and that invest in securitisations originated by the institutions or in securitisation positions issued by SSPEs sponsored by the institutions |
||||||||
Article 449(g) CRR |
(g) |
A summary of their accounting policies for securitisation activity, including where relevant a distinction between securitisation and re-securitisation positions |
||||||||
Article 449(h) CRR |
(h) |
The names of the ECAIs used for securitisations and the types of exposure for which each agency is used |
||||||||
Article 449(i) CRR |
(i) |
Where applicable, a description of the Internal Assessment Approach as set out in Chapter 5 of Title II of Part Three CRR including the structure of the internal assessment process and the relation between internal assessment and external ratings of the relevant ECAI disclosed in accordance with point (h), the control mechanisms for the internal assessment process including discussion of independence, accountability, and internal assessment process review, the exposure types to which the internal assessment process is applied and the stress factors used for determining credit enhancement levels |
Template EU-SEC1 - Securitisation exposures in the non-trading book
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
n |
o |
|
Institution acts as originator |
Institution acts as sponsor |
Institution acts as investor |
||||||||||||||
Traditional |
Synthetic |
Sub-total |
Traditional |
Synthetic |
Sub-total |
Traditional |
Synthetic |
Sub-total |
||||||||
STS |
Non-STS |
|
of which SRT |
|
STS |
Non-STS |
|
STS |
Non-STS |
|
||||||
|
of which SRT |
|
of which SRT |
|||||||||||||
1 |
Total exposures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Retail (total) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
residential mortgage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
credit card |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
other retail exposures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
re-securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
Wholesale (total) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
loans to corporates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
commercial mortgage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
lease and receivables |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
other wholesale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 |
re-securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Template EU-SEC2 - Securitisation exposures in the trading book
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
|
Institution acts as originator |
Institution acts as sponsor |
Institution acts as investor |
|||||||||||
Traditional |
Synthetic |
Sub-total |
Traditional |
Synthetic |
Sub-total |
Traditional |
Synthetic |
Sub-total |
|||||
STS |
Non-STS |
|
STS |
Non-STS |
|
STS |
Non-STS |
|
|||||
1 |
Total exposures |
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Retail (total) |
|
|
|
|
|
|
|
|
|
|
|
|
3 |
residential mortgage |
|
|
|
|
|
|
|
|
|
|
|
|
4 |
credit card |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
other retail exposures |
|
|
|
|
|
|
|
|
|
|
|
|
6 |
re-securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
Wholesale (total) |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
loans to corporates |
|
|
|
|
|
|
|
|
|
|
|
|
9 |
commercial mortgage |
|
|
|
|
|
|
|
|
|
|
|
|
10 |
lease and receivables |
|
|
|
|
|
|
|
|
|
|
|
|
11 |
other wholesale |
|
|
|
|
|
|
|
|
|
|
|
|
12 |
re-securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
Template EU-SEC3 - Securitisation exposures in the non-trading book and associated regulatory capital requirements - institution acting as originator or as sponsor
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
n |
o |
EU-p |
EU-q |
||
Exposure values (by RW bands/deductions) |
Exposure values (by regulatory approach) |
RWEA (by regulatory approach) |
Capital charge after cap |
||||||||||||||||
≤ 20 % RW |
> 20 % to 50 % RW |
> 50 % to 100 % RW |
> 100 % to < 1 250 % RW |
1 250 % RW/ deductions |
SEC-IRBA |
SEC-ERBA (including IAA) |
SEC-SA |
1 250 % RW/ deductions |
SEC-IRBA |
SEC-ERBA (including IAA) |
SEC-SA |
1 250 % RW/ deductions |
SEC-IRBA |
SEC-ERBA (including IAA) |
SEC-SA |
1 250 % RW/ deductions |
|||
1 |
Total exposures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Traditional transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
Securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
Retail |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
Of which STS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
Wholesale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
Of which STS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
Re-securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
Synthetic transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
Securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
Retail underlying |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 |
Wholesale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
Re-securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Template EU-SEC4 - Securitisation exposures in the non-trading book and associated regulatory capital requirements - institution acting as investor
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
m |
n |
o |
EU-p |
EU-q |
||
Exposure values (by RW bands/deductions) |
Exposure values (by regulatory approach) |
RWEA (by regulatory approach) |
Capital charge after cap |
||||||||||||||||
≤ 20 % RW |
> 20 % to 50 % RW |
> 50 % to 100 % RW |
> 100 % to < 1 250 % RW |
1 250 % RW/ deductions |
SEC-IRBA |
SEC-ERBA (including IAA) |
SEC-SA |
1 250 % RW/ deductions |
SEC-IRBA |
SEC-ERBA (including IAA) |
SEC-SA |
1 250 % RW/ deductions |
SEC-IRBA |
SEC-ERBA (including IAA) |
SEC-SA |
1 250 % RW/ deductions |
|||
1 |
Total exposures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Traditional securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
Securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
Retail underlying |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
Of which STS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
Wholesale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
Of which STS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
Re-securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
Synthetic securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
Securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
Retail underlying |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 |
Wholesale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
Re-securitisation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Template EU-SEC5 - Exposures securitised by the institution - Exposures in default and specific credit risk adjustments
|
a |
b |
c |
|
Exposures securitised by the institution - Institution acts as originator or as sponsor |
||||
Total outstanding nominal amount |
Total amount of specific credit risk adjustments made during the period |
|||
|
Of which exposures in default |
|||
1 |
Total exposures |
|
|
|
2 |
Retail (total) |
|
|
|
3 |
residential mortgage |
|
|
|
4 |
credit card |
|
|
|
5 |
other retail exposures |
|
|
|
6 |
re-securitisation |
|
|
|
7 |
Wholesale (total) |
|
|
|
8 |
loans to corporates |
|
|
|
9 |
commercial mortgage |
|
|
|
10 |
lease and receivables |
|
|
|
11 |
other wholesale |
|
|
|
12 |
re-securitisation |
|
|
|
ANNEX XXVIII
Instructions for disclosure on exposures to securitisation positions
Table EU SECA - Qualitative disclosure requirements related to securitisation exposures.
Free format text boxes for disclosure of qualitative information
Legal references and instructions |
|||||||||
Row reference |
Explanation |
||||||||
(a) |
Description of securitisation and re-securitisation activities; includingrisk management and investment objectives in connection with those activities, their role in securitisation and re-securitisation transactions whether they use the Simple Transparent and Standardised (STS) securitisation framework and the extent to which they use securitisation transactions to transfer the credit risk of the securitised exposures to third parties with, where applicable, a separate description of their synthetic securitisation risk transfer policy, in accordance with point (a) of Article 449 CRR |
||||||||
(b) |
The type of risk that institutions are exposed to in their securitisation and re-securitisation activities by level of seniority of the relevant securitisation positions, providing a distinction between STS and non-STS positions and:
in accordance with point (b) of Article 449 CRR |
||||||||
(c) |
Institutions’ approaches to calculating the risk-weighted exposure amounts that they apply to their securitisation activities, including the types of securitisation positions to which each approach applies with a distinction between STS and non-STS positions, in accordance with point (c) of Article 449 CRR |
||||||||
(d) |
A list of SSPEs falling into any of the following categories, with a description of types of institution’s exposures to those SSPEs, including derivatives contracts:
in accordance with point (d) of Article 449 CRR |
||||||||
(e) |
A list of any legal entities in relation to which the institutions have disclosed that they have provided support in accordance with point (e) of Article 449 of Chapter 5 of Title II of Part Three CRR |
||||||||
(f) |
A list of legal entities affiliated with the institutions and that invest in securitisations originated by the institutions or in securitisation positions issued by SSPEs sponsored by the institutions, in accordance with point (f) of Article 449 CRR |
||||||||
(g) |
A summary of their accounting policies for securitisation activity, including where relevant a distinction between securitisation and re-securitisation positions, in accordance with point (g) of Article 449 CRR |
||||||||
(h) |
The names of the ECAIs used for securitisations and the types of exposure for which each agency is used, in accordance with point (h) of Article 449 CRR |
||||||||
(i) |
Where applicable, a description of the Internal Assessment Approach as set out in Chapter 5 of Title II of Part Three CRR, including the structure of the internal assessment process and the relation between internal assessment and external ratings of the relevant ECAI disclosed in accordance with point (h), the control mechanisms for the internal assessment process including discussion of independence, accountability, and internal assessment process review, the exposure types to which the internal assessment process is applied and the stress factors used for determining credit enhancement levels, in accordance with point (i) of Article 449 CRR |
EU-SEC1 - Securitisation exposures in the non-trading book.
Fixed format.
Legal references and instructions |
|
Column reference |
Explanation |
a - g |
Institution acts as originator When the ‘institution acts as originator’, as defined in point (13) of Article 4 (1) CRR, the securitisation exposures are the retained positions, even where not eligible for the securitisation framework due to the absence of significant risk transfer. Securitisation exposures in transactions that have achieved significant risk transfer (SRT) shall be presented separately. Originator institutions shall disclose the carrying amount at the disclosure date of all current securitisation exposures they hold in the securitisation transactions that they originated. As such, on-balance sheet securitisation exposures (e.g. bonds, subordinated loans) as well as off-balance sheet exposures and derivatives (e.g. subordinated credit lines, liquidity facilities, interest rate swaps, credit default swaps, etc.) in those securitisation shall be disclosed. |
h - k |
Institution acts as sponsor When ‘the institution acts as sponsor’ (as defined in point (14) of Article 4(1) CRR) the securitisation exposures shall include exposures to commercial paper conduits to which the institution provides programme-wide enhancements, liquidity and other facilities. Where the institution acts both as originator and sponsor, it shall avoid double-counting. In this regard, the institution can merge the two columns of ‘institution acts as originator’ and ‘institution acts as sponsor’ and use ‘institution acts as originator/sponsor’ columns. |
l - o |
Institution acts as investor Securitisation exposures when ‘the institution acts as an investor’ are the investment positions purchased in third-party deals. The CRR does not provide an explicit definition for investor. Therefore, in this context it shall be understood as an institution that holds a securitisation position in a securitisation transaction for which it is neither the originator, nor the sponsor. In case the pool of securitised exposures is a mix of the types of securitisation position, the institution shall indicate the most important type. |
a – d; h, i, l, m |
Traditional transactions In accordance with point (13) of Article 242 CRR, in connection with point (9) of Article 2 of Regulation (EU) 2017/2402(2), ‘traditional securitisation’ means a securitisation involving the transfer of the economic interest in the exposures being securitised. This shall be accomplished by the transfer of ownership of the securitised exposures from the originator institution to an SSPE or through sub-participation by an SSPE. The securities issued do not represent payment obligations of the originator institution. In the case of traditional securitisations where the originator does not hold any position, then the originator shall not consider that securitisation in the disclosing of this template. |
e, f, j, n |
Synthetic transactions In accordance with point (14) of Article 242 CRR, in connection with point (10) of Article 2 of Regulation (EU) 2017/2402, ‘synthetic securitisation’ means a securitisation where the transfer of risk is achieved by the use of credit derivatives or guarantees, and the exposures being securitised remain exposures of the originator institution. If the institution has purchased protection it shall disclose the net exposure amounts to which it is exposed and which are not subject to the purchased protection under columns originator/sponsor (i.e. the amount that is not secured) of this template. If the institution has sold protection, the exposure amount of the credit protection shall be disclosed in the ‘investor’ column of this template. |
a, b, h, l, |
STS exposure Total amount of STS securitisation positions in accordance with the criteria set out in Articles 18 to 26 of the Regulation (EU) 2017/2402 |
b, d, f |
SRT exposure Total amount of securitisation positions in respect of which the originator institution has achieved significant risk transfer (SRT) in accordance with Article 244 (traditional securitisation) and Article 245 (synthetic securitisation) CRR |
Legal references and instructions |
|
Row number |
Explanation |
06, 12 |
Re-securitisation Total amount of outstanding re-securitisation positions as defined in points (63) and (64) of Article 4(1) CRR All securitisation exposures related to re-securitisation shall be completed in rows ‘re-securitisation’, and not in the preceding rows (by type of underlying asset) which contain only securitisation exposures other than re-securitisation. |
Template EU SEC2 - Securitisation exposures in the trading book.
Fixed format.
Template EU SEC3 - Securitisation exposures in the non-trading book and associated regulatory capital requirements - institution acting as originator or as sponsor.
Fixed format.
Legal references and instructions |
|||||||||
Column reference |
Explanation |
||||||||
a to d |
Exposure values (by risk weight bands /deductions) Values to be disclosed in columns (a) to (d) of this template in relation to regulatory risk weights shall be determined in accordance with Chapter 5 of Title II of Part Three CRR. |
||||||||
f to h |
Exposure values (by regulatory approach) Columns (f) to (h) of this template corresponding to the regulatory approach used in accordance with the hierarchy of approaches of Article 254 CRR |
||||||||
j, k, l |
RWEA (by regulatory approach) Risk weighted exposure amount (RWEA) by regulatory approach in accordance with Chapter 5 of Title II of Part Three CRR Part Three before application of cap |
||||||||
n to EU-p |
Capital charge after cap These columns refer to capital charge after application of the cap in accordance with Articles 267 and 268 CRR. |
||||||||
e, i, m, EU-q |
1 250 % RW/deductions Columns refer to items:
|
Legal references and instructions |
|
Row number |
Explanation |
1 |
Total Exposures Total exposures shall refer to the total amount of securitisation and re-securitisation positions held by the institution acting as originator or sponsor. This row shall summarise information on traditional and synthetic securitisation disclosed by originators and sponsors in subsequent rows. |
2 |
Traditional transactions See explanation for template EU SEC1. |
3, 10 |
Securitisation Total amount of outstanding securitisation positions as defined in point (62) of Article 4(1) CRR that are not re-securitisation positions as defined in point (64) of Article 4(1) CRR |
5, 7 |
STS See explanation for template EU SEC1. |
8, 13 |
Re-securitisation See explanation for template EU SEC1. |
9 |
Synthetic transactions See explanation for template EU SEC1. |
Template EU SEC4 - Securitisation exposures in the non-trading book and associated regulatory capital requirements - institution acting as investor.
Fixed format.
Template EU SEC5 - Exposures securitised by the institution - Exposures in default and specific credit risk adjustments.
Fixed format.
Legal references and instructions |
|
Column reference |
Explanation |
a |
Total outstanding nominal amount Total outstanding nominal amount of exposures securitised by the institution (institution acts as originator or as sponsor), broken down by type of securitisation exposure |
b |
Total outstanding nominal amount - Of which exposures in default Total outstanding nominal amount of exposures securitised by the institution (institution acts as originator or as sponsor) which have been classified as ‘defaulted exposures’ in accordance with Article 178 CRR, broken down by type of securitisation exposure |
c |
Specific credit risk adjustments made during the period Amount of the specific credit risk adjustments made during the period, in accordance with Article 110 CRR, on the exposures securitised by the institution (institution acts as originator or as sponsor), broken down by type of securitisation exposure |
ANNEX XXIX
Table EU MRA: Qualitative disclosure requirements related to market risk
|
Flexible format disclosure |
|||||
a |
Points (a) and (d) of Article 435 (1) CRR A description of the institution's strategies and processes to manage market risk, including:
|
|
||||
b |
Point (b) of Article 435 (1) CRR A description of the structure and organisation of the market risk management function, including a description of the market risk governance structure established to implement the strategies and processes of the institution discussed in row (a) above, and that describes the relationships and the communication mechanisms between the different parties involved in market risk management. |
|
||||
c |
Point (c ) of Article 435 (1) CRR Scope and nature of risk reporting and measurement systems |
|
Template EU MR1 - Market risk under the standardised approach
|
a |
|
|
|
RWEAs |
|
Outright products |
|
1 |
Interest rate risk (general and specific) |
|
2 |
Equity risk (general and specific) |
|
3 |
Foreign exchange risk |
|
4 |
Commodity risk |
|
|
Options |
|
5 |
Simplified approach |
|
6 |
Delta-plus approach |
|
7 |
Scenario approach |
|
8 |
Securitisation (specific risk) |
|
9 |
Total |
|
Table EU MRB: Qualitative disclosure requirements for institutions using the internal Market Risk Models
|
Flexible format disclosure |
|||
EU (a) |
Article 455(c) CRR Description of the procedures and systems implemented for the assurance of tradability of the positions included in the trading book in order to comply with the requirements of Article 104. Description of the methodology used to ensure that the policies and procedures implemented for the overall management of the trading book are appropriate. |
|
||
EU (b) |
Article 455(c) CRR For exposures from the trading and the non-trading book that are measured at fair value in accordance with the applicable accounting framework and that have their exposure value adjusted in accordance with Part Two, Title I, Chapter 2, Article 34 and Part Three, Title I, Chapter 3, Article 105 of the CRR (as well as the Commission Delegated Regulation (EU) No 2016/101), institutions shall describe systems and controls to ensure that the valuation estimates are prudent and reliable. These disclosures shall be provided as part of the market risk disclosures for exposures from the trading book. |
|
||
Point (i) of Article 455(a) CRR
|
|
|||
(a) |
Point (i) of Article 455 (a) and Article 455 (b) CRR Description of activities and risks covered by VaR and SVaR models, specifying how they are distributed in portfolios/sub-portfolios for which the competent authority has granted permission. |
|
||
(b) |
Article 455(b) CRR Description of the scope of application of the VaR and SVaR models for which the competent authority has granted permission, including which entities in the group use these models and how the models represent all the models used at the group level, as well as the percentage of own funds requirements covered by the models or if the same models of VaR/SVaR are used for all entities with market risk exposure |
|
||
|
Point (i) of Article 455(a) CRR Characteristics of the models used, including: |
|
||
(c) |
General description of regulatory VaR and SVaR models |
|
||
(d) |
Discussion of the main differences, if any, between the model used for management purposes and the model used for regulatory purposes (10 day 99%) for VaR and SVaR models. |
|
||
(e) |
For VaR models: |
|
||
(i) |
Data updating frequency; |
|
||
(ii) |
Length of the data period that is used to calibrate the model. Describe the weighting scheme that is used (if any); |
|
||
(iii) |
How the institutions determines the 10-day holding period (for example, does it scale up a 1-day VaR by the square root of 10, or does it directly model the 10-day VaR?); |
|
||
(iv) |
Aggregation approach, which is the method for aggregating the specific and general risk (i.e. do the institutions calculate the specific charge as a stand-alone charge by using a different method than the one used to calculate the general risk or do the institutions use a single model that diversifies general and specific risk?); |
|
||
(v) |
Valuation approach (full revaluation or use of approximations); |
|
||
(vi) |
Whether, when simulating potential movements in risk factors, absolute or relative returns (or a mixed approach) are used (i.e. proportional change in prices or rates or absolute change in prices or rates). |
|
||
(f) |
For SVaR models, specify: |
|
||
(i) |
How the 10-day holding period is determined. For example, does the institution scale up a 1-day VaR by the square root of 10, or does it directly model the 10-day VaR? If the approach is the same as for the VaR models, the institutions may confirm this and refer to disclosure (e) (iii) above; |
|
||
(ii) |
The stress period chosen by the institution and the rationale for this choice; |
|
||
(iii) |
Valuation approach (full revaluation or use of approximations). |
|
||
(g) |
Point (iii) of Article 455(a) CRR Description of stress testing applied to the modelling parameters (main scenarios developed to capture the characteristics of the portfolios to which the VaR and SVaR models apply at the group level). |
|
||
(h) |
Point (iv) of Article 455(a) CRR Description of the approach used for backtesting/validating the accuracy and internal consistency of data and parameters used for the internal models and modelling processes. |
|
||
Point (ii) of Article 455(a) CRR
|
|
|||
(a) |
Point (ii) of Article 455 (a) and Article 455 (b) CRR Description of risks covered by the IRC models, specifying how they are distributed in portfolios/sub-portfolios for which the competent authority has granted permission. |
|
||
(b) |
Article 455(b) CRR Description of the scope of application of the IRC model for which the competent authority has granted permission, including which entities in the group use these models and how the models represent all the models used at the group level, the percentage of own funds requirements covered by the models /or if the same models of IRC is used for all entities with market risk exposure |
|
||
(c) |
Point (ii) of Article 455(a) CRR General description of the methodology used for internal models for incremental default and migration risk, including: |
|
||
(i) |
Information about the overall modelling approach (notably, the use of spread-based models or transition matrix-based models); |
|
||
(ii) |
Information on the calibration of the transition matrix; |
|
||
(iii) |
Information about correlation assumptions; |
|
||
(d) |
Approach used to determine liquidity horizons; |
|
||
(e) |
Methodology used to achieve a capital assessment that is consistent with the required soundness standard; |
|
||
(f) |
Approach used in the validation of the models. |
|
||
(g) |
Point (iii) of Article 455(a) CRR Description of stress testing applied to the modelling parameters (main scenarios developed to capture the characteristics of the portfolios to which the IRC models apply at the group level). |
|
||
(h) |
Point (iv) of Article 455(a) CRR Description of the approach used for backtesting/validating the accuracy and internal consistency of data and parameters used for the IRC internal models and modelling processes. |
|
||
Point (ii) of Article 455(a) CRR
|
|
|||
(a) |
Point (ii) of Article 455 (a) and Article 455 (b) CRR Description of risks covered by the comprehensive risk measure models, specifying how they are distributed in portfolios/sub-portfolios for which the competent authority has granted permission. |
|
||
(b) |
Article 455(b) CRR Description of the scope of application of the comprehensive risk measure models for which the competent authority has granted permission, including which entities in the group use these models and how the models represent all the models used at the group level, including the percentage of own funds requirements covered by the models /or if the same models of IRC is used for all entities with market risk exposure |
|
||
(c) |
Point (ii) of Article 455(a) CRR General description of the methodology used for correlation trading, including: |
|
||
(i) |
Information about the overall modelling approach (choice of model correlation between default/migrations and spread: (i) separate but correlated stochastic processes driving migration/default and spread movement; (ii) spread changes driving migration/default; or (iii) default/migrations driving spread changes); |
|
||
(ii) |
Information used to calibrate the parameters of the base correlation: LGD pricing of the tranches (constant or stochastic); |
|
||
(iii) |
Information on the choice of whether to age positions (profits and losses based on the simulated market movement in the model calculated based on the time to expiry of each position at the end of the 1-year capital horizon or using their time to expiry at the calculation date); |
|
||
(d) |
Approach used to determine liquidity horizons. |
|
||
(e) |
Methodology used to achieve a capital assessment that is consistent with the required soundness standard. |
|
||
(f) |
Approach used in the validation of the models. |
|
||
(g) |
Point (iii) of Article 455(a) CRR Description of stress testing applied to the modelling parameters (main scenarios developed to capture the characteristics of the portfolios to which the comprehensive risk measure models apply at the group level). |
|
||
(h) |
Point (iv) of Article 455(a) CRR Description of the approach used for backtesting/validating the accuracy and internal consistency of data and parameters used for the comprehensive risk measure internal models and modelling processes. |
|
||
(i) |
Point (f) of Article 455 CRR Information on weighted average liquidity horizon for each subportfolio covered by the internal models for incremental default and migration risk and for correlation trading |
|
Template EU MR2-A - Market risk under the internal Model Approach (IMA)
|
a |
b |
|
RWEAs |
Own funds requirements |
||
1 |
VaR (higher of values a and b) |
|
|
(a) |
Previous day’s VaR (VaRt-1) |
|
|
(b) |
Multiplication factor (mc) x average of previous 60 working days (VaRavg) |
|
|
2 |
SVaR (higher of values a and b) |
|
|
(a) |
Latest available SVaR (SVaRt-1)) |
|
|
(b) |
Multiplication factor (ms) x average of previous 60 working days (sVaRavg) |
|
|
3 |
IRC (higher of values a and b) |
|
|
(a) |
Most recent IRC measure |
|
|
(b) |
12 weeks average IRC measure |
|
|
4 |
Comprehensive risk measure (higher of values a, b and c) |
|
|
(a) |
Most recent risk measure of comprehensive risk measure |
|
|
(b) |
12 weeks average of comprehensive risk measure |
|
|
(c) |
Comprehensive risk measure - Floor |
|
|
5 |
Other |
|
|
6 |
Total |
|
|
Template EU MR2-B - RWEA flow statements of market risk exposures under the IMA
|
a |
b |
c |
d |
e |
f |
g |
|
VaR |
SVaR |
IRC |
Comprehensive risk measure |
Other |
Total RWEAs |
Total own funds requirements |
||
1 |
RWEAs at previous period end |
|
|
|
|
|
|
|
1a |
Regulatory adjustment |
|
|
|
|
|
|
|
1b |
RWEAs at the previous quarter-end (end of the day) |
|
|
|
|
|
|
|
2 |
Movement in risk levels |
|
|
|
|
|
|
|
3 |
Model updates/changes |
|
|
|
|
|
|
|
4 |
Methodology and policy |
|
|
|
|
|
|
|
5 |
Acquisitions and disposals |
|
|
|
|
|
|
|
6 |
Foreign exchange movements |
|
|
|
|
|
|
|
7 |
Other |
|
|
|
|
|
|
|
8a |
RWEAs at the end of the disclosure period (end of the day) |
|
|
|
|
|
|
|
8b |
Regulatory adjustment |
|
|
|
|
|
|
|
8 |
RWEAs at the end of the disclosure period |
|
|
|
|
|
|
|
Template EU MR3 - IMA values for trading portfolios
|
a |
|
VaR (10 day 99%) |
||
1 |
Maximum value |
|
2 |
Average value |
|
3 |
Minimum value |
|
4 |
Period end |
|
SVaR (10 day 99%) |
||
5 |
Maximum value |
|
6 |
Average value |
|
7 |
Minimum value |
|
8 |
Period end |
|
IRC (99.9%) |
||
9 |
Maximum value |
|
10 |
Average value |
|
11 |
Minimum value |
|
12 |
Period end |
|
Comprehensive risk measure (99.9%) |
||
13 |
Maximum value |
|
14 |
Average value |
|
15 |
Minimum value |
|
16 |
Period end |
|
Template EU MR4 - Comparison of VaR estimates with gains/losses
ANNEX XXX
Market risk standardized and internal approach disclosure tables and templates: Instructions
Table EU MRA - Qualitative disclosure requirements related to market risk:
Free format text boxes
Legal references and instructions |
|||||||||
Row number |
Explanation |
||||||||
(a) |
When disclosing information referred to in points (a) and (d) of Article 435 (1) CRR on the risk management objectives and policies to manage market risk, institutions shall include:
|
||||||||
(b) |
When disclosing information referred to in point (b) of Article 435 (1) CRR on the structure and organisation of the market risk management function, institutions shall include:
|
||||||||
(c) |
When disclosing information referred to in point (c) of Article 435 (1) CRR on the scope and nature of market risk disclosure and measurement systems, institutions shall provide a description of the scope and nature of market risk disclosure and the measurement systems. |
Template EU MR1 - Market risk under the standardised approach
: fixed format
Legal references and instructions |
|
Row number |
Explanation |
Outright products |
|
1 |
Interest rate risk (general and specific) General and specific risk of positions in traded debt instruments in the trading book, in accordance with Chapter 2 of Title IV of Part Three CRR, excluding specific risk related to securitisation, and which are not optional |
2 |
Equity risk (general and specific) General and specific risk of positions in equities in the trading book, in accordance with Chapter 2 of Title IV of Part Three CRR, excluding optional instruments |
3 |
Foreign exchange risk Risk of positions in foreign exchange in accordance with Chapter 3 of Title IV of Part Three CRR, excluding optional instruments |
4 |
Commodity risk Risk of positions in commodities in accordance with Chapter 4 of Title IV of Part Three CRR, excluding optional instruments |
Options |
|
5 |
Simplified approach Options or warrants as defined in Article 329 (3) of Chapter 2 of Title IV of Part Three CRR for which institutions calculate the own funds requirements related to the non-delta risk using the simplified approach(2) |
6 |
Delta plus approach Options or warrants in the trading book as defined in Article 329 (3) of Chapter 2 of Title IV of Part Three CRR for which institutions calculate the own funds requirements related to the non-delta risk using the delta plus approach(3). |
7 |
Scenario approach Options or warrants in the trading book as defined in Article 329 (3) of Chapter 2 of Title IV of Part Three CRR for which institutions calculate the own funds requirements related to the non-delta risk using the scenario approach(4). |
8 |
Securitisation (specific risk) Specific risk of securitisation positions in the trading book in accordance with in Articles 337 and 338 of Chapter 2 of Title IV of Part Three CRR. |
9 |
Total Sum of amounts in rows 1 to 8 of this template. |
Column letter |
Explanation |
a |
RWEAs Disclosure of risk weighted exposures referred to in point (d) of Article 438 CRR, computed as the value in column b multiplied by 12.5 in accordance with point (b) of Article 92 (4) CRR |
Table EU MRB: Qualitative disclosure requirements for institutions using the internal Market Risk Models
: free text format
Legal references and instructions |
|||||||
Row number |
Explanation |
||||||
EU (a) |
When disclosing information referred to in point (c) of Article 455 CRR on the extent and methodologies for compliance with the requirements of Article 104 CRR, institutions shall include:
|
||||||
EU (b) |
When disclosing information referred to in point (c) of Article 455 CRR on the extent and methodologies for compliance with the requirements of Article 105 CRR, institutions shall include:
|
||||||
(A) |
Institutions using VaR models and SVaR models, as defined in Article 365 CRR |
||||||
(a) |
When disclosing information referred to in point (a)(i) of Article 455 and point (b) of Article 455 CRR, institutions shall include a description of activities and risks covered by the VaR and SVaR models, specifying how they are distributed in portfolios/sub-portfolios for which the competent authority has granted permission. |
||||||
(b) |
When disclosing referred to in point (b) of Article 455 CRR, institutions shall include:
|
||||||
|
Disclosures of information referred to in point (a)(i) of Article 455 CRR on the characteristics of the model used shall include: |
||||||
(c) |
A general description of regulatory VaR and SVaR models |
||||||
(d) |
A discussion of the main differences, if any, between the models used for management purposes and the model used for regulatory purposes (10 day 99%) for VaR and SVaR models |
||||||
(e) |
For VaR models: |
||||||
(i) |
The data updating frequency; |
||||||
(ii) |
The length of the data period that is used to calibrate the model. A description of the weighting scheme that is used (if any); |
||||||
(iii) |
A description on how the institutions determines the 10-day holding period (for example, does it scale up a 1-day VaR by the square root of 10, or does it directly model the 10-day VaR?); |
||||||
(iv) |
A description of the aggregation approach, which is the method for aggregating the specific and general risk (i.e. do the institutions calculate the specific charge as a stand-alone charge by using a different method than the one used to calculate the general risk or do the institutions use a single model that diversifies general and specific risk?); |
||||||
(v) |
Valuation approach (full revaluation or use of approximations); |
||||||
(vi) |
Whether, when simulating potential movements in risk factors, absolute or relative returns (or a mixed approach) are used (i.e. proportional change in prices or rates or absolute change in prices or rates). |
||||||
(f) |
For SVaR models: |
||||||
(i) |
A description on how the 10-day holding period is determined. For example, does the institution scale up a 1-day VaR by the square root of 10, or does it directly model the 10-day VaR? If the approach is the same as for the VaR models, the institutions may confirm this and refer to disclosure (e) (iii) above; |
||||||
(ii) |
A description of the stress period chosen by the institution and the rationale for this choice; |
||||||
(iii) |
A description of the valuation approach (full revaluation or use of approximations). |
||||||
(g) |
When disclosing information referred to in point (a)(iii) of Article 455 CRR, institutions shall include a description of stress testing applied to the modelling parameters consistent with information disclosed under (A)(a) above (main scenarios developed to capture the characteristics of the portfolios to which the VaR and SVaR models apply at the group level). |
||||||
(h) |
When disclosing information referred to in point (a)(iv) of Article 455 CRR, institutions shall disclose a description of the approach used for backtesting/validating the accuracy and internal consistency of data and parameters used for the internal models and modelling processes. |
||||||
(B) |
Institutions using internal models to measure the own funds requirements for the incremental default and migration risk (IRC) in accordance with Sections 3 and 4 of Chapter 5 of Title IV of Part Three CRR |
||||||
(a) |
When disclosing information referred to in point (a)(ii) of Article 455 and with point (b) of Article 455 CRR, institutions shall include a description of risks covered by the IRC models, specifying how they are distributed in portfolios/sub-portfolios for which the competent authority has granted permission. |
||||||
(b) |
Information referred to in point (b) of Article 455 CRR shall include a description of the scope of application of the IRC model for which the competent authority has granted permission, and shall be complemented by information on which entities in the group use these models and how the models represent all the models used at the group level, including the percentage of own funds requirements covered by the models or if the same models of IRC is used for all entities with market risk exposure. |
||||||
|
Information referred to in point (a)(ii) of Article 455 CRR on the characteristics of the IRC models used shall include: |
||||||
(c) |
A general description of the methodology used for internal models for incremental default and migration risk, including: |
||||||
(i) |
Information about the overall modelling approach (notably, the use of spread-based models or transition matrix-based models); |
||||||
(ii) |
Information on the calibration of the transition matrix; |
||||||
(iii) |
Information about correlation assumptions; |
||||||
(d) |
Institutions shall include a description of the approach used to determine liquidity horizons; |
||||||
(e) |
Institutions shall include a description of the methodology used to achieve a capital assessment that is consistent with the required soundness standard; |
||||||
(f) |
Institutions shall include a description of the approach used in the validation of the models. |
||||||
(g) |
Information referred to in point (a)(iii) of Article 455 CRR shall include a description of the stress testing applied to the modelling parameters consistent with information disclosed under (B)(a) above (main scenarios developed to capture the characteristics of the portfolios to which the IRC models apply at the group level). |
||||||
(h) |
Information referred to in point (a)(iv) of Article 455 CRR shall include a description of the approach used for backtesting/validating the accuracy and internal consistency of data and parameters used for the IRC internal models and modelling processes |
||||||
(C) |
Institutions using internal models to measure own funds requirements for correlation trading portfolio (comprehensive risk measure) in accordance with Section 5 of Chapter 5 of Title IV of Part Three CRR |
||||||
(a) |
When disclosing information referred to in point (a)(ii) of Article 455 and point (b) of Article 455 CRR, institutions shall include a description of risks covered by the comprehensive risk measure models, specifying how they are distributed in portfolios/sub-portfolios for which the competent authority has granted permission. |
||||||
(b) |
Information referred to in point (b) of Article 455 CRR shall include a description of the scope of application of the comprehensive risk measure models for which the competent authority has granted permission. It shall be complemented by information on which entities in the group use these models and how the models represent all the models used at the group level, including the percentage of own funds requirements covered by the models or if the same models of IRC is used for all entities with market risk exposure. |
||||||
|
Information referred to in point (a)(ii) of Article 455 CRR on the characteristics of the comprehensive risk measure models used shall include: |
||||||
(c) |
A general description of the methodology used for correlation trading, including: |
||||||
(i) |
Information about the overall modelling approach (choice of model correlation between default/migrations and spread: (i) separate but correlated stochastic processes driving migration/default and spread movement; (ii) spread changes driving migration/default; or (iii) default/migrations driving spread changes); |
||||||
(ii) |
Information used to calibrate the parameters of the base correlation: LGD pricing of the tranches (constant or stochastic); |
||||||
(iii) |
Information on the choice of whether to age positions (profits and losses based on the simulated market movement in the model calculated based on the time to expiry of each position at the end of the 1-year capital horizon or using their time to expiry at the calculation date); |
||||||
(d) |
Institutions shall include a description of the approach used to determine liquidity horizons. |
||||||
(e) |
Institutions shall include a description of the methodology used to achieve a capital assessment that is consistent with the required soundness standard. |
||||||
(f) |
Institutions shall include a description of the approach used in the validation of the models. |
||||||
(g) |
Information referred to in point (a)(iii) of Article 455 CRR shall include a description of stress testing applied to the modelling parameters (main scenarios developed to capture the characteristics of the portfolios to which the comprehensive risk measure models apply at the group level). |
||||||
(h) |
Information referred to in point (a)(iv) of Article 455 CRR shall include a description of the approach used for backtesting or validating the accuracy and internal consistency of data and parameters used for the comprehensive risk measure internal models and modelling processes. |
||||||
(i) |
Institutions shall complement the disclosed information regarding the internal models for the incremental default and migration risk and for correlation trading portfolios with the information referred to in point (f) of Article 455 on the weighted average liquidity horizon for sub-portfolios, coherent with the description provided under rows (B) (a) and (d) and (C) (a) and (d)) of table EU MRB. |
Template EU MR2-A - Market risk under the internal Model Approach (IMA):
fixed format
Legal references and instructions |
|
Row number |
Explanation |
1 |
VaR (higher of values a and b) |
a |
Previous day’s VaR (VaRt-1) Previous day’s value at-risk number (VaRt-1) calculated in accordance with Article 365(1) CRR |
b |
Multiplication factor (mc) x average of previous 60 working days (VaRavg) Average of the daily value at-risk numbers calculated in accordance with Article 365(1) CRR, on each of the preceding 60 business days (VaRavg) x multiplied by the multiplication factor (mc) in accordance with Article 366 CRR |
2 |
SVaR (higher of values a and b) |
a |
Latest available SVaR (SVaRt-1)) Latest available stressed-value-at-risk number (sVaRt-1) calculated in accordance with Article 365(2) CRR |
b |
Multiplication factor (ms) x average of previous 60 working days (sVaRavg) Average of the stressed value-at-risk numbers calculated in the manner and frequency specified in Article 365(2) CRR during the preceding sixty business days (sVaRavg), multiplied by the multiplication factor (ms) in accordance with Article 366 CRR |
3 |
IRC (higher of values a and b) |
a |
Most recent IRC measure Most recent risk number for the incremental default and migration risk calculated in accordance with Section 3 of Chapter 5 of Title IV of Part Three CRR |
b |
12 weeks average IRC measure Average of risk number for the incremental default and migration risk calculated in accordance with Section 3 of Chapter 5 of Title IV of Part Three CRR over the preceding 12 weeks |
4 |
Comprehensive risk measure (higher of values a, b and c) |
a |
Most recent risk measure of comprehensive risk measure Most recent risk number for the correlation trading portfolio calculated in accordance with Section 5 of Chapter 5 of Title IV of Part Three CRR |
b |
12 weeks average of comprehensive risk measure Average of the risk number for the correlation trading portfolio calculated in accordance with Section 5 of Chapter 5 of Title IV of Part Three CRR, over the preceding 12-weeks |
c |
Comprehensive risk measure – Floor 8 % of the own funds requirement that would, at the time of calculation of the most recent risk number referred to in row (a) of this template, be calculated in accordance with Article 338 (4) CRR, for all those positions incorporated into the internal model for the correlation trading portfolio |
5 |
Other Other refers to additional own funds required by supervisors for institutions using the internal model approach for market risk (e.g. additional capital according to Article 101 of Directive 2013/36/UE). |
6 |
Total (1+2+3+ 4+5) |
Column letter |
Explanation |
a |
RWEAs Disclosure of risk weighted exposures referred to in point (d) of Article 438 CRR, computed as the value in column b multiplied by 12.5 in accordance with point (b) of Article 92(4) CRR. |
b |
Own funds requirements Own funds requirements for market risk as determined in Chapter 5 of Title IV of Part Three CRR in accordance with instructions in rows 1 to 4 above. |
Template EU MR2-B - RWEA flow statements of market risk exposures under the IMA:
fixed format
Legal references and instructions |
|
Row number |
Explanation |
1 |
RWEAs at previous period end Risk weighted exposure amounts at the end of the previous period derived from the sum of own funds requirements in accordance with Article 364 CRR with the exception of point (a) of Article 364 (2) CRR, and any additional own funds required by supervisors for institutions using the internal model approach for market risk, multiplied by 12.5 in accordance with point (b) of Article 92(4) CRR |
2 |
Movement in risk levels Changes due to position changes, other than those driven by regulatory policy changes |
3 |
Model changes Significant updates to the model to reflect recent experience (e.g. recalibration), as well as significant changes in model scope. If more than one model update has taken place, additional rows could be necessary. |
4 |
Methodology and policy Methodology changes to the calculations driven by regulatory policy changes |
5 |
Acquisitions and disposals Modifications due to acquisition or disposal of business/product lines or entities |
6 |
Foreign exchange movements Changes arising from foreign currency translation movements |
7 |
Other This category shall be used to capture changes that cannot be attributed to any category of drivers included in rows 2 to 6 of this template, and the explanations regarding the drivers of these changes must be provided in the accompanying narrative. |
8 |
RWEAs at the end of the disclosure period Risk weighted exposure amounts at the end of the period derived from the sum of own funds requirements in accordance with Article 364 CRR with the exception of point (a) of Article 364 (2) CRR, and any additional own funds required by supervisors for institutions using the internal model approach for market risk, multiplied by 12.5 in accordance with point (b) of Article 92(4) CRR |
1a/1b/ 8a/8b |
Rows 1a/1b and 8a/8b of this template shall be used when the RWEA/own funds requirement for any of the columns a to d of this template is the 60-day average (for VaR and SVaR) or the 12-week average measure or the floor measure (for IRC and Comprehensive risk measure) and not the RWEA/own funds requirement at the end of the period (previous or disclosure) in accordance with points (a)(i) and (b)(i) of Article 364 (1), with point (b)(i) of Article 364(2) and with point (a) of Article 364(3) CRR. The amount in additional rows 1a and 8b shall be the difference between the final derived RWEA on average measures, as disclosed in rows 1 or 8 of this template, and the measures derived directly from the models in rows 1b/8a of this template. In these cases, additional rows for regulatory adjustment (1a and 8b of this template) ensure that the institution is able to provide the source of changes in RWEA/own funds requirement on the basis of the last RWEA/own funds requirement measure at the end of the period (previous or disclosure), in rows 1b and 8a of this template. In this case, rows 2, 3, 4, 5, 6, 7 of this template reconcile the value in row 1b and 8a(5) of this template. |
Column letter |
Explanation |
a |
VaR Key drivers of changes over the period in accordance with row (2) to (7) of this template (on the basis of a reasonable estimation), of the value at-risk RWEAs derived from the own funds requirements in accordance with point (a) of Article 364(1) CRR. |
b |
SVaR Key drivers of changes over the period in accordance with row (2) to (7) of this template (on the basis of a reasonable estimation), of the stressed value at-risk RWEAs derived from the own funds requirements in accordance with point (b) of Article 364 (1) CRR, and any additional own funds required by supervisors |
c |
IRC Key drivers of changes over the period in accordance with row (2) to (7) of this template (on the basis of a reasonable estimation), of the incremental default and migration RWEAs derived from the own funds requirements in accordance with point (b) of Article 364(2) CRR, and any additional own funds required by supervisors |
d |
Comprehensive risk measure Key drivers of changes over the period in accordance with row (2) to (7) of this template (on the basis of a reasonable estimation), of the correlation trading portfolio RWEAs derived from the own funds requirements in accordance with Article 364(3) CRR, and any additional own funds required by supervisors |
e |
Other Key drivers of changes over the period in accordance with row (2) to (7) of this template of RWEAs on the basis of model approaches not reported in columns (a) to (d) |
f |
Total RWEAs (a + b + c + d + e) |
g |
Total own funds requirements (f × 8%) |
Template EU MR3 - IMA values for trading portfolios:
fixed format
Legal references and instructions |
|
Row number |
Explanation |
|
VaR (10 day 99%) Value at-risk measure in accordance with Article 365(1) CRR The amounts shall not include additional own fund requirements on supervisor’s decision (related to the multiplier, for instance). |
1 to 4 |
Highest/Lowest/mean of daily value at-risk measures over the period and period end daily value at-risk measure. |
|
SVaR (10 day 99%) Stressed Value at-risk measure in accordance with Article 365(2) CRR The amounts shall not include additional own fund requirements on supervisor’s decision (multiplier). |
5 to 8 |
Highest/Lowest/mean of stressed daily value at-risk measure over the period and period end daily value at-risk measure. |
|
IRC (99.9%) Incremental default and migration risk value in accordance with Section 3 of Chapter 5 of Title IV of Part Three CRR The amounts shall not include additional own fund requirements on supervisor’s decision (multiplier). |
9 to 12 |
Highest/lowest/mean of IRC measures over the period and period end daily value at-risk measure |
|
Comprehensive risk measure (99.9%) Correlation trading portfolios value in accordance with Section 5 of Chapter 5 of Title IV of Part Three CRR |
13 to 16 |
Highest/lowest/mean of correlation trading portfolios measures over the period and period end daily value at-risk measure |
Column letter |
Explanation |
a |
Highest/lowest/mean values over the disclosure period and end of period values corresponding to rows (1) to (16) of this template |
Template EU MR4 - Comparison of VaR estimates with gains/losses: Flexible template
Legal references and instructions |
|
|
Explanation |
|
Information referred to in point (g) of Article 455 CRR shall include the value of the risk measure used for regulatory purposes in accordance with Article 365(1) CRR, calibrated to a 1-day holding period to compare with the 99 % confidence level with institution’s trading outcomes |
|
Institutions shall present an analysis of ‘outliers’ (backtesting exceptions as per Article 366 CRR) in backtested results, specifying the dates and the corresponding excess (VaR-P&L). The analysis should at least specify the key drivers of the exceptions. Institutions shall disclose similar comparisons for actual P&L and hypothetical P&L (i.e. on the basis of hypothetical changes in portfolio values that would occur if end-of-day positions remain unchanged) as per Article 366 CRR. Institutions shall complement this information with information about actual gains/losses, and especially a clarification whether they include reserves and, if not, how reserves are integrated into the backtesting process. |
ANNEX XXXI
Table EU ORA - Qualitative information on operational risk
Legal basis |
Row number |
Qualitative information - Free format |
Points (a), (b), (c) and(d) of Article 435(1) CRR |
(a) |
Disclosure of the risk management objectives and policies |
Article 446 CRR |
(b) |
Disclosure of the approaches for the assessment of minimum own funds requirements |
Article 446 CRR |
(c) |
Description of the AMA methodology approach used (if applicable) |
Article 454 CRRR |
(d) |
Disclose the use of insurance for risk mitigation in the Advanced Measurement Approach (if applicable) |
Template EU OR1 - Operational risk own funds requirements and risk-weighted exposure amounts
Banking activities |
a |
b |
c |
d |
e |
|
Relevant indicator |
Own funds requirements |
Risk exposure amount |
||||
Year-3 |
Year-2 |
Last year |
||||
1 |
Banking activities subject to basic indicator approach (BIA) |
|
|
|
|
|
2 |
Banking activities subject to standardised (TSA) / alternative standardised (ASA) approaches |
|
|
|
|
|
3 |
Subject to TSA: |
|
|
|
|
|
4 |
Subject to ASA: |
|
|
|
|
|
5 |
Banking activities subject to advanced measurement approaches AMA |
|
|
|
|
|
ANNEX XXXII
Instructions for operational risk disclosure templates
Table EU ORA - Qualitative information on operational risk.
Flexible table
Legal references and instructions |
|||||||||||
Row number |
Explanation |
||||||||||
(a) |
Disclosure of the risk management objectives and policies In accordance with Article 435(1) CRR, institutions shall disclose their risk management objectives and policies for operational risk, including:
|
||||||||||
(b) |
Disclosure of the approaches for the assessment of minimum own fund requirements Institutions shall provide a description of the methods used for calculating the own funds requirements for operational risk and the methods for identifying, assessing and managing operational risk. In case of partial use of methodologies, institutions shall disclose the scope and coverage of the different methodologies used. |
||||||||||
(c) |
Description of the AMA methodology approach used (if applicable) Institutions that disclose the information on the operational risk in accordance with Article 312(2) CRR shall disclose a description of the methodology used, including a description of standards on the external and internal data referred to in Articles 322(3) and (4) CRR. |
||||||||||
(d) |
Disclose the use of insurance for risk mitigation in the Advanced Measurement Approach (if applicable) Institutions should provide information on the use of insurances and other risk transfer mechanism for operational risk mitigation when using Advance measurement approaches in accordance with Article 454 CRR. |
Template EU OR1 - Operational risk own funds requirements and risk-weighted exposure amounts.
Fixed template
Instructions for completing the disclosure template EU OR1 |
|
Column |
Explanation |
a, b, c |
Relevant Indicator The term ‘relevant indicator’ refers to ‘the sum of the elements’ at the end of the financial year as defined in Table 1 (for institutions using BIA) included in Article 316(1) CRR. For institutions using TSA or ASA the ‘relevant indicator’ at the end of financial year as defined in Articles 317 to 319 CRR. Institutions using the relevant indicator to calculate the own funds requirements for operational risk (BIA, TSA and ASA) shall disclose the relevant indicator for the respective years in columns a to c of this template. Moreover, in the case of a combined use of different approaches as referred in Article 314 CRR, institutions also disclose the relevant indicator for the activities subject to AMA. AMA banks shall also disclose the relevant indicator for the activities subject to AMA. If the institution has less than 3 years of data on ‘relevant indicator’ available, the available historical data (audited figures) shall be assigned by priority to the corresponding columns in the template. If, for instance, historical data for only one year is available, it shall be disclosed in column c of this template. If it seems reasonable, the forward looking estimates shall then be included in column b (estimate of next year) and column a (estimate of year +2) of this template. Furthermore if there are no historical data on "relevant indicator" available the institution may disclose forward-looking business estimates used for own funds requirements computation. |
d |
Own fund requirements The own fund requirements calculated in accordance with the approach used, in accordance with Articles 312 to 324 CRR. The resulting amount is disclosed in column d of this template. |
e |
Risk exposure amount Point (e) of Article 92(3) and Article 92(4) CRR. Own funds requirements in column d of this template multiplied by 12.5. |
Row |
Explanation |
1 |
Banking activities subject to Basic indicator approach (BIA) This row shall present the amounts corresponding to activities subject to the BIA to calculate the own funds requirements for operational risk (Articles 315 and 316 CRR). |
2 |
Banking activities subject to Standardised (TSA) / Alternative Standardised (ASA) approaches This row shall present the own funds requirements calculated in accordance with the TSA and ASA (Articles 317 to 320 CRR). |
3 |
Subject to TSA In the case of using the TSA, relevant indicator for each respective year shall include all the business lines as defined in table 2, included in Article 317 CRR. |
4 |
Subject to ASA Institutions using the ASA (Article 319 CRR) shall disclose the relevant indicator for the respective years. |
5 |
Banking activities subject to Advanced measurement approaches AMA The relevant data for AMA institutions (Article 312(2) and Articles 321 to 323 CRR) shall be disclosed. In the case of combined use of different approaches in accordance with Article 314 CRR, the relevant indicator for activities subject to AMA shall also be disclosed. AMA banks shall also disclose the relevant indicator for the activities subject to AMA. |
ANNEX XXXIII
Table EU REMA - Remuneration policy
Qualitative disclosures |
|||||||||||
(a) |
Information relating to the bodies that oversee remuneration. Disclosures shall include:
|
||||||||||
(b) |
Information relating to the design and structure of the remuneration system for identified staff. Disclosures shall include:
|
||||||||||
(c) |
Description of the ways in which current and future risks are taken into account in the remuneration processes. Disclosures shall include an overview of the key risks, their measurement and how these measures affect remuneration. |
||||||||||
(d) |
The ratios between fixed and variable remuneration set in accordance with point (g) of Article 94(1) CRD. |
||||||||||
(e) |
Description of the ways in which the institution seeks to link performance during a performance measurement period with levels of remuneration. Disclosures shall include:
|
||||||||||
(f) |
Description of the ways in which the institution seeks to adjust remuneration to take account of longterm performance. Disclosures shall include:
|
||||||||||
(g) |
The description of the main parameters and rationale for any variable components scheme and any other non-cash benefit in accordance with point (f) of Article 450(1) CRR. Disclosures shall include:
|
||||||||||
(h) |
Upon demand from the relevant Member State or competent authority, the total remuneration for each member of the management body or senior management. |
||||||||||
(i) |
Information on whether the institution benefits from a derogation laid down in Article 94(3) CRD in accordance with point (k) of Article 450(1) CRR.
|
||||||||||
(j) |
Large institutions shall disclose the quantitative information on the remuneration of their collective management body, differentiating between executive and non-executive members in accordance with Article 450(2) CRR. |
Template EU REM1 - Remuneration awarded for the financial year
|
a |
b |
c |
d |
||
MB Supervisory function |
MB Management function |
Other senior management |
Other identified staff |
|||
1 |
Fixed remuneration |
Number of identified staff |
|
|
|
|
2 |
Total fixed remuneration |
|
|
|
|
|
3 |
Of which: cash-based |
|
|
|
|
|
4 |
(Not applicable in the EU) |
|
|
|
|
|
EU-4a |
Of which: shares or equivalent ownership interests |
|
|
|
|
|
5 |
Of which: share-linked instruments or equivalent non-cash instruments |
|
|
|
|
|
EU-5x |
Of which: other instruments |
|
|
|
|
|
6 |
(Not applicable in the EU) |
|
|
|
|
|
7 |
Of which: other forms |
|
|
|
|
|
8 |
(Not applicable in the EU) |
|
|
|
|
|
9 |
Variable remuneration |
Number of identified staff |
|
|
|
|
10 |
Total variable remuneration |
|
|
|
|
|
11 |
Of which: cash-based |
|
|
|
|
|
12 |
Of which: deferred |
|
|
|
|
|
EU-13a |
Of which: shares or equivalent ownership interests |
|
|
|
|
|
EU-14a |
Of which: deferred |
|
|
|
|
|
EU-13b |
Of which: share-linked instruments or equivalent non-cash instruments |
|
|
|
|
|
EU-14b |
Of which: deferred |
|
|
|
|
|
EU-14x |
Of which: other instruments |
|
|
|
|
|
EU-14y |
Of which: deferred |
|
|
|
|
|
15 |
Of which: other forms |
|
|
|
|
|
16 |
Of which: deferred |
|
|
|
|
|
17 |
Total remuneration (2 + 10) |
|
|
|
|
Template EU REM2 - Special payments to staff whose professional activities have a material impact on institutions’ risk profile (identified staff)
|
a |
b |
c |
d |
|
MB Supervisory function |
MB Management function |
Other senior management |
Other identified staff |
||
|
Guaranteed variable remuneration awards |
||||
1 |
Guaranteed variable remuneration awards - Number of identified staff |
|
|
|
|
2 |
Guaranteed variable remuneration awards -Total amount |
|
|
|
|
3 |
Of which guaranteed variable remuneration awards paid during the financial year, that are not taken into account in the bonus cap |
|
|
|
|
|
Severance payments awarded in previous periods, that have been paid out during the financial year |
||||
4 |
Severance payments awarded in previous periods, that have been paid out during the financial year - Number of identified staff |
|
|
|
|
5 |
Severance payments awarded in previous periods, that have been paid out during the financial year - Total amount |
|
|
|
|
|
Severance payments awarded during the financial year |
||||
6 |
Severance payments awarded during the financial year - Number of identified staff |
|
|
|
|
7 |
Severance payments awarded during the financial year - Total amount |
|
|
|
|
8 |
Of which paid during the financial year |
|
|
|
|
9 |
Of which deferred |
|
|
|
|
10 |
Of which severance payments paid during the financial year, that are not taken into account in the bonus cap |
|
|
|
|
11 |
Of which highest payment that has been awarded to a single person |
|
|
|
|
Template EU REM3 - Deferred remuneration
|
a |
b |
c |
d |
e |
f |
EU - g |
EU - h |
|
|
Deferred and retained remuneration |
Total amount of deferred remuneration awarded for previous performance periods |
Of which due to vest in the financial year |
Of which vesting in subsequent financial years |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in the financial year |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in future performance years |
Total amount of adjustment during the financial year due to ex post implicit adjustments (i.e.changes of value of deferred remuneration due to the changes of prices of instruments) |
Total amount of deferred remuneration awarded before the financial year actually paid out in the financial year |
Total of amount of deferred remuneration awarded for previous performance period that has vested but is subject to retention periods |
1 |
MB Supervisory function |
|
|
|
|
|
|
|
|
2 |
Cash-based |
|
|
|
|
|
|
|
|
3 |
Shares or equivalent ownership interests |
|
|
|
|
|
|
|
|
4 |
Share-linked instruments or equivalent non-cash instruments |
|
|
|
|
|
|
|
|
5 |
Other instruments |
|
|
|
|
|
|
|
|
6 |
Other forms |
|
|
|
|
|
|
|
|
7 |
MB Management function |
|
|
|
|
|
|
|
|
8 |
Cash-based |
|
|
|
|
|
|
|
|
9 |
Shares or equivalent ownership interests |
|
|
|
|
|
|
|
|
10 |
Share-linked instruments or equivalent non-cash instruments |
|
|
|
|
|
|
|
|
11 |
Other instruments |
|
|
|
|
|
|
|
|
12 |
Other forms |
|
|
|
|
|
|
|
|
13 |
Other senior management |
|
|
|
|
|
|
|
|
14 |
Cash-based |
|
|
|
|
|
|
|
|
15 |
Shares or equivalent ownership interests |
|
|
|
|
|
|
|
|
16 |
Share-linked instruments or equivalent non-cash instruments |
|
|
|
|
|
|
|
|
17 |
Other instruments |
|
|
|
|
|
|
|
|
18 |
Other forms |
|
|
|
|
|
|
|
|
19 |
Other identified staff |
|
|
|
|
|
|
|
|
20 |
Cash-based |
|
|
|
|
|
|
|
|
21 |
Shares or equivalent ownership interests |
|
|
|
|
|
|
|
|
22 |
Share-linked instruments or equivalent non-cash instruments |
|
|
|
|
|
|
|
|
23 |
Other instruments |
|
|
|
|
|
|
|
|
24 |
Other forms |
|
|
|
|
|
|
|
|
25 |
Total amount |
|
|
|
|
|
|
|
|
Template EU REM4 - Remuneration of 1 million EUR or more per year
|
a |
|
|
EUR |
Identified staff that are high earners as set out in Article 450(i) CRR |
1 |
1 000 000 to below 1 500 000 |
|
2 |
1 500 000 to below 2 000 000 |
|
3 |
2 000 000 to below 2 500 000 |
|
4 |
2 500 000 to below 3 000 000 |
|
5 |
3 000 000 to below 3 500 000 |
|
6 |
3 500 000 to below 4 000 000 |
|
7 |
4 000 000 to below 4 500 000 |
|
8 |
4 500 000 to below 5 000 000 |
|
9 |
5 000 000 to below 6 000 000 |
|
10 |
6 000 000 to below 7 000 000 |
|
11 |
7 000 000 to below 8 000 000 |
|
x |
To be extended as appropriate, if further payment bands are needed. |
|
Template EU REM5 - Information on remuneration of staff whose professional activities have a material impact on institutions’ risk profile (identified staff)
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
|
Management body remuneration |
Business areas |
|
|||||||||
MB Supervisory function |
MB Management function |
Total MB |
Investment banking |
Retail banking |
Asset management |
Corporate functions |
Independent internal control functions |
All other |
Total |
||
1 |
Total number of identified staff |
|
|
|
|
|
|
|
|
|
|
2 |
Of which: members of the MB |
|
|
|
|
|
|
|
|
|
|
3 |
Of which: other senior management |
|
|
|
|
|
|
|
|
|
|
4 |
Of which: other identified staff |
|
|
|
|
|
|
|
|
|
|
5 |
Total remuneration of identified staff |
|
|
|
|
|
|
|
|
|
|
6 |
Of which: variable remuneration |
|
|
|
|
|
|
|
|
|
|
7 |
Of which: fixed remuneration |
|
|
|
|
|
|
|
|
|
|
ANNEX XXXIV
Instructions for the disclosure of remuneration policy templates
Table EU REMA – Remuneration policy:
Flexible format
Legal references and instructions |
|||||||||||
Row number |
Explanation |
||||||||||
(a) |
Information relating to the bodies that oversee remuneration. Disclosures shall include:
|
||||||||||
(b) |
Information relating to the design and structure of the remuneration system for identified staff. Disclosures shall include:
|
||||||||||
(c) |
Description of the ways in which current and future risks are taken into account in the remuneration processes Disclosures shall include an overview of the key risks, their measurement and how these measures affect remuneration. |
||||||||||
(d) |
The ratios between fixed and variable remuneration set in accordance with point (g) of Article 94(1) of Directive (EU) 2013/36(‘CRD’)(2) |
||||||||||
(e) |
Description of the ways in which the institution seeks to link performance during a performance measurement period with levels of remuneration Disclosures shall include:
|
||||||||||
(f) |
Description of the ways in which the institution seeks to adjust remuneration to take account of long-term performance Disclosures shall include:
|
||||||||||
(g) |
The description of the main parameters and rationale for any variable components scheme and any other non-cash benefit, as referred to in point (f) of Article 450(1) CRR. Disclosures shall include:
|
||||||||||
(h) |
Upon demand from the relevant Member State or competent authority, the total remuneration for each member of the management body or senior management, as referred to in point (j) of Article 450(1) CRR |
||||||||||
(i) |
Information on whether the institution benefits from a derogation laid down in Article 94(3) CRD, as referred to in point (k) of Article 450(1) CRR For the purposes of this point, institutions that benefit from such a derogation shall indicate whether this is on the basis of point (a) and/or point (b) of Article 94(3) CRD. They shall also indicate which of the remuneration requirements they apply the derogation(s), (i.e., point (l) and/or (m) and/or (o) of Article 94(1) CRD), the number of staff members that benefit from the derogation(s) and their total remuneration, split into fixed and variable remuneration. |
||||||||||
(j) |
Large institutions shall disclose the quantitative information on the remuneration of their collective management body, differentiating between executive and non-executive members, as referred to in Article 450(2) CRR. |
Template EU REM1 – Remuneration awarded for the financial year:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1 and 9 |
Number of identified staff The number of staff whose professional activities have a material impact on the institutions’ risk profile in accordance with Article 92 CRD and the Commission Delegated Regulation on identified staff(3) implementing Article 94(2) CRD (identified staff) and are beneficiaries of the remuneration components listed in this template. It shall be calculated using the FTE (full time equivalent) approach for identified staff other than members of the management body where numbers shall be disclosed as headcount. |
2 |
Total fixed remuneration Sum of amounts in rows 3 to 7 of this template |
3 |
Of which: cash-based The amount of cash-based remuneration within the fixed remuneration |
EU-4a |
Of which: shares or equivalent ownership interests The sum of the amounts of shares or equivalent ownership interests, subject to the legal structure of the institution concerned referred to in point (l)(i) of Article 94(1) CRD, within the fixed remuneration. |
5 |
Of which: share-linked instruments or equivalent non-cash instruments The sum of the amounts of share-linked instruments or equivalent non-cash instruments referred to in point (l)(i) of Article 94(1) CRD, within the fixed remuneration |
EU-5x |
Of which: other instruments The amount of other instruments referred to in point (l)(ii) of Article 94(1) CRD, within the fixed remuneration |
7 |
Of which: other forms The amounts of fixed remuneration awarded for the financial year that are other than disclosed in other rows under the total fixed remuneration heading This could include proportionate regular pension contributions, or benefits (where such benefits are without consideration of any performance criteria), referred to in recital (64) CRD or other forms of remuneration like car allowances. |
10 |
Total variable remuneration Sum of amounts in rows 11, EU-13a, EU-13b, EU-14x and 15 of this template The sum of all remuneration components that are not fixed remuneration that is disclosed in row 2 of this template, including guaranteed variable and severance payments awarded during that year. |
11 |
Of which: cash-based The amount of cash-based remuneration within the variable remuneration |
12, EU-14a, EU-14b, EU-14y and 16 |
Of which: deferred The amounts of variable remuneration by different types of component that are deferred, determined in accordance with Article 94 CRD. |
EU-13a |
Of which: shares or equivalent ownership interests The sum of the amounts of shares or equivalent ownership interests, subject to the legal structure of the institution concerned referred to in point (l)(i) of Article 94(1) CRD, within the variable remuneration |
EU-13b |
Of which: share-linked instruments or equivalent non-cash instruments The sum of the amounts of share-linked instruments or equivalent non-cash instruments referred to in point (l)(i) of Article 94(1) CRD, within the variable remuneration |
EU-14x |
Of which: other instruments The amount of other instruments referred to in point (l)(ii) of Article 94(1) CRD, within the variable remuneration |
15 |
Of which: other forms The amounts of variable remuneration awarded for the financial year that are other than those disclosed in other rows under the variable remuneration heading |
17 |
Total remuneration Sum of amounts in rows 2 and 10 of this template. |
Column letter |
Explanation |
a |
MB Supervisory function The Management Body in its Supervisory function, as the management body acting in its role of overseeing and monitoring management decision-making, as defined in point (8) of Article 3(1) CRD Institutions shall disclose information based on headcount. In accordance with Article 13 CRR, EU parent institutions shall disclose this information on the basis of their consolidated situation and large subsidiaries of EU parents institutions shall disclose this information on an individual basis or, where applicable in accordance with this Regulation and with CRD, on a sub-consolidated basis. The disclosure entity will reflect in this column information on their management body. If following Articles 6 and 13 CRR, the disclosure is at consolidated or sub-consolidated level, information on the identified staff of the management bodies of the subsidiaries shall be disclosed under the relevant business area |
b |
MB Management function The members of the Management Body, who are responsible for its Management functions Institutions shall disclose information based on headcount. Institutions shall disclose information based on headcount. In accordance with Article 13 CRR. EU parent institutions shall disclose this information on the basis of their consolidated situation and large subsidiaries of EU parents institutions shall disclose this information on an individual basis or, where applicable in accordance with this Regulation and with CRD, on a sub-consolidated basis .The disclosure entity will reflect in this column information on their management body. If following Articles 6 and 13 CRR, the disclosure is at consolidated or sub-consolidated level, information on the identified staff of the management bodies of the subsidiaries shall be disclosed under the relevant business area |
c |
Other senior management Senior management as defined in point (9) of Article 3(1) CRD Institutions shall disclose the number of senior managers that are not disclosed under Management Body in its management function and as Other identified staff. Institutions shall disclose information based on FTE. |
d |
Other identified staff Other staff than Management Body in its Supervisory function or in its Management function, and other than senior management, whose professional activities have a material impact on the institution’s risk profile in accordance with the criteria set out in the Commission Delegated Regulation on identified staff implementing Article 94(2) CRD and where appropriate in addition based on institutions’ criteria Institutions may include in this template the breakdown by business areas proposed in template EU REM5. Institutions shall disclose information based on FTE. |
Template EU REM2 – Special payments to staff whose professional activities have a material impact on institutions’ risk profile (identified staff):
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1, 4 and 6 |
Number of identified staff The number of identified staff whose professional activities have a material impact on the institutions’ risk profile in accordance with Article 92 CRD and the Commission Delegated Regulation on identified staff implementing Article 94(2) CRD, for each specific remuneration components For columns a and b (MB) of this template the value shall be based on headcount. For columns c and d of this template the value shall be calculated using the FTE (full time equivalent) method. Row 4 of this template refers to severance payments awarded in previous periods and paid out during the financial year (present year) while row 6 of this template refers to awarded during the financial year (present year). |
2 |
Guaranteed variable remuneration awards – Total amount The amount of guaranteed variable remuneration awards, as referred to in point (e) of Article 94(1) CRD. |
3 |
Of which, guaranteed variable remuneration awards paid during the financial year, that are not taken into account in the bonus cap The amounts of guaranteed variable remuneration awards as referred to in point (e) of Article 94(1) CRD paid during the financial year (present year), which are not taken into account in the bonus cap With regard to the disclosed information referred to in points (g) and (h)(v)-(vi) of Article 450(1) CRR, institutions shall clearly state whether the aggregate quantitative information on remuneration broken down by business area reflects the bonus cap when new sign-on and severance payments are involved. |
5 |
Severance payments awarded in previous periods, that have been paid out during the financial year – Total amount The amount of severance payments as referred to in point (h) of Article 94(1) CRD that have been awarded in previous periods and have been paid out during the financial year (present year) |
7 |
Severance payments awarded during the financial year – Total amount The amount of severance payments as referred to in point (h) of Article 94(1) CRD, awarded during the financial year (present year) |
8 |
Of which, severance payments awarded during the financial year – Paid during the financial year The amount of severance payments as referred to in point (h) of Article 94(1) CRD, awarded during the financial year that has been paid during the financial year |
9 |
Of which, severance payments awarded during the financial year – Deferred The amounts of severance payments as referred to in point (h) of Article 94(1) CRD, awarded during the financial year, which are deferred, determined in accordance with Article 94 CRD |
10 |
Of which, severance payments paid during the financial year, that are not taken into account in the bonus cap The amounts of severance payments as referred to in point (h) of Article 94(1) CRD, paid during the financial year, which are not taken into account in the bonus cap With regard to the disclosed information referred to in points (g) and (h)(v)-(vi) of Article 450(1) CRR, institutions shall clearly state whether the aggregate quantitative information on remuneration broken down by business area reflects the bonus cap when new sign-on and severance payments are involved. |
11 |
Of which, severance payments awarded during the financial year – Highest payment that has been awarded to a single person The amount of the highest severance payment, as referred to in point (h) of Article 94(1) CRD, that has been awarded to a single person during the financial year. |
Column letter |
Explanation |
a |
MB Supervisory function The Management Body in its Supervisory function, as the management body acting in its role of overseeing and monitoring management decision-making, as defined in point (8) of Article 3(1) CRD (Headcount) |
b |
MB Management function The members of the Management Body, who are responsible for its Management functions (Headcount) |
c |
Other senior management Senior management as defined in point (9) of Article 3(1) CRD Institutions shall disclose the number of senior managers that are not disclosed under Management Body in its management function and as Other identified staff (FTE). |
d |
Other identified staff Other staff than Management Body in its Supervisory function or in its Management function, and other than senior management, whose professional activities have a material impact on the institution’s risk profile in accordance with the criteria set out in the Commission Delegated Regulation on identified staff implementing Article 94(2) CRD and where appropriate in addition based on institutions’ criteria Institutions may include in this template the breakdown by business areas proposed in template EU REM5 (FTE). |
Template EU REM3 –Deferred remuneration:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1 |
MB Supervisory function The Management Body in its Supervisory function, as the management body acting in its role of overseeing and monitoring management decision-making, as defined in point (8) of Article 3(1) CRD Sum of amounts in rows 2, 3, 4, 5, and 6 of this template |
2, 8, 14 and 20 |
Cash-based The amount of cash-based remuneration within the variable remuneration |
3, 9, 15 and 21 |
Shares or equivalent ownership interests The sum of the amounts of shares or equivalent ownership interests, subject to the legal structure of the institution concerned referred to in point (l)(i) of Article 94(1) CRD, within the variable remuneration |
4, 10, 16 and 22 |
Share-linked instruments or equivalent non-cash instruments The sum of the amounts of share-linked instruments or equivalent non-cash instruments referred to in point (l)(i) of Article 94(1) CRD, within the variable remuneration |
5, 11, 17 and 23 |
Other instruments The amount of other instruments referred to in point (l)(ii) of Article 94(1) CRD, within the variable remuneration |
6, 12, 18 and 24 |
Other forms The amounts of variable remuneration other than disclosed in rows ‘Cash-based’, ‘Shares or equivalent ownership interests, subject to the legal structure of the institution concerned or share-linked instruments or equivalent non-cash instruments’ and ‘Other instruments’ This could include proportionate regular pension contributions, or benefits (where such benefits are without consideration of any performance criteria), referred to in recital (64) CRD, or other forms of remuneration like car allowances. |
7 |
MB Management function The members of the Management Body, who are responsible for its Management functions; sum of amounts in rows 8, 9, 10, 11 and 12 of this template. |
13 |
Other senior management Senior management as defined in point (9) of Article 3(1) CRD; sum of amounts in rows 14, 15, 16, 17 and 18 of this template Institutions shall disclose the number of senior managers that are not disclosed under Management Body in its management function and as Other identified staff. |
19 |
Other identified staff Other staff than Management Body in its Supervisory function or in its Management function, and other than senior management, whose professional activities have a material impact on the institution’s risk profile in accordance with the criteria set out in the Commission Delegated Regulation on identified staff implementing Article 94(2) CRD and where appropriate in addition based on institutions’ criteria; sum of amounts in rows 20, 21, 22, 23 and 24 of this template |
25 |
Total amount Sum of amounts in rows 1, 7, 13 and 19 of this template |
Column letter |
Explanation |
a |
Total amount of deferred remuneration awarded for previous performance periods The amount of deferred remuneration, as determined in accordance with Article 94 CRD, that has been awarded for previous performance periods (sum of amounts in columns b and c of this template) |
b |
Of which due to vest in the financial year The amount of deferred remuneration awarded for previous performance periods, as determined in accordance with Article 94 CRD, that is due to vest in the financial year |
c |
Of which vesting in subsequent financial years The amount of deferred remuneration awarded for previous performance periods, as determined in accordance with Article 94 CRD, that will be vested in the subsequent financial years |
d |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in the financial year The amount of performance adjustment to deferred remuneration, as determined in accordance with Article 94 CRD, that was due to vest in the financial years |
e |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in future financial years The amount of performance adjustment to deferred remuneration, as determined in accordance with Article 94 CRD, that was due to vest in future performance years |
f |
Total amount of adjustment during the financial year due to ex post implicit adjustments during the financial year (i.e. changes of value of deferred remuneration due to the changes of prices of instruments) When relevant the amount of change of value during the financial year due to ex post implicit adjustments, like changes of value of deferred remuneration due to the changes of prices of instruments, estimated on a best effort basis. |
EU - g |
Total amount of deferred remuneration awarded before the financial year actually paid out in the financial year The amount of deferred remuneration, as determined in accordance with Article 94 CRD, that has been paid out in the financial year As soon as the deferred remuneration is vested it shall be considered as paid out. |
EU - h |
Total of amount of deferred remuneration awarded for previous performance period that has vested but is subject to retention periods The amount of deferred remuneration, awarded for previous performance periods, that has been vested but is subject to retention periods, as determined in accordance with Article 94 CRD |
Template EU REM4 – Remuneration of 1 million EUR or more per year:
Fixed format
Legal references and instructions |
|
Row number |
Explanation |
1 to 8 |
Remuneration between 1 and 5 million EUR per financial year, broken down by 500.000 EUR bands |
9 to x |
Remuneration more than 5 million EUR per financial year, broken down by 1 million EUR bands |
Column letter |
Explanation |
a |
Number of identified staff that have been remunerated EUR 1 million or more per financial year Institutions shall disclose information based on headcount. |
Template EU REM5 – Information of staff whose professional activities have a material impact on institutions’ risk profile (identified staff):
Fixed format
Legal references and instructions |
|||||||||||||||||
Row number |
Explanation |
||||||||||||||||
1 |
Total number of identified staff Staff members, whose professional activities have a material impact on institutions’ risk profile (identified staff) of an institution and its subsidiaries, including subsidiaries not subject to the CRD and all members of their respective management bodies The value shall be disclosed based on FTE. |
||||||||||||||||
2 |
Of which: members of the MB The number of members in the respective Management body in its Supervisory function and in its Management function, and in the whole Management body |
||||||||||||||||
3 |
Of which: other senior management Other staff than the members of the Management Body, who are senior management as defined in point (9) of Article 3(1) CRD |
||||||||||||||||
4 |
Of which: other identified staff Other staff than members of the Management Body, and other than senior management, whose professional activities have a material impact on the institution’s risk profile in accordance with the criteria set out in the Commission Delegated Regulation on identified staff implementing Article 94(2) CRD and where appropriate in addition based on institutions’ criteria |
||||||||||||||||
5 |
Total remuneration of identified staff The total amount of remuneration shall mean all forms of fixed and variable remuneration and shall include payments and benefits, monetary or non-monetary, awarded directly to staff by or on behalf of institutions in exchange for professional services rendered by staff, carried interest payments within the meaning of point (d) of Article 4(1) of Directive 2011/61/EU(4), and other payments made via methods and vehicles which, if they were not considered as remuneration, would lead to a circumvention of the remuneration requirements of CRD. |
||||||||||||||||
6 |
Of which: variable remuneration The sum of all remuneration components which are not fixed remuneration that are referred to in row 7 of this template. |
||||||||||||||||
7 |
Of which: fixed remuneration Institutions shall consider remuneration fixed where the conditions for its award and its amount:
|
||||||||||||||||
Column letter |
Explanation |
||||||||||||||||
a, b and c |
Management body (MB) The Management body of the institution, with the breakdown of Supervisory function and Management function Institutions shall disclose information based on headcount. |
||||||||||||||||
d to h |
Business areas The major business areas of the institution, as Investment banking, Retail banking, Asset management, Corporate functions, Independent internal control functions Information shall be disclosed based on FTE. |
||||||||||||||||
i |
All other All other business areas that were not covered in the previous columns separately Information shall be disclosed based on FTE. |
ANNEX XXXV
Template EU AE1 - Encumbered and unencumbered assets
|
Carrying amount of encumbered assets |
Fair value of encumbered assets |
Carrying amount of unencumbered assets |
Fair value of unencumbered assets |
|||||
|
of which notionally eligible EHQLA and HQLA |
|
of which notionally eligible EHQLA and HQLA |
|
of which EHQLA and HQLA |
|
of which EHQLA and HQLA |
||
010 |
030 |
040 |
050 |
060 |
080 |
090 |
100 |
||
010 |
Assets of the disclosing institution |
|
|
|
|
|
|
|
|
030 |
Equity instruments |
|
|
|
|
|
|
|
|
040 |
Debt securities |
|
|
|
|
|
|
|
|
050 |
of which: covered bonds |
|
|
|
|
|
|
|
|
060 |
of which: securitisations |
|
|
|
|
|
|
|
|
070 |
of which: issued by general governments |
|
|
|
|
|
|
|
|
080 |
of which: issued by financial corporations |
|
|
|
|
|
|
|
|
090 |
of which: issued by non-financial corporations |
|
|
|
|
|
|
|
|
120 |
Other assets |
|
|
|
|
|
|
|
|
Template EU AE2 - Collateral received and own debt securities issued
|
Fair value of encumbered collateral received or own debt securities issued |
Unencumbered |
|||
Fair value of collateral received or own debt securities issued available for encumbrance |
|||||
|
of which notionally eligible EHQLA and HQLA |
|
of which EHQLA and HQLA |
||
010 |
030 |
040 |
060 |
||
130 |
Collateral received by the disclosing institution |
|
|
|
|
140 |
Loans on demand |
|
|
|
|
150 |
Equity instruments |
|
|
|
|
160 |
Debt securities |
|
|
|
|
170 |
of which: covered bonds |
|
|
|
|
180 |
of which: securitisations |
|
|
|
|
190 |
of which: issued by general governments |
|
|
|
|
200 |
of which: issued by financial corporations |
|
|
|
|
210 |
of which: issued by non-financial corporations |
|
|
|
|
220 |
Loans and advances other than loans on demand |
|
|
|
|
230 |
Other collateral received |
|
|
|
|
240 |
Own debt securities issued other than own covered bonds or securitisations |
|
|
|
|
241 |
Own covered bonds and securitisations issued and not yet pledged |
|
|
|
|
250 |
TOTAL COLLATERAL RECEIVED AND OWN DEBT SECURITIES ISSUED |
|
|
|
|
Template EU AE3 - Sources of encumbrance
|
Matching liabilities, contingent liabilities or securities lent |
Assets, collateral received and own debt securities issued other than covered bonds and securitisations encumbered |
|
010 |
030 |
||
010 |
Carrying amount of selected financial liabilities |
|
|
Table EU AE4 - Accompanying narrative information
Row number |
Qualitative information - Free format |
(a) |
General narrative information on asset encumbrance |
(b) |
Narrative information on the impact of the business model on assets encumbrance and the importance of encumbrance to the institution's business model, which provides users with the context of the disclosures required in Template EU AE1 and EU AE2. |
ANNEX XXXVI
Instructions for the assets encumbrance disclosure templates
Template EU AE1- Encumbered and unencumbered assets
Legal references and instructions |
|
Row number |
Explanation |
010 |
Assets of the disclosing institution International Accounting Standards (IAS) 1.9 (a), Implementation Guidance (IG) 6, in the case of IFRS institutions Total assets of the institution registered in its balance sheet, with the exception of own debt securities and own equity instruments when the applicable accounting standards allow their recognition on-balance sheet The value disclosed in this row shall be the median of the sums of four quarterly end-of-period values over the previous twelve months for rows 030, 040 and 120. |
030 |
Equity instruments The median values of equity instruments as defined in the applicable accounting principles (IAS 32.1 in the case of IFRS institutions), with the exception of own equity instruments when the applicable accounting standards allow their recognition on-balance sheet |
040 |
Debt securities The median values of debt instruments held by the institution issued as securities that are not loans in accordance with the Regulation (EU) 1071/2013 of the European Central Bank (‘ECB BSI Regulation’)(3), with the exception of own debt securities when the applicable accounting standards allow their recognition on-balance sheet |
050 |
of which: covered bonds The median values of debt securities held by the institution that are bonds referred to in the first subparagraph of Article 52(4) of Directive (EC) 2009/65(4), irrespective of whether these instruments take the legal form of a security or not |
060 |
of which: securitisations The median values of debt securities held by the institution that are securitisation positions as defined in point (62) of Article 4(1) CRR |
070 |
of which: issued by general governments The median values of debt securities held by the institution which are issued by general governments |
080 |
of which: issued by financial corporations The median values of debt securities held by the institution issued by credit institutions as defined in point (1) of Article 4(1) CRR and by other financial corporations Other financial corporations shall include all financial corporations and quasi-corporations other than credit institutions such as investment firms, investment funds, insurance companies, pension funds, collective investment undertakings, and clearing houses as well as remaining financial intermediaries, financial auxiliaries and captive financial institutions and money lenders. |
090 |
of which: issued by non-financial corporations The median values of debt securities held by the institution issued by corporations and quasi-corporations not engaged in financial intermediation but principally in the production of market goods and non-financial services in accordance with the ECB BSI Regulation |
120 |
Other assets The median value of other assets of the institution registered in the balance sheet, other than those disclosed in the above rows and different from own debt securities and own equity instruments that may not be derecognised from the balance sheet by a non-IFRS institution In this case, own debt instruments shall be included in row 240 of template EU AE2 and own equity instruments excluded from the asset encumbrance disclosure. Other assets shall include cash on hand (holding of national and foreign banknotes and coins in circulation that are commonly used to make payments), loans on demand (IAS 1.54(i) for IFRS institutions) including the balances receivable on demand at central banks and other institutions. Other assets also include loans and advances other than loans on demand, that is, debt instruments held by the institutions that are not securities, other than balances receivable on demand, including loans collateralized by immovable property as defined in point (a) of paragraph 86 of Part 2 of Annex V to Commission Implementing Regulation (EU) 680/2014. Other assets may also include intangible assets, including goodwill, deferred tax assets, property, plant and other fixed assets, derivative assets, reverse repo and stock borrowing receivables. When underlying assets and cover pool assets of retained securitisations and retained covered bonds are loans on demand or loans and advances other than loans on demand, they shall also be included in this row. |
Legal references and instructions |
|
Column number |
Explanation |
010 |
Carrying amount of encumbered assets The median value of the carrying amount of the assets held by the institution that are encumbered Carrying amount shall mean the amount on the asset side of the balance sheet. For each asset class, the disclosed carrying amount shall be the median value of the different disclosed carrying amounts at the end of each disclosure period considered for the computation of the median. |
030 |
of which: notionally eligible EHQLA and HQLA The median value of the carrying amount of encumbered assets which are notionally eligible to the qualification of assets of extremely high liquidity and credit quality (EHQLA) and assets of high liquidity and credit quality (HQLA) For the purpose of this Regulation, notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA shall be those assets listed in Articles 10, 11, 12, 13, 15 and 16 of Commission Delegated Regulation (EU) 2015/61(5) and that would comply with the general and operational requirements set out in Articles 7 and 8 of that Delegated Regulation, were it not for their status as encumbered assets in accordance with Annex XVII to Commission Implementing Regulation (EU) 680/2014. Notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA shall also comply with the exposure class-specific requirements set out in Articles 10 to 16 and 35 to 37 of Delegated Regulation (EU) 2015/61. The carrying amount of notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA shall be the carrying amount before the application of the haircuts specified in Articles 10 to 16 of Delegated Regulation (EU) 2015/61. For each asset class, the disclosed carrying amount shall be the median value of the different disclosed carrying amounts at the end of each disclosure period considered for the computation of the median. |
040 |
Fair value of encumbered assets The median value of the fair value of the debt securities held by the disclosing institution that are encumbered in accordance with the definition of asset encumbrance Fair value of a financial instrument shall be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (see IFRS 13 Fair Value Measurement and IFRS 13 and Article 8 of Directive 2013/34/EU(6) for non-IFRS institutions). For each asset class, disclosed fair value shall be the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. |
050 |
of which: notionally eligible EHQLA and HQLA The median value of the fair value of encumbered assets that are notionally eligible to the qualification of EHQLA and HQLA. For the purpose of this Regulation, notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA are those assets listed in Articles 10, 11, 12, 13, 15 and 16 of Delegated Regulation (EU) 2015/61 and that would comply with the general and operational requirements set out in Articles 7 and 8 of Commission Delegated Regulation (EU) 2015/61, were it not for their status as encumbered assets in accordance with Annex XVII to Commission Implementing Regulation (EU) 680/2014. Notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA shall also comply with the exposure class-specific requirements set out in Articles 10 to 16 and 35 to 37 of Commission Delegated Regulation (EU) 2015/61. The fair value of notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA shall be the fair value before the application of the haircuts specified in Articles 10 to 16 of Commission Delegated Regulation (EU) 2015/61. For each asset class, disclosed fair value is the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. |
060 |
Carrying amount of unencumbered assets The median value of the carrying amount of the assets held by the institution that are unencumbered in accordance with the definition provided of asset encumbrance. Carrying amount means the disclosed amount in the asset side of the balance sheet. For each asset class, the disclosed carrying amount is the median value of the different disclosed carrying amounts at the end of each disclosure period considered for the computation of the median. |
080 |
of which: EHQLA and HQLA The median value of the carrying amount of unencumbered EHQLA and HQLA as listed in Articles 10, 11, 12, 13, 15 and 16 of Commission Delegated Regulation (EU) 2015/61 and that comply with the general and operational requirements set out in Articles 7 and 8 of Commission Delegated Regulation (EU) 2015/61, as well as with the exposure class-specific requirements set out in Articles 10 to 16 and 35 to 37 of Commission Delegated Regulation (EU) 2015/61. The carrying amount of EHQLA and HQLA shall be the carrying amount before the application of the haircuts specified in Articles 10 to 16 of Commission Delegated Regulation (EU) 2015/61. For each asset class, the disclosed carrying amount is the median value of the different disclosed carrying amounts at the end of each disclosure period considered for the computation of the median. |
090 |
Fair value of unencumbered assets The median value of fair value of the debt securities held by the institution that are unencumbered. Fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. (See IFRS 13 Fair Value Measurement and IFRS 13 and Article 8 of Directive (EU) 2013/34). For each asset class, disclosed fair value is the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. |
100 |
of which: EHQLA and HQLA The median value of the fair value of unencumbered EHQLA and HQLA as listed in Articles 10, 11, 12, 13, 15 and 16 of Commission Delegated Regulation (EU) 2015/61 and that comply with the general and operational requirements set out in Articles 7 and 8 of Commission Delegated Regulation (EU) 2015/61, as well as with the exposure class-specific requirements set out in Articles 10 to 16 and 35 to 37 of Commission Delegated Regulation (EU) 2015/61. The fair value of EHQLA and HQLA shall be the fair value before the application of the haircuts specified in Articles 10 to 16 of Commission Delegated Regulation (EU) 2015/61. For each asset class, disclosed fair value is the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. |
Template EU AE2 - Collateral received and own debt securities issued
Legal references and instructions |
|||||
Row number |
Explanation |
||||
130 |
Collateral received by the disclosing institution All classes of collateral received by the institution. All securities received by a borrower institution in any securities borrowing transactions shall be disclosed in this row. The total collateral received by the institution is the median of the sums of four quarterly end of period values over the previous twelve months for rows 140 to 160, 220 and 230. |
||||
140 |
Loans on demand The median value of collateral received by the institution that comprises loans on demand shall be disclosed in this row (see legal references and instructions regarding row 120 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
150 |
Equity instruments The median value of collateral received by the institution that comprises equity instruments (see legal references and instructions regarding row 030 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transactions. |
||||
160 |
Debt securities The median value of collateral received by the institution that comprises debt securities (see legal references and instructions regarding row 040 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
170 |
of which: covered bonds The median value of collateral received by the institution that comprises covered bonds (see legal references and instructions regarding row 050 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
180 |
of which: securitisations The median value of collateral received by the institution that comprises asset- backed securities (see legal references and instructions regarding row 060 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
190 |
of which: issued by general governments The median value of collateral received by the institution that comprises debt securities issued by general governments (see legal references and instructions regarding row 070 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
200 |
of which: issued by financial corporations The median value of collateral received by the institution that comprises debt securities issued by financial corporations (see legal references and instructions regarding row 080 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
210 |
of which: issued by non-financial corporations The median value of collateral received by the institution that comprises debt securities issued by non-financial corporations (see legal references and instructions regarding row 090 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
220 |
Loans and advances other than loans on demand The median value of collateral received by the institution that comprises loans and advances other than loans on demand (see legal references and instructions regarding row 120 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
230 |
Other collateral received The median value of collateral received by the institution that comprises other assets (see legal references and instructions regarding row 120 of template EU AE1). It includes all securities received by a borrower institution in any securities borrowing transaction. |
||||
240 |
Own debt securities issued other than own covered bonds or securitisations The median value of own debt securities issued other than own covered bonds or securitisations. As the retained or repurchased own debt securities issued, in accordance with IAS 39.42, for IFRS institutions, decrease the relating financial liabilities, these securities are not included in the category of assets of the disclosing institution. Own debt securities that may not be derecognised from the balance sheet by a non-IFRS institution shall be included in this row. |
||||
241 |
Own covered bonds and securitisations issued and not yet pledged The median value of own covered bonds and securitisations issued that are retained by the disclosing institution and not encumbered. To avoid double counting, the following rule applies in relation to own covered bonds and securitisations issued and retained by the disclosing institution:
|
||||
250 |
Total collateral received and own debt securities issued All classes of collateral received by the institution and own debt securities issued retained by the institution that are not own covered bonds issued or own securitisations issued. This row is the sum of the median values for row 010 in template EU AE1 and rows 130 and 240 in template EU AE2. |
Legal references and instructions |
|
Column number |
Explanation |
010 |
Fair value of encumbered collateral received or own debt securities issued The median of the fair value of the collateral received, including in any securities borrowing transaction, or own debt securities issued held/retained by the institution that are encumbered in accordance with Article 100 CRR. The fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (as in IFRS 13 Fair Value Measurement for IFRS institutions). For each item of collateral, disclosed fair value is the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. |
030 |
of which: notionally eligible EHQLA and HQLA The median value of the fair value of the encumbered collateral received, including in any securities borrowing transaction, or own debt securities issued held/retained by the institution that are notionally eligible to the qualification of EHQLA and HQLA. For the purpose of this Regulation, notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA are items of collateral received or own debt securities issued held/retained by the institution listed in Articles 10, 11, 12, 13, 15 and 16 of Commission Delegated Regulation (EU) 2015/61 and that would comply with the general and operational requirements set out in Articles 7 and 8 of Commission Delegated Regulation (EU) 2015/61, were it not for their status as encumbered assets in accordance with Annex XVII to Commission Implementing Regulation (EU) 680/2014. Notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA shall also comply with the exposure class-specific requirements set out in Articles 10 to 16 and 35 to 37 of Commission Delegated Regulation (EU) 2015/61. The fair value of notionally eligible encumbered EHQLA and notionally eligible encumbered HQLA shall be the fair value before the application of the haircuts specified in Articles 10 to 16 of Commission Delegated Regulation (EU) 2015/61. For each item of collateral, disclosed fair value is the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. |
040 |
Fair value of collateral received or own debt securities issued available for encumbrance The median of the fair value of the collateral received, including in any securities borrowing transaction, by the institution that are unencumbered but are available for encumbrance since the institution is permitted to sell or re-pledge it in absence of default by the owner of the collateral. It also includes the fair value of own debt securities issued, other than own covered bonds or securitisation positions, that are unencumbered but available for encumbrance. For each item of collateral, disclosed fair value is the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. |
060 |
of which: EHQLA and HQLA The median value of the fair value of the unencumbered collateral received or own debt securities issued held/retained by the institution other than own covered bonds or securitisation positions available for encumbrance which qualify as EHQLA and HQLA as listed in Articles 10, 11, 12, 13, 15 and 16 of Commission Delegated Regulation (EU) 2015/61 and that comply with the general and operational requirements set out in Articles 7 and 8 of Commission Delegated Regulation (EU) 2015/61, as well as with the exposure class-specific requirements set out in Articles 10 to 16 and 35 to 37 of Commission Delegated Regulation (EU) 2015/61. The fair value of EHQLA and HQLA shall be the fair value before the application of the haircuts specified in Articles 10 to 16 of Commission Delegated Regulation (EU) 2015/61. |
Template EU AE3 - Sources of encumbrance
Legal references and instructions |
|
Row number |
Explanation |
010 |
Carrying amount of selected financial liabilities The median value of the item ‘Carrying amount of selected financial liabilities’ of the institution, insofar as these liabilities entail asset encumbrance for that institution. |
Legal references and instructions |
|
Column number |
Explanation |
010 |
Matching liabilities, contingent liabilities or securities lent The median values of matching liabilities, contingent liabilities (loan commitments received and financial guarantees received) or securities lent with non-cash collateral, insofar as these transactions entail asset encumbrance for that institution. Financial liabilities are disclosed at their carrying amount; contingent liabilities are disclosed at their nominal value; and securities lent with non-cash collateral are disclosed at their fair values. Disclosed fair value is the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. Liabilities without any associated funding, such as derivatives, shall be included. |
030 |
Assets, collateral received and own securities issued other than covered bonds and securitisations encumbered The amount of the assets, collateral received and own securities issued other than covered bonds and securitisations that are encumbered as a result of the different types of transactions hereby disclosed. To ensure consistency with the criteria in templates EU AE1 and EU AE2, assets of the institution registered in the balance sheet shall be disclosed at the median value of their carrying amount, whereas re-used collateral received and encumbered own securities issued other than covered bonds and securitisations shall be disclosed at the median value of their fair value. Disclosed fair value is the median value of the different fair values observed at the end of each disclosure period considered for the computation of the median. Assets encumbered without matching liabilities shall also be included. |
Table EU AE4 - Accompanying narrative information
Legal references and instructions |
|||||||||||||||||||||||||||
Row number |
Explanation |
||||||||||||||||||||||||||
a |
General narrative information on asset encumbrance, including:
|
||||||||||||||||||||||||||
b |
Narrative information relating to the impact of the institution’s business model on its level of encumbrance and the importance of encumbrance on the institution’s funding model, including the following:
|